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Abstract  
The pervasive demand and desire for an ideal body evident in today’s society has led to 
the normalisation of beautification and enhancement treatments. Unlicensed weight loss 
(UWL) drugs which comprise of 2,4 dinitrophenol (DNP), sibutramine and rimonabant are 
just one method used in enhancing and improving the body in line with social expectations. 
However, previous research exploring the use of these drugs has been confined to male 
dominated bodybuilding communities, despite women experiencing increasing pressures 
to look a certain way. This doctoral research explores the use of UWL drugs by women, 
focusing specifically on attitudes and perceptions of UWL drug use, motivations for use, 
experiences of use and self-reported adverse effects.  
This qualitative research involved an online forum analysis. Online discussion forms (n=10) 
were selected based on their levels of popularity, the proportion of female users accessing 
them and because they contained relevant UWL drug discussion.  All threads (470) relating 
to UWL drug discussion were downloaded and analysed using thematic analysis conducted 
through the software package NVivo version 10. Four forum moderators and three female 
UWL drug users were also recruited, with their interviews presented as case studies.  
Online communities can provide a raft of knowledge concerning hidden or hard to reach 
populations. This research however advocates for greater consideration to be given to the 
methodological and ethical implications of online research and reflects on what is public 
information, the protection of anonymity and protecting online users from harm. This 
research also identified that removal of a license from a drug does not prevent use, but 
once outside regulatory control or medical supervision, UWL drugs are often purchased 
online with risks to the user of potential drug interactions, adulteration and 
contamination. UWL drug user engagement needs to be reclaimed as part of a wider health 
agenda, something that has been lacking due to the unlicensed status of the drugs.  
However, the findings highlighted the diverse motivations for why women use UWL drugs 
as well as differences in experiences, drugs used, willingness to take risks and adverse 
effects and argues against there being a typical female UWL drug user. Given this 
heterogeneity, a one size fit all model for harm reduction may be ineffective. Additionally 
the rapid changes in online communities as well as the diffusion of these drugs into 
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different populations creates another challenge for public health in identifying and 
targeting specific groups.  
Online discussion of these drugs focuses on user experience and anecdotal evidence. 
Education on the different types of drugs as well as the risks and harms of using them is 
therefore warranted for all online communities as well as a focus on specific harm 
reduction strategies including harm minimisation, engagement with health care 
practitioners and peer to peer education. However, further consideration is needed 
concerning how this information should be disseminated, identifying those who have 
authority within the community, but also have the appropriate credentials, knowledge, 
skills and desire to offer advice. 
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Chapter 1. Introduction  
1.1 Introduction 
This doctoral research offers a detailed understanding of the female use of unlicensed 
weight loss (UWL) drugs. Specifically, this study provides insight into the differing female 
users of UWL drugs, their motivations for use, which drugs are discussed and being used 
by women and where they are being accessed. Furthermore, this study explores attitudes 
and perceptions around UWL drug use and the self-reported risks of using UWL drugs. 
Finally, this research considers what the appropriate response to UWL drug use in women 
should be as well as discussing the role of online forums in online harm reduction. This 
chapter will provide an overview of the background to the research, as well as how it was 
conducted, researcher reflections and aims and justification for the research. An outline 
of the thesis is also provided. 
1.2 Rationale for the research 
There are a number of weight loss drugs available on the market which fall into three main 
groups 
1) Licensed weight loss drugs. These are drugs that are currently licensed for weight 
loss and can be accessed through the NHS. At present in the UK only orlistat is 
licensed for weight loss. 
2) Licensed drugs but not for weight loss. These are drugs which are licensed for other 
conditions but are also used as weight loss drugs. These include T3 and T4 which 
are used to treat thyroid disorders and ephedrine which is used to treat asthma. 
Clenbuterol is used to treat asthma and is a controlled drug.  
3) Unlicensed weight loss drugs. This includes weight loss drugs which have previously 
been licensed for weight loss use but subsequently banned such as sibutramine 
and rimonabant and those which are untested such as 2,4 Dinitrophenol (DNP).  
Table 1 outlines the different type of weight loss drugs currently available on the market 
and their licensed status in the UK (Evans-Brown et al. 2012). 
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Table 1. Weight loss drugs available on the market 
Status Name How it works 
Licensed for weight loss (Prescription only) Orlistat Reduces dietary fat being absorbed 
Licensed but not for weight loss (Prescription only) Ephedrine Increases metabolic rate 
Controlled drug (Prescription only) Clenbuterol Increases metabolic rate 
Licensed but not for weight loss (Prescription only) T3 / T4 Increases metabolic rate 
Unlicensed weight loss drug (Banned) Sibutramine Appetite suppressant 
Unlicensed weight loss drug (Banned) Rimonabant Appetite suppressant 
Unlicensed weight loss drug (Untested) 2,4 dinitrophenol Increases metabolic rate 
 
This research has focused upon the three main UWL drugs; DNP, sibutramine and 
rimonabant. Despite these drugs being unlicensed they are readily available to purchase 
online. The sale of drugs online can be either via the surface web or the dark web.  Whilst 
traditional drug are more usually purchased via dark web, an online black market, involving 
anonymous communication via encrypted and hidden parts of the internet, lifestyle drugs 
such as UWL drugs are generally purchased via the publically accessible surface web 
(Koenraadt and van de Ven 2017). Whilst little information exists regarding how many 
people are purchasing these drugs and which drugs are being purchased the demand for 
such drugs online does appear to be high. For example a Google.co.uk online search of 
DNP - “buy DNP online” produces over 30,000 results. Research exploring marketing 
strategies used by unregulated online pharmacies found that they focused upon customer 
convenience, such as the websites being secure, quick or free delivery, discreet packaging 
whilst downplaying the potential risks of the products themselves (Orizio et al. 2010).  
Often websites which are selling weight loss drugs do not appear to be UK based but do 
post to the UK and are usually relatively inexpensive to purchase ranging from as little as 
80pence per tablet. For sibutramine and rimonabant, which were previously licensed, 
information pertaining to these drugs is often taken from outdated NHS pages whilst 
failing to highlight that these drugs have since been withdrawn from the market. DNP is 
legally allowed to be sold as a chemical although not legally allowed to be sold as a weight 
loss product. Websites and sellers seemingly circumnavigate this by stating in small print 
that the drug is not for human consumption and is only being sold as a research chemical. 
However, the adverts and promotion remains heavily focused on the drug and its weight 
loss properties. Additionally these products are often advertised alongside legal herbal or 
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natural weight loss products, making it difficult for potential consumers to identify the 
differences between them.  
Being unlicensed, these drugs are unregulated and particularly for DNP, where there have 
been no clinical trials testing its efficacy, the evidence concerning impact and risks of use 
are unknown. Consumers of these drugs are doing so without any input or support from 
health care professionals. This means there is far less protection from effects caused by 
drug interactions or drug related adverse effects. Furthermore, access to these drugs from 
potentially illicit markets provide no guarantees for accuracy of information given, the 
quality of drugs supplied, potential for online scamming or contaminated drugs (Koenraadt 
and van de Ven, 2017). This presents a risk of harm due to a lack of regulation and 
safeguarding in those using them. However, little research has explored the use of these 
drugs. 
Research which does exist focuses mainly upon male dominated bodybuilding 
communities or single case studies in the case of DNP (Petróczi et al. 2015, McFee et al. 
2004, McVeigh et al. 2016, Han Chih Hencher Lee et al. 2014) or the efficacy of the drugs 
prior to regulatory controls in the case of rimonabant and sibutramine (Arterburn et al. 
2004, James  et al. 2010, Sam et al. 2011, Scheen 2011). Furthermore, little is known 
specifically about the use of these drugs in women, despite women being under increasing 
contemporary pressures to conform to an ideal body shape (All Party Parliamentary Group 
2012, Orbach 2009, Yamamiya et al. 2005).  
Within Western society, the ‘thin ideal’ is pervasive, with women taught from an early age 
to be accepting and admiring of thin images, viewing those who do not conform to those 
ideal bodies as undesirable and unacceptable (Orbach 2009). Furthermore, there is an 
acceptance that women who are thin are considered more likely to be successful (Evans 
2003) with women equating thinness to happiness. These pressures have been linked to 
the media where  the focus is often on women who are thin and appearance focused 
(Dakanalis and Riva 2013, Fouts and Burggraf 1999, Grabe et al. 2008, Halliwell 2013, 
Harper and Tiggemann 2008, Harrison and Cantor 1997, Hawkins et al. 2004, Stice et al. 
1994). Also discussed are pressures linked to social media, via a surge of photo shopped 
and edited images setting unattainable goals for women and contributing to lower levels 
of body confidence and body satisfaction (Fardouly et al. 2015, McLean et al. 2015, Royal 
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Society for Public Health 2017, Tiggemann and Slater 2013, Tiggemann and Zaccardo 
2015).  
Coupled with the drive for the perfect body is the increase in physical and cosmetic 
enhancement in order to reshape, hone and perfect bodies (Orbach 2009). Whilst cosmetic 
surgery figures have declined in recent years (British Association of Aesthetic Plastic 
Surgeons 2017), adverts for procedures such as Botox, lip fillers, and contoured makeup 
are commonplace in today’s society and are often driven by celebrity and societal trends. 
Body reshaping and improvement dominates and is indicative of the appearance and 
image obsessed society where we currently find ourselves.  
Beyond non-surgical and surgical cosmetic procedures, in recent years, there has also been 
a surge of interest in image and performance enhancing drugs (IPEDs)1. This group of drugs 
are designed to improve the body and mind and can be split into six broad categories 
(McVeigh et al. 2012). These are 1) muscle building drugs, 2) weight loss drugs, 3) drugs to 
change the appearance of skin and hair, 4) drugs to improve sexual function, 5) drugs to 
improve cognitive function and 6) drugs to improve mood. Whilst the focus of this research 
is on weight loss drugs, the rise and interest of other human enhancement drugs 
demonstrates the desire for perfect bodies and minds as well as the lengths in which 
people will go to achieve their goals. 
The three UWL drugs of focus within this doctoral research are; DNP, sibutramine and 
rimonabant. DNP is a fat burner, first used during World War 1 in the munitions industry 
(Grundlingh et al. 2011, Phillips and Singer 2013, Petroczi et al. 2015, McVeigh et al. 2016) 
in making explosives. It was later found to act as a weight loss agent resulting in DNP being 
marketed and readily available to the general public during the 1930s (Margo and Harman 
2014). However, DNP has a narrow therapeutic range meaning that there are little 
differences between toxic and therapeutic doses. Side effects associated with using DNP 
include hyperthermia, tachycardia, cardiac arrest and coma amongst others (Petroczi et al. 
2015). The combination of these side effects can result in death (Yen and Ewald 2012). Due 
to linked harms and a number of deaths identified following DNP use, it was withdrawn 
from the market in 1938 (Yen and Ewald 2012). Sibutramine and rimonabant are both 
                                                          
1 Please note, IPEDs can also be referred to as Performance and Image Enhancing Drugs (PIEDs), Human 
Enhancement Drugs (HEDs) and Performance Enhancing Drugs (PEDs) and are often used interchangeably  
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appetite suppressants, previously available as anti-obesity drugs on the NHS in the UK. 
However, after sibutramine was linked to increased risk of tachycardia, hypertension and 
arrhythmias (Arterburn et al. 2004, Caterson et al. 2012, James  et al. 2010, Padwal and 
Majumdar 2007, Scheen 2011) and rimonabant linked to an increased risk of psychiatric 
adverse effects (Astrup et al. , Burch et al. 2009, Caterson et al. 2012, Padwal and 
Majumdar 2007, Sam et al. 2011, Wathion 2009), they were both withdrawn from the 
market. Despite this, today, all three drugs are readily available to purchase online, sold 
with no regulations or safety measures put in place.  
It is important to note that whilst the focus of the research here is based within the UK and 
focused predominately on Western women, body image concerns are not unique to 
Western women. Additionally, what each culture considers to be beautiful will differ and 
is influenced by the ideals of each particular culture. However the ‘thin ideal’ is now more 
pervasive than ever, both in Western and non-Western cultures and intrinsically linked to 
levels of Westernisation, modernisation and socio-economic status within each culture 
and community (Swami 2015). With body image concerns not being unique to the UK or 
Western cultures, the use of enhancement drugs to improve and hone one’s body is also 
not restricted to the UK or Western society. The globalised nature of the internet and the 
speed in which online drug markets change, update and adapt poses problems for public 
health and enforcement and also means that the accessibility and availability of 
enhancement drugs is now more far reaching than ever before. Enhancement drug use is 
now a significant public global health challenge with their use being displaced from 
bodybuilding and athletic subgroups into mainstream populations (Van Hout and Kean 
2015). For example, anabolic androgenic steroids have a global lifetime prevalence rate of 
3.3%, 6.4% for men and 1.6% for women (Sagoe et al. 2014) and their use is now being 
seen increasingly amongst the general population (Zahnow et al. 2017). For weight loss 
drug use, data take from the Global Drug Survey (GDS) 20152 shows that 4,048 
respondents had ever taken a weight loss drug3. Respondents who had used a weight loss 
drug resided across 63 countries with the highest proportions coming from Germany 
                                                          
2 Public Health Institute has access to data generated from the GDS. Data presented here is from 
unpublished analysis conducted by the researcher. Syntax for creation of variables can be found in 
Appendix A 
3 Ephedrine, DNP, Sibutramine, Clenbuterol, Rimonabant, T3 and T4 
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(38%), Brazil (16%), United States (7%), United Kingdom (5%) and Australia (4%). It should 
be noted that whilst there is limited evidence exploring weight loss drug use globally, the 
data within the GDS does suggest that use of weight loss drugs is not limited to the UK. 
Whilst the scale of the problem of weight loss drug use does appear to the global, the remit 
and focus of the research presented here is national.   
1.3 Rationale for the methods 
This research employs a qualitative design that compromises of a comprehensive online 
forum analysis of UWL drug discussion and interviews with online forum moderators and 
UWL drug users to explore motivations, experiences and attitudes surrounding UWL drug 
use. The largest component of this research was an online forum analysis.  Online research 
methods are particularly useful when researching illicit or sensitive behaviour, which may 
be judged in the offline world or where populations may be undefined, not obvious or hard 
to reach (Germain et al. 2017, Barratt and Lenton 2010).  
Harm reduction aims to reduce negative consequences associated with engaging in 
potential harmful behaviour such as the use of drugs (Stimson 2016). Successful harm 
reduction strategies include early adoption of needle exchange programmes which 
contributed to the avoidance of a major drug related HIV infection epidemic in the UK (Ball 
2007, Stimson 2016). Harm reduction strategies for drugs can include safer ways of using, 
spaces which facilitate safer uses of substances and the dissemination of harm reduction 
information.  Whilst there is little research exploring harm reduction in UWL drug users, 
research with users of other enhancement drugs such as AAS has found that interventions 
employing scare tactics are ineffective as well as users being reluctant to seek or take 
advice from health care professionals (Pope et al. 2004, Ainsworth et al. 2018, Petróczi et 
al. 2014). Online communities have been identified as ideal places for the dissemination 
of harm reduction strategies (Davey et al. 2012) and are often used in sharing advice 
around drug practices, including the safety of drugs, side effects and user experiences 
(Soussan and Kjellgren 2014). Furthermore, online forums may be ideally placed for the 
sharing of this information (Davey et al. 2012), particularly in those communities which 
have a strong identity and sense of community.  For UWL drug use, little is known about 
the users and due to the illicit status of the drugs, it is likely be a hidden and covert 
behaviour amongst users who additionally may not view themselves as drug users and may 
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not traditionally be in contact with health professionals about their drug use. However, 
UWL drug discussion online is plentiful, with online forums presenting a natural 
opportunity to find out about UWL drug use and those who use them. Furthermore, this 
research can explore the types of information being shared online as well as what methods 
in disseminating advice is effective.  
The predominately online nature of this research was a pragmatic decision made due to a 
lack of knowledge about the users of UWL drugs. However, the methodological and ethical 
considerations given in researching online forums in this doctoral research became as 
important as the content and findings from the online forums. Although procedures for 
conducting online research exist, for example in Kozinet’s netnography (Kozinets 2002, 
Kozinets 2010, Kozinets 2015), researchers often differ in how much information they 
provide about how they selected their online communities. Furthermore, the amount of 
consideration given to the ethical implications of conducting online research, such as 
consent, private versus public online spaces and the use of verbatim quotes also varies. 
This issue is exacerbated by the lack of clarity in ethical guidelines (Trevisan and Reilly 
2014) as well as inconsistencies in how ethics committees view online research (Sharkey 
et al. 2011). The detailed consideration within this doctoral research, given to both 
methods employed in selecting appropriate and relevant online communities, as well as 
the ethical implications associated in conducting research of this nature is a significant 
feature of this work and has contributed to the debate around the use of online methods 
in research. 
1.4 Researcher reflections 
Throughout this thesis, I have presented a number of reflections that occurred at various 
points during the research process. My personal and broader interest in the topic of body 
dissatisfaction in women however, originated when studying for my BSc degree in 
Psychology. Here, I learnt about how sociocultural pressures as well as early childhood 
influencers and biological factors could influence eating behaviours and practices. 
Furthermore, I became interested in how pressures on women could influence levels of 
body satisfaction as well as the methods used in order to achieve an ideal body. This 
interest was exacerbated through my own experiences as a woman living in an image 
conscious society and my own personal issues with body dissatisfaction and excessive 
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dieting. Throughout my time working as a researcher within the Public Health Institute, I 
became aware of the area of image and performance enhancement drugs. Whilst, this was 
not a research area I was particularly involved in at that point, I became fascinated by this 
group of drugs and the use of these drugs in order to achieve the ‘perfect body and mind’.  
When beginning to plan for this research, I quickly realised the extent to which these drugs 
are discussed online. I equally became fascinated by the seemingly real connections and 
relationships people fostered online; people brought together by a shared interest and 
who may feel embarrassed or judged discussing these matter in ‘real life’. In some ways, 
the online nature of this research became equally if not more important than the research 
topic and drove my interest of online methods and the use of online communities to share 
experiences and advice. It became apparent to me that the level of UWL drug use 
discussion online firstly indicated a growing interest in this group of drugs but also meant 
that users of these drugs were gaining information from often anecdotal and wildly 
differing experiences. This, coupled with the limited research conducted which explored 
the use of UWL drugs presented an appropriate, growing and under-researched public 
health issue.  
1.5 Aims of the research 
This research provides an overview of the female use of UWL drugs and the types of UWL 
drug related discussion that occurs within online communities. A systematic process for 
conducting online research has been presented as well as an exploration of the 
characteristics of UWL drug users and online forums where this discussion resides. A 
particular focus is given to the influencers, structure, content and perceptions of risks of 
UWL drug use on those forums. The motivations for both UWL drug use and online 
engagement have also been explored. This research has identified the ways in which 
women engage on online forums as well as exploring the ways in which information is 
shared and how the environment of the forums plays a role in this. Additionally, this 
research has contributed to the current knowledge base of the users of UWL drugs as well 
as considering the need for UWL drug user engagement to be reclaimed as part of wider 
health agenda. 
The overarching objectives for this doctoral research were fourfold and designed to: 
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1) Identify attitudes and perceptions of UWL drug use; 
2) Identify the self-reported risks of using UWL drugs; 
3) Identify the reasons and motivations behind why UWL drug users begin to use 
UWL drugs and the associated trigger points; 
4) Assess the role of online forums in health promotion and sharing of harm 
reduction information. 
1.6 Overview of thesis 
This doctoral thesis is based on work from three studies. The first part of this thesis 
(Chapter 2), the literature review places the research in the context of the literature. In 
particular, focus is given to the increasing pressures on women to have an ‘ideal body’ and 
the ways in which women are attempting to achieve their ideal physique. Discussion 
around the rise of human enhancement drugs is also presented with a focus on how these 
drugs are being used to shape and perfect the body. The different groups of weight loss 
drugs and a rationale for focusing upon UWL drugs is provided. Finally, the role of online 
communities in sharing experiences and advice are also discussed within the context of 
UWL drugs and weight loss in the pursuit of the ideal female body. 
Chapter 3 describes the methods employed within this research. Particular focus is given 
to methodologies and protocols in how to select online communities for use in research 
and a systematic process for online research is described. An overview of the methods 
used in each of the studies is also provided. Chapter 4 provides an in-depth analysis of each 
of the online communities included with the research focusing upon the types of 
discussion occurring, the advice given and the dynamics within the communities. Chapter 
5 presents the findings from the thematic analysis of online communities. Five themes are 
discussed which are; 1) Perceptions around the use of weight loss drugs, 2) Motivations 
for the use of UWL drugs, 3) UWL drug avoidance, 4) Experiences of using UWL drugs and 
5) The UWL drug user. Chapter 6 presents interviews from both online community 
moderators and UWL drug users which are presented as case studies. The final chapter 
(Chapter 7) presents the integrated findings from all studies. The chapter discusses the 
different types of UWL drug user, the different types of online communities as well as 
offering advice for the role of online forums in harm reduction. Ethical considerations in 
conducting online research are also discussed. The thesis is concluded by discussing the 
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strengths and limitations of the studies as well as offering implications for future research, 
practice and policy.   
1.7 Overview of the research 
Figure 1 provides an overview of the specific studies within this PhD and how they will each 
contribute to UWL drug use knowledge, online communities and harm reduction. In 
particular each stage adds to knowledge around the heterogeneity of online drug 
communities, forum moderators and UWL drug users.  
 
Figure 1. Overview of research stages 
 
 
 
Online forum 
analysis
•Explores how harm reduction online is disseminated as well as whether advice is 
seemingly taken on board 
•Describes each community included to assess how supportive each forum is, the types 
of information shared, attitudes of the forum
• Presents the idea of perceived expert user and hierarchy within the forum
•Explore the motivations for using UWL drugs as well as well as attitudes towards UWL 
drug use and experiences of use
•Identifies differences between the communities. UWL drug knowledge online is 
dispersed, fractured and variable
•Detailed information shared online, however often reliant on user experiences and 
anecdotal advice
•Explores the female voice within male dominated environments
Interviews with 
forum moderators
•Considers the role of the online forum moderator in the dissemination of harm 
reduction information
•Explores mistrust UWL drug users have in health care professionals and lack of 
engagement with academic and researchers
•Discusses role of moderator and their priorities with regards to harm reduction, drug 
promotion and selling
Interviews with 
UWL drug users
•Harm reduction needs to look different for different users of UWL drugs
•Explores Heterogeneous and diverse users of UWL drugs
•Considers different motivations, atittudes and knowledge of the drugs
•Looks at UWL drug use within bodybuilding as well as use within the general 
population
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Chapter 2. Literature Review 
2.1 Introduction 
This chapter provides a review of literature examining the use of unlicensed weight loss 
(UWL) drugs taking into account the complex interplay of societal, cultural and 
technological influencers for why women may use enhancement drugs, in particular UWL 
drugs. The growing use of all human enhancement drugs and their harms will be discussed 
as well as issues around body image and the pressures on women to have an ‘ideal body’. 
As this research is focusing on online discussion of UWL drug use, consideration will also 
be given to the role of online communities, the dynamics of these communities and the 
impact they have on drug use.  
Literature searches were conducted to identify women’s issues around body image, to 
identify publications exploring the use of enhancement drugs as well as those that had 
made use of online communities in their research. Attention was also given to the online 
group dynamics of these spaces as well as their role in harm reduction.  Searches of 
PubMed, PsychInfo, Medline and Science Direct databases as well as Google Scholar were 
carried out using the key phrases: weight loss drugs, 2,4-dinitrophenol, DNP, sibutramine, 
rimonabant, human enhancement drugs, performance and image enhancing drugs, online 
forums, online communities, and harm reduction. Additionally, manual searches of found 
papers reference lists, Government websites and the World Health Organisation (WHO) 
were conducted. Each identified record was considered against the specific aims and 
research questions (see 4.1) as well as the relevance of the methods used, particularly 
when searching for studies making use of online methods.  
Whilst the literature around the use of weight loss drugs is limited, a suitable starting point 
for this research was to explore why women may use weight loss drugs. In order to do this, 
it is important to consider the contemporary wider social and cultural context in which 
women find themselves, in particular the beautification, sexualisation and objectification 
of women and the normalisation of enhancement and beautification treatments in order 
to achieve their perceived ideal body.  
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2.2 Social and cultural context 
“What is beautiful is good” (Dion et al. 1972 p.285) 
2.2.1 Pressures on women to have an ‘ideal body’  
There are contemporary pressures placed upon women to be slim, tanned, toned and 
beautiful. Idealized, sexualised and normalized  media images of the ‘perfect woman’ are 
abundant in Western modern society and this coupled with wider societal and cultural 
pressures on women has led to growing body image concerns (Yamamiya et al. 2005). It 
has been argued that the pressures to conform to a thin ideal is greater for women than 
men within Western society (Grogan 1999). Whilst thinness is now idealised, previously 
the ideal female body was fuller figured, rounder and softer up until the late 19th century. 
This shift towards thinness seemingly coincided with a sense of women’s perceived 
competencies moving away from maternity and instead towards superficial aspects 
associated with beauty and appearance (Swami 2015). This shift towards the thin ideal is 
epitomized by the growing use of the corset during the 19th century. Whilst in Western 
society, body ideals have changed over the years, e.g. from flat chested athletic flapper 
dancers to the slim but curvy Marilyn Monroe type figure, slimness has stayed consistent 
throughout (Swami 2015).  
It is important to note that whilst the focus of the research here is on Western women 
primarily those based in the United Kingdom (UK), body image concerns are not unique to 
Western women. Furthermore, what is considered beautiful within each culture is 
influenced by the ideals of each particular culture and previous research has identified that 
a move from one culture to another may lead to a change in the perceived idealised body 
(Grogan 1999). Historically, in more deprived cultures, thinness was equated with 
malnutrition, poor health and poverty with increased weight seen as a sign of wealth 
(Grogan 1999) and research conducted in the 1980’s and 1990’s found that some ethno-
cultural groups associated a larger female body with marriageability, attractiveness and 
fertility (Townsend et al. 2014). From this, in the 20th century a distinction  was made 
between the thin ideal in Western society and plumper and curvier figures in Non-Western 
society (Swami 2015). Whilst body image concerns are often considered to be ‘culture 
bound syndromes’ that only impact upon Western women, it is less clear whether these 
cultural differences still exist (Swami 2015). Research has shown that many women in Non-
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Western cultures are equally determined to achieve a thin ideal (Jung and Lee 2006). For 
example, findings have shown high levels of body dissatisfaction in young girls and women 
in Korea and this was linked to higher levels of awareness and internalisation of Western 
appearance ideals (Hye-Ryeon Lee et al. 2014). Similarly, studies asking participants to rate 
images found that both Western and non-Western communities rated the thinner figures 
as the most attractive (Swami 2015). The ‘thin ideal’ is now more pervasive than ever, both 
in Western and non-Western cultures and intrinsically linked to levels of Westernisation, 
modernisation and socio-economic status within each culture and community (Swami 
2015).  
Specifically within Western cultures, Orbach (2009) explores the inescapable obsession 
with the acquisition of physical perfection. In particular, Orbach discusses how pressures 
relating to body image are placed upon women from an extremely early age and illustrates 
this point with Miss Bimbo, an online game, aimed at young girls with the main aim of the 
game to keep the doll thin and attractive through the use of diet pills, breast augmentation 
and facelifts. Orbach argues that young girls are being primed to be teenagers and later 
accepting of fashion models with skeletal figures shown in magazines, as well as the means 
required to achieve that body. Beyond this, the use of diet pills in an online game 
normalises this behaviour and contributes towards body preoccupation becoming second 
nature. Orbach argues that bodies are increasingly becoming viewed as objects which can 
be honed and improved and that women feel better and in control when finding fault with 
their bodies and improving them without realising that these feelings are the result of 
outside pressures.  
Orbach also suggests that whilst fashions change, the one constant is being thin and thus 
women become prey for both fashion and diet industries which establish these body ideals 
and exhort women to meet them (Orbach 1986).  The advent of social media means that 
pressures upon women are further intensified through the constant stream of filtered, 
edited and photo shopped images, with those uploading these images found to have 
higher levels of body dissatisfaction (McLean et al. 2015) as well as those viewing the 
images (Tiggemann and Slater 2013). Furthermore, evidence indicates that peer 
comparisons can have an even more devastating impact on self-esteem than comparisons 
made to celebrities or models (Fardouly et al. 2015). Women who make these 
14 
 
comparisons, whether through the media, social media or peer comparison and buy into 
the idea of a thin ideal may simply be equating thinness with happiness (Evans 2003). This 
is something which Orbach argues is drilled into women from an early age, with being 
overweight seen as deviant. Language such as the ‘obesity crisis’ epitomises this, 
suggesting that bodies which are obese are out of control, require discipline and are 
therefore ultimately nonstandard and undesired (Orbach 2009).  
2.2.2 Impact of body image pressures on women 
“Most women are able to describe what is wrong with their body with no difficulty, but 
find it hard to identify any part that is satisfactory” (Grogan 1999 p.33) 
 
Idealised thinness is linked with being happy, successful, youthful and accepted. Being 
overweight is equated with laziness and having no will power, with slimness in women 
considered the ultimate desirable attribute (Grogan 1999). These contemporary and 
increasingly significant pressures to conform to an idealised body manifest in how women 
feel about themselves. Findings from the British Social Attitudes survey found that only 
63% of women are satisfied with how they look and around three quarters of those 
surveyed felt there was too much pressure on women to have a sexualised appearance 
(Government Equalities Office 2014). Furthermore, a large proportion (87%) of girls and 
young women aged between 11 and 21 years of age felt that women were judged more 
on their appearance than ability (Swinson 2013).  
 
Dissatisfaction with the body is often centred on an individual’s weight and many women 
attempt different strategies in order to try to lose weight. Estimates indicate that 95% of 
women have at some point in their lives been on a diet and information from a survey 
published in 2004 found that 15% of adults in the UK were at that point trying to lose 
weight (McMurray 2004). A study carried out in America found that 75 million dieters had 
spent close to $61 billion on weight loss products during 2010 (Yen and Ewald 2012). Diet 
culture is pervasive in our society, global weight loss and weight management markets 
have been estimated at approximately $158.2 billion in 2015, a figure that is expected to 
reach $259.8 billion by 2022 (Industry Today 2017, Yen and Ewald 2012). In the UK 
specifically, it was estimated that on average a woman spends approximately £25,000 on 
diets throughout her lifetime (One Family 2010).  
15 
 
During 2011 and 2012, an inquiry was established by the All Party Parliamentary Group on 
Body Image, using evidence from online consultation with the general public, as well as 
expert witnesses giving evidence relating to body image at the House of Commons. The 
subsequent report (All Party Parliamentary Group 2012), found that 42% of women felt 
that one of the most negative elements of being women was the pressure to look 
attractive. The inquiry also found that pressures to conform to an ideal body were evident 
in those of a young age, with between one third and half of young girls being scared of 
becoming fat and one in four seven year old girls having attempted a weight loss strategy 
at least once. Finally, this report underscored that high levels of body dissatisfaction 
manifest in a number of negative consequences including higher prevalence of disordered 
or unhealthy behaviours, such as depression, eating disorders, low self-confidence, 
reduced participation in sport and social activities and wider societal issues such as higher 
levels of drug and alcohol use and unemployment.  
2.2.3 The role of the media 
“Even though virtually all women are exposed to idealized media images, it is clear that 
not everybody is ashamed of their body appearance.” (Dakanalis and Riva 2013 p. 217) 
 
Body image concerns have been documented in girls as young as seven and these concerns 
are evident amongst girls and women of different body sizes and ethnicities (Grabe et al. 
2008, All Party Parliamentary Group 2012). The role of the media in contributing towards 
body image concerns in women has been well documented and is apparent in many 
aspects of the media. When we consider the presence of women and girls in television and 
film, those who are considered overweight are far less likely to be seen on screen than 
those who are underweight. Furthermore, women who are below an average weight are 
far more likely to receive positive comments on their appearance than those above an 
average weight (Fouts and Burggraf 1999). Overall, there is a difference between women 
portrayed in the media (who are becoming thinner) and those in the real world where size 
and weight is generally increasing (Evans 2003). However, this depiction can also reflect 
real life with overweight people being treated in a different manner to their peers and 
judged as being less popular, attractive and successful (Grogan 1999).  
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Previous literature has focused upon the role of press media (Myers and Biocca 1992) in 
causing or at least increasing the risk of body dissatisfaction and eating disorders (Harrison 
and Cantor 1997, Stice et al. 1994). Women themselves feel that the media has a strong 
influence on their body image, with 70% of women (compared to only 40% of men)  citing 
the media, including television and magazines as a major contributory cause of body 
dissatisfaction (All Party Parliamentary Group 2012). Additionally, women often do not like 
how other women are represented in the media, with 90% arguing that television and 
magazines focus too much on the appearance of women, as opposed to their 
achievements.   
Despite women feeling that the media is impacting on their body image and much 
literature claiming the strong link between negative body image and the media (Harper 
and Tiggemann 2008, Hawkins et al. 2004, Anschutz et al. 2008, Harrison et al. 2006), this 
argument has been challenged. Instead, it has been argued that whilst the media’s 
presentation of thin ideals can have an effect on body image, this is limited to a subgroup 
of women who already have body dissatisfaction (Ferguson 2013). This argument is further 
supported by literature which claims that women who have a positive body image are 
‘protected’ from thin ideals in the media (Halliwell 2013). Halliwell (2013) suggests that we 
should focus on promoting positive body image as an effective intervention strategy for 
protecting women against the negative impact of thin ideals.  
2.2.4 The impact of social media 
“Women evaluate their own appearance by comparing themselves with the cultural 
ideals of beauty and thinness presented in the media. Almost invariably this will be an 
upward comparison by which women fall short, resulting in dissatisfaction with their own 
appearance and body.” (Tiggemann and Zaccardo 2015 p.62) 
 
Media comparisons (Dakanalis and Riva 2013, Halliwell 2013, Harper and Tiggemann 2008, 
Harrison and Cantor 1997, Hawkins et al. 2004) and pressures on women to conform to an 
idealised body (Evans 2003, Grogan 1999, O'Dea and Cinelli 2006, Orbach 1986, Orbach 
2009) have well been documented. The advent of social media and the impact these 
platforms can have on women’s body image are in recent years becoming better 
researched (Holland and Tiggemann 2016, McLean et al. 2015, Meier 2013, Royal Society 
for Public Health 2017, Tiggemann and Slater 2013, Tiggemann and Zaccardo 2015). Social 
17 
 
media sites allow users to create online profiles where they can interact with other 
members of the same sites (Holland and Tiggemann 2016). Previous research has found 
that young women are more likely to engage with social media than their male 
counterparts (Kimbrough et al. 2013) and this group are one of the most at risk for higher 
levels of body dissatisfaction (Fardouly et al. 2015). A survey published by the Royal Society 
for Public Health alongside the Young Health Movement (Royal Society for Public Health 
2017) found that among 14-24 year olds, social media negatively impacted on this groups 
body image, as well as increasing levels of anxiety and depression. The social media 
platforms with the greatest negative impact were Instagram and Snapchat, both platforms 
with a focus on heavily filtered photograph sharing. The authors of this report argued that 
edited and photo shopped photographs are becoming the norm and contributing to low 
levels of body satisfaction and body confidence. Other studies have found lower levels of 
body confidence in Facebook users as opposed to non-Facebook users (Tiggemann and 
Slater 2013) as well as positive relationships between social media use, body image 
concerns and disordered eating (Holland and Tiggemann 2016). Even in social media 
considered to have a positive message, such as fitspiration posts4, there appears to be 
negative consequences on body image. Tiggemann and Zaccardo (2015) found that 
women who were exposed to fitspiration images had increased body dissatisfaction and 
negative mood when compared to those who viewed neutral images. Other research has 
found that appearance exposure on Facebook, i.e. the proportion of photo related 
features used on Facebook relative to participants overall Facebook use positively 
correlated with body dissatisfaction and a drive for thinness (Meier 2013). The authors 
concluded that their findings did not simply show that social media exposure causes body 
dissatisfaction. Instead, they argued a more complex relationship whereby those who 
already have a high level of body dissatisfaction sought out and engaged with social media, 
which further exacerbated or reinforced negative body image.   
One major theory which has been linked to both the media and social media effect on body 
image is social comparison theory which argues that individual’s drive for self-evaluations 
encourages them to compare themselves to others (Festinger 1954) with peer 
                                                          
4 Amalgamation of fitness and inspiration, meant to empower body image and presented as a heathier 
alternative to another Internet trend, thinspiration (thin and inspiration) which consists of images of thin 
and emaciated women.  
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comparisons thought to be the most importance and impactful appearance comparisons 
(Tiggemann and Zaccardo 2015). These comparisons are driven by and contributing to the 
wide levels of body dissatisfaction seen in women and has been linked to the use of drugs 
in order to alter appearances and enhance bodies (O'Dea and Cinelli 2006). 
2.2.5 The normalisation of enhancement 
“A relentless desire to reshape the body is evident everywhere.” (Orbach 2009 p.5) 
 
Orbach (2009) discusses the rise of physical enhancement and reshaping of bodies citing 
an increase in the numbers of gym and health bars, as well as advertisements for cosmetic 
surgical procedures. Orbach goes on to say that we are now moving away from the body 
being the means of production to the production itself, exacerbated by celebrity culture 
and branding, with our bodies becoming a form of work. This desire to reshape the body 
is heightened by the fact that the ability to enhance it is now so pervasive in our society. 
Adverts for such procedures as botox, lip fillers, false tan, eyelash extensions, hair 
extensions and contoured make up are everywhere and completely commonplace in 
today’s society.  
 
As to be expected the use of beautifying agents in general are on the increase. An example 
of this is sunless tanning, where estimates indicate that 11% of American adults had used 
sunless tanning products in the previous year such as tanning booths and false tan (Stryker 
et al. 2007). A more recent review of what the authors classed as indoor tanning (using an 
UV emission device) found a lifetime prevalence of 37% for adults, 55% for university 
students and 19% for adolescents (Wehner et al. 2014). Furthermore, Wehner et al. (2014) 
found that 14% of adults, 43% for university students and 18% for adolescents had used 
sunless tanning  in the previous 12 months.  
 
Up until 2016, cosmetic surgery in the UK was on the increase, reaching an all-time high in 
2015 of 51,140 procedures, with 46,526 of these undertaken in women. During this time 
for women the most popular procedures were for breast augmentation, eyelid surgery, 
face and neck lift as well as liposuction and fat transfer (British Association of Aesthetic 
Plastic Surgeons 2016). In 2016, however, the number of cosmetic surgeries dropped by 
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approximately 40% (British Association of Aesthetic Plastic Surgeons 2017). The reasons 
for this are unclear, and could be due to an uncertain economy, people considering the 
risks of cosmetic surgery more carefully or due to people travelling abroad for cheaper 
operations (Hanefeld et al. 2015). Alternatively, the availability of non-surgical procedures 
such as Botox, chemical peels, lip fillers, tanning, make up contouring and teeth whitening 
could also play a part. Whilst at first glance this decrease in cosmetic surgery procedures 
suggests that women are becoming less body focused, it in fact appear that that methods 
in how the ideal body and look are being achieved has just shifted and this is often celebrity 
and trend driven. This drive is epitomised by the surge of interest in lip fillers following 
their use by the high profile celebrity, Kylie Jenner, (Ward et al. 2017).  
Another method which can be used to improve the body is through the use of image and 
performance enhancing drugs (IPEDs). IPEDs5 includes drugs to improve muscle such as 
anabolic steroids and growth hormones, drugs to improve the skin such as melanoton II 
and bremelanotide, drugs to improve cognitive function and sexual functions as well as a 
group of drugs used for weight loss purposes. Whilst data on the numbers using these 
drugs is scarce, a recent review indicated a global lifetime prevalence of 3.3% for anabolic 
steroid use (Sagoe et al. 2014). There is very little information available on the prevalence 
of UWL drug use however prescriptions for licensed weight loss drugs, have until recently 
been on the increase (Health and Social Care Information Centre 2014). The next section 
will discuss the rise of IPEDs, with a particular focus upon weight loss drugs. 
2.3 Human enhancement drugs 
The desire to look a certain way and the use of enhancement drugs to improve the body 
or mind is not a new phenomenon. Historically, people have frequently used ‘quick fixes’ 
in order to make both their body and mind look and work better. However, it was during 
the 1880s that this market really begin to grow, in part due to a lack of regulation 
concerning the marketing of products as well as developments in drug manufacturing. By 
the mid-1930s ‘secret remedies’ in the United Kingdom and ‘patent medicines’ in the 
United States were big business, with DNP, used for weight loss, at the forefront of 
popularity (McVeigh et al. 2016). Drugs at this time were widely and publically available 
                                                          
5 Please note, IPEDs can also be referred to as Performance and Image Enhancing Drugs (PIEDs), Human 
Enhancement Drugs (HEDs) and Performance Enhancing Drugs (PEDs) and may be used interchangeably  
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and targeted towards people’s insecurities, most commonly at ‘male weakness’ (often 
erectile dysfunction and premature ejaculation), baldness and those who were overweight 
(McVeigh et al. 2012). Between the late 1930s and early 1960s, as a response to drug 
disasters such as thalidomide (treatment for morning sickness during pregnancy which 
caused birth defects in thousands of children (Kim and Scialli 2011), increased legal and 
regulatory systems were put in place including requirements for medication testing, and 
restrictions on which drugs could be sold and who they could be sold to (Evans-Brown et 
al. 2012). Despite this, availability of off label, diverted and counterfeit drugs on the illicit 
market continues, although enhancement drugs were until recently predominately used 
by elite athletes or bodybuilders (McVeigh et al. 2012). However, in part due to the 
globalised and networked world we now live in, market demand as well as increased 
pressures to look a certain way means drugs designed to improve, hone and perfect are 
once again becoming prominent.  
Enhancement drugs which are currently being used fall into six broad categories which are: 
• Those to increase the structure and function of muscle, e.g. anabolic steroids, 
growth hormones 
• Those to enhance weight loss, e.g. appetite suppressants, fat burners 
• Those to change the appearance of skin and hair, e.g. mercury creams, melanotan 
II 
• Those to improve sexual function and behaviour, e.g. sildenafil 
• Those to improve cognitive function, e.g. modafinal 
• Those to improve mood and social behaviour, e.g. fluoxetine 
Whilst this research focuses upon UWL drugs it is interesting to consider these other 
groups of enhancement drugs, which cater for and signify the demand for perfect bodies 
and minds and the desire to be ‘better than well’ (McVeigh et al. 2012). 
2.4 Weight loss drugs today 
The weight loss industry is an expanding business; estimates indicate that health problems 
associated with being overweight or obese cost the NHS over £5 billion per year 
(Department of Health and Social Care 2015). Around two thirds of adults are now obese 
or overweight (NHS Digital 2017b) with the prevalence of obesity increasing by 11% 
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between 1993 and 2014 (NHS Digital 2016). However the prevalence of those underweight 
has also increased somewhat with women more likely to be underweight than men (Public 
Health England, 2014). The amount of money being spent on reducing weight by the public 
is vast resulting in a poignant contrast between increasing obesity levels and the desire to 
be body beautiful that equates with the tanned, fit, slim ideal. 
Research has examined the characteristics of those who are engaged in unhealthy weight 
loss strategies such as the use of weight loss pills. One such study based in America looked 
at the longitudinal effects of dieting and unhealthy weight loss strategies on body mass 
index (BMI) over a 10 year period. In this study middle school and high school male and 
female adolescents were asked a series of questions relating to their eating behaviours 
and then followed up 10 years later to look at their subsequent eating behaviour and any 
potential effects on BMI (participants had a mean age of 12.8 years at the beginning of 10 
year period; mean age of 23.3 years at the 10 year point) (Neumark-Sztainer et al. 2012). 
Unhealthy weight loss strategies included the use of fasting, diet pills, laxatives and the 
use of food substitutes. It was found that there was a much higher prevalence of unhealthy 
weight loss strategies in women (43.7% of females and 18.7% of males). When specifically 
examining the use of weight loss drugs, around 6% of women and 1% of men had used diet 
pills. Another study found that those who were overweight were more likely to engage in 
unhealthy weight control behaviours such as diet pills than those who were of a normal 
weight (Boutelle et al. 2002). Blanck et al. (2001) found that eleven percent of women and 
three percent of men (population based sample in America aged 18 years or older) had 
used non-prescription weight loss products between 1996 and 1998. In both men and 
women the largest proportion were aged between 18 and 34 years of age and overall 
overweight (13%) and obese (16%) woman showed the highest prevalence of weight loss 
product use.  
2.4.1 Prescription weight loss drugs 
Currently, in the United Kingdom (UK), orlistat is the only licensed weight loss drug 
available and is obtained through prescription, or at a lower dosage (under the name Alli) 
over the counter. Orlistat can be prescribed to somebody with a Body Mass Index (BMI) of 
28 (with a weight related condition) or a BMI of 30  (NHS UK 2016) and works by preventing 
the body from absorbing fat from food. Between 2006 and 2011, prescriptions for anti-
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obesity drugs were high, peaking in 2009 with 1,453,682 prescriptions (NHS Digital 2017a).  
In 2011, the number of prescriptions began to reduce, due to orlistat at that point being 
the only anti-obesity drug on the market following the withdrawal of sibutramine and 
rimonabant and due to supply shortages of orlistat in 2011/12 (Baker 2017). Whilst there 
was an increase in 2013, from then on, the number of orlistat prescriptions has reduced 
(from 563,399 in 2013 to 449,542 in 2016). Despite this the number of people who are 
overweight or obese is still increasing (Baker 2017) and whilst orlistat is currently licensed 
for prescription within the UK it can also be easily purchased online, with or without a 
prescription and costing approximately £22 for 42 capsules (equal to a two week supply).   
2.4.2 Herbal weight loss products 
There also are many ‘natural’ or ‘herbal’ weight loss products sold online designed to aid 
weight loss. The popularity of these tend to fluctuate with products going in and out of 
favour. Searches across online discussion forums suggests that caffeine, raspberry ketone 
supplements and green tea extracts appear to be those most often considered. As with 
orlistat, these products are easily available to purchase online and often advertised using 
straplines such as ‘miracle fat burners’ or ‘safe natural weight loss supplements’. Whilst 
there is no evidence for the efficacy and safety of herbal products, one risk of purchasing 
any medicine online is whether the product is authentic and is not substituted for 
something else, contaminated or adulterated. For example, there have been many 
reported cases where herbal products have been found to be contaminated with other 
substances.  One such case was the sale and use of Herbal Xenicol (diet supplement sold 
as a ‘fat blocker’) which resulted in a patient being hospitalised. This product was later 
tested and found to be adulterated with the UWL drug sibutramine (Medicines and 
Healthcare Products Regulatory Agency 2011) 
2.4.3 Prescription drugs with a different purpose 
Another group of drugs exist which have the potential to cause weight loss but this is 
secondary to their licensed purpose. Levothyroxine sodium (T4) and liothyronine (T3) are 
synthetic thyroid hormones used for the treatment of hypothyroidism. Historically, 
products containing thyroid extracts such as Marmola, which can mimic the weight loss 
seen with hyperthyroidism have been marketed as weight loss drugs (Evans-Brown et al. 
2012). Both T3 and T4 are sold online as ‘cutting agents’ and ‘metabolic regulators’. 
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Levothroid (a market name for T4) is available to purchase from a number of websites 
without prescription, from as little as 40 pence per tablet. Human chorionic gonadotropin 
(HCG), a hormone used to enhance fertility (Filicori et al. 2005) has also been found to have 
an impact on weight loss by diminishing and changing fat distribution (Yen and Ewald 
2012). Although HCG is not licensed as a weight loss drug, it can be purchased online as 
drops, tablets or injections. Similarly, Clenbuterol and Ephedrine, are both licensed for the 
treatment of asthma. However, Clenbuterol has been shown to enhance lipolysis, 
glycolytic capacity, and minimise protein degradation in both animal and human studies, 
making it attractive to those seeking simultaneous fat loss and muscle retention (Spiller et 
al. 2013). Ephedrine, can reduce appetite, promoting the burning  of calories and targets 
fat while saving lean muscle (Hall et al. 2015). Both Clenbuterol, which is controlled under 
the Misuse of Drugs Act and Ephedrine can be purchased online without a prescription and 
at a relatively low cost.  
2.5 Unlicensed weight loss drugs 
“An illicit market has developed selling a range of potent weight loss drugs.” (Evans-
Brown et al. 2012 p.81 ) 
 
The final group of weight loss drugs and the focus of this research are those which are 
unlicensed or banned. There are other drugs which are also unlicensed that can be used 
for weight loss such as Melanotan II (Van Hout 2014b, Langan et al. 2010). However, here 
weight loss is most likely the secondary effect of the drug, with tanning and increased 
libido most likely being the primary reason for using and effect. Drugs of this nature were 
not included as the focus of this research is to explore drugs used primarily for weight loss 
and it would be unclear for drugs such as Melanotan II what the primary motivation for 
use was. Therefore, the main drugs and the focus of this research are 2,4-dinitrophenol 
(DNP), sibutramine and rimonabant. 
2.5.1 2,4-dinitrophenol (DNP) 
DNP was first used in the early 1900s. It is a manufactured odourless yellow chemical and 
one of its first uses was in France during World War 1 in the munitions industry (Grundlingh 
et al. 2011, Phillips and Singer 2013, Petroczi et al. 2015). DNP is a fungicide, preservative 
and insecticide used in making dyes, wool preservatives, explosives and in photographic 
development (Politi et al. 2007, McVeigh et al. 2016).  During the 1930s, after French 
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workers exposed to DNP were found to have lost weight, it was established that 
consumption of DNP did lead to weight loss. Despite, acute toxicity reported in munition 
workers and deaths in those working in the dye industry (Tainter et al. 1935), a Stanford 
University research group reported that DNP stimulated human metabolism and DNP 
became available to the general public with an estimated 100,000 people taking it as a 
weight loss agent between 1933 and 1934 (Margo and Harman 2014). During this time, 
DNP was readily available and sold over the counter without a prescription (Cutting et al. 
1933, Tainter et al. 1935, Grundlingh et al. 2011, Yen and Ewald 2012). Adverts at the time 
were often targeted at women and played into their insecurities with straplines and 
testimonials such as “You can have the slender figure of youth” and “here at last is a 
reducing remedy that will bring you a figure men admire and women envy without danger 
to your health” (Evans-Brown et al. 2012 p.27).  
 
DNP works by increasing metabolism through inhibiting the mitochondria from making 
adenosine triphosphate (ATP), which results in heat being produced instead of ATP. This 
thermogenesis and subsequent fat burning leads to weight loss (McFee et al. 2004, 
McVeigh et al. 2016). Across bodybuilding communities, DNP is recognised as an extremely 
effective drug for weight loss (Llewellyn 2012, Duchaine 1989). However, DNP has a 
narrow therapeutic range, meaning that there are little differences between toxic and 
therapeutic doses. The side effects associated with DNP include hyperthermia, 
tachycardia, cardiac arrest and coma amongst others (Petroczi et al. 2015). The 
combination of these side effects can result in death (Yen and Ewald 2012). Due to the 
identification of harms associated with DNP use, in particular multiple cases of cataracts 
and linked deaths (Yen and Ewald 2012), DNP was banned in 1938 by the Food and Drug 
Administration (FDA).  
 
Between 1916 and 2010, there were 62 reported deaths from DNP in the medical 
literature. Between 1916 and 1919, there were 38 reported deaths following exposure in 
an occupational setting within France. From 1933, when DNP became available as a weight 
loss agent up until its ban in 1938, there were eight reported fatalities. These deaths (6 
female and 2 male) were all attributed to people using DNP for weight loss. Between 1936 
and 2002, there were only two reported deaths following DNP exposure, one reported as 
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accidental and one as an overdose. However, from 2002 to 2010 there were 12 reported 
deaths (five female and seven male), with seven of these deaths linked to people using for 
weight loss or to assist in bodybuilding (Grundlingh et al. 2011). Data from the Office for 
National Statistics (2017), which looked at instances where DNP was mentioned on a death 
certificate (In England and Wales between 2007 and 2016), identified 15 deaths linked to 
DNP, with 13 of these being post 2012. Deaths following the use of DNP have also been 
frequently reported in the media. Probably one of the most highly reported and discussed 
of these deaths, was Eloise Parry, a young woman aged 21, who died in 2015 after 
reportedly taking eight times the recommended dose of DNP (BBC News 2015) contained 
in tablets she had purchased online. Deaths have also been reported in bodybuilders, 
sports competitors, extreme dieters and those suffering with an eating disorder (McVeigh 
et al. 2016, Sawer and Mendick 2013, Brooke 2013, BBC 2012, Matharu 2014). 
 
DNP is widely available to purchase through online methods, particularly within the body 
building communities and is often marketed as a safe weight loss drug (Grundlingh et al. 
2011). However, DNP is a metabolic poison and illegal to sell as a fat burner within the UK.  
Despite this, with the market place being predominately online this makes it very difficult 
to regulate due to anonymity and the ease of moving online markets from one website to 
another (Petroczi et al. 2015). Whilst little is known about the prevalence of DNP use, the 
increase in the number of DNP related fatalities plus a surge in online discussion relating 
to this drug suggests that its use is rising.  
2.5.2 Rimonabant 
Rimonabant (brand name Acomplia©) is an appetite suppressant developed to treat 
obesity that works by blocking cannabinoids (Padwal and Majumdar 2007, Halford 2006).  
Early trials of rimonabant found that it was more effective than a placebo for all weight 
related outcomes including blood pressure, levels of cholesterol and weight, and was 
found to be more effective than both sibutramine and orlistat (Burch et al. 2009). It was 
also found to reduce food intake and hunger in obese people over a 7 day period and 
during trials it was considered to have potential in greater and longer lasting weight loss 
than previous anti-obesity medicines (Halford 2006). At this point, rimonabant was 
thought to have few safety concerns with the Rimonabant in Obesity (RIO) Europe study 
concluding that rimonabant was well tolerated with minimal side effects (Christensen et 
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al. 2007). As such, rimonabant was authorised for use by the European Agency for the 
Evaluation of Medicinal Products (EMEA) in June 2006 throughout the European Union 
(EU) (Christensen et al. 2007) and made available across 56 countries (Kang and Park 2012). 
Rimonabant was licensed as an anti-obesity drug in the UK for use in patients with a BMI 
greater than 30, or greater than 27 with an associated risk factor such as type II diabetes 
(Wathion 2009).  
However separate individual trials found that rimonabant increased levels of depression 
with a meta-analysis of randomised controlled trials examining the safety of rimonabant 
(Christensen et al. (2007). This meta analysis found that whilst those taking rimonabant 
did experience a greater weight loss than those who were taking a placebo, a range of 
harms were identified. For patients who were taking 20mg a day of rimonabant, there was 
an increased risk of psychiatric adverse events, namely depressive mood disorders and 
anxiety. A separate report conducted by the FDA echoed these findings and in fact argued 
that Christensen et al. (2007) may have underestimated the level of psychiatric 
complications attributed to rimonabant (Mitchell and Morris 2007). The FDA study found 
that 26% of patients who took rimonabant had an adverse psychiatric event and 
additionally found evidence that rimonabant was linked to an increased risk of suicide 
attempts.  At least two deaths from suicides were reported in patients who had been 
taking rimonabant (Sam et al. 2011, Astrup et al.). Due to these findings rimonabant was 
withdrawn from the European Market in 2009 (Kang and Park 2012).  
Despite being withdrawn in Europe, and never approved elsewhere, rimonabant can be 
purchased online. It is usually marketed under the brand name of Acomplia© and often 
advertised as a drug both for weight loss and for smoking cessation. One website states 
that whilst rimonabant can have side effects such as depression and anxiety, these are 
most often temporary. It should be noted, however, that whilst it is still possible to 
purchase rimonabant online many websites that did offer it have now been closed. It is 
not clear whether websites where forcibly closed, however it does seem that new websites 
are created to take the place of old ones.  
2.5.3 Sibutramine 
Sibutramine (brand name Meridia©) is an appetite suppressant, originally developed as an 
antidepressant but later found to increase satiety (Padwal and Majumdar 2007) and 
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stimulate thermogenesis (Arterburn et al. 2004). As such, sibutramine was approved as an 
anti-obesity drug by the European Union in 1999. The efficacy of sibutramine for weight 
loss in both the short and long term (up to 2 years) was identified (Nisoli and Carruba 2003) 
with an optimal dose of between 10 and 15 mg per day established. Approximately 69% of 
patients receiving sibutramine were found to have achieved a 5% or greater reduction 
from their baseline weight (Lean 1997). From three randomised double blind, placebo-
controlled weight loss trials of one year, sibutramine was found to on average reduce 
weight by 4.6% in overweight and obese patients (Padwal and Majumdar 2007).  
Early identified side effects from sibutramine included headaches, dizziness, dry mouth, 
nausea, insomnia and constipation (Nisoli and Carruba 2003). Concerns were also raised 
about the potential for sibutramine in increasing blood pressure and heart rate and about 
the link between sibutramine and cardiovascular toxic effects. In 2002, sibutramine was 
temporarily suspended in Italy following reports of tachycardia, hypertension and 
arrhythmias with sibutramine being linked to two deaths (Padwal and Majumdar 2007). At 
this point sibutramine was reinstated with the condition it was not to be used by patients 
with a history of cardiovascular disease (James  et al. 2010). The Sibutramine 
Cardiovascular Outcomes Trial (SCOUT) was set up to assess the long-term effects of 
sibutramine on cardiovascular events and death in overweight and obese participants who 
already had pre-existing cardiovascular disease (Caterson et al. 2012). The SCOUT trial was 
conducted in 13 countries across Europe, Central America, South America and Australia 
between 2003 and 2009 with around 10,000 participants taking part (Caterson et al. 2012). 
The SCOUT trial  found that patients who had pre-existing cardiovascular disease and were 
on a long term treatment of sibutramine (10-15 mg per day for five years) were 
significantly more at risk of non-fatal myocardial infraction and strokes, although there 
was no significant risk of cardiovascular death (Scheen 2011). The EMEA decided that the 
benefits of weight loss did not outweigh the risks and sibutramine was withdrawn in 
Europe (and later in America) due to safety concerns in 2010 (Williams 2010).  
Despite sibutramine being withdrawn from the market, it is still available to purchase 
online often under a variety of brand names including Reductil, Meridia and Sibutrex. 
Sibutramine can be purchased online at a cost of approximately £50 per month’s supply. 
Additionally there have also been concerns about the adulteration in so called ‘herbal’ or 
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‘natural’ weight loss supplements (Chen et al. 2010), with the addition of sibutramine 
being detected in many slimming products (Mathon et al. 2014). 
2.5.4 Why these drugs? 
The decision to focus on these three drugs was primarily due to their unlicensed status. 
Being unlicensed, they are unregulated and particularly for DNP, where there have been 
no clinical trials testing its efficacy, the evidence concerning impact and risks of use are 
unknown. Furthermore, consumers of these drugs are doing so without any input or 
support from health care professionals. This means there is far less protection from effects 
caused by drug interactions or drug related adverse effects, for example in those taking 
more than one serotonergic agent (Thanacoody 2016, Goudarzi et al. 2016), such as both 
sibutramine and selective serotonin reuptake inhibitors (SSRIs). This can lead to increased 
serotonin levels within the central nervous system causing mild to severe toxicity and side 
effects such as muscular spasms, elevated body temperature, increased heart rate, 
agitation and confusion (Buckley et al. 2014). Due to the unlicensed status, access to these 
drugs from potentially illicit markets provide no guarantees for accuracy of information 
given, the quality of drugs supplied, potential for online scamming or contaminated drugs 
(Koenraadt and van de Ven 2017). This presents a risk of harm due to a lack of regulation 
and safeguarding in those using them. 
Whilst the focus of this research is UK based, enhancement drug use is not confined to this 
geography. For other drug use, prevalence varies worldwide, for example 41.9% those 
residing in New Zealand had ever used cannabis as opposed to only 6.6% and 1.5% of those 
residing in Italy and Japan respectively. Similarly, drugs in different cultures may be 
favoured over others, for example methamphetamine use in Japan is high but other drugs 
which are more widespread elsewhere  have a low prevalence  (Kanayama et al. 2012). 
Enhancement drug use prevalence rates amongst gym users has been found to range 
between 0.4% to 35% (Ainsworth et al. 2018). The majority of research which has looked 
at enhancement drug use prevalence has focused upon anabolic androgenic steroids 
(AAS). Whilst AAS drug use was initially seen as a Western trend, driven by Western 
attitudes towards muscularity (Kanayama et al. 2012), research looking at global 
prevalence found highest rates in the Middle East and South America with an overall global 
lifetime prevalence rate of 3.3% (Sagoe et al. 2014). The authors of this research declare 
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AAS use as being a widespread and serious public health problem and these findings 
suggest it global and cross-cultural. Whilst there are not equivalent prevalence rates for 
UWL drug use, unpublished analysis of the Global Drug Survey 2015, found that 5% of 
women (n=1,934; N=36,502) had ever used a weight loss drug6. The largest majority were 
of White ethnicity (1,684; 87%) and 38% (737) resided in Germany. One in five was from 
Brazil (396; 21%), 126 (7%) from the United States and 90 (5%) from the United Kingdom.  
Whilst the numbers using these drugs are small, these findings do suggest that UWL drug 
use is not limited to the UK. Research which posed the hypothetical scenario ‘what if DNP 
was a licensed pharmaceutical drug’ to participants identified that young women aged 
between 18 and 25 years of age showed the least concerns for legality, were most 
interested in losing weight and were at a higher risk for disordered eating. The authors 
concluded the increasing body image concerns in these groups coupled with a lack of 
concern for legality meant that young women were at risk of becoming vulnerable to using 
weight loss products such as DNP  (Bleasdale et al. 2018). Whilst identifying global 
prevalence of UWL drugs is at present problematic with users reluctant to admit to use 
(Ainsworth et al. 2018), there is also a paucity of studies, which explore the experiences of 
UWL drug users and patterns of use.   
2.5.5 Harm reduction 
The term harm reduction was coined in 1987 and whilst often overshadowed in the UK by 
a focus on recovery and treatment, harm reduction aims to reduce the negative 
consequences, associated with a potentially harmful behaviour such as the use of drugs 
(Stimson 2016). Some harm reduction strategies aim to provide those using with safer 
ways of using, e.g. by providing clean needles whilst others promote alternatives which 
are regarded as safer such as using methadone as a substitute to heroin. Other harm 
reduction strategies look at creating spaces which aim to facilitate the safer use of 
substances (Hardon and Hymans 2016) and online spaces with caring and sharing 
communities have been found to be pivotal in the dissemination of harm reduction 
information (Van Schipstal et al. 2016). Harm reduction strategies specifically for UWL drug 
use has not been well considered and research which does exist has thus far only focused 
on DNP (Ainsworth et al. 2018). However, it is possible to also draw from strategies 
                                                          
6 Ephedrine, DNP, Sibutramine, Clenbuterol, Rimonabant, T3 and T4 
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employed in other enhancement drug use. In particular, previous research has identified 
that strategies designed to ‘scare’ users away from the use of anabolic steroids has limited 
effect (Petróczi et al. 2014). Similarly, for this group there is a reluctance to seek advice 
from health care professionals due to users of steroids often considering themselves to be 
more knowledgeable about the drugs (Pope et al. 2004). For steroid users there have been 
recommendations that strategies should focus on reducing harm from using drugs rather 
than trying to encourage users to stop using drugs and this has approach has also been 
suggested for experienced DNP users (Ainsworth et al. 2018). Online communities have 
been identified as places ideal for the dissemination of harm reduction strategies (Davey 
et al. 2012), particularly in those communities which have a strong identity and sense of 
community. It has also been argued that harm does not have to be a consequence of using 
drug and the networks the user engages with can shape the impact of using drugs (Van 
Schipstal et al. 2016). Furthermore, for those who view themselves as being 
knowledgeable about drugs such as DNP and where peer experiences are considered 
valuable the inclusion of online groups in discussions concerning policy creation and harm 
reduction strategies could be empowering for those users (Ainsworth et al. 2018). Harm 
reduction from below, i.e. that which comes from peers and is often evident within online 
drug communities has been seen as a valuable strategy in minimising potential risks and 
harms and it has been argued that those working at a policy level could learn from these 
communities (Van Schipstal et al. 2016). However, it is unclear thus far from previous 
research exactly what harm reduction strategies should look like and whether they would 
need to be different for novice and experienced DNP users. Additionally, there has been 
no research that has looked at those using rimonabant and sibutramine and whether 
parallels can be drawn across all UWL drug users. Finally, for online communities, whilst 
they can be effective in the sharing of harm reduction information consideration also 
needs to be given to who the peers are and whether information shared is incorrect or 
harmful in any way (Boothroyd and Lewis 2016).  
 
2.5.6 Online drugs market and associated risks 
The globalised and networked world we live in now makes the accessibility and availability 
of drugs including weight loss drugs, as well as other lifestyle and recreational drugs, 
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extremely easy. The use of the internet to purchase drugs, in particular also appears to be 
increasing (European Monitoring Centre for Drugs and Drug Addiction 2017). A survey 
conducted with people worldwide investigated  the number of people purchasing any 
drugs online and the types of drugs which were purchased (Winstock 2015). In this Global 
Drug Survey (GDS), 22% of UK respondents reported that they had bought drugs online. 
This included licensed drugs purchased with or without a prescription, unlicensed, banned 
and illegal drugs. Due to the difficulties of placing legal restrictions on those selling or 
purchasing weight loss drugs online, the internet does appear pivotal in the circumvention 
of medicinal regulation, and the supplying of drugs (Evans-Brown et al., 2012). 
Lifestyle drugs, which include weight loss drugs are readily available to purchase online. 
Online searches for UWL drugs demonstrate the high level of availability with Google.co.uk 
searches for ‘Buy DNP online’ producing close to 5 million results.  It is important to note, 
however that during the span of this research many online websites and shops, which 
previously sold UWL drugs no longer exist or no longer advocate the use of UWL drugs. 
However, it is still possible to purchase these drugs, often from websites seemingly based 
outside of the UK and for as little as £1.60 per capsule for DNP, £1 per capsule for 
sibutramine and £1.30 for rimonabant.  
Research conducted in the Netherlands explored online purchasing of ‘lifestyle drugs’, 
namely weight loss drugs, sexual enhancers, birth control, smoking cessation drugs and 
muscle building drugs (Koenraadt and van de Ven 2017). This study asked over 50,000 
people about medicines they had purchased online. From this, it was estimated that 10.2% 
of the Dutch population had purchased drugs online and 1.6% had purchased illicit drugs 
online. Weight loss drugs were the second most popular drug group purchased (primarily 
sibutramine or orlistat without a prescription), accounting for 27% of drugs bought online. 
Whilst overall, men purchased illicit medicines online significantly more than women, this 
was reversed for weight loss drugs (61.3% female), the only group of drugs where this was 
the case.  
Whilst there is little evidence for the risks associated with using UWL drugs purchased 
online, research is available which has examined the risks of buying any drug online. When 
buying drugs online the consumer has no real guarantee that what they are purchasing is 
what they believe it to be. Even for those who believe they are purchasing ‘natural’ or 
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‘herbal’ products, this may not always be the case. For example, harms caused from using 
herbal weight loss drugs which were later found to have been adulterated with the potent 
drug n-nitrosofenfluramine have included liver damage and death (Evans-Brown et al., 
2012). Drugs may be missing the correct instructions for use or without the correct 
equipment, e.g. needles and sterile water missing from a synthetic tanning order (Van 
Hout and Brennan 2014). This may increase the risk of users sharing injecting equipment 
and the lack of proper sterilisation can cause localised infections (Evans-Brown et al., 
2012). Furthermore, drugs sold online may not always have the correct labelling and 
information on how to use them safely and effectively (Evans-Brown et al., 2012). There 
are also risks of purchasing counterfeit products, made in illegal laboratories which are not 
subject to any quality control or safety assessment (Rocha et al. 2016).  
There is limited knowledge about those who use weight loss drugs and scholarly articles 
discussing this are limited. Those papers which do exist and discuss experiences of using 
weight loss drugs tend to be for DNP and focus on bodybuilders  or single case studies 
(Chan et al. 2013, Petroczi et al. 2015, McFee et al. 2004, McVeigh et al. 2016) and for 
sibutramine and rimonabant only focus on efficacy of the drugs prior to regulatory 
controls.  
There is likely to be a reluctance for users of these drugs to admit to using them. Whilst 
Orbach (2009) discusses the rise of physical enhancement and reshaping of bodies and 
suggests that this has become normalised within today’s society, not all human 
enhancement is considered normal or acceptable. For example, extreme body 
modification, such as tongue splitting is seen by many as deviant behaviour (Lingel and 
boyd 2013). For image and performance enhancement drug injectors (mainly AAS and 
melanotan II users), the illicit nature of using these drugs as well as the widely circulated 
argument that steroids increase levels of aggression contributes to use being hidden and 
secretive (Hope et al. 2013, van de Ven 2016, Bunsell 2013). Bodybuilders tend to hide 
their drug use and for women, the use of steroids is seen as doubly deviant due to steroids 
being deemed unfeminine and the commonly held belief that muscular women are 
unattractive (Bunsell 2013).  With regards to weight, more generally there is a stigma 
attached to being overweight with feelings of failure and guilt when not losing weight or 
achieving lifestyle changes (Grønning and Tjora 2016). Furthermore, the use of products 
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to assist with losing weight may be seen as the quick fix and lazy option, for example 
research has found that those who lose weight through the use of diet pills were viewed 
less favourably than those who lost weight through either diet and exercise or bariatric 
surgery (Carels et al. 2015).  For DNP in particular, the high risk associated with use as well 
as severe side effects may contribute to users not wanting to admit to use. Petróczi et al. 
(2015) likened this to traditional drug use where users are more likely to admit to using 
relatively harmless substances such as marijuana but less likely to confess to a ‘harder’ 
drugs such as heroin.  
Whilst users may be reluctant to discuss UWL drug use, experiences of using these drugs 
are plentiful within online communities, most likely due to the perceived anonymity these 
communities offer. The next section of the literature review will explore the rise in online 
research as well as the role of online communities in exploring UWL drug discussion.  
2.6 Online communities 
“The Internet is increasingly taking the form of a laboratory for the social sciences, in 
much the same way as astronomers might use a virtual observatory to understand the 
mysteries of the night sky.” (Eynon et al. 2008 p.7) 
 
Close to two decades ago, Lyman and Wakeford (1999) argued that research involving 
digital and networked technologies was the fastest expanding field within social sciences. 
Given the rise in social media and online communities, this statement is now even more 
applicable.  Eynon et al. (2008) describes the internet as the laboratory for the social 
sciences. Kozinets argues that “online access to vast amounts of archived social 
interactions alongside live access to the human beings posting it (has) entirely changed the 
practice of ethnography and, in fact all of the social sciences” (Kozinets 2015 p.4).  The 
internet is one of the most prominent fixtures in modern life. We live in a technological 
society and a vast amount of our time is spent online. Whereas once our social identities 
and networks were solely constructed within the context of our ‘real life’ physical settings, 
this is no longer the case. The online world should be considered as another social space  
(Donath and Boyd 2004) just like our physical spaces. Humans’ social identities go beyond 
that of physical interactions and encounters and our online presence and online profiles 
make up just as much of who we are. So much of what we do in our ‘real world’ lives can 
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also be done online; through the internet we can purchase goods, engage in social 
interactions and source information.  Worldwide, there are over three billion users of the 
internet, which represents approximately 40% of the global population (Conrad et al. 
2016). Within the United Kingdom (UK), 89% of households have access to the internet 
with 82% of adults using the internet on a daily or almost daily basis and 63% having a 
social media account (Office for National Statistics 2016). There is now a blending of our 
online and offline lives with our online aspects becoming just as much part of our ‘real 
world’ as our offline aspects. 
Online forums represent one way that people communicate and seek information online, 
and although somewhat eclipsed by social media, forums are still used by approximately 
10% of internet users in the UK (Pendry and Salvatore 2015). It is unclear exactly how many 
online forums currently exist but what is obvious is that they exist for all manner of 
purposes. Over recent years, there has been a rise in researcher interest in understanding 
online communities as well a proliferation of research methodologies, computer assisted 
scraping and crawling tools, and ethical protocols. Specifically, within the context of health, 
online forums are used in research to help tease out the perceptions, beliefs, motivations, 
knowledge and decision making processes concerning issues such as drug use (Norman et 
al. 2014, Van Hout 2014a, Mitchell et al. 2016), health conditions (Hilliard et al. 2015, 
Bender et al. 2013) and mental health (Moore et al. 2016) amongst many others.  
Online forums are an extremely useful tool for researchers who are researching sensitive 
or illicit behaviour particularly where there is a fear of judgement in the offline world, have 
undefined populations or hard to reach groups (Barratt and Lenton 2010, Germain et al. 
2017). Additionally the use of the internet to seek weight loss advice is relatively high. A 
survey carried out in America found that 39% of women aged between 16 and 24 years of 
age had used the Internet to seek weight loss advice and 7% had used diet pills (although 
it did not state where the diet pills had been purchased); those who had used the Internet 
to seek weight loss advice were significantly more likely to have used diet pills (Laz and 
Berenson).  
Research has also identified the role of online communities in sharing advice and harm 
reduction around drug practices. Discussion concerning drug safety, side effects, dosage, 
user experiences and support for the use of novel psychoactive substances has been found 
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on online forums (Soussan and Kjellgren 2014) and suggestions made for drug prevention 
or sharing of evidence designed to reduce harms being part of online forums to also be 
considered (Davey et al. 2012). This may be particularly effective in communities which 
have a “strong sense of shared experience” (Davey et al. 2012 p.390) whereby members 
are close knit, unified and have a commitment to protect the community they are in. Social 
identity theory (Tajfel and Turner 1979) highlights the importance of membership within 
a community and specifies in which cases members may become in-group or out-group 
members. Those who are in-group members are those whose beliefs, attitudes and 
opinions align with others in the group, with those not conforming considered to be out-
group members, with in-group members being more influential on others in the group 
(Farrow et al. 2016). Strength of identity within a group has been shown to influence 
behaviours such as smoking, drinking and drug use as well as influencing harm reduction 
and health promotion behaviours (Hynes and Zinkiewicz 2007). Previous research 
exploring IPED discussion (predominately steroids)  in online forums has already found 
strong identities within these groups as well as advice shared concerning harm reduction 
with online peers experiences viewed as valuable and highly sought after (Tighe et al. 
2017). This research suggested that in-group members or high ranking peers within these 
online communities may act as a link between health care professional and those using 
IPEDs in providing advice on harm reduction. Whilst it is not at present clear, whether UWL 
drug users have the same shared identity as other drug group users, this is an important 
factor in identifying how best to share advice and information with this group. Online 
research can provide researchers with what people are discussing but it can also explore 
the hows, whys and whos. How are people sharing best advice, why are they using online 
forums to do so and who is best placed to give advice? This is important, particularly for a 
group such as UWL drug users, where little is known their attitudes and perceptions, not 
only towards UWL drugs but also towards the online communities they frequent, the 
advice they are given and the role of online forums play in providing advice on harm 
reduction.   
This doctoral research explores the use of unlicensed weight loss (UWL) drugs in women. 
Due to the illicit nature of UWL drug use, its use may be hidden and likely to be amongst a 
group of users who are not traditionally in contact with health care professionals around 
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their weight loss drug use. In addition, it may be that as UWL drug users do not identify 
themselves as drug users they may be less likely to access a health care service for 
treatment. What is known however, is that people often purchase their UWL drugs online 
and also that online discussion relating to the use of UWL drugs are prevalent across a 
range of websites. Thus, online forums present a natural opportunity to find out more 
about UWL drug use and the people who use them. As an emerging research area with 
relatively little literature it is not yet wholly clear what some of the key issues around UWL 
drug use are and by looking at existing online discussions relating to UWL drug use this 
doctoral work allows for identification of some of those key areas, e.g. who are using 
weight loss drugs, why are they using, why have they stopped and what are people’s 
perceptions and attitudes towards weight loss in general.  
2.7 Conceptual framework 
Whilst little is known about the reasons women use UWL drugs, a conceptual framework 
(Figure 1) has been developed. This explores some of the reasons why women may have a 
preoccupation with their body as well as motivations that may influence women in 
engaging in risky behaviours in order to have the physique they desire. However, it is 
expected that this may vary depending on which drugs are being used and for which 
purpose, e.g. overweight and wanting to be thin compared with bodybuilder preparing for 
a competition. This framework also takes into account motivations for engaging with 
online communities and proposes a sequential relationship, whereby women have 
pressures on them to be thin with one outcome potentially being UWL drug use. Due to 
the illicit status of UWL drugs, and the hidden nature of this drug use, it appears that 
women are using online forums to discuss their experiences and receive advice. However, 
it should be noted that this study is exploratory and will be guided by the research findings 
as they arise. In particular stage 1, the online forum analysis, a large scoping exercise of 
online discussion assessing the content of UWL drug discussion and this will inform the 
remainder of the research. Therefore, this framework is a guide and not a rigid framework.  
However, from the literature it is clear that body preoccupation exists as well as the 
intense and inescapable pressures placed upon women in order to meet ideal body 
expectations. Secondly, the literature has identified a normalisation of body and face 
enhancement with high levels of invasive and non-invasive cosmetic procedures coupled 
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with the rise in interest of all human enhancement drugs. Finally, the rise of online 
research methods and the identification of this particular method when researching 
hidden or illicit behaviours is pivotal for this research and key to gaining an understanding 
of UWL drug use in women.  
Figure 2. Framework of UWL drug use 
 
 
2.8 Chapter summary 
In this chapter, literature has been presented identifying the growing pressures placed 
upon women to look a certain way as well the methods currently being employed to 
achieve that look and the normalisation and acceptance of those methods, including the 
use of enhancement drugs.  Finally, the reasons why women may be engaging with online 
forums to discuss UWL drugs has been considered as well as the role online communities 
play in the sharing of experiences and advice. This literature review highlights the under 
researched nature of UWL drug use as well as offering some insights into the societal and 
cultural pressures impacting on women which may be contributing to their use of UWL 
drugs. The next chapter discusses the methodology for each of the three studies within 
the research.  
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Chapter 3. Methodology and Research Design 
 
This chapter gives an overview of the methods used in this research. Specifically, 
qualitative research, netnography, online recruitment, data collection methods and 
limitation of the study are discussed. 
3.1 Aims and objectives 
The aim of this doctoral research is to identify and characterise the emerging issue of the 
use of unlicensed weight loss (UWL) drugs in women. Specifically, this research aims to 
identify attitudes and perceptions of those who are using UWL drugs and the underlying 
decision-making processes, which occur when choosing to take harmful substances. This 
research is divided into three distinct studies -  study 1) an online forum analysis; study 2) 
interview with the forum moderators; and study 3) interviews with female UWL drug users 
(Figure 2).  
Figure 3. Order of research studies 
 
The overarching objectives for this doctoral research aimed: 
1) To identify attitudes and perceptions of UWL drug use; 
2) To identify the self-reported risks of using UWL drugs ; 
Study 1. Online forum 
analysis
Study 2. Interviews 
with forum moderators
Study 3. Interviews 
with UWL drug users
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3) To identify the reasons and motivations behind why UWL drug users begin to use UWL 
drugs and the associated trigger points; 
4) To assess the role of online forums in health promotion and sharing of harm reduction 
information. 
3.2 Theoretical framework 
Before commencing research, it is essential to consider and establish a theoretical 
framework, as a framework will assist in informing both research methods used and types 
of data collected. A paradigm, or worldview, as termed by Creswell (2013) can be defined 
as “a basic set of beliefs that guide action” (p.35). A paradigm is a researcher’s belief about 
how a problem should be understood and addressed, essentially how reality can be viewed 
via research.  
Within a paradigm, researchers need to consider both their ontological stance, ‘what is 
reality or truth’, and their epistemological stance, ‘how can we understand and know that 
reality or truth’.  This research initially started out as mixed method research using a Quan 
 QUAL sequential explanatory design.  The quantitative element, involved analysis of the 
Global Drug Survey (GDS) in order to set baseline characteristics of female UWL drug users 
followed by a qualitative analysis of online forum analysis and interviews to gain a deeper 
understanding of women’s motivations and experiences of using UWL drugs. This 
combination of methods meant at that point the research fell outside of both the positivist 
paradigm, which demands complete objective, scientific, deductive research and also the 
constructivist paradigm where the focus is solely on inductive, subjective research 
(Bloomberg and Volpe 2016). For mixed method research, a pragmatist paradigm is often 
the most appropriate. A pragmatic approach is used when both quantitative and 
qualitative methods are needed to fully understand an issue and that methods can be 
combined creatively in order to fully understand and address research questions 
(Bloomberg and Volpe 2016). However, following analysis of the GDS it was apparent that 
the data was not contributing unique findings and did not merit inclusion in the research7, 
therefore the research became a qualitative study. Despite this, pragmatism  argues for a 
‘what works’ approach and instead of focusing upon the methods, the research should 
focus upon the research problem and use appropriate methods to help understand the 
                                                          
7 A small section was added to the literature review 
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problem (Creswell 2013). Researchers following a pragmatic approach are not tied to one 
philosophy and due to this are not tied to one methodology. Instead pragmatism 
advocates using a variety of methods which work together to best understand a research 
problem (Creswell 2013). In order to answer the research questions in this research and 
given that the quantitative stage did not elicit any novel or detailed findings, a qualitative 
multi method approach was deemed most suitable in answering the research questions. 
Therefore, this research still follows a pragmatic paradigm.  
3.3 Study 1. Online forum analysis 
This study aimed to build upon information gathered in stage 1 and addressed aim 1 ‘To 
identify attitudes and perceptions of UWL drug use’, aims 2 ‘To identify the self-reported 
risks of using UWL drugs’ and aim 3, ‘To identify the reasons and motivations behind why 
UWL drug users begin to use UWL drugs and the associated trigger points’. 
3.3.1 Netnographic approach 
Netnography is described by Kozinets as “ethnography on the Internet, a new qualitative 
research methodology that adapts ethnographic research techniques to study the cultures 
and communities that are emerging through computer-mediated communications” 
(Kozinets 2002 p.62). Originating in market research, netnography was part of a movement 
aiming to gain ‘thick descriptions’ of consumers experiences, attitudes, beliefs, 
perceptions and feelings (Langer et al. 2005).  Netnography can be considered less time-
consuming, less obtrusive and also a more cost effective option than other research 
methods. Beyond this though, netnography can be used for sensitive research topics such 
as illicit drug use and for research topics where access to participants is difficult (Langer et 
al. 2005) making it an optimal method for this study. Kozinets (2002) p.63-66 recommends 
the following stages for use in a netnographic study: 
1) Entrée – Research question formulation. Also of importance is identifying relevant 
forums and learning about the forums and its members. 
2) Data collection – Including both data taken directly from forums and also 
researcher observations of the forum including its members, interactions and 
meanings 
3) Interpretation – Following conventional methods of analysis, classifying and coding 
data, analysis and contextualisation.   
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4) Ensuring Ethical Standards – Particular emphasis given to importance of researcher 
disclosure, confidentiality and anonymity, feedback from online community and 
awareness of private versus public spaces. 
5) Member checks – Presenting research findings to participants for their comments.  
This chapter describes steps taken during Kozinets recommended methodology. Whilst 
this study has incorporated elements of ‘true’ netnography as described by Kozinets, there 
are some deviations which will be discussed. 
3.3.2 Entrée – Forming the research questions 
The aim of this research is to explore the use of unlicensed weight loss (UWL) drugs in 
women. This work will contribute to formulating an appropriate public health response 
supporting people in making healthier lifestyle choices.   
Entrée – Forum selection 
This section describes the steps taken in deciding which forums were selected for inclusion. 
Whilst online forum analysis is increasing in popularity, often researchers do not 
thoroughly describe the processes involved in selecting forums used in analysis. However, 
this is an important part of the process and this section describes in detail how forums 
were selected. In netnography, Kozinets (2002) describes how assessing the aims of a 
forum, the level of traffic to a forum, number of users and richness of data is essential prior 
to data collection. Without thorough steps being taken to ensure that the most relevant 
and appropriate online communities are being accessed, then there is no way of knowing 
whether the forums a researcher is analysing are the most suitable. Parallels can be drawn 
between conducting a systematic review and carrying out an online forum analysis. In the 
same way a systematic review is used to draw out only the most reliable and useful 
research and evidence, a systematic process within online research can also be employed 
to select only the most relevant and useful online communities. As in a systematic review, 
key stages for selecting online forums include deciding upon search terms, appraising the 
quality and relevance of the sources and using inclusion and exclusion criteria.  
Stage 1. Searching for and identifying forums 
The first stage of the forum analysis involved carrying out specific key term searches on 
Google.co.uk search engine. The search terms used are presented in Table 2. The search 
terms were chosen to include both the generic (e.g. sibutramine) and trade (e.g. Slimex) 
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names of each drug of interest as described in Evans-Brown et al. (2012). Additional trade 
names were also discovered throughout the searching process (e.g. Sibutrex). Searches 
were also carried out for ‘weight loss drugs’ and ‘weight loss pills’ as, although the focus 
of this research is on DNP, sibutramine and rimonabant, it may be that other unlicensed 
weight loss drugs are also being used or the drugs of interest are not explicitly named 
within forum posts. In addition, these searches may also pick up on additional trade names 
of the three main drugs. The number of Google results from each search was recorded 
with ‘DNP forum’ and ‘weight loss pills forum’ producing the largest number of results.  
Table 2. Google search terms8 
Drug Search term Google results 
DNP DNP forum 1,270,000 
DNP Dinitrophenol forum 48,900 
Sibutramine Sibutramine forum 352,000 
Sibutramine Reductil forum 411,000 
Sibutramine Meridia forum 486,000 
Sibutramine Sibutrex forum 2,350 
Sibutramine Slimex  forum 227,000 
Rimonabant Rimonabant forum 347,000 
Rimonabant Acomplia forum 384,000 
General weight loss "Weight loss drugs" forum 301,000 
General weight loss "Weight loss pills" forum 1,140,000 
For each individual search, the top 30 Google hits were accessed and information on the 
website link, website home page, date accessed and type of website were recorded. Eleven 
searches were carried out with the top 30 websites for each accessed, meaning there were 
330 websites altogether. Of these 201 (61%) were excluded from the study through an 
initial screening process (Table 3). Websites were excluded if they were not forums; in 
these cases, the websites were often online shops or adverts advertising weight loss drugs 
or the websites were duplicates from within the same search, i.e. a search term may have 
had two separate hits to the same website appearing within the top 30 hits.  
Table 3. Reasons for stage 1 inclusion 
Reason for exclusion Number of websites % 
Not a forum 127 63% 
Duplicate 24 12% 
Website not working 18 9% 
Not weight loss related or a forum 17 8% 
Not weight loss related 10 5% 
Not in English 5 2% 
Total 201 100% 
                                                          
8 Please note, tables may not add up to 100% due to rounding 
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A further 45 websites were excluded as they were duplicate results from a different search 
term, e.g. the search term “DNP forum” and “Rimonabant forum” may have both linked to 
the same website.  
Stage 2. Identifying relevance of forums 
The second stage of analysis involved collecting more detailed information about the 
forums. A Geolocation tool will give information on the location of where a website was 
registered based on its IP address or hostname. Digital Points geolocation tool (Digital 
Point n.d.) was used to identify where each of the 84 websites in stage 2 had been 
registered. The majority of websites were registered in either the USA or UK (Table 4) 
however, country of registration does not necessarily mean the users of that website will 
primarily be from that country. 
Table 4. Country of registration 
Country of registration Number % 
USA 31 37% 
UK 16 19% 
France 11 13% 
Poland 7 8% 
Germany 5 6% 
Netherlands 4 5% 
Switzerland 2 2% 
Canada 1 1% 
Ireland 1 1% 
Italy 1 1% 
Lithuania 1 1% 
New Zealand 1 1% 
Panama 1 1% 
Portugal 1 1% 
Sweden 1 1% 
Total 84 100% 
 
Each website was visited to ascertain the nature of the forum, e.g. body building, weight 
loss etc (Table 5). Twenty six percent of the forums were classified as other. ‘Other’ 
included gaming forums, entertainment forums and parenting forums, in these cases 
discussion on weight loss was often found in miscellaneous sub-forums and in some cases 
specific weight loss sub-forums. Of these, 12 were excluded as they did not include weight 
loss drug user discussion, for example one of the forums was for chemists discussing the 
chemical make-up of DNP. A further 25% (21 forums) were excluded as the websites were 
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not in English and therefore difficult to translate and also less likely to have UK members. 
An additional forum was excluded from analysis as all weight loss drug discussion on the 
forum centred around the advertisement of weight loss drugs. This left 50 forums included 
in the analysis at this stage.  
Table 5. Nature of forum 
Nature of forum Number % 
Other 22 26% 
Translation issue 21 25% 
Body building 18 21% 
Drugs 10 12% 
Weight loss 6 7% 
General Health 3 4% 
Health condition specific 3 4% 
Adverts 1 1% 
Total 84 100% 
 
In order to identify the feasibility of identifying female forum users, each forum was visited 
to see whether there was a designated female sub-forum within the site. Several of the 
forums did have a female specific sub-forum (18; 36%) and three forums were specifically 
aimed at women (Table 6). Checks were also made to see whether it was possible to 
identify the gender of forum posters, i.e. was sex recorded as part of the user profiles. The 
majority of forum profiles did not routinely include this information (Table 6). Similarly, 
forums were also checked to see whether it was possible to identify the location of forum 
posters, i.e. from which country were they posting from. Again, many forum profiles did 
not routinely include this information (Table 6). An additional two forums were excluded 
at this point as the websites had not been working throughout Stage 2. 
Table 6. Gender/location identification on forums 
  Female section  Gender on profile Location on profile 
Unknown 5 11 12 
Yes 18 11 18 
No 24 28 20 
Female forum 3 NA NA 
Total 50 50 50 
 
Stage 3. Search engine cross checking 
The third stage of the forum analysis involved validating the Google search results by 
carrying out the same searches across other search engines. Whilst Google is the most 
widely used search engine in the UK, holding 89% of the market share in the UK (as of 
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October 2014), Bing and Yahoo hold 6% and 4% respectively (Statista 2014). Google, Yahoo 
and Bing all uses different algorithms to dictate both which search results will appear and 
the order in which they appear, with hundreds of factors influencing this. Factors include 
age of domain, number of links to that webpage and number of shares on social media 
(Moz 2015). As each search engine uses different algorithms it may be that the same 
searches on different search engines will produce different results. In order to ensure that 
the most relevant forums were being accessed the original searches carried out on Google 
were repeated on Yahoo and Bing. Of the remaining 48 websites found from the original 
Google search, 32 (67%) were also generated from the Bing searches and 31 (65%) were 
generated from the Yahoo search. An additional 12 websites generated from Bing/Yahoo 
were added to the forum list which had not appeared in the Google search resulting in 60 
forums altogether. Of the 60 websites accessed via Google, Bing or Yahoo, 30 were found 
across all three searches.  
Many websites were excluded in stage 1 as they were duplicate results from previous 
searches. For example, the search term “DNP forum” and “Rimonabant forum” may have 
both linked to the same website. In these cases, the forum was only recorded once. 
However, this information is still useful to see which search terms brought up which 
forums. Bodybuilding forums were generally more likely to have resulted from 
DNP/Dinitrophenol search terms whereas the weight loss forums more often resulted 
from sibutramine and rimonabant key search terms (Table 7). 
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Table 7. Search terms and types of forum 
Nature of 
forum 
DNP 
forum 
Dinitrophenol 
forum 
Sibutramine 
forum 
Reductil 
forum 
Meridia 
forum 
Sibutrex 
forum 
Slimex  
forum 
Rimonabant 
forum 
Acomplia 
forum 
"Weight loss 
drugs" forum 
"Weight loss 
pills" forum 
Weight loss N Y N N N N N N N N N 
Weight loss N N N Y N N N N N N N 
Weight loss N N N Y N N N N Y N N 
Weight loss N N N Y N Y N Y Y N Y 
Weight loss N N N Y N N N Y N N N 
Weight loss N N N N N N N N N N Y 
Weight loss N N N Y Y N N N N N Y 
Weight loss N N N N N N N Y N Y Y 
Weight loss N N N N N N N N N N Y 
Weight loss N N N N N N N N N N Y 
Other N N Y N N N N N N N N 
Other N N Y N N N N Y Y N N 
Other N N Y N N N N N N N N 
Other N N N Y N N N N N N Y 
Other N N N Y N N N N Y N N 
Other N N N N N Y N N N N N 
Other N N N N N N N N N N Y 
Other N N N N N N N N N N Y 
Other N N N Y N N N N N N N 
Health 
 
 
N N Y N N N N Y Y N Y 
Health 
 
 
N N N N N N N N Y N N 
Health 
 
 
N N N N N N N N N N Y 
General health N N Y Y N N N N N N Y 
General health N N N Y N N N N Y N N 
General health N N N N N N N N N Y N 
Drugs Y Y Y N N N N N N N N 
Drugs Y Y Y N N N N N N N N 
Drugs Y N Y N N N N Y N Y N 
Drugs N Y N N N N N N N N N 
Drugs N Y Y N N N N Y N N N 
Drugs N Y N N N N N N N N N 
Drugs N N Y N Y N N N N N N 
Drugs N N Y N N N N Y N Y N 
Drugs N N N N N N N Y N N N 
Drugs Y N N N N N N N N N N 
Drugs N N N N N N N N Y N N 
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Drugs N N N N N N N N N Y N 
Body building Y Y Y Y N Y N Y N N N 
Body building Y Y N N N N N N N N N 
Body building Y N N N N N N N N N N 
Body building Y Y N N N N N N N N N 
Body building Y Y N N N N N N N N N 
Body building Y Y Y N N N Y Y Y N N 
Body building N Y N N N N N N Y N N 
Body building N Y N N N N N N N N N 
Body building N Y Y N N N Y N N Y N 
Body building N Y N N N N N N N N N 
Body building N Y N N N N N N N N N 
Body building N Y N N N N N N N N N 
Body building N Y N N N N N N N N N 
Body building N Y N N N N N N N N N 
Body building N N Y N N N N N N N N 
Body building N N Y N N N N N N N N 
Body building N N N N N Y N N N N N 
Body building N N N N N N N Y N N N 
Body building N N N N N N N N N N Y 
Body building Y N N N N N N N N N N 
Body building N Y N N N N N N N N N 
Body building N Y N N N N N N N N N 
Body building N N N N N N N Y N N N 
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Stage 4. Alexa 
Alexa provides data on traffic estimates and ranks for websites (Alexa n.d.). These 
estimates and ranks are based on the browsing behaviour of people in Alexa’s global data 
panel. The global data panel is made up of a sample of all internet users; details of the 
demographics and numbers of those in the panel has not been released by Alexa. Each 
website is given a rank that is based on the number of unique visitors and page views, and 
these ranks are provided at both a global and national level. If a website has a low level of 
traffic then it may be that there is not enough data, i.e. not enough visitors and Alexa 
records this as ‘No Data’ traffic ranks.  Both global and national ranks were recorded for 
the home page9 of each of the 60 forums remaining in the forum analysis. Ranks are 
updated every day so are likely to change during the progression of the forum analysis. 
When checked (on the 15th March 2015) the highest global ranking recorded was 117 and 
the lowest was 22,712,845. Nationally the highest rank recorded was 14 and the lowest 
157,934. Twenty three of the websites did not have enough traffic to be ranked. Alexa also 
records the country of visitor to the website; the percentage of website visitors who were 
from the UK varied from 2.9% to 79.6%; again this information was not recorded for 23 of 
the websites. Alexa also provides some information on the demographic breakdown of the 
users to a particular website. Information is available on how the gender breakdown of 
website visitors compares to the general internet population; 17 of the websites had an 
over representation of female visitors, in 23 of the websites women were 
underrepresented and for 20 websites there was not enough information available.   
The 23 websites which did not have enough information to provide their rank within the 
UK were excluded at this stage. Not having a rank means the traffic to the website would 
be quite small and not represent a high number of visitors to the website. This left 37 
forums for potential inclusion in the forum analysis. 
2,4-dinitrophenol 
Seventeen of the 37 forums remaining forums were found following either the DNP forum 
(seven) or Dinitrophenol forum searches (15); of these 16 were generated from the Google 
search, 13 from Bing and 12 from Yahoo. Twelve forums appeared in all three searches.   
                                                          
9 Separate rankings for subpages are not provided 
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Most of the forums were body building forums (11) with five being drugs forums and one 
being for weight loss. Eight of the forums had specific female sections and three had 
gender as part of the user profiles. Only one of the websites had an over-representation 
of female users. 
Sibutramine 
Eighteen of the 37 forums had been found following searches for sibutramine forum (12), 
Reductil forum (8), Meridia forum (0), Sibutrex forum (2), Slimex forum (2); of these 17 
were generated from the Google search, 16 from Bing and 17 from Yahoo. Fifteen forums 
appeared in all three searches. 
The types of forums were varied; five were drugs forums, five other, three body building, 
three weight loss, one general health and one health condition specific. Five of the forums 
had specific female sections and five had gender as part of the user profiles. Ten of the 
forums had an over-representation of female users.  
Rimonabant 
Twelve of the 37 forums had been found following searches for rimonabant forum (10) 
and Acomplia forum (6); of these 11 were generated from the Google search, 10 from Bing 
and 11 from Yahoo. Nine forums appeared in all three searches. 
The types of forums were varied; four were bodybuilding forums, three drugs, two other, 
two weight loss and one health condition specific. Four of the forums had specific female 
sections and five had gender as part of the user profiles. Seven of the forums had an over-
representation of female users. 
Weight loss 
Fourteen of the 37 forums had been found following searches from “weight loss drugs” 
forum (5) or “weight loss pills” forum (9); of these 11 were generated from the Google 
search, 11 from the Bing search and 11 from Yahoo. Nine of the forums appeared in all 
three searches. 
The types of forums were varied; three were drugs forums, three weight loss, three other, 
two body building, two general health and one health condition specific.  
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Four of the forums had specific female sections and three had gender as part of the user 
profiles. Ten of the forums had an over-representation of female users. 
Stage 5. Final forum selection 
 
This section of the methodology discusses the final forum selection (Table 8). The final 
selection of forums took into account: 
Identification of female forum users – As this study focuses upon use of UWL drugs in 
women one of the first criteria taken into consideration was the proportion of forum users 
who are women and also whether women could be identified, e.g. through female specific 
forum subgroups or user profiles.  
                           Established by: Proportion of users who are women 
  Gender specified on forum profiles 
  Female specific sub-groups 
The search term – In order to have discussion relating to each drug included, consideration 
was also given to which search term(s) was used in finding the forum. There was 
representation from DNP, Sibutramine, Rimonabant and weight loss pills/drugs searches.  
  Established by: Search term used to find forum 
Type of forum – In order to have a range of different types of UWL drug use, the nature of 
the forum was also considered. Representation was gained from each of the main forum 
types that were bodybuilding, weight loss and drugs. Other forum types were also included 
if they met other criteria and contained relevant UWL drug discussion.  
  Established by: Type of forum 
Search engine – As search engines use different algorithms to decide the search engine 
rank (i.e. what order websites appear) forums which were found across Google, Bing and 
Yahoo were considered optimal. However, other additional factors such as the 
identification of female forum users was given more weight in this decision process. 
  Established by: Search engine used 
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Forum popularity – Websites which had a higher UK rank were considered more likely to 
have a higher amount of traffic, i.e. a higher number of visitors from the UK to the website. 
Information on number of threads and member numbers was also recorded and taken into 
consideration.  
Established by: Global rank (Low – 1-15,000, Mid- 15,001-50,000, High –                
50,001+) 
UK rank (Low – 1-15,000, Mid- 15,001-50,000, High –  50,001+) 
Ease of searching – Forum which were searchable through keywords without a time period 
restriction and did not require an account in order to view posts were considered optimal. 
When deciding which forums would be included, extra weighting was given to those 
forums that had a higher than average number of female users and a high ranking within 
the UK. See Appendix B for a more detailed inclusion/exclusion breakdown of each forum.  
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Table 8. Final forum selection 
Forum 
number 
Search 
engine Search term Forum type 
Female 
sub 
forum? 
Identify female 
forum poster? 
Female population 
proportion compared to 
average 
UK 
ranking Include? 
1 All Dinitrophenol + forum Bodybuilding   Lower High  
2 All Dinitrophenol + forum Bodybuilding   Lower Low  
3 Google Dinitrophenol + forum Bodybuilding   Lower Low  
4 Google DNP + forum Bodybuilding   Lower Low  
5 All Dinitrophenol + forum Bodybuilding   Lower Low  
6 All DNP, Dinitrophenol, Sibutramine, Reductil, Sibutrex, Rimonabant  + forum Bodybuilding   Higher High  
7 All Dinitrophenol + forum Drugs   Lower High  
8 Google Dinitrophenol + forum Bodybuilding   Lower Low  
9 Google + Bing Dinitrophenol + forum Drugs   Lower Mid  
10 All DNP, Sibutramine, Rimonabant, ‘weight loss drugs’ + forum Drugs   Lower High  
11 All DNP, Dinitrophenol + forum Bodybuilding   Lower Mid  
12 All DNP, Dinitrophenol, Sibutramine + forum Bodybuilding   Lower Mid  
13 All DNP, Dinitrophenol, Sibutramine + forum Drugs   Lower Mid  
14 Google Dinitrophenol + forum Weight loss   Not available Low  
15 All DNP, Dinitrophenol, Sibutramine, Slimex, Rimonabant, Acomplia + forum Bodybuilding   Lower High  
16 Bing + Yahoo Dinitrophenol + forum Bodybuilding   Not available Low  
17 All Dinitrophenol, Sibutramine, Slimex, ‘weight loss drugs’ + forum Bodybuilding   Lower High  
18 Google Rimonabant + forum Bodybuilding   Lower Mid  
19 Bing + Yahoo Rimonabant + forum Bodybuilding   Lower Low  
20 All Reductil + forum Weight loss   Higher Low  
21 All Sibutramine, Rimonabant,‘weight loss drugs’ + forum Drugs   Higher High  
22 Google Sibutramine + forum Sex + drugs   Lower Low  
23 Google + Bing Sibutramine, Rimonabant, Acomplia + forum Women 
Female 
forum  Higher High  
24 All Sibutramine, Rimonabant, Acomplia, ‘weight loss pills’ + forum Health   Higher High  
2510 All Sibutramine, Reductil, ‘weight loss pills’ + forum Health   Higher High  
                                                          
10 Whilst forum 25 does appear to meet the criteria for inclusion, it has a very limited search function and only a small number of threads relating to UWL drugs 
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Forum 
number 
Search 
engine Search term Forum type 
Female 
sub 
forum? 
Identify female 
forum poster? 
Female population 
proportion compared to 
average 
UK 
ranking Include? 
2611 All Reductil, Sibutrex, Rimonabant, Acomplia, ‘weight loss pills + forum Weight loss   Higher High  
27 All Reductil, Acomplia + forum Entertainment   Higher High  
28 All Reductil + forum Weight loss   Higher High  
2912 All Reductil, ‘weight loss pills’ + forum Area specific   Higher High  
30 Bing + Yahoo Reductil + forum Financial   Lower High  
31 Bing + Yahoo ‘Weight loss pills’ + forum Weight loss   Higher High  
32 Bing + Yahoo ‘Weight loss drugs’ + forum Drugs   Lower Low  
3313 Google + Bing ‘Weight loss drugs’ + forum Health   Higher High  
3414 Google ‘Weight loss pills’ + forum Newspaper   Higher High  
35 Yahoo ‘Weight loss pills’ + forum Weight loss   Higher High  
36 All ‘Weight loss drugs’ + forum Parenting Female forum  Higher High  
37 All ‘Weight loss drugs’ + forum Bodybuilding   Lower High  
                                                          
11 Whilst forum 26 does appear to meet the criteria for inclusion, users can only access this forum by creating an account and paying a subscription fee 
12 Whilst forum 29 does appear to meet the criteria for inclusion, it is a forum aimed at residents in one city with the UK and not UK residents in general 
13 Whilst forum 33 does appear to meet the criteria for inclusion, it a forum monitoring by health care professionals and discussing the legal use of weight loss drugs 
14 Whilst forum 34 does appear to meet the criteria for inclusion, it has only a small number of threads relating to UWL drugs 
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3.3.3 Data collection 
Nine forums were selected for inclusion in the analysis. Each forum was found to have a 
high female use, high female ranking and advanced search functions. The forums include 
a body building forum, one drugs, 3 weight loss, 1 health condition and 3 other. Each forum 
was given a code ranging from A to I.  
Threads accessed 
For each of the nine forums included in the forum analysis, the key term searches 
described in table 6 (minus the word forum) which were carried out on search engines 
were repeated on the forums. This is regardless of whether the forum was found following 
that search term or not. In total 666 threads were accessed with 44015 threads selected 
for inclusion.  Seventy six threads were excluded as duplicates and 146 threads were 
removed as they involved irrelevant discussion.  The threads were downloaded between 
April 2016 and June 2016. The average number of posts in each thread was 102. Each 
forum was represented with the most threads coming from forum A and forum F (Table 9) 
Table 9. Number of threads 
Forum code Forum type Number of threads 
A Bodybuilding 132 
B Drugs 16 
C Health condition 15 
D Entertainment 14 
E Weight loss 50 
F Weight loss 120 
G Parenting 20 
H Weight loss 47 
I Women 26 
 
Gender identification  
Whilst steps were taken to choose forums with a high proportion of female users and a 
way of identifying female forum users, it was not possible to check every user who had 
posted a comment on each thread. To attempt to estimate the proportion of female users, 
10% of threads from each forum were selected and user profiles from those posting were 
visited to ascertain gender. The threads were randomly selected by assigning each thread 
                                                          
15 For ten of these threads, only part of the thread (which included discussion relating to UWL drugs was 
accessed) 
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a random number using a random number generator in Microsoft Excel (= RAND()) and 
sorting from smallest to largest on that columns value. The top 10% of threads were taken 
from each forum16. Table 10 shows the gender breakdown for each forum; each forum had 
a substantially higher number of women posting than men with the exception of Forum A. 
Due to this, only threads taken from the female specific sub forum on forum A will be used 
in the analysis.  
Table 10. Forum gender check 
Forum code Forum type Female Male Unknown 
A Bodybuilding 7% 52% 41% 
B Drugs 70% 10% 20% 
C Health condition 70% 20% 10% 
D Entertainment 58% 13% 30% 
E Weight loss 73% 9% 18% 
F Weight loss 64% 18% 18% 
G Parenting 93% 0% 7% 
H Weight loss 95% 0% 5% 
I Women 70% 0% 30% 
3.3.4 Interpretation 
Four hundred and forty threads were included in the analysis. Data were analysed using 
NVivo 10 for initial coding and organisation of themes. Thematic analysis was carried out 
as recommended by. This method has been used successfully previously within previous 
online forum analyses (e.g. Attard and Coulson (2012)). Themes were generated and are 
described in chapter 5.  This method follows a six step process: 
1) Familiarising yourself with the data: This involved reading and immersion of the data. 
This was particularly important for the online forum analysis as data had not been 
collected through an interactive way, e.g. through an interview and had not required 
transcription. Instead forum threads and posts were downloaded and  as such there 
was not the same level of familiarity as there would have been through other methods 
of data collection. All forum threads were read through once initially with meaning and 
patterns beginning to emerge throughout this process.  
2) Generating initial codes: The data was then read again, this time more actively looking 
for meaning within the data. Patterns and themes were coded in NVivo version 10.  
                                                          
16 If the selected threads did not include discussion from at least 10 forum users additional threads were visited.  
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3) Searching for themes: Codes were then grouped into overarching themes and 
subthemes within NVivo.  
4) Reviewing the themes: Themes were reviewed. Coded data was reviewed to assess its 
suitability within a particular theme. Themes were re-grouped and reworked until 
identified themes were thought to best fit the data.  
5) Defining and naming the themes: Themes were defined based on the main essence of 
the themes purpose and name. 
6) Producing the report: The analysis was written up, data extracts chosen to capture the 
main points of each theme or sub-theme and accompanying description of each theme 
written.  
3.4 Study 1b. Analysis of other online communities 
In addition to online forums, other online communities were analysed to assess whether 
they contained discussion concerning UWL drugs. In particular Twitter, YouTube and one 
further online discussion group were examined. Searches were carried out on these 
platforms for UWL drugs discussion involving women. Whilst Twitter contained some 
discussion referring to UWL drugs, the data was limited and was not felt to add anything 
Reflexive pit stop – Data analysis 
Originally, I had planned to use Empirical phenomenological psychological (EPP) five step 
method would be used for this analysis. EPP is based on phenomenology theory and allows 
for the collection and qualitative analysis of textual data in an unbiased manner, with the aim 
of describing rather than explaining phenomena. Furthermore, this method has been used 
successfully previously within online forum analyses(A. Kjellgren, Jonsson, K 2013). This 
method involves breaking up text into meaning units each time a new meaning is introduced, 
and transforming these meaning units into researcher language. However, I decided that EPP 
five step method would not be appropriate to use and a standard thematic analysis would be 
more suitable.  
There are three main reasons for this; the first is that the volume of data generated from the 
forum analyses means that it would not be practical to carry out the process of breaking up 
the text into meaning units and transforming into researcher language. With the exception of 
this stage of the analysis, EPP is very similar to a standard thematic analysis and it was felt 
that this additional step would not improve the data quality. 
Secondly, the process of transferring quotes to researcher language may mean that there is a 
loss in data quality as the original utterance is not being used, which could potentially lead to 
misinterpretation or degradation of quotes. Therefore, it was considered preferable to keep 
the quotes as close as possible to the original utterance.  
Thirdly, there is very little research that has looked at the use of UWL drugs in females and as 
such there are no pre-conceptions of what may be found during the analysis process. Due to 
this, I felt that a standard thematic analysis would be appropriate, as a more inductive, 
exploratory method of analysis is required.  
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additional to the forum analysis. Similarly, searches were carried out on YouTube for 
videos relating to UWL drugs. Here whilst there were many videos looking at people’s 
weight loss transformations following UWL drug use, this was predominately carried out 
by men. However, adverts promoting the use of UWL drugs were most commonly aimed 
at women. Whilst an interesting observation, it was not felt that analysis of the videos 
would add anything to this research and they were therefore excluded. Finally, an online 
discussion group was examined. This discussion group had been mentioned by forum users 
on forums examined in study 2 as somewhere they discussed UWL drug use. This online 
group is public and has a subgroup dedicated to the discussion of DNP; however, as posters 
are anonymous it is not possible to ascertain whether those posting are men or women. 
Nonetheless, it was felt that there was interesting discussion concerning the use of DNP 
on this subgroup. Searches were made for posts where the original poster had identified 
themselves as being a woman. This resulted in 30 threads that were included in the overall 
forum analysis. There were no instances of women on this forum discussing either 
sibutramine or rimonabant. In future reference, this forum will be referred to as Forum J. 
3.5 Study 2. Forum moderator interviews 
This study aimed to address number 4 of the overall research aims ‘To assess the role of 
online forums in health promotion and sharing of harm reduction information’ 
3.5.1 Recruitment and procedure 
Study three involved interviews with forum moderators. Moderators of forums where 
discussion relating to UWL drug is occurring are ideally placed, as they are likely to have 
knowledge of the drugs in question, the drugs market and the ways in which online forums 
are used and managed. A selection of forum moderators from forums analysed in study 2 
were originally approached. Original selections attempted to include a mix of male and 
female moderators and from a range of different types of forums, e.g. bodybuilding, 
weight loss and drugs. However, due to a poor response, the forum moderator selection 
process was widened to include moderators from forums that had been considered but 
not included in study 2. Where possible, moderators were invited to participate if they 
specifically moderated female or enhancement drug sub forums. Moderators were 
provided with a participant information sheet (Appendix C), which contained detail of the 
study and contact details for the researcher. Participants either signed the consent form 
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(Appendix D) prior to the interview or, for those who had not returned the consent form 
in time, they were consented at the start of the interview. 
 
Moderators of online forums considered for inclusion in stage 2 were recruited. 
Participants were eligible if they moderated a forum and were able to give informed 
consent to participate. Where the option was available, moderators were sent a private 
message inviting them to participate. If no private message function17 was available then 
moderators were emailed or posts detailing the study were uploaded to ‘Ask the 
moderator’ pages (See Appendix E for forum moderator recruitment message). Non-
respondents were contacted again after a period of two weeks. Those who had still not 
responded after the second message were not contacted again and excluded from the 
study. Forums moderators included in study 2 were originally invited to take part. Once 
happy to proceed, times and places convenient for the participants were agreed. Of the 
nine forums included in study 1 and following attempts to recruit a moderator, one forum 
permanently banned18 the researcher, two stated that no moderators wanted to take part, 
five did not respond and one agreed to take part. Due to low uptake, recruitment was then 
opened up to moderators who moderated other forums. These were forums which had 
been identified during stage 2 but discounted. Priority was given to forums that had had 
female specific sub forums but had been discounted for other reasons. A further nine 
forums were contacted with moderators with a second forum banning the researcher, 
many not responding and three agreeing to take part.  Additionally moderators from the 
online community identified in stage 2b were also recruited. For those that did not wish to 
take part, the reasons given varied. Some just stated that they were not interested in being 
involved, one had been involved in research previously and was not happy with how their 
information had been used, some said they were new moderators and did not think they 
would be helpful and two wanted paying for their time. Follow up messages to those 
moderators to reassure about e.g. how their information would be used or the value of 
their knowledge did not receive a response. 
Given difficulties in recruiting and the reluctance of moderators to take part, a pragmatic 
approach was needed. Moderators who had agreed to take part were allowed to choose 
                                                          
17 Some forums required members to have posted a certain number of times before they could use the 
private message function/ 
18 No reason was given by the forum for the ban 
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how the interview was conducted with most not wishing to speak directly with the 
researcher. Moderators often did not want to give their real names and instead were 
referred to by their moderator names. Throughout this research, a mix of interview 
techniques were implemented; one interview was done through a Skype call, two through 
Skype messenger and one through email. The advantages and disadvantages of this are 
discussed in the limitations section of this chapter.  
The final sample consisted of four moderators. One from the forums included in study 2, 
two from other online communities identified in study 2b and one from forums discounted 
during study 2. One moderator was from a fitness forum, one from an enhancement drug 
forum, one from a weight loss drug forum and one from general drug forums. The original 
aim was to conduct six to 12 interviews, which is in line with previous research which has 
found that data saturation is reached within the first 12 interviews (Guest 2006).  Whilst 
the number of interviews is less than anticipated, all main forum types identified in study 
2 were represented.  
3.5.2 Interview schedule 
The interview schedule (Appendix F) was informed by areas of interest identified during 
stages 1 and 2.  During stage 2 in particular, the volume and variety of information shared 
and accessed concerning UWL drugs across different forums was identified. Whilst initially 
forum moderators were originally included in the study design as it was felt that they 
would hold information about UWL drugs markets, the research focus changed to instead 
being more interested in the role of online forums in providing knowledge around harm 
reduction and good practice information sharing. In particular, the interview schedule 
aimed to tease out forum moderator's’ views of the online discussion relating to UWL 
drugs, the stance of the forum in regards to UWL drug use, and discussion of the role 
forums can play in online harm reduction. Interviews were semi-structured and the 
interview schedule was used as a guide and not a rigid instrument with participants 
encouraged to discuss and explore their attitudes and opinions around UWL drugs 
(Bloomberg and Volpe 2016). The interview schedule however did loosely form three 
parts, 1) participants’ moderating history, 2) how information is shared and managed on 
online forums, and the role of the moderator in this and 3) the role of online forums in 
harm reduction.  
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3.5.3 Data analysis 
Interviews lasted up to three hours and were (when through telephone) audio recorded 
and transcribed verbatim.  Interviews which were conducted through email or messenger 
were copied and pasted into a Word document and identifying information, e.g. names, 
locations or names of forums were removed. Data were analysed using NVivo 10 for initial 
coding and organisation of themes. Thematic analysis was carried out as recommended by 
Braun and Clarke (2006).  
3.6 Study 3. UWL drug user interviews 
This study was used to complement previous stages and help to answer all aims. Interviews 
with UWL drug users were carried out in order to complement data accessed from the 
forums and provide richer data around individual experiences. 
3.6.1 Recruitment and procedure 
Moderators of forums used in study 1 and study 2 were asked whether messages could be 
posted on their forums advertising the study in order to recruit UWL drug users (Appendix 
G). The study details were posted in seven forums and was also advertised on Twitter and 
Instagram (Appendix H). Analysis of online forums and discussion with moderators had 
highlighted that the most common UWL drugs in use for women were sibutramine 
followed by DNP with rimonabant generally being used far less. Whilst recruitment 
material did include rimonabant users, it was anticipated that it was unlikely for those 
users to be recruited.  UWL drug users were provided with a participant information sheet 
(Appendix I) which detailed the study and contact details for the researcher. Participants 
either signed the consent form (Appendix J) prior to the interview or were consented at 
the start of the interview. 
UWL drug users were recruited. Participants were considered eligible if they were women 
and were currently using or had ever used an UWL drug (sibutramine, rimonabant or DNP). 
Recruitment was attempted through forums identified in study 1 and 2 and moderators 
were asked if messages could be posted on the forum advertising the study. As in study 3, 
often this response was not replied to and in two cases resulted in the researcher being 
banned from the forums. One additional forum had a ban on all research recruitment 
requests as they had received multiple requests in the past. Searches were carried out on 
Twitter and Instagram for tweets or posts relating to weight loss drug use and notes were 
made of the most commonly used hashtags. These hashtags were then used within the 
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researcher’s recruitment tweets to enable potential UWL drug users to find the study 
details more easily. Hashtags used referred to fitness, e.g. #fitspo, #fitspiration, #fitgirl, 
being slim, e.g. #thinspo, #thinspiration, the drugs themselves, e.g. #dnp, dietpills, 
#acomplia, bodybuilding, e.g. #fbb, #bodybuildinggirls or just general weight loss, e.g. 
#weightloss, #weightlosstransformation. There was also some indication that DNP in 
particular was discussed within pro-anorexia groups so hashtags like #proana and 
#proanna were also used. Those interested in taking part were encouraged to direct 
message the researcher through Twitter, Instagram or the online forum or email the 
researcher via the project specific account weightlossdrugs@ljmu.ac.uk.  
As with study 2, there were difficulties in recruiting. Often recruitment attempts via forums 
led to responses from forum members stating that women did not use these drugs despite 
the forum analysis not suggesting this. Again as in study 2, a pragmatic approach was taken 
with those UWL drug users who were interested in taking part in the interview being 
allowed to choose their preferred method of doing so. One participant in particular 
expressed strong wishes to carry out the interview through Skype messenger but did not 
want to give her real name, rather she was referred to by her online user name. One 
interviews was conducted through Skype messenger, one through the forum and one 
through the telephone. Again, the disadvantages of this will be discussed in the limitations 
section of this chapter.  
The final sample consisted of three UWL drug users, one who was a DNP user and one who 
used sibutramine. In addition, a response from a female DNP user to the study advert will 
also be included. Whilst this response did not result in an interview, this information was 
still considered useful. Whilst the sample size is small, it was felt more important to gain 
representation from users of different weight loss drugs and from also different groups of 
users, e.g. the informed user versus uninformed user. 
3.6.2 Interview schedule 
The interview schedule (Appendix K) was developed following the completion of previous 
stages and was informed by those stages. During stage two interest was generated around 
the value of online forums and how and why information is shared on them. Many of the 
questions here focused on which online communities or forums people use and why. 
Additional focus was given to what information was gained from online forums, and what 
information participants shared. Questions specific to the use of UWL drugs were also 
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asked, with particular focus on motivations for use, other weight loss strategies, positive 
and negative experiences and side effects. Again, interviews were semi-structured and the 
interview schedule was used as a guide and not a rigid instrument, with participants 
encouraged to discuss issues which they perceived to be of importance. 
3.6.3 Data analysis 
Interviews lasted up to 90 minutes and were (when through telephone) audio recorded 
and transcribed verbatim.  Interviews which were conducted through email or messenger 
were copied and pasted into a Word document and identifying information, e.g. names, 
locations or names of forums were removed. Data were analysed using NVivo 10 for initial 
coding and organisation of themes. Case studies from each interview were created and 
described in chapter 6. 
3.7 Ethical considerations 
Ethical approval was granted for each study by Liverpool John Moores University ethics 
committee.  Study 1, the online forum analysis was granted approval in March 2015 (ref 
code 15/EHC/028). Study 2, interviews with forum moderators was granted approval in 
June 2016 (ref code 16/CPH/016) and study 3, interviews with UWL drug users was granted 
approval in November 2016 (ref code 16/CPH/027). See Appendix L for approval letters 
from the ethics committee. 
3.7.1 Study 1. Online forum analysis 
For study one, guidance was sought from the British Psychological Society (BPS) guidelines 
(The British Psychological Society 2013) on conducting internet mediated research and 
Kozinets’ work on netnography (Kozinets 2002, Kozinets 2010, Kozinets 2015). In line with 
the guidelines and following discussion with the LJMU ethics committee and colleagues 
the following guidelines have been followed; 
1. Only publically accessible forums have been used 
2. Consent was not gained from participant as the information can be considered in the 
public domain 
3. Information has not been included  regarding the name of the forum or forum posters 
4. Direct quotations from forum posters were used as the potential for causing forum 
posters harm by doing this was minimal. 
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Participants/Forums were assigned a unique identifier and forum posts and analyses were 
stored securely on a password protected LJMU computer. Any information relating to user 
names, actual names and location of residence of the participant were removed.  
Whilst this research does specify that only publically accessible forums will be used, 
consideration does need to be given to the fact that even if a forum is publically accessible 
the forum users may not perceive that a public audience will be accessing it . Previous 
research has found in some cases where forum users have found their words have been 
used in research a breach of trust or privacy is felt to have occurred (Barratt 2010). 
However, as previously mentioned this should be considered alongside the potential to 
cause harm to participants, if it was felt that participants could be identified from verbatim 
quotes and this had to potential to cause them harm, e.g. through the discussion of illegal 
drug use then steps were taken to minimize this, e.g. slight modifications made to the 
quotes (without changing the meaning) to ensure they cannot be found. Further 
considerations relating to the ethics of online research is discussed within chapter 7.  
3.7.2 Study 2 and 3 Interviews with moderators and forum users 
In both study two and three, participants who had seen recruitment adverts and contacted 
the researcher stating that they would like to take part in the research were provided with 
written information (via a participant information sheet (Appendix C And I) about the 
purpose of the study. The participant information sheet outlined the purpose of the 
research and what would be expected of participants. Participants were also at this point 
given the opportunity to ask questions about the study. If participants were happy to 
proceed then they were also asked to sign a consent form (Appendix D and J) prior to the 
interview. Those who did not sign the consent form gave verbal consent before the 
interview commenced. Participants were told that their participation was voluntary, they 
could stop the interview at any point and that their data would be treated confidentially. 
It was considered that for study 4, participants may become distressed whilst discussing 
their UWL drug use. Participants were advised if they wished to seek support concerning 
their UWL drug use that they could contact ‘Talk to Frank’ and contact details for this 
service were provided. All interviews were coded, identifiable data was removed from the 
transcripts and transcripts were stored on password protected University computers. To 
ensure confidentially of the participants, transcripts were anonymised of identifying 
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features. Mentions of forum user names, the name of the forum, locations and any other 
names were removed.   
3.8 Limitations  
A number of limitations were identified throughout this research. In particular issues 
around online forum analysis and interview methods are discussed. 
3.8.1 Online forum analysis 
Here there were three main issues. The first was in the forum selection. Due to ethical 
issues, only public forums were accessed. However, often the researcher was made aware 
of closed or private groups where discussion around UWL drug was taking place. As UWL 
drug use is a sensitive issue with legal implications, it may be that not including those 
groups means that this research has missed more open and honest discussion about these 
drugs. The second issue is concerned with how the volume of data generated in study 1 
(due to trying to account for different UWL drug users and using multiple forums to do 
this) meant that it was not possible to look in more detail at online user profiles. There was 
Reflexive pit stop – Identifying female forum users 
Outlined throughout the methodology are steps taken in order to best identify forums that 
have a high female presence as well as steps taken to identify female forum posters. Here I 
only selected those forums that were female focused, had a specific female sub-forum or only 
used forum threads where the poster had specifically said that they were a woman or their 
profile indicated as such. Identifying female forum members was easier for some forums than 
others. For example, on some forums such as those discussing parenting techniques or those 
with female specific topics, it was much clearer whether posters were women or not due to 
the nature or subject matter of their posts. On the bodybuilding and drugs forums however, 
differentiating between male and female members was far more difficult. This was 
particularly difficult when looking at posters who were responding to a question within the 
forum. For example, a member may say I am a woman who wants to lose 20 pounds and ask 
for advice on which weight loss drugs to use. Here, the post explicitly states that the member 
is a woman. However, responses to that post may not always be as a clear. This is because in 
these instances members may not state anything personal about themselves but rather just 
offer advice to the original poster. 
Furthermore, even for those posters who appeared to be women, it is not possible to know 
whether this was the case. The predominately online nature of this research and lack of 
contact between myself and the ‘participants’ of the study means I have no way of knowing 
for sure whether those using the forums are who they say they are. However, this is the case 
in all research where there is a lack of contact between the researcher and participant, such 
as an online questionnaire and may also even also be the case where this is contact.  
Given the online nature of this research there is potential for male forum user’s posts to have 
been inadvertently selected. However, the systematic processes utilised both in selecting 
forums and forum threads means that there can be the same level of confidence as we would 
have in any research in saying that those participating are who they say they are.  
 
65 
 
no attempt to collate individual’s posts or retrospectively monitor their posts to see if the 
forum had for example influenced their behaviour. Furthermore, user profiles were not 
examined so, unless explicitly stated in the post, the researcher had no knowledge of their 
background or their weight loss journey.  
3.8.2 Interviewing 
It was anticipated at the start of the study that most interviews in study 3 and 4 would be 
carried out via telephone or Skype call due to the probable geographical dispersion of 
participants and the potential sensitive nature of the subject. However, the intention was 
for all interviews to be carried out using the same method and not doing so results in 
obvious disadvantages. Different strategies of conducting an interview can cause 
differences in both the type and quality of information gained. Conducting email or 
messenger emails can result in extended access to participants (Opdenakker 2006) as was 
the case in this research; it was felt that not offering these options would have resulted in 
less participants recruited. However, using face-to-face interviews means that the 
researcher can pick up on social and non-verbal cues such as tone of voice, intonation, 
gestures and body language, some of which will be missing in telephone interviews and all 
of which will be missing in messenger or email interviews. Whilst some arguments are 
made that in messenger or email interviews, emoticons can be used to suggest intonation, 
there are differences across cultures in how emoticons are used and what their perceived 
meaning is (Opdenakker 2006). However, it can be argued that affective contributions in 
any interviews are subjective and open to researcher interpretation. Kazmer and Xie 
(2008) discuss how in their research when a participant laughed it was the researcher’s 
decision whether to include this or not but in typed responses, e.g. messenger or email 
interviews it becomes the participant’s decision.   
3.9 Chapter summary 
This chapter has provided an overview of both the methodology chosen for this research 
and in detail outlined the methods taken. Three studies have been outlined; an online 
forum analysis, interviews with forum moderators and interviews with UWL drug users. 
Each method was described and particular attention was given to the discussion of the 
online methods used and the systematic process involved in undertaking this study. The 
next chapter (Chapter 4) presents a summary of each of the forums analysed. 
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Chapter 4. The group dynamics of online forums 
4.1 Introduction 
The aim of this chapter is provide an understanding of the types of online communities 
where UWL discussion takes place. A description of each community is provided as well as 
information on the purpose of the forum, the dynamics of the forums, the role of the 
moderator, the way experiences are shared and how those experiences influences forum 
users behaviour.  
This chapter presents findings from study 2, (Figure 4), analysis of online forums. Data 
obtained from the online forum analysis is presented with extracts provided to illustrate 
the findings19.  
Figure 4. Order of research studies 
 
Ten forums were selected for inclusion in this research. Forums were selected according 
to a specific methodology and inclusion and exclusion criteria. For a more detailed 
breakdown of how the forums were selected see Chapter 3. This section provides an 
overview of each of the different forums, what they are used for, how information is 
shared on them and how members interact.  
                                                          
19 Quotes provided are as written in online forum posts. Whilst quotes have been checked to ensure 
Google Searching does not bring up the original post, they have not been edited for spelling or grammar. 
Study 1. Online forum 
analysis
Study 2. Interviews 
with forum moderators
Study 3. Interviews 
with UWL drug users
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4.2 Forum A: The in-group bodybuilder 
Forum A is aimed at bodybuilders. It is a large forum with over 10 million members and 
over 6 million threads. It is hosted on a website which supports training plans and weight 
loss plans for both men and women as well as an online shop which sells supplements for 
weight loss, muscle building and increased energy. The forum has a number of sub forums 
with a focus on fitness, nutrition, bodybuilding and supplements. Initial searches on forum 
A found 132 threads where discussion about an UWL drug was taking place. However, due 
to small female numbers on these threads only those threads which were in a female sub-
forum were included (n=22). Despite discussion taking place on the forum around UWL 
drugs, the forum rules requested that users did not discuss any drugs, which were illegal 
or banned substances. Discussion of these substances could result in the forum poster 
being banned. Whilst forum threads discussing UWL drugs were available on this forum, it 
did appear that many of these threads had been closed potentially due to them discussing 
unlicensed substances. Invitations by the researcher to forum moderators to take part in 
interviews for this research resulted in the researcher being banned from the forum with 
no reason given. 
4.2.1 Attitudes towards UWL drugs 
Several threads on forum A were from women asking for advice on the use of DNP with 
thread titles such as “DNP for weight loss” and “Has anyone tried DNP?”. There were a few 
references to sibutramine and rimonabant but in most cases just as a comparison to DNP 
to say that they were not as effective. Attitudes towards the use of enhancement drugs on 
this forum was generally mixed with many women stating that they used some form of 
weight loss drug or fat burner often alongside other supplements or enhancement drugs. 
However, the women on this forum did strongly advise against the use of DNP in “newbies” 
or those who had not done their research making such comments as “Do you really want 
to be suggesting DNP and Clenbuterol to her? She's a first-time competitor trying to lose 
several lbs”. Additionally there was much discussion concerning the side effects of DNP 
and other UWL drugs such as “besides killing you in less than a day, can also cause 
cataracts, and cell mutations...hmm cell mutations and oestrogen and breast = cancer”.  
There were many women who did not advocate the use of UWL drugs but did not openly 
judge other for using or considering their use stating “I prefer to stay legal, though. No 
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judgement, just the way I roll”. Many discussed competing in bodybuilding competitions 
and having lean muscular physiques commenting that “my abs are starting to show 
muscular form...legs also”, suggesting that the use of UWL drugs in these women was 
mostly as an addition to rigorous diet and exercise programmes.  
4.2.2 Sharing of experiences  
Forum A was often used by women as an avenue to share their own experiences of weight 
loss and more specifically UWL drug use. As it is a bodybuilding forum, much of the 
discussion was centred around competing in body building competitions and losing weight 
in preparation for this, for example, “I am finally planning to do my first even BB 
competition and I'm looking for some advice regarding supplementation”.  Whilst women, 
despite their views on UWL drugs most often responded to these threads in a respectful 
and informative manner there were some instances where this was not the case. This was 
often in response to others who stated they were considering using UWL drugs due to 
being overweight, “I am overweight and trying to lose 50 lbs… I want a toned, muscular, 
firm body and I will pretty much do anything to get it”. In threads of this nature, there were 
far fewer responses. Those who did respond were often dismissive of the forum poster 
appearing to feel that they were just looking for a quick way to lose weight and seemingly 
assuming that they had given no consideration to their diet or exercise regime arguing that 
“Fat loss will always go back to your diet, there is no magic pill”. What was also clear here 
was the definite division between the long-term Forum A members and those considered 
‘newbies’. New members frequently sought advice from those longer term members who 
they believed to be experts  saying “I am looking for sound advice and relying on the 
expertise of people on this site because they at least look like they know what they are 
talking about - have been doing it for a long time and likely have some wisdom to impart 
to someone who is starting to rebuild her body back all over again”. Similarly women often 
recommended specific people to speak to on the forums saying “DNP can kill u.. hop onto 
[name of forum member] site or pm her...she can get u on the right track...the correct 
track”. This suggested a sense of community on the forum with members having 
awareness of each other’s knowledge and interest.  However, attitudes towards new 
members was often quite negative with established forum members believing them to 
have little knowledge, making such comments as “BLAH. I feel like a newbie retard, 
drowning in a sea of valuable information that I can't use because I can't process it”.   
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Women were extremely candid about sharing their experiences suggesting a feeling of 
comfortableness posting within a forum setting. They spoke about the specific drugs they 
had used, for example, “i used two substances known as "DNP" and "clen" as well as 
motivations for use, “I have been weight training for a few months now and I have put on 
alot of muscle but I cant seem to lose any body fat in fact I have gained weight…I have 
heard that DNP works really well to lose weight and lose it fast has anyone heard this or 
tried it?”. There was also a willingness from some members to share their own experiences 
in order to assist others in using UWL drugs, “i can give you some pointers and tell you 
what it was like for me to take it if you like”. Women often seemed to want to share their 
experiences in order to educate others and prevent them from wasting their time on costly 
and ineffective weight loss products arguing, “when it comes down to cutting, it’s my 
subject. I've done numerous amounts of supplements, over the counter and black 
market…I’ve lost 45- 50 pounds in a year, but lost a lot more money wasted on things that 
didn't work so hopefully I can help”.    
4.2.3 Supportive community 
On forum A it was clear that there was often friendship and collective understanding 
between the women. There were many ‘in-jokes’ such as  participating in online role play 
where they pretended to be attending a night out, “I'll DJ lol”, enquiring after specific 
members “Hey [member name]! How is your Sunday treating you?” and greeting and 
saying farewell to members “Heeeeeeeeey! Just popping in to say goodnight everyone!”.  
Beyond this, members also used the forums to discuss issues and events occurring in their 
real lives such as other peoples reactions to their physique, e.g. “She said that she only 
wants to lose her fat, and not build any muscle because she doesn't want to look gross like 
me”,  and feelings of insecurity and unhappiness such as “I feel like clawing my face off 
when I look at myself in the mirror. (STRONG SELF LOATHING) right now”. Issues with 
health and the impact of this on competing  were also discussed, for example, “well ladies 
this is a very depressing post for me and I’m scared. So I’m sitting at 67 days out which is 
about 9.5 weeks out from my comp and the past 4 days have been horrible”. When women 
expressed feeling negative about their weight loss or other aspects of their lives, others 
responded in supportive and encouraging ways saying “Don’t ever give up on a dream due 
to the amount of time it will take to achieve it, the time will pass anyway”. Similarly, they 
expressed concern over the lives of others on the forum such as enquiring after their 
health, e.g. “Morning [member name], you feeling any better today?” and posting 
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supportive messages when members discussed negative reactions from those in their ‘real 
lives’. Additionally when women posted feeling positive about how they looked, they got 
positive reactions towards their appearance such as “CONGRATULATIONS!!!!! You are so 
pretty! You should try getting on the cover of [female fitness magazine]” as well as their 
achievements and potential future achievements, “Yay for the 17.8% body fat!!!! woo-
hoo!!!! That is awesome! You are going to be great on stage!”.  
4.2.4 Impact of forum on members attitudes or behaviour 
There was a lot of information given on the forums by women concerning the use of UWL 
drugs both advising for such as “it sounds like the DNP would be something you might want 
to start looking into” and against their use, for example “DNP is banned. It is for research 
purposes and not appropriate to talk about on this forum, and it CAN KILL YOU”. As 
previously mentioned, both the level and type of information varied dependent on how  
those asking the questions were viewed. However, what was apparent was that those 
posting advice did have an impact on others in their decisions whether to use or not use 
weight loss drugs. For example, one woman posted asking generally about diet pills stating 
that she was only 18, was in her cutting phase and wanted to know what other drugs 
people had used and whether she should use them. Members originally commented on 
her diet and exercise regime and made suggestions from where she could improve 
prompting her to respond “Thanks for the advice. I will definitely try that”. Furthermore, 
women on this thread also argued for losing weight without resorting to diet pills. Drugs 
like DNP were mentioned but argued that whilst DNP was effective it was “not a cool toy 
to play with”. In this case, responses from other members prompted the original poster to 
respond stating that “Thanks everyone for your words of confidence and knowledge! You 
guys really know your stuff. I feel a lot better about dieting without the use of diet pills...I 
feel like I will actually succeed now!” For a woman considering using a fat burner to lose 
weight for a body building competition there were many suggestions of different UWL 
drugs and other weight loss products that she could consider taking including DNP. 
However, others suggested that something like DNP would be too “hardcore” and instead 
suggested fat burners that were considered less dangerous. In this case, the forum 
member responded by saying “Thanks to everyone who posted... I will take the advice of a 
fat burner... I agree that trying anything more than that at this stage is inappropriate... but 
thanks for the information anyway”. Whilst it is impossible from the forums to know for 
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certain whether members did take advice or not, their postings suggested that they were 
intending to. 
4.3 Forum B: The risk averse 
Forum B is a drugs forum. It is a large forum with over 700,000 members and over 300,000 
threads. There is a focus on legal drugs and the forum is aimed at both those using drugs 
and health care professionals who administer them. Information is given about drugs, their 
side effects and interactions but the sale of drugs is not permitted on this website nor is 
seeking advice concerning illegal substances. Forum B had 16 threads that included 
relevant UWL drug discussion. There was no DNP discussion on forum B. Instead there was 
a focus on sibutramine and rimonabant. Whilst there was some discussion of these drugs 
prior to the drugs withdrawal of license, focus was given to discussion that occurred since 
they become banned. No response was received from forum moderators to take part in 
an interview. 
4.3.1 Attitudes towards UWL drugs 
There were many threads on forum B where women requested information about UWL 
drugs and were looking for quick weight loss. Thread titles such as “I’m in need!!” and 
“What else is good for quick weight loss?” illustrates this. However, often UWL drug 
discussion on this forum was closed down quickly with members arguing that they “don’t 
promote selling drugs on the forum”. In addition, answers to threads of this nature was 
often limited with usually only one or two members responding. There was also a lot of 
discussion promoting other weight loss strategies over UWL drugs with members saying 
“Drugs aren't the way to go for weight loss” and instead promoting diet and exercise such 
as “I would recommend exercising and no junk food. This should solve your weight problem. 
You are in good health, why do you want to spoil yourself, getting addicted to drugs”. There 
was a high level of scepticism towards UWL drugs on forum B with women often arguing 
that they were not the answer to for sustained weight loss saying “most of the time they 
do not work”.   There was also some discussion around where to purchase UWL drugs with 
women arguing that buying any drug online was risky and advising members against this, 
e.g. “Buying medication online can be dicey. Be careful”. Although limited, there were 
some posts promoting the use of UWL drugs and advertising their sale, “We can supply 
Rimonabant with best price and quality”.  
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4.3.2 Sharing of experiences  
Forum B was used by many women to share experiences of their weight gain and 
motivations for considering the use of UWL drugs as well as their experience of using the 
drugs, both negative, e.g. “I have been taking 1/2 tablet...I have energy and my appetite is 
suppressed but I have not noticed a weight difference” and positive, e.g. “I have been on 
Meridia for around a week now and don’t have craving for sweets anymore”. Members 
also used the forum to ask about other methods of weight loss they could use, for example 
“What am I doing wrong? I am looking to lose 20 to 25 lbs. I haven't even lost 1 lb yet!”. 
Whilst women were very open about sharing experiences in their lives and explored the 
motivations for using UWL drugs, there was very little information on this forum 
concerning in depth experiences of using the drugs. This may have been due to negative 
or limited responses to those who were enquiring about these drugs. 
4.3.3 Supportive community 
There was a great sense of support and nurturing on this forum. Women on the forum 
appeared comfortable talking about many personal issues. One recurring topic which was 
discussed was depression with many discussing how their use of antidepressants had 
caused them to gain weight, e.g. “I just got to this site by searching for a possible new 
antidepressant (I suffer from anxiety, panic attacks, and depression), that wouldn’t result 
in weight gain”.  Beyond discussion around weight and how to lose it, women discussed 
many personal aspects of their lives including their home situation such as “My husband 
decided after being together for 11 years and married for 4, to announce that he doesn't 
love me and wants a divorce”. In many instances women appeared to view the forum as 
an outlet for them to discuss stressful situations as seen here, “Anyone out there know 
what I'm saying? Thank you for listening”. Women frequently stated how much the forum 
meant to them, e.g. “I am so grateful that I found this forum” and seeming comforted by 
other members being in similar situations to themselves saying “I can't believe I found 
someone that is in the same situation!”. Women on the forum seemed to have been 
members for sustained periods of time rather than dipping in and out and frequently kept 
others up to date on their lives with comments such as “Will keep you posted because I am 
determined not to be fat anymore. Thank you to all of you for your posts”. It was clear from 
the posts that the women on this forum had shared histories and were aware of ongoing 
issues and events in other member’s lives that demonstrated familiarity, e.g. “I am sorry 
to hear that. It is good that you are being strong. Don't give up” and explicitly asking them 
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about ongoing issues such as “[Forum member]. Just wondering how the reduction in 
medication is going. Have you lost any weight”. Women on the forum generally displayed 
caring tendencies towards those seeking UWL drug advice however advised caution to 
members in using UWL drugs.  
4.3.4 Impact of forum on members attitudes or behaviour 
There was very little evidence of forum B influencing others decision in using UWL drugs. 
This is likely due to women not frequently engaging in discussion of this nature. For the 
few occasions where patients did ask about UWL drugs or share their experiences, for 
example “I took 10mg of Meridia for four weeks. I lost 16 lbs”, responses were minimal and 
negative arguing that the discussion of drugs of this nature was not permitted on forum B 
or that they were unsafe. Usually this resulted in the thread being closed so it was then 
not possible for the original poster to respond meaning it was impossible to know whether 
advice from forum members had been taken. Unfortunately, due to a lack of advice to 
forum members it meant in some cases women were given incorrect information about 
UWL drugs but did not have this error rectified by other members, e.g. “I was under the 
impression that Sibutramine and Phentermine are the same so I ordered 120 of the 15mg”. 
It is unclear whether this was due to a lack of knowledge on the forum about the drugs or 
whether it was due to a lack of engagement about the topic.  However, it was clear that 
women did take advice from others or were at least receptive to the advice and 
experiences that had been shared as seen in this comment “Thank you everybody for 
sharing your experiences. I thought I was going crazy”.  
4.4 Forum C: Overweight and frustrated 
Forum C is a forum designed for people with Type 1 or Type 2 diabetes. It is a fairly large 
forum with over 100,000 members and over 50,000 threads. Whilst the main focus of this 
forum is not UWL drugs, discussion of these drugs is still evident. Fifteen threads were 
included in the analysis and all discussion focused on rimonabant or sibutramine. Much of 
the discussion of these drugs related to women using them prior to them becoming 
unlicensed which was excluded. There are no explicit rules banning the discussion of UWL 
drugs, rather the rule focus upon encouraging a positive and respectful environment.  No 
response was received from forum moderators to take part in an interview. 
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4.4.1 Attitudes towards UWL drugs 
Forum C had discussion from women who claimed to use UWL drugs pre-ban as well as 
some querying where they could get them from. Most of the threads centred on struggles 
with losing weight with thread titles such as “Unable to lose weight” and views on the use 
of these drugs were mixed with some members advocating the use, e.g. “Losing weight is 
the main problem but I can suggest you one drug that help in losing weight named as 
Acomplia” and others advising against, for example “Sounds like Rimonabant. However, 
reading side effects etc I don't think you want to go there!”.  Generally, though women on 
this forum did not consider UWL drugs as an option for them. There were many who had 
used rimonabant or sibutramine prior to their ban but due to them now being unlicensed 
would not consider still using them stating “Acomplia and Meridia were withdrawn on 
safety grounds several years ago”. Furthermore, many members expressed unhappiness 
at these drugs being banned as they considered them effective weight loss drugs and had 
not been able to find an adequate replacement saying “They’re not working at the 
moment, if only they had not banned Acomplia”. 
4.4.2 Sharing of experiences 
Women did discuss their experiences of weight loss, for example “Within 6 weeks and with 
little effort, I lost over half a stone” and the reasons why they wished to lose weight saying 
“I am overweight, my BMI is 29”. Most often on this forum, weight was  linked to diabetes 
and much of the discussion was centred on the use of oral-antidiabetic drugs, coping with 
diabetes and trying to lose weight, for example “I was diagnosed with type 2 diabetes and 
had to change my diet”. There were instances where women asked for others experiences 
of using UWL drugs such as “Anyone else struggling to lose weight or has started on 
Reductil?” or for other members to share their knowledge of some of the effects 
associated with their use, e.g. “What side effects are there for Reductil?”. Whilst some 
women did respond with comments such as “Have tried Reductil. It made me very 
hyperactive and unable to sleep so I stopped taking it after 2 weeks”, this was very limited. 
Women on this forum generally took the stance that UWL drugs should not be used and 
therefore discussion of their use was not encouraged. Some did share motivations for 
using UWL drugs such as “my daughter is getting married in august so I have been trying 
to lose weight. Is anyone taking ACOMPLIA? I have heard a lot about it and would like to 
hear more.” but again threads of this nature did not elicit a large response from others on 
the forum.  
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Women were very open on the forum, discussing their own experiences as well as those 
in their personal life, for example “As a result I have lost about half a stone. My partner 
has also lost over a stone”. Women also frequently turned to the forum to ask for advice 
such as “Does anybody have experience of these two drugs or any wisdom to impart?”, as 
well as experiences of using weight loss drugs, “I’d be very interested to hear from anybody 
who has on them longer and can report on weight loss.”.  Women also shared their 
experiences of using UWL drugs and discussed using the drugs in relation to their weight 
loss. 
4.4.3 Supportive community 
Overall, the forum was a supportive community. However, there was not the sense of 
familiarity as on other forums. Whilst members were courteous to each other, many of 
those posting had low post counts indicating that they were not regular forum users. 
Despite this, they were welcoming to new members with comments such as “hiya [forum 
member] and welcome”, wished members well in their weight loss, for example “Good 
luck” and were grateful for responses to their posts saying “Thanks for all your kind advice”. 
There were some instances where members eluded to keeping in touch with others on the 
forum, e.g. “thank you for the answers. I just wanted confirmation before I started 
changing my diet. I will keep you informed of my progress” but this was limited.  
4.4.4 Impact of forum on members attitudes or behaviour 
The impact of forum member’s posts on others was not as evident on this forum as others. 
This is likely due to lower response numbers on threads with women seemingly not 
wanting to discuss UWL drugs. Compared to e.g. Forum A that had an average of 
approximately 250 posts per thread, this forum only had an average of six posts. This 
indicates that women on this forum did not often answer others questions and when they 
did it was rare for those members to return to the forum to report their progress. 
 
4.5 Forum D: Advice seekers 
Forum D is an entertainment forum covering television, films, gaming, sport as well as 
general discussion topics. The number of members is not given by this forum however, 
there are over 1 million threads. There were 14 relevant UWL drug related threads that 
were all about sibutramine. There were no explicit rules banning the discussion of UWL 
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drugs, however there are rules banning the discussion of illegal behaviour. No response 
was received from forum moderators to take part in an interview. 
4.5.1 Attitudes towards UWL drugs 
Not being a forum dedicated to weight loss or related area, most of the discussion related 
to UWL drugs took placed within the ‘seeking advice’ threads. Much of the discussion was 
women querying whether UWL drugs works and how safe they are to use with thread titles 
such as “Do weight loss pills work and is if safe if I took them? :S” and “how safe are diet 
pills?”. Attitudes towards UWL drugs and those using UWL drugs were mixed. Some 
women were very supportive towards to others and showed concern over their UWL drug 
use and potential side effects. Many women however, viewed the administration of UWL 
drugs as something that should only be carried out by health care professionals as they 
would be able to offer the best advice arguing “I wouldn't recommend taking these pills 
without medical back up however - just to make sure you are getting the right guidance 
from a qualified person”. Other women were also extremely against the idea of purchasing 
UWL drugs online and felt that these drugs were only for someone who was clinically obese 
and should only be prescribed saying “diet pills are for obesity, not for losing a size or two. 
A size 14 is absolutely fine. I assume the reason for you getting them online, is that NO 
respectable doctor would prescribe them to you”.  
4.5.2 Sharing of experiences  
Women were generally very open about sharing motivations for using UWL drugs, with 
comments on the forum such as “Although I did manage to lose nearly 2 stones in a year, 
since Christmas it has been steadily creeping back on again”, experiences of using, for 
example “I am currently back taking Reductil, I have lost 13lbs in a couple of weeks but I 
have a lot of weight to lose” and also used to forum to source information, asking “Does 
anyone have any success stories with diet pills?”. Women also spoke about the temptations 
of UWL drugs arguing that feeling unhappy with how they looked and seeing what they 
perceived as successful before and after pictures did encourage them to consider using, 
for example “It is VERY hard to lose weight when you're obese, obviously self-esteem is very 
low, and you need encouragement. So a quick fix is very attractive, especially when 
packaged with rather exaggerated before and after pictures”. Whilst threads discussing 
UWL drugs, such as “But has anyone had success stories with diet pills?” were fairly popular 
with an average of 33 responses on each thread, often women did not seem to want to 
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specifically discuss these drugs in any detail. In most cases, however, it was unclear 
whether this was due to a lack of knowledge about them or because they did not approve 
of them. Instead, women often just posted general statements around how no weight loss 
drugs worked, for example “All these pills are good for is a kick up the arse reminder that 
there is only one way to lose weight - healthy eating and exercise”. 
4.5.3 Supportive community 
On this forum, many of the women posting had been members for a long time and had 
posted thousands of comments. However, perhaps in part due to this being an 
entertainment forum with many different forums and sub-forums that people posted on 
there did not seem to be the same level of familiarity between forum members as was 
evident on some other forums. Information and discussion generally tended to be more 
informative rather than personal. Despite this, members were supportive and occasionally 
there were requests for others to keep them updated with e.g. weight loss progress, “Keep 
us updated with your progress. We will all try and encourage you”. However, there were 
instances where women on the forum were judgemental about the use of UWL drugs with 
comments such as “I'll give you 2 weeks tops at doing that before you're back to stuffing 
your face with pizzas and pies and lounging around on the sofa all day” and “I find it crazy 
that someone who is intelligent enough to be at University as a medical student even needs 
ask something like this” illustrating this. In these cases it led to the original poster either 
not responding or becoming frustrated with those members saying “Have you always been 
so judgemental or did you have to practice?”. For more general weight loss discussion 
however, members were generally supportive giving tips and motivational advice such as 
“well done on losing the 7lbs [forum member]!”.   
4.5.4 Impact of forum on members attitudes or behaviour 
Discussion concerning weight loss methods such as diet and exercise were generally very 
positively received by women on the forum, perhaps because this information was given 
in a non-judgemental way. There were also some instances where women’s negative 
attitudes towards UWL drugs led others to decide against using them as seen in this 
instance, “Thanks guys for the info. Well I read some of the replies here it makes me not 
want to get a weight loss pill”. However, in many cases the perceived judgemental 
responses to those asking about UWL drugs such as “Stop being lazy and looking for some 
fast track way to lose weight, look into what foods you shouldnt be eating and what foods 
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you should be eating and start exercising” often resulted in the original poster not posting 
again or questioning the attitudes of the members with responses such as “How rude”.  
4.6 Forum E: Non-judgemental novices 
Forum E is a weight loss forum covering weight loss, fitness, health and support and 
tracking calories. No information is provided on member numbers or the number of 
threads. There was not a focus on this forum on UWL drugs nor was there an explicit ban 
on discussing them. There were 50 relevant threads however, which included UWL drug 
discussion. The majority discussed sibutramine, however discussion covering DNP and 
rimonabant was also evident. There are no explicit rules banning the discussion of UWL 
drugs, however there are rules banning the discussion of illegal behaviour. No response 
was received from forum moderators to take part in an interview. 
4.6.1 Attitudes towards UWL drugs 
The majority of discussion was from women asking for advice on the efficacy of UWL drugs 
and which drugs they should take, e.g. “Has anyone taken Meridia?” and “So..are there 
any diet pills that actually work?”. Whilst some felt that UWL drugs were not a viable 
option as seen here “It sounds like diet pills probably aren't a good idea for you”, most 
others expressed most positive opinions, for example “I disagree. There's plenty that 
works”. Others also argued that specific drugs such as DNP were scientifically proven to 
work and were effective weight loss drugs arguing “I was talking about DNP, thyroid drugs 
and harsh stimulants. They actually work and are scientifically proven”. There also 
appeared to be some frustration from women due to the drugs that they felt worked 
having been banned and feeling that weight loss products that were available over the 
counter were not effective e.g. “Yeah, everything that has ever been proven to work has 
been banned by the FDA. Well, except creatine, but that's not for weight loss. So if you are 
getting anything over the counter, it doesn't work”. Furthermore, some felt that these 
drugs being banned was dangerous as some people would still be willing to use them. In 
these cases women argued that “I think doctors are doing more harm than good by not 
considering that people may take things into their own hands”.  
4.6.2 Sharing of experiences 
Forum E was used by many women to share their own experiences and knowledge of UWL 
drugs, for example “I think Reductil is wonderful, I don't think about food any more!”. 
Members were open about their use of UWL drugs, even stating that they had tried many 
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different ones saying “I've taken them all, hun. ALL.”. Women also shared their motivations 
for using UWL drugs, e.g. “I started trying diet pills, not for a magic fix, but because I would 
get stuck with my weight loss every five pounds or so. I just wanted something to boost my 
metabolism a little bit”. Others used the forum in order to hear others experiences, 
“Anybody know anything about DNP, if so holler. Ive heard that if taken correctly you can 
lose a significant amount of weight in a short time” and seemed genuinely interested in 
hearing what others had to say stating that “I'd be interested in seeing what other people 
have for suggestions”. There was also a lot of discussion on this forum around the side 
effects of using UWL drugs, motivations for use and both positive and negative experiences 
of use. Forum E was relatively supportive with some members feeling those who used UWL 
drugs should not be judged or treated in a negative manner arguing that “My beef is when 
others are belittled if they do take them b/c for me and it seems for you too, they are a life 
saver”. There were some instances when women felt their questions were not being 
answered or ignored saying “Well, ive had no replies for this post so I guess either nobody 
has heard of Reductil (Sibutramine), dont care about it, or im typing with invisible ink. Lol”. 
Whilst on other forums it appeared this was due to a lack of interest or due to negative 
perceptions of UWL drugs, in this case, it appeared to be due to a lack of knowledge from 
other members on the forum. This was evident through comments such as “Sorry, never 
heard of it! Good luck with it though”. Whilst some members did respond with their 
experiences of using, it was clear this forum did not have the same ‘expert members’ as 
was evident on other forums with members stating they were not aware of the drug or to 
“google it”.  
4.6.3 Supportive community 
Whilst this forum generally saw women being polite to each other, there was not a sense 
of familiarity between members. Whilst, it is not possible to ascertain the size of this 
forum, the average number of responses to each thread was 17 posts indicating less 
engagement to posters questions or advice seeking as seen on other forums. Comments 
like “Sorry if this has been posted before. I didnt have time to check through all of the 
previous posts” suggests that members dip in and out of the forum rather than being 
regular users of the forum. Despite this, members were supportive of each other, wishing 
each other good luck in their weight loss attempts and empathising with others, “I'm where 
you are as well”.  
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4.6.4 Impact of forums on members attitudes or behaviours 
Members on this forum appeared keen to garner advice, experiences and suggestions from 
others saying “I'd be interested in seeing what other people have for suggestions” 
suggesting an openness to taking advice from other forum members.  There were 
instances where members seeking advice about a particular drug, e.g. “Does anybody 
know anything about this drug...Meridia?” were later dissuaded from using it after others 
posted negative attitudes towards UWL drugs or negative experiences following their use 
such as “Thank you very much for the responses!! I defiantely WILL NOT get on the drug!”. 
There were also others who received conflicting information both on whether they should 
use a UWL drug at all and also what they should use leading them to feel confused about 
their different options. 
4.7 Forum F: The hardliners 
Forum F is a fitness forum covering weight loss, diet, exercise, food and nutrition. No 
information is given on member numbers or the number of threads. Posts seen to be 
promoting the use of illegal substances or controversial weight loss methods were banned. 
However, there were 120 relevant threads, which included UWL drug discussion. Each 
UWL drug was discussed with most focus on DNP and sibutramine and a small number of 
threads discussing rimonabant. A forum moderator (Moderator A) was recruited to 
interview from Forum F. 
4.7.1 Attitudes towards UWL drugs 
Many of the threads came from women asking for advice on which drugs would work or 
asking whether they should consider using them, “FAT BURNERS YAY OR NAY?”. Attitudes 
towards the use of UWL drugs were fairly negative with women saying “If weight loss pills 
worked there'd be no fat people, would there?”. This forum advocates healthy eating and 
exercising and does not promote faddy diets or unconventional weight loss methods and 
this attitude was evident in with many women arguing that any form of diet pill or fat 
burner was a scam, for example “It burns your money, not your fat, unfortunately” costly, 
“The only thing which will get lighter is your wallet” and instead promoting what they 
considered to be a healthy weight loss strategy, essentially exercise and diet. Many argued 
that UWL drugs were just not effective saying “Just avoid them. There is no such thing as a 
pill which burns fat. UWL drugs were generally considered the domain of bodybuilders only 
and the average person who wanted to improve fitness or lose weight should not follow 
advice from that group saying, “a high-level or pro bodybuilder is the worst possible person 
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for the average person to take advice from”. Often those women who wished to discuss 
UWL drugs were shouted down by other members, arguing that this community was not 
a place for discussion of this nature with comments such as “You're not going to find 
support on this site for diet aides”. This led some to feel that those who were criticised for 
using weight loss products were being unfairly criticised and judged arguing that “This site 
has become less about support and more about being self righteous”.  
4.7.2 Sharing of experiences 
There were many women who shared experiences of using UWL drugs with thread titles  
such as “My negative experience with weight loss and fat burner pills” as well as their 
motivations for use, for example “I have the last few pounds which are sticking around”. 
Women appeared to want to use the forum to seek advice from those they considered 
experts, e.g. “Weight loss pills that help? Anyone experienced pls look” as well as to learn 
about others experiences, “I guess everyone's body is different. That is why I wanted to get 
people's opinions and experiences” and to gain knowledge of UWL drug side effects, for 
example “is the side effect a long term one?”.  However, questions of this nature were not 
well received by other users with responses such as “You can't be serious?” and members 
strongly advising against use with comments such as “Read the article-these pills contained 
pesticide-NOT meant for human consumption! do NOT buy/take medications on the 
Internet and/or street”. In some cases, when the experiences of members did not tally with 
other members there were a lot of negative responses to this which appeared to leave the 
person posting frustrated. This was seen in comments such as “I knew this would happen. 
I  was just trying to help you with what my own experience has been as well as the advice 
of the professional nutritionists, trainers and bodybuilders in my life. To each his own!” 
4.7.3 Supportive community 
Women were often supportive to each other and there was a level of familiarity between 
members, e.g. “Vote for all this, plus what the lovely [forum member] suggested. You can 
do this, OP!”. This familiarity was evident in members who had high numbers of posts and 
appeared to have been members of the forum for a long time. However for those who 
were newer or specifically asking questions about UWL drugs there was a lot of negativity 
and judgemental responses. Whilst in some cases women appeared to just want to steer 
others away from these drugs and promote a healthier weight loss strategy arguing “None 
of the products you've mentioned are backed by clinical study that show any significant 
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help that a good diet does”, others were far more critical believing motivations for using 
UWL drugs to be due to laziness and stating “People are way too damned afraid of exercise 
these days.”. Often this led to either the person asking the question to not respond or to 
become defensive and annoyed by other forum members. This appeared to be a frequent 
occurrence on this forum with one forum member noting “95% of the time you get a thread 
like this, you get a similar barrage of messages from people telling you it's a huge waste of 
money. The OP usually has nothing of it, says that she's only looking for people who have 
tried it and will only accept positive, supportive advice for the pills.”. However, some longer 
term members did not appear to appreciate this approach instead arguing that the forum 
should be about educating and advice rather than being judgemental, “So i'm not going to 
jump on the bandwagon and make out like you're stupid because you're not - so please 
don't think you asked a stupid question up there. This is what this forum is for - advice and 
support and educating”.  
4.7.4 Impact of forum on members attitudes or behaviour 
Whilst often negative responses concerning UWL drugs led to a lack of engagement with 
the forum there were instances when members took advice on board and valued hearing 
about others experiences as seen here “Thanks, it’s nice to hear other people's opinions 
and experiences”. In one thread a member asked about different UWL drugs and received 
a lot of negative comments with people arguing that if she had to ask what they were then 
she should not be using them, “What you're saying isn't true, Clen, T3, DNP, and other 
chemicals that if you have to ask what they are, you'd probably kill yourself trying to use 
them”. In this instance the member appeared to take this advice on board saying 
“Wow!ok.ok.i will not take them then!i really appreciate everyone's advice and I will take 
it” and others appeared surprised by this “Did the OP just accept and is responding 
positively to all the mean people in this thread?”. One issue which was mentioned on this 
forum more so than others was whether forums were really the best place to gain advice 
on drugs of this nature with some members arguing that health care professional would 
be a more appropriate place to seek advice. In these cases it was argued “before you take 
anything, talk to a health care professional. Do not rely on Internet postings from strangers 
to guide you on what to put into your body.” 
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4.8 Forum G: The weight loss journey mums 
Forum G is a parenting forum covering children and parenting as well as a range of 
miscellaneous topics. Whilst UWL drugs are not the focus of this forum, 20 relevant 
threads which included UWL drug discussion were found. Forum G is a large forum with 
other 2 million members and over 1 million threads. Forum members are advised against 
discussing illegal activities. All three UWL drugs were discussed on this forum, however 
sibutramine was given the most focus. Forum moderators were contacted but did not wish 
to take part citing a lack of interest in the research. 
4.8.1 Attitudes towards UWL drugs 
Women on forum G often used the forum to seek advice about general weight loss drugs 
and products, for example “I need advice on slimming tabs”. Whilst those considering UWL 
drugs were not judged negatively, the advice was often to steer clear of them with 
comments such as “Do not buy reductil. It was withdrawn in the UK and in other places as 
it can cause renal failure, heart attacks and strokes”. Women also discussed there being 
no magic pill saying“[forum member name] I hate to be the one to tell you this, but if you 
want to look good there is no real quick fix” and potential side effects or risks of using, e.g. 
“I wouldn't recommend diet pills as you don't know what they'll do to your body.”. 
Discussion of DNP was limited to discussing media stories of those who had died following 
its use with many on the forum displaying surprise and shock that such a drug existed, for 
example “My god...I didn’t know that such pills were so readily available”. However, there 
were many women who reported positive experiences of UWL drugs and subsequently 
advocated their use saying “my advice is reductil. I'm on it for only a week and I can see the 
result. I'm -1kg, no cravings, no appetite...”.  There were also others who had heard about 
UWL drugs from family or friends and were looking for advice regarding these drugs from 
forum members asking “Reductil. Has anyone tried the above? I am thinking of buying 
some online a friend at work is taking them and seem to be helping her to lose weight”. 
Others also specifically mentioned online sources they had used to purchase UWL drugs 
but still used the forum to get advice about how to take them asking “today I've received 
my reductil pills from [name of website] and I wanna start them asap. Do I take Reductil in 
the morning or in the evening?”. 
4.8.2 Sharing of experiences 
Women often spoke of gaining weight and the associated negative feelings that came with 
this, e.g. “rapidly putting on weight. I’m depressed and the doctors won’t listen!” as well 
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as sharing reasons for why they wished to lose weight saying “With this lovely warm 
weather approaching, I am desperate to lose some weight!”.  Women were generally very 
supportive of each other “good luck with it just keep positive” often sharing diet and 
exercise tips and motivating each other with many using the forum to log their weight loss 
progress, for example “I am starting again today. I want to lose the 5lb I have put on so 
keep posting how you’re getting on. We can motivate each other”. Women were very open 
on this forum, sharing their feelings about their weight as well as other aspects of their 
lives, e.g. “I’m currently sitting here balling my eyes out… Since having my daughter who is 
now one I’ve put on 6 stone. I’ve gone from a happy size 8 to a 18-20”. As well as more 
general weight loss discussion women were open about sharing their UWL drug 
experiences and making recommendations to other members, for example “I'm losing 
weight with Acomplia…I bought a supply of these pills online and started them right away. 
I take them for about 6 weeks and find them very effective at suppressing my appetite, 
speeding up my metabolism and losing weight fast”. Women used the forum to gain 
information on UWL drugs as well as sharing their desperation in finding a solution which 
would help them to lose weight, “Anybody know of any fast weight loss or slimming pills? 
I'm desperate to lose weight, my baby is 11 weeks old tomorrow”. Finally, women kept 
others up to date on their weight loss journey and there was often a sense of a collective 
effort to lose weight as seen here “I’ve lost half a stone so far, have you noticed any 
difference yet?”. 
4.8.3 Supportive community 
There was a real sense of community on this forum. Women referred to each other by 
name, even when their forum user name did not include their real name, e.g. “awwwwww 
[forum member name] we can stay positive together” and frequently asked after each 
other. Forum members were welcoming to new members, taking time to ask their 
questions and there was not a ‘newbie’/established forum member divide as was clear on 
other forums. Women frequently exchanged pleasantries, asking after each other and 
wishing each other luck with their weight loss, for example “wishing you luck and a nice 
day!”. Frequently there was a sense of the women on this forum belonging as a group with 
shared understanding and experiences as seen here, “i know how you feel”. Due to this 
women were very open about sharing personal elements of their life such as having had a 
miscarriage and issues with confidence, for example “Anyone know of any good appetite 
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suppressants or diet pills ? Still carrying extra weight after a miscarriage. lost so much 
confidence.”.  
4.8.4 Impact of forum on members attitudes or behaviour 
Women shared their experiences of using UWL drugs, however there was often a 
reluctance to advise others of what they were using as they did not want to put others at 
risk of side effects. This may be due to the close relationship they appeared to have. In 
these instances, women spoke of the risks of using these drugs but argued that they only 
did so because they were desperate, saying “I know of pills that work…Every so often I get 
depressed about my weight and take them, then get palpitations, dizziness, etc and realise 
how dangerous they are…Saying that I've just ordered more cos I'm that desperate” or 
argued that they did not want the responsible of putting others at risk of harm saying 
“These are serious medicines and I would not be responsible for anyone taking them and 
becoming ill.”. In the instances where members did advise on what UWL drugs to take 
other members responded positively saying “no havent heard of them but tell me more” 
and wanted forum members to give them information about these drugs suggesting an 
element of trust between members. Prominent on this forum was the notion of women 
risking their health taking UWL drugs when they were mothers and had children to look 
after with many members advising against UWL drugs in these cases. In one instance a 
woman who had asked about UWL drugs and was advised against them due to risks opted 
instead to use a herbal weight loss product as she had “4 beautiful daughters to look after”.  
4.9 Forum H: The caregivers 
Forum H is a weight loss forum covering slimming clubs, diet plans, fitness and weight loss 
diaries. Whilst UWL drugs are not the focus of this forum, 47 relevant threads which 
included UWL drug discussion were found. This forum is not as large as other forums 
included in this study however, it still has over 100,000 members and over 300,000 
threads. There are no specific rules against posting about illicit behaviour or drugs. The 
focus on this forum was on the appetite suppressants sibutramine and rimonabant. Forum 
H moderators were contacted with details of the study but did not wish to take part in the 
research just stating no to all contact. 
4.9.1 Attitudes towards UWL drugs 
There were several threads on this forum from women asking others for advice on whether 
to use UWL drugs, for other people’s experiences of using these drugs, for example “Have 
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you ever tried Acomplia, what did you think?” asking for support, “Reductil, can anyone 
offer help or support?”, information on side effects such as “Having heard of the side 
effects of Rimonabant (Acomplia) recently I am scared of taking any more pills. (Anyone 
used/using this?)” and information on prices and where to purchase. Attitudes towards 
UWL drugs were mixed. Some felt that purchasing any drug online was a risk as you could 
not be sure of the products contents saying “And you're never quite sure what you're going 
to get, are you?”, whilst others discussed their own negative experiences of using them, 
for example “As somebody that used Reductil I would say Don't Use Tablets... They're no 
good for you and if you do weight watchers properly you really won't need them”. However, 
other women felt that there was a risk with taking any medicine and UWL drugs were no 
more likely to produce negative side effects than using any other drugs: “I agree they sound 
dangerous but have you ever read the warnings of Ibuprofen?”.  
4.9.2 Sharing of experiences 
Forum H was frequently used by women to share experiences of weight loss and UWL 
drugs but also a range of other issues they were experiencing such as illness, “I am off work 
sick. Had an operation that led to a more serious medical thing”. As a weight loss forum, 
much of the discussion was concerned with member’s weight loss journeys and women on 
the forum were extremely open about negative experiences and feelings associated with 
their weight and their use of UWL drugs. They spoke of such issues as binge eating saying 
“I’m the same as you, I binge eat and have awful trouble stop myself or knowing when to 
stop”, as well as discussing their use of UWL drugs; “I started reductil yesterday. Does 
anybody have any advice on this method of weight loss. I am in desperate need”. Feelings 
of desperation was a common theme with many women making such comments as “i was 
desperate to get reductil. I even thought about buying it from these websites!” and 
discussing what they felt to be extreme measures to help with their weight loss, for 
example “Stupidly I got some Rimonobant online from India”.  Many also discussed UWL 
drugs being their last chance at weight loss. Women on the forum seemed interested in 
each other’s weight loss progress saying “Yay, so happy you updated us, I was wondering 
how you were getting on! Congratulations on your weight loss!” and regularly sharing 
updates with each other, for example “I can say that after only 8 days I lost 4 pounds which 
is an achievement for me as i cant usually lose anything”. Women discussed and shared 
personal information including levels of emotional distress concerning their weight such 
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as “Rather not be here than be this fat thing” suggesting feelings of comfortableness 
posting on this forum. 
4.9.3 Supportive community 
Forum H is a supportive online community. Women on the forum were very caring towards 
each other and welcoming to new members, “Aww wow everyone's so nice here thank you 
for being so welcoming”. There was also a lack of judgement on this forum around the use 
of UWL drugs as seen here “I don’t think I’d want to try them, but if it helps you and any 
other dieters on here, then good luck to you”. They were congratulatory of others successes 
saying “congratulations on losing over 5 stones of unwanted fat, that is a great 
achievement” as well as supportive when members needed help and advice, for example 
“I'm glad that shared your feelings on the forum, it gives us the chance to help you as and 
where we can”. Furthermore, there was a definite sense of friendship and community 
between women with much referral to each other by name, e.g. “Which website did you 
get them off [forum name member]?” and shared experiences and feelings, “Don’t ever 
feel like you are the only person feeling like this. Believe me, you're not”. Those women 
who were established members offered guidance to new members and wanted to help 
support them. Due to the supportive nature of this forum, in some cases, women reported 
having being recommended the forum by other people stating that “My friend told me 
about this forum, about how supportive you all are to her mum and I thought I would give 
it a go”.  
4.9.4 Impact of forum on members attitudes or behaviour 
Due to the supportive nature of this forum, women were receptive to advice received from 
other members. When women advised against UWL drug use, they did so in a non-
judgemental manner such as “please be careful with these tablets, at the end of the day its 
your choice, but just be careful, please” and appeared to care about other forum members 
rather than judging them. Similarly, due to women being so open about sharing their own 
experiences, for example “They sound awful, don't use them. I ended up a wreck after 
taking Reductil, it isn’t worth it”, meant that others were more likely to pay attention to 
their advice. Women seemed to be grateful to the forum and were pleased to have 
somewhere where they could discuss these issues stating “Thanks for providing a forum 
like this - I'm hoping it'll keep me on the straight and narrow!”. Furthermore, there were 
many instances where women appeared to take others advice, either in considering the 
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side effects or risks of using a UWL drug, for example “Oh I feel so worried after reading 
that.... I’m a worrier! So this will be on my mind all day now!” or in changing their mind 
about whether to use a weight loss drug at all, “thank you for sharing your story, it’s making 
me realise I should forget using them”. 
4.10 Forum I: The weight loss drug promoters 
Forum I is a forum targeted at women covering health, fitness, parenting and beauty. 
Whilst UWL drugs are not the focus of this forum, 26 relevant threads which included UWL 
drug discussion were found. No information is provided on member numbers of the 
number of threads. There was not a focus on this forum on UWL drugs nor was there an 
explicit ban on discussing them. Much discussion on this forum centred around the 
appetite suppressants sibutramine and rimonabant. No response was received from forum 
moderators to take part in an interview. 
4.10.1 Attitudes towards UWL drugs 
This forum generally consisted of those looking for advice on what UWL drugs to use, those 
sharing experiences and those promoting the sale of drugs. This forum had much 
discussion from women looking to lose weight and who were looking for alternatives to 
diet or exercise, for example “How to reduce your tummy without exercise?”. There were 
many instances of members sharing their experiences of using UWL drugs such as “Reductil 
pill helped me”. Attitudes towards UWL drugs on this forum were very positive with most 
members citing positive experiences, e.g. “The only thing which really helped me lose 
weight were Reductil slimming pills which I bought on [name of website]...26kg off in just 
four months” and were keen to make recommendations to other users saying “Reductil is 
one of the few things that actually work for me…I recommend this to anyone who is serious 
about getting into shape and becoming healthy again”. Many used the forum to gain 
advice on which UWL drugs to use, e.g. “Diet pills-advice needed”. One element which was 
not as common on other forums was the promotion of UWL drugs, both in terms of people 
advocating them, “Slimming pills that work!  (Sibutramine pills in the uk )” and promoting 
the sale of them, e.g. “Sibutramine for sale”. In some cases, women made specific 
recommendations for where UWL drugs could be purchased from such as “I know Reductil 
might not be for everyone, but it definitely worked for me. Here is the email address of the 
lady I got them from [email address]”. It was unclear however, whether women on this 
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forum were merely citing positive experiences of UWL drugs in order to promote the sale 
of the drugs. 
4.10.2 Sharing of experiences 
Forum I was often used by women to share their experiences of weight gain, their weight 
loss journey and UWL drug use. Women were very open about sharing their experiences 
saying “I have gained 9 pounds. I feel ashamed and don't really want to go out” and 
motivations for using UWL drugs, for example “I want to be back in my 'thin' clothes from 
last year”. In particular, members shared negative feelings associated with their weight 
such as being repelled by their image making such comments as “i looked at myself in the 
mirror and saw a cow like ten lbs overweight” and how this had impacted upon their 
mental health, for example “I was getting so depressed staying in bed in the mornings cuz 
i was so disgusted to look at myself”. Women also regularly posted updates about their 
weight loss, e.g. “it's been a few months now and so I thought I would update you. I too 
have reached my goal. I've lost a total of 2.5stone”.  Finally, women turned to this forum 
to seek advice, “any one have any ideas?? i just need real good motivation but ?? where 
from i cant motivate myself long enough!” and help from others.  
4.10.3 Supportive community 
The forums were also very supportive with women sharing experiences of the difficulties 
in losing weight and supporting each other in their weight loss attempts; “You are definitely 
NOT the only one who can't stick to a diet. LOL”. Women were keen to hear about others 
experiences asking “Would you be willing to talk more about your weight loss and diet pills. 
I would really interested in them” and there was a feeling that the women on this forum 
felt they were all going through the same thing, for example “You are definitely NOT the 
only one” and because of this understood how others were feeling: “Hi Hun I completely 
understand where you are coming from, I was in the same position as you”. Members 
referred to each other often by name (even when their name was not part of their 
username), e.g. “Thanks for all the info on this thread [Name]..“Its been a while since u 
posted, hows the weight loss going?”. There was a focus on mutual support on the forum , 
for example “I love coming on these forums and reading other peoples stories on weight 
loss. It's so good that we can share ideas and tips”.  
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4.10.4 Impact of forum on members attitudes or behaviour 
There was some evidence of Forum I having an impact upon members. Many women were 
keen to share their stories “I know there are alot of you out there struggling with your 
weight and I know how unhappy it can make you - i've been there myself and I know how 
miserable it can make you. Don't give it trying!” and many being keen to hear others stories 
asking “does anyone else have this problem, or anyone have any ideas how i can get out of 
this rut!!!!!”. In particular, women seemed to take on board advice regarding where to 
purchase UWL drugs from: “Thank you for the tip of where to purchase these safely”. 
Similarly advice regarding consideration of fake UWL drugs was also seemingly taken on 
board by women with comments such as “anyway u are underling my worries: buying 
through the net...I’ve heard about fakes... how did you buy slimming pills through the net 
in a safe way?”. This forum had a very positive attitude towards UWL drugs so whilst 
commenting regarding which drugs to take and where to purchase them from did appear 
to be considered by members, comments regarding the negative aspects of UWL drugs 
were ignored. Comments highlighting UWL drugs not solving the problem of e.g. 
overeating, “In my opinion diet pills don’t really solve the problem!” or negative effects 
they may have on the body such as “Pills are chemicals..so I do not really feel they are good 
for the body” were generally ignored and not responded to on this forum.  
4.11 Forum J: The self-righteous experts 
Forum J is an online discussion forum on which there is a DNP specific sub-forum. No sub-
forums exist on this forum for sibutramine or rimonabant therefore all discussion analysed 
here is DNP related. There was no way of identifying female forum posters from forum 
profiles on this thread, therefore only threads where the original poster stated they were 
female were included. Thirty-one threads were included from this forum. This is a small 
forum that has over 1,000 members. There was no way of identifying the number of 
threads on this forum. Forum rules stated that members should be respectful to other 
users and should not post personal information. Discussion on where to purchase DNP was 
permitted but should be posted within a specific thread dedicated to this subject. Two 
moderators originally agreed to take part from this forum however one did not respond to 
subsequent emails. One forum moderator was recruited to take part in an interview.  
4.11.1 Attitudes towards UWL drugs 
As a forum specifically set up for the discussion of DNP, many of the women commeting 
were already using DNP and as such attitudes towards DNP were generally positive. Many 
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of the threads related to information on progress reports and dosing information such as 
“First Time DNP Log. I’m female, 5'7" and 155lbs”. However, there were also many women 
using the forum to ask questions about DNP including whether it was the right drug for 
them, for example “Is dnp the right choice for me? I’m a 25 year old woman who is obese”, 
side effects of use, “Have any women had spotting whilst using DNP?” and where to 
purchase, e.g. “I’m a 21 year old women looking for reliable source in the UK”. The vast 
majority of discussion on this forum appeared to be from men, and women often appeared 
grateful to other women who were posting their experiences commenting “Online we need 
more DNP experiences by women so hello there”. However, perhaps in part due to this 
forum being so male focused and DNP seen as a male or experts drug, some women felt 
they were unfairly judged for using DNP saying “On this forum, there is a huge double 
standard”. Additionally there was much judgement if the user was considered to be a 
novice with comments such as “RIP OP” and those users being advising against using, for 
example “please don't use DNP”. One new female forum user who asked about receiving 
advice, “Would also appreciate any advice for first timers” received far fewer responses 
than those who posted regularly and who appeared to have a lot more experience using 
DNP and were considered “DNP veterans”. Similarly female users often were judged for 
using DNP users, for example “I saw 2 men discussing who were obese and using DNP to 
lose weight. Nobody had a go at them”. Women asking for advice were often frequently 
ignored or responded to in a very judgemental manner, with comments such as “You sound 
like a young inexperienced woman trying to lose weight the easy way. This is not for you". 
There were also many men on this forum asking for advice on behalf of their wife or 
girlfriend “If she could show me that she can attend the gym regularly, “I would however 
allow her to take 200mg”, Phrasing from this quote such as “allow” and “show me” 
suggests that some male DNP users do consider DNP as ultimately a drug for men. 
Furthermore, comments on this forum such as “I don't think a lot of women use dnp, 
they’re more bothered about bullshit ketone supplements…or other ineffective money 
sinking crap” suggests that members on this forum did not consider females as serious 
UWL drug users, instead expecting them to stick to herbal products.  
4.11.2 Sharing of experiences 
On this forum, although in small numbers, women were very open about sharing their use 
of DNP and posted logs of their dosage and weight loss, for example “I’ve lost 15lbs in 19 
days of using, Hoping to use again if I can maintain or continue to lose” as well as their 
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physical statistics, “Taking 250mg a day for 21 days. I’m female and fat”. Whilst some did 
share information concerning more personal elements such as motivations for weight loss 
such as “I had depression for upwards of a year due to my job, and during this time I gained 
about 50 pounds”, these were in the minority. There was very little evidence of sharing of 
personal experiences and instead this forum was instead mainly used for the sharing of 
practical experiences of using DNP such as weight loss, dosages, side effects and other 
drugs used. Advice given was often very prescriptive but as previously mentioned 
depending on the forum member it could also be very judgemental.  
4.11.3 Supportive community 
Overall, this community was not supportive in the same way as other forums were. There 
was not a sense of shared experiences and members did not appear to know each other 
as they did on other forums. However, there were pockets of support of this forum and 
this was overwhelmingly the groups who had been judged negatively by others on the 
forums, most often for being considered inexperienced users or for being female users of 
DNP. In these instances, members requested others to share their experiences “You're like 
me, I’ve been wondering about trying dnp. Let me know if you end up taking it and how 
you get on!”, were supportive of each other, e.g. “Can't wait to see your results!”, shared 
experiences as seen here “I hope this [DNP review] is useful to everyone!” and were 
grateful for those sharing their experiences, “Exceedingly helpful, thanks for the insight!”. 
For those members who were considered the experienced DNP there were also some 
indications of those groups being supportive and being concerned for new users harming 
themselves, for example “I’m giving you a hard time because I’m worried.. you make a 
mistake and this could kill you. why mess with fire if you don’t understand the risks”. This 
was however, considered to be in the minority as seen here “Read this expecting to see 
dog pile on the OP, but pleasantly surprised to read this much helpful and well intentioned 
advice.” 
4.11.4 Impact of forum on members attitudes or behaviour 
Whether the forum impacted on others was influenced by how judgemental those giving 
the information were perceived. Comments such as “She is and always will be a victim, 
who won’t take responsibility for her actions and subsequent results” were either ignored 
or caused friction within the forum, for example “You're a real asshole”. However, there 
were indications that some members views were considered important than others, e.g. 
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“I hoped that you would respond” and due to the lack of information available for women, 
posts made by women often seemed to be taken on board “I'm a women and thank you 
for sharing this information. It's great to have multiple resources. I've been having trouble 
figuring out a dose for women”. Furthermore, there was some evidence that some 
members had impacted on others, “Great i'll give that a go, thanks!” particularly with 
regards to issues like dosage such as “I would recommend trying 125mg of DNP for at least 
a few days before you go fully into your cycle”. However, there was an overwhelming 
attitude on the forum that some members would never take advice and would use DNP 
regardless of what others recommended, for example “I can imagine most people who ask 
questions about DNP wouldn't be put off when they get replies saying they're not ready for 
it yet”.  
Reflexive pit stop  - Online research as a snapshot 
Whilst DNP, sibutramine and rimonabant are not new drugs, their diffusion into online 
markets and use by those outside of bodybuilding communities is a relatively new 
phenomenon.  The fast changing nature of this market means that the research presented 
here can only present a snapshot and is not indicative of all UWL drug use by all users. 
Similarly, whilst a systematic search strategy was employed in order to try and capture as 
many different UWL drug users as possible, the popularity and discussion within online 
communities will also change and adapt over time. Searches conducted on different days for 
online forums where UWL drug discussion is taking place will inevitably find different 
communities and different users. 
Data searches for the online forum analysis were conducted during late 2014 and early 2015 
and the majority of forums were primarily focused on bodybuilding, weight and general drug 
use. However, searches conducted at the end of the research found discussion relating to 
UWL drugs on proana and eating disorder forums. As these forums did not present during 
initial searches, those using UWL drugs and suffering with eating disorders have not been 
represented within this research. Examination of these forums suggests that whilst there 
was some discussion relating to UWL drugs at the time I was conducting my searches this 
was limited. Much of the discussion related to the death of Eloise Parry, a young girl who 
died after taking DNP in April 2015 and who had been identified as suffering with an eating 
disorder.  It appeared that Eloise’s death triggered much of the discussion relating to UWL 
drugs on these particular communities with many threads being started following her death.  
Whilst it is not within the remit of this research to fully explore the discussion on these 
forums, cursory examination has identified some worrying practices.  This included 
extremely underweight women using DNP for several months and at doses, which would be 
recommended as the maximum dose for male bodybuilders. However, even within these 
forums which promote the most extreme eating practices, most women warned others over 
the use of DNP, echoing the opinions of many within this research that its use was 
synonymous with a trip to the morgue.   
The surge of UWL drug discussion on forums which previously had limited discussion 
illustrates how quickly the market for these re-emerging drugs can change and poses  yet 
another challenge for those researching these communities. 
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4.12 Forum comparison 
The forums presented in this chapter are varied in nature with differing purposes, users, 
motivations and types of advice given (Table 11). Furthermore, the way each community 
views UWL drug use also varies. The overall stance of the forum members appears to be 
dependent on a number of criteria, in particular which drug is being considered and what 
is the perceived level of expertise of both the person asking the question and the person 
answering it. All forums that had a lot of DNP discussion viewed its use as either negative 
for all or negative for those who were considered to be novice users. For those users 
considered novices, the judgemental and at times rude manner (particularly seen in Forum 
A; The in-group bodybuilders and Forum J; The self-righteous experts) in which their 
questions were answered by other forum members may mean that they became alienated 
from that forum, which was often seen by the original poster no longer posting on the 
forum. The lack of follow up on the forum from that UWL drug novice means it is not then 
possible to know whether they took the advice, ignored the advice or went somewhere 
else to ask their question. For sibutramine and rimonabant, opinions were more mixed. 
Those members who when discussing DNP as an experts only drugs, often did not see a 
place for sibutramine or rimonabant, considering them ineffective. On other forums, there 
was a mix. In some cases women validated or encouraged use, particularly on Forum E 
(The non-judgemental novices) and Forum I (The weight loss drug promoters), however in 
these instances this appeared to be due to a lack of knowledge concerning UWL drugs on 
Forum E and a desire to sell the drugs on Forum I. Finally, there were the forums which 
took a hard stance (or were mixed with a group of users taking a hard stance) against all 
UWL drugs (namely Forum B; the risk averse, Forum C; the overweight and frustrated, 
Forum D; the advice seekers and Forum F; the hardliners). On these communities, all UWL 
drugs were frowned upon, for Forum B because of the perceived risks, Forum C due to the 
fear of using a drug not prescribed by a health care professional and Forum F because users 
argued that weight loss should only be achieved through diet and exercise. Similar to what 
is seen in novice led DNP discussion, here users appear frustrated by the forums hard 
stance, particularly in forum B and F and either do not post on the forum again or become 
seemingly frustrated by negative responses. The remaining forums, (Forum G; the weight 
loss journey mums and Forum H; the caregivers) had more mixed responses concerning 
UWL drug use. Whilst these forums were extremely caring and supportive communities, 
there was a lack of knowledge about UWL drugs on this forum. Although advice was taken 
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on board by other women on the forum, the advice given in some instances was not always 
appropriate.  
4.13 Harm reduction 
Whilst the findings within this chapter are descriptive in nature, the lack of knowledge 
about users of UWL drugs as well as the online communities they inhabit warrants this. 
When considering strategies designed to reduce harm in this user group, consideration 
needs to be given to the heterogeneity of UWL drug users as what may be effective for 
one user or community may not for another. Table 11 provides an overview of each forum 
and it is clear that they are diverse and multifaceted and therefore strategies designed to 
prevent and reduce harm will need to be also. Strategies which aim to provide basic 
awareness and evidence-based information and education is recommended for all 
communities as even within those forums where users considered themselves the experts, 
there was conflicting and unsubstantiated advice shared. A focus on advice, prevention 
and education will be particularly useful for forums where advice is readily taken on board 
or where users have not yet or only recently begun using UWL drugs, such as forums E, D, 
G H and I.  
Alongside this, those who consider themselves to be experienced UWL drug users, as seen 
on forums  A and J may not be easily be discouraged from using  these drugs. Therefore 
harm reduction strategies here need to focus on minimising harm from UWL drug use as 
opposed to reducing or preventing drug use.  
This research has also identified key online UWL drug communities such as those using 
other drugs, women who have recently given birth and those with health conditions such 
as diabetes. For these forums with a specific user base, harm reduction needs to be 
targeted. For example for online communities in which members are using other drugs, in 
particular recreational drugs, information should be provided on the interactions between 
different drugs. For mothers, harm reduction strategies need to be linked in with health 
visitors and maternity services and for those with health conditions, those using UWL drugs 
should be encouraged to divulge use to a health care professional in order to receive 
advice on any potential contraindications.  
 
 
96 
 
 
Table 11. Overview of forums 
Forum Type Category Forum user type Atmosphere UWL drugs 
discussed 
UWL drug advice Impact 
A Large forum discussing 
bodybuilding, fitness and 
nutrition 
The in-group 
bodybuilders 
Competing 
bodybuilders. Male 
focused but with 
female sub-forum 
Supportive and positive for 
those considered 
knowledgeable about 
bodybuilding and UWL drugs 
All but 
predominately DNP 
More positive views for those 
considered experts. UWL drug 
use, particularly DNP 
discouraged in novice users.  
For those considered experts 
or long established members 
advice was shared and 
received in a positive 
manner.  Potential to 
alienate new members 
B Large forum discussing a 
range of illegal drugs 
The risk averse Mixed user base. 
Those considering 
using UWL drugs 
rather than those 
currently taking 
Supportive with a sense of 
community. Warning off UWL 
drug use due to fears of harm 
for those individuals 
sibutramine and 
rimonabant 
Negative. UWL drug use 
frowned on, considered ‘not 
the answer’ for weight loss 
Whilst members were 
supportive, responses to 
posts asking about UWL 
drugs were often negative. In 
most cases, the person asking 
the question did not post 
again. 
C Large forum aimed at 
people with Diabetes 
The overweight 
and frustrated 
Diabetic, often 
overweight 
Whilst supportive, there was 
no sense of community. 
Members seemed to dip in 
and out of the forum. 
sibutramine and 
rimonabant 
Discussion focused on the 
drugs pre them becoming 
withdrawn. Limited discussion 
of use but frustration over no 
longer being able to access 
Not evident. Forum members 
often did not report on 
updates and responses to 
UWL drug questions were 
limited. 
D Popular entertainment 
forum 
The advice 
seekers 
Mixed user base.  Fragmented forum with 
differing discussion, users and 
needs. Informative not 
personal 
sibutramine Mixed views. Most posts 
centred on whether to take 
UWL drugs or what to take. 
Responses did not appear to 
be dependent on the type of 
person asking but opinions of 
person replying.  
Mixed. Posts viewed as non-
judgemental were received 
positively. Some members 
very negative towards UWL 
drug user which received 
hostile and frustrated 
responses 
 
E Weight loss, fitness and 
health forum 
The non-
judgemental 
novices 
Those looking to 
improve fitness and 
lose weight 
Functional, lacking familiarity 
and community of other 
forums. Limited amount of 
engagement 
All but 
predominately 
sibutramine 
Mixed views however non-
judgemental regardless of 
attitude towards UWL drugs. 
Lack of understanding 
however by members 
concerning different drug 
types and side effects 
Perhaps due to non-
judgemental manner of 
forum members, advice was 
well received regardless of 
whether negative or positive. 
Mixed opinions sometimes 
left users confused 
F Fitness forum The hardliners Fitness fanatics Supportive generally. Very 
negative and judgemental 
towards UWL drug discussion 
All but 
predominately 
sibutramine and 
DNP 
Negative. UWL drug use 
considered not effective or 
dangerous / for the domain of 
the expert only 
Users asking for UWL drug 
advice appeared either 
frightened into not taking 
them or frustrated by 
negative responses 
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G Large forum aimed at 
parents 
The weight loss 
journey mums  
Mums looking to 
lose weight, usually 
post pregnancy 
Supportive with a strong 
sense of community. 
Unwilling to advise about 
UWL drug due to concern 
over other forum members 
All but 
predominately 
sibutramine 
Mixed views. Many cases of 
forum users sharing their 
weight loss journey with in 
some cases UWL drugs being 
a part of that. Those put off 
using UWL drugs particularly 
by the media  
There was often a reluctance 
on the forum to advice due 
to lack of knowledge or due 
to fears over other forum 
members being put at risk. 
Where advice was given, 
forum members did appear 
to take it into account 
seemingly due to the trusting 
nature of the forum and long 
established connections.  
H Weight loss, diet plan 
and fitness forum 
The caregivers  Those looking to lose 
weight. Those taking 
part in slimming 
clubs or formal diet 
plans 
Caring and welcoming. Non-
judgemental to UWL drug 
questions and supportive to 
new members 
sibutramine and 
rimonabant 
Mixed views. Negative views 
not concerned with specifics 
of UWL drugs but more 
generally concerned about 
taking non-prescribed drugs 
or drugs sold online 
Members were receptive to 
advice given causing them to 
consider their UWL drug use 
or not using them at all 
I Health, fitness, parenting 
and beauty forum. 
Targeted at women 
The weight loss 
drug promoters 
Women Real sense of ‘knowing each 
other’. Supportive with long 
established online 
relationships 
sibutramine and 
rimonabant 
Positive. Mix of people 
positive experiences of using 
UWL drugs as well as those 
promoting the sale of the 
drugs 
Positive experiences or 
discussion taken on board. 
Negative discussion relating 
to UWL drug ignored 
J Small general forum, 
DNP specific sub-forum 
The self-
righteous experts 
Bodybuilders, those 
interested in losing 
weight 
Lack of community. Strong 
hierarchy of  Judgemental 
towards those considered 
novices or new on the forum 
DNP Positive towards those 
deemed experts. Negative 
towards those considered 
novices or women 
Positive when advice given 
was advocating UWL drug 
use or was given from a 
respected forum member. 
Female members and those 
considered novices seemingly 
frustrated at judgemental 
responses 
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4.14 Chapter summary 
The chapter has presented a detailed overview of the types of forums where UWL drug 
discussion is occurring as well as the differing attitudes and user groups. Whilst some 
forums presented here have a supportive atmosphere where advice is given with good 
intentions and take on board, these are not always the communities that have a good 
knowledge base of UWL drugs. Those forums that do have a higher level of expertise, are 
often dismissive of new forum members and those new to UWL drugs which often leaves 
those members alienated, frustrated and potentially less likely to take advice on board. 
The next chapter (Chapter 5) looks across the forums to highlight some of the key themes 
that have presented through the ten forums presented here. 
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Chapter 5. A thematic analysis of UWL drug discussion on 
online forums 
5.1 Introduction 
This chapter highlights the reasons, motivations and trigger points for women starting to 
use UWL drugs together with the perceived short and long-term risks. Findings from three 
qualitative studies are presented, the first of which is the online forum analysis (Figure 5). 
Data obtained from the online forum analysis will be presented as five key themes; 1) 
Perceptions around the use of weight loss drugs, 2) Motivations for the use of UWL drugs, 
3) UWL drug avoidance, 4) Experiences of using UWL drugs and 5) The UWL drug user.  
Figure 5. Order of research studies 
 
Case studies are also presented from interviews carried out with both forum moderators 
and UWL drug users to further illustrate the findings. Direct quotations are provided from 
all stages20.  
5.2 Perceptions around the use of weight loss drugs 
This theme explores some of the attitudes and perceptions towards weight loss drug use 
in general and does not specifically focus on UWL drugs. Whilst many women on the 
                                                          
20 Quotations are as presented in online forum discussion. For interviews carried out through Skype chat, 
quotations are presented as typed.  
Study 1. Online forum 
analysis
Study 2. Interviews 
with forum moderators
Study 3. Interviews 
with UWL drug users
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forums had negative perceptions of weight loss drugs, believing them to be a quick fix and 
ineffective others reported positive experiences and perceptions.  
5.2.1 Quick fix: Why is everyone always focused on body in a bottle? 
Perceptions and attitudes towards weight loss drugs in general21 varied considerably. 
Views frequently differed across the forums and in discussing different types of drugs. 
However, many expressed negative views towards all weight loss drugs. Most frequently, 
this type of conversation occurred on forums where the primary focus was weight loss or 
more general forums such as parenting or entertainment forums. In these cases, women 
often argued that weight loss drugs were merely a quick fix that would not resolve 
underlying issues, such as overeating.  Women also spoke of their own experiences of using 
weight loss drugs and stated that they had not helped them lose weight in the long term. 
However, comments such as “it just depends on the person” suggest that some forum 
members accepted that experiences of using weight loss drugs would be different for 
everyone.   
You have unresolved over eating issues with food, once you stop using an appetite 
suppressant you'll just go back to stuffing your face without really knowing why 
(Forum H) 
I have tried weight loss drugs in the past and they worked well, but once I stopped 
taking them I gained the weight back plus more. (Forum F) 
Women often argued that losing weight required a full lifestyle change and weight loss 
strategy, including diet and exercise, and that weight loss drugs should not feature within 
this. Some felt that those who used these drugs just wanted a quick fix without having to 
put any effort in to losing weight. Some women also attributed blame to those working in 
health and fitness arguing that they promoted a “quick fix mentality”.  
Why the focus on "body in a bottle"? Diet and exercise is still the fundamental way 
to do It in my opinion. (Forum A) 
The health and fitness industry is a big business which tries togive people that 'quick 
fix' mentality. Really though, nothing will change the obvious which is that diet, 
lifestyle and exercise has to be a lifestyle choice, not a 'fad' or something that can 
suddenly be acquired through some magic pill. (Forum G) 
 
Other women did however argue that weight loss drugs could feature within a weight loss 
strategy but should not be the only component.  
                                                          
21 Not specifically UWL drugs 
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It [DNP] will work if you have a very good diet and exercise regimen. (Forum J) 
5.2.2 Scepticism: If diet pills worked, there would be no fat people 
Many women on the forums were sceptical of benefits of weight loss drugs believing them 
to be ineffective and arguing that if weight loss drugs worked then nobody would be 
overweight. Some also discussed how weight loss required commitment and could not be 
achieved through the use of drugs. Also discussed was the idea that whilst some weight 
loss drugs such as DNP were effective they were not a magic bullet.   
If there was a magical pill that stripped off fat and made us lose weight, we'd all be 
on it and look like gods/goddesses. Like anything else worth having, it involves some 
work and commitment. (Forum E) 
If this stuff worked, do you think we would still have fat people? Do you think it 
would be kept a big secret, and not on the national news? (Forum F) 
Even the most powerful weightloss agents such as DNP can only increase 
Metabolism by around 30% (Forum E) 
Many women, particularly on the weight loss forums, treated weight loss drugs with 
disdain. There was much discussion concerning how these drug were a drain on resources 
and merely a money making scheme for those who provided them. There were also some 
reports of companies selling weight loss drugs by lying to consumers about their user 
success stories.  
Diet pills are expensive, crappy and don't do anything except make your bank 
account lose weight. (Forum E) 
I read that the company that sells them has been stealing blogger weight-loss 
photos and claiming the loss was due to their pills. They liiiiiieeee. (Forum F) 
Others had a more balanced view and argued that whilst some weight loss drugs did not 
work, some drugs, including DNP, did have a positive impact on weight loss. 
I've done numerous amounts of supplements, over the counter and black market.. 
(i've lost 45- 50 pounds in a matter of a year, but lost a lot more money wasted on 
things that didn't work. (Forum A) 
Except for the ones proven effective like ephedrine, yohimbine, clenbuterol, 
cytomel, DNP etc etc. (Forum F) 
Women on the forums were sometimes negative about those who recommended weight 
loss drugs to others. 
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Hire a new trainer ASAP. Tell the old one that you are leaving for the simple reason 
he/she suggested you take fat burning pills which is nothing more than being a shil. 
(Forum F) 
I’m surprised a trainer wouldn't first recommend a good BCAA22 product to help you 
train and heal better or a multivitamin and omega 3 supp. I hope he didn't tell you 
to take a thermo unless you are already managing your macros and he knows it. 
(Forum F) 
5.2.3 Dangerous: A very dangerous, expensive and unhealthy scam 
Many women spoke of the dangers and potential harms of using weight loss drugs. Some 
spoke of having a general fear of using this group of drugs, whilst others were fearful that 
they would not work. 
Diet pills are bad news. (Forum F) 
My view is that they could potentially do more harm than good. (Forum H) 
I have always been scared that I’ll be the person that the drug kills! So in the past 
I’ve always steered clear of anything like that. (Forum H) 
I'd be afraid that if I stopped taking one of the aforementioned pills/powders - that 
I'd regain all that I've lost plus more. (Forum E) 
Some women discussed how alternative weight loss strategies such as diet and exercise 
were safer and less expensive than weight loss drugs. There was also some discussion 
around whether the use of weight loss drugs was indicative of an eating disorder as those 
using these drugs are prepared to put their health in danger in order to reach their weight 
goals.  
Ever notice how pills claim to work with "diet and exercise"? So does just diet and 
exercise. It's a scam =/ a very dangerous, expensive and unhealthy scam (Forum F) 
People taking laxatives daily to stop weight gain have an eating disorder treated by 
doctors. How is taking a 'diet pill' that makes you have oily poo and go the toilet a 
lot not considered the same behaviour? (Forum F) 
There was also much discussion concerning the side effects of using weight loss drugs. 
Whilst side effects from the use of specific UWL drugs will be discussed in more detail later, 
some women did voice concerns about the side effects from using any weight loss drugs.   
Its not uncommon to be rushed to the hospital with the Dr ordering ice water shot 
into your colon because they can't cool you down). (Forum E) 
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The pills just felt like they were "too much" for me, and I kept picturing myself 
dropping dead from a heart attack just because I wanted to lose the weight 
quicker... I stopped taking them shortly after I thought about that. (Forum F). 
Pills are no good, they race your heart and cause internal issues you may not even 
notice until it is to late. (Forum B) 
5.2.4 Effective: Diet pills aren’t the devil 
Many women also expressed positive views towards the use of weight loss drugs arguing 
that without them it would not have been possible for them to lose the weight they did. 
There was again however also acknowledgement that they should be used alongside diet 
and exercise.  
they defo work with the right diet and exercise. i take them to increase the speed of 
my weight loss (Forum I) 
I've been taking tablets for a while now supplementing my diet and excercise and 
they do work for me. (Forum I) 
Some women spoke specifically about how weight loss drugs had helped to suppress their 
appetite and how they acted as a “jumpstart” for their weight loss. 
By suppressing my appetite, the pills gave me the room to learn about food choices. 
The pills gave me the room to learn about exercise. The pills gave me the jumpstart 
that I needed. (Forum F) 
Without the drug, I would not have started learning about food. Without the drug, 
I would not have started working on the Wii. Without the drug, I would not have 
started walking. (Forum F) 
Many women defended their drug use vigorously against other forum members’ strong 
anti-drug views.  
But what do you mean by "i don’t believe in diet pills " ? Are you saying they don’t 
work ? If that’s what you are saying, then you are wrong, because as you can see 
from this thread, there are so many people who use appetite suppressants with 
great results. (Forum E) 
That's not true. Some diet pills, like thermogenics do work very well. They increase  
your metabolism, so you burn more calories giving you a greater caloric deficit, 
loosing weight faster. (Forum E member) 
Some women argued that, just because other people felt they could lose weight without 
using drugs, that this did not mean they should feel judged for not being able to. There 
was also criticism of the argument that weight loss drugs were a quick fix. 
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I tried for 3 bloody years, eating only vegetables and grilled lean meat, and got 
nowhere. Why? Because I don’t have some enzymes that help in processing lipids 
and therefore can’t lose weight. These pills have been helping me enormously 
recently. Please don't assume to why I or anyone else choose to take pills and insult 
us just because you can lose weight the natural way. (Forum F) 
Forum members often debunked other members statements concerning the risk of 
putting weight back on once drug use had ceased. 
Basically I took them because they suppressed my appetite, and boosted my 
metabolism, so the weight came off more quickly and predictably than it would 
have via just dieting.  Now that I am off of them... nothing magical has happened 
to my body to make me regain weight. (Forum E).  
5.3 Motivations for the use of UWL drugs 
Whilst some women discussed their motivations as solely to lose weight, others described 
the impact they had experienced from the media, friends and family.  
5.3.1 Weight loss: I’m literally working my ass off! 
Motivations for the use of weight loss drugs differed. Some women reported being 
overweight and were already taking UWL drugs or seeking advice about whether they 
should use them. Often women posted logs of their progress, detailing their initial start 
weight, exercise and diet regimes as well as UWL drugs or other supplements they were 
taking.  
I am not really overweight but could do with losing about 15 lbs! If anyone could 
recommend something better, that would be great! (Forum A) 
I have been having some weight problems for a while and was really getting 
frustrated. (Forum I) 
I am not a body builder. I am running dnp to lose weight. I am sick of being fat, 
dieting all the time, plateauing. I am 27/F/4'10"/136 lbs. I'm not sure what my 
ultimate weight goal is but 115 lbs or less. I started DNP this week for a few days to 
see how my body reacted. I am barely having side effects at all, so I'm motivated to 
post a quick log to get feedback. (Forum J) 
Others discussed how their weight loss had plateaued and they were using UWL drugs as 
an extra boost. Additionally, some women discussed how they wanted to use weight loss 
drugs to help kick-start their weight loss and to help them get into the habit of eating less. 
I’m only using them because I have plateaued in my weight loss and need a boost. 
(Forum F) 
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I'm literally working my ass off! I'm not looking for a quick fix, just a boost into 
weight loss. (Forum E) 
Has anyone tried any tablets to help reduce appetite and do they really work? I only 
plan on using them for a short while until I get used to not eating in between meals 
- I just need time to form habits - it just the way I work sadly. (Forum D) 
There were some instances where women discussed having metabolic disorders and this 
had led them to use a UWL drug. 
I honestly know that there is something metabolically wrong with me. So after much 
reading and contemplating, I decided to try low dose DNP. I have purchased crystal 
DNP, 250mg, from the well known supplier (Forum J) 
Some women also discussed how the traditional weight loss strategies had not been 
effective and it was their frustrations at not losing weight which had led them to use, or 
consider using, UWL drugs. Some also spoke specifically of the merits of UWL drugs arguing 
that they were effective in losing weight and burning fat. 
I've been back on track all week. Only my disappointment post wi23 that led me to 
these tablets! (Forum H) 
Therefore to reduce weight Slimex is the best weight loss diet pill that works with 
the burning of fats stored in body (Forum F) 
i have recently put on a lot of weight - about a stone and a half since new year! i 
have tried dieting by eating less during the day and i find i cant for some reason i 
still end up getting something to eat is their any diet pills that help you lose weight 
faster and supress hunger? need to lose about 2 n a half stone ideally. (Forum D) 
Some women spoke of specific events that had triggered their weight gain, such as quitting 
smoking, dealing with stress, depression or pregnancy. Women discussed how weight loss 
had become more difficult following these events but, for most women there was an 
awareness that UWL drugs were not a universal remedy.  
I was thin most of my life, so I know where each side is coming from. It seemed so 
simple back then. "Eat less, weight less". It wasn't until I quit smoking and started 
eating when I was stressed that I had a weight problem. (Forum E) 
I had depression for upwards of a year due to my job, and during this time I gained 
about 50 pounds. A few months ago I quit, and travelled the world to gain some 
level of confidence again. It worked! I’m back in [place of residence] now, and ready 
to shed the weight. I chose to use DNP after reading everything about it and 
determining that if I do it safely, I should be fine. (Forum J) 
                                                          
23 Wi = Weigh in  
106 
 
I became pregnant and ten months later, I am taking it again for that initial boost. 
Up to now I’ve lost 8 pounds in 5 weeks, it isn’t a fix all but definitely a motivator. 
(Forum F) 
In particular, when discussing DNP, other women often advised against the use of this drug 
for quick weight loss until the potential user had adjusted their diet and exercise regime. 
There was also much criticism of those who used DNP when overweight or obese with 
members arguing that it was easy to ‘out eat’ 24 DNP and the drug would be ineffective 
without proper diet and exercise.  
Look I’ve seen other mothers also ask for advice on here and we give them all the 
same advice.. This isn’t what you want. I know it sucks after having a kid with all 
this extra weight but not having any extra time for the gym you want something 
you can just take and see pounds come off. (Forum J) 
Are you actually mentally retarded? If you don't know the BASICS of dnp how do 
you expect to run it and not completely shrek yourself25? How about before using a 
lethal substance you try putting the fork down and not being a fat land whale 
(Forum J) 
There was also some discussion about the use of UWL drugs to help women cutting26 
weight in time for fitness or bodybuilding competitions. 
I have 11 weeks to this competition and for this one I want to lose 7-8lbs max.... 
And never having really tried much in the line of supplements... I am really 
wondering if they would be worth trying out.... would it be worth trying at all? 
(Forum A) 
Are you talking about fat burners? I have thought about taking some before. I think 
they might be useful when on a tight schedule, e.g. prepping for a bodybuilding 
competition. (Forum F) 
Some women spoke of achieving specific goals such as ‘getting abs’ or ‘lowering their body 
fat’. In these cases, women were often already physically fit but used a UWL drug for an 
extra edge.  
I'm a bit greedy haha. I was like ok cool, I have an alright body... let's see if I can get 
abs! But I have to lower  my body far percentage for that. I've been trying to do 
some body recomposition for a bit, and DNP is pretty much perfect for this. (Forum 
J) 
                                                          
24 Using DNP without a calorie deficit / overeating whilst using DNP 
25 Slang. Assumed to mean wreck yourself 
26 Period when in calorie deficit to lose fat or weight. Often done in run up to bodybuilding competition 
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Women often appeared conflicted about whether to use UWL drugs. They often cited 
weight loss as the potential benefits whilst still voicing concerns about side effects. In one 
case a forum member discussed how she had discarded DNP due to fear over cataracts but 
was feeling tempted in trying to drug again. 
I just read up on DNP cause I never heard of it, it does not sound pleasant says the 
angel on my left shoulder. but losing half pound a day would be tempting says the 
devil on my right shoulder. (Forum F) 
I have thought of taking DNP or Clenbuterol/T-3 to reach 5-6% bodyfat. I have some 
pro body builder friends that have done it but man do they say some scary stuff 
about DNP. (Forum F) 
So, I am interested in trying DNP again. But as a woman I am concerned about 
cataracts. I (stupidly) got rid of the rest of my DNP supply out of fear, and I regret 
it. (Forum J) 
5.3.2 Appetite reduction: My hunger meter doesn’t seem to work very well 
Many forum members discussed how they struggled to lose or maintain weight due to 
overeating. In some cases, women discussed how they knew weight loss drugs were scams 
or money makers but they were still curious to see whether they were effective. Members 
often asked other online users about which drugs work or which they would recommend. 
I have been thinking about using an appetite suppressant does anyone tried any 
that actually work I know their are cons but I have a big problem with the late night 
munchies like I cant control myself . so I need something to help me. (Forum E) 
is there any about cause i cant bloody stop eating im a joke. (Forum H member) 
Some women openly discussed that they used UWL drugs because they overate and were 
overweight. In some cases, these members appeared frustrated by others who denied this 
being their motivation for use.  
You are taking dnp because you are fat. We are all fat and that is why we’re using 
it. It is obvious that you do not know how to eat correctly because you are here. Join 
the club (Forum J) 
Some women discussed how they struggled with feeling hungry all the time and appetite 
suppressants such as sibutramine helped with this. Often members discussed using UWL 
drugs due to them having not having the willpower to diet without them. 
 I took Reductil tablets from when I struggled to suppress my appetite. (Forum H) 
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It's nice to be losing weight and not be hungry. My 'hunger meter' doesn't seem to 
work very well, as I can feel hungry even after having eaten a good meal. This is 
where I found Meridia helped me. (Forum E) 
For me, thermogenics that supress the appetite really helped me stop obsessing 
about food. (Forum F) 
I need to lose a few pounds and whilst I eat 3 healthy meals a day and take 
moderate exercise, my downfall is snacking in between. I have a huge appetite 
unfortunately and my will power at the moment is rubbish. (Forum D) 
Women who had used an UWL drug in the past reported struggling with their appetite 
once they stopped taking the drug. In some cases, women reported that they were using 
these drugs again.  
yes i'm still on reductil. i took a break for a bit to see if i could make it on my own. i 
was okay but kept being obsessed with food.Thought about it every minute so i'm 
back on the pills. (Forum G) 
5.3.3 Desperation: It’s gonna be a last resort thing for me 
Some women spoke about UWL drugs as their last resort for weight loss. Often these 
women felt as though they had tried every method to lose weight. 
i've heard of it, i know its expensive, have you tried it? “ if i don't lose weight with 
alli. (Forum I) 
I've been back on track all week. Only my disappointment post wi27 that led me to 
these tablets! (Forum H) 
Some women described how they felt it was impossible to lose weight. They also 
acknowledged that, whilst people may be anti UWL drug use, they felt as though they had 
no other option. Some also discussed how they felt it was worth the risk of taking UWL 
drugs as it was the only thing that worked for them. Specifically, when discussing DNP, one 
forum member argued that she would rather “feel somewhat miserable for 20 days than 
miserable throughout my life”.  
there are probably people who are really anti-pill... but I was finding it impossible 
to lose weight without literally starving myself. I dieted really carefully for about 8 
weeks and lost 1lb. I could lose that through natural fluctuation without dieting, 
and eating normally (ei generally sensible food with the occasional treat thrown in) 
never took me over what I started at. My motivation and self-esteem had reached 
rock bottom. (Forum E) 
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You don’t know what others have done to lose weight in the past. I've tried counting 
calories, have lost very little compared to the sheer amount of misery that eating 
less comes with. I'm young and have a life and I don’t want to through that again. 
I would much rather feel unhappy for 20 days than miserable throughout my life for 
a small amount of weight loss/maintenance. (Forum J) 
Other women described the need to lose weight quickly, for e.g. a holiday, and did not feel 
like diet and exercise would help them to lose the weight quickly enough. Many women 
spoke about their reluctance to starve themselves and it appeared that this group felt that 
severely restricting food intake or using UWL drugs were their only choices for losing 
weight.  
I do think I’ll get addicted I just need something alongside the exercise that I am 
starting to do. Nothing is working and nothing has done in the past this is all I can 
see working. I am going travelling next year and don’t want to be a a size 14 when 
I go. I need to get down to a 10. I am not going to starve while I take these I will still 
eat, just smaller portions. (Forum D) 
Some women spoke of their weight loss journey and discussed how their lack of success 
had led to their UWL drug use.  Women also discussed how they used the internet to try 
and source the help they felt they needed. 
I was fighting with my weight for many years. I was on diet for a long period of time, 
but without any positive results. So, I've decided to drink28 Reductil (Meridia) weight 
loss pills. (Forum I) 
After being on many diets for without any positive results, I turned to the internet 
to look for diet pills. (Forum I) 
Women often requested that other forum members advise them on which UWL drug to 
use. Often, this group appeared to want to focus only on the positive experiences of these 
drugs.  
I know using diet pills is seen as an easy way out, but I would like some suggestions 
on some to try that work. Post your opinions and of course success stories. (Forum 
F) 
5.3.4 As part of a weight loss strategy: Fat burners are just the icing on the cake  
Many women described how UWL drugs could be used as part of their complete weight 
loss strategy. Many also argued the importance of healthy eating and diet and advised 
against relying solely on UWL drug. 
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Your best bet (whether you decide to use it or not) would be to have a CLEAN diet 
and good workout regime first. Then add it in for enhancement. (Forum A) 
A clean diet, and workout regime will produce results. Fat burners and other 
supplements are just the icing on a cake. (Forum A) 
Often women described how UWL drugs gave them extra motivation and could be used as 
an add on to diet and exercise. Many women described how the addition of UWL drugs 
made weight loss easier. 
Of course you can lose fat without using diet pills. I certainly have but the reason 
why I use them is that it makes the diet easier. Notice how I focus on the diet and 
not on the supplement. (Forum A) 
Some women drew parallels between the use of UWL drugs and bariatric surgery arguing 
that both required a lifestyle change. Furthermore, women also argued that whilst UWL 
drugs featured in their weight loss plan, they felt that they could continue to lose weight 
without them.   
A lot of people will down the use of pills. But I see it no differently than if you had 
surgery. Surgery and pills can help and fail. With both you need to change you 
lifestyle/way of eating for the rest of your life to keep it off. I know this, And when I 
stop the pills I will still be losing weight and keep it off. (Forum F) 
Women were critical of those who expected UWL drugs to do all the work for them arguing 
that hard work and motivation to lose weight were still required. The second quote 
presented was from a bodybuilder who was very critical of drug use within bodybuilding 
competitions.  
There is no "magic" pill, where you can still eat all the junk you did. Weight loss is 
about putting in the hard work. That is the mistake most people make when taking 
a pill. (Forum F) 
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Truthfully there is no pill that will work for you.. dnp wont work for you.. you have 
to change your diet. you can not eat curry while taking dnp. you will feel shitty. 
(Forum J) 
Alternatively, some women felt that they were being wrongly criticised for their UWL drug 
use and felt that these drugs have a place within a weight loss strategy. Furthermore, 
women felt that they could learn from the use of UWL drugs in terms of how to continue 
with their weight loss plan. Some women on the forums described how they used UWL 
drugs to help them get into good habits and then gradually reduced their intake. 
Okay, this is pissing me off. No, I do not believe in diet pills alone, but they DO have 
their place with proper diet and exercise…They're a tiny aid in an uphill battle that 
is going to be 95% you and changing your lifestyle. Don't bash people for trying 
everything they can to beat the fat. It's really hard and frustrating as we all know! 
This site has become less about support and more about self-righteous (Forum F) 
Learn from the usage of the pills and continue to eat in a moderately healthy way 
after their use. (Forum F) 
it’s for the short term- get into good habits then ween off- keeping (hopefully) the 
good habits. (Forum E) 
5.3.5 Influence from others: Everyone that is cut nowadays uses some sort of diet pill 
Some women spoke about how they felt pressured into using UWL drugs by others around 
them. In some cases, this was because they noticed that other people who were using 
Reflexive pit stop – Motivations for UWL drug use 
Around the time of my third year of my PhD, I was asked to write a blog about my PhD for a 
human enhancement drugs website. At the point of being asked I had been looking at the 
online forums at some of the varied reasons for why females use UWL drugs and thought 
writing about this particular issue would make for an interesting blog. With this being a blog 
however and not a traditional piece of academic writing, I felt that that this gave me the 
opportunity to include some more personal reflections of this phase of my PhD. It got me 
thinking about some of the assumptions I held about why I thought women used UWL drugs at 
the start of my PhD and why I had these assumptions in the first place. I might not have 
admitted it at the time but I felt that women used drugs of this nature simply because they 
were desperate to be thin. I thought about my own experiences as a female living in an image 
conscious society and how at certain points in my life I had gone to extreme lengths to be 
thinner. I’m sure that if I had known about drugs such as DNP at the age of 20, that I would 
have considered using them and my own experiences and thoughts had shaped the way I 
thought about UWL drugs. I felt that those using these drugs would be deeply unhappy with 
their bodies and willing to try anything to achieve the ideal body, i.e. a thin body. Whilst feelings 
of desperation are apparent from some members of the online forums I analysed, what is also 
apparent is that to say that is the only reason why women use UWL drugs would be an 
extremely simplistic way of viewing this group.  
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these drugs were achieving the bodies that they themselves desired. This was seen across 
bodybuilders and dieters and those in their cutting phase for competitions as well as those 
looking for a quick boost to the weight loss.  
I am in my cutting phase but want to know "it is possible to successfully diet without 
the aid of diet pills?" It seems everyone that is cut and ripped nowadays uses some 
sort of diet pill. (Forum A) 
I met an old friend of mine just in the beginning of January. I hadn't seen her for a 
while and the funny thing was I could hardly recognize her. She had lost 3 stones 
since I last saw her (yes she was a bit overweight). I asked her what she had done 
to lose so much and she explained that all she had done was taking a diet pill every 
day before lunch. (Forum I) 
I’ve been taking diet pills for 3 days now whilst doing slimming world. I started 
taking them because my friends sister took them for 1 week and lost 8lb. She was 
dieting, having 3 meals and snacking on fruit! so I though oh I’ll give them a try.... 
(Forum H) 
My friend was telling me about how great some sort of diet pill is, and I was thinking 
about trying it to see if I could boost my results a little. (Forum F) 
Some women spoke about how UWL drugs had been recommended to them by fitness 
trainers and this had influenced their decision to use. 
I'm a female, 5"3 and just over 120lbs, I started using DNP because some of my 
trainers from my fitness club mentioned using it to get rid of fat. I bought them from 
the same trusted dealers they use. (Forum J) 
Other women spoke about receiving more direct pressure from family and friends who 
had actively encouraged them to use UWL drugs. In some cases this was linked to family 
and friends concerns about their health due to their weight. In other cases, women were 
influenced by others who were using the drugs and having positive results. 
 Haha i was talked into it (Forum J) 
So i was walking around with my dad, and he started talking about how worried 
he's about my weight. He obviously told me pills weren't enough and i needed to 
start eating healthy stuff, but long story short, he got me Sibutramine. (Forum E) 
My best friend just forwarded me a email with her thin pictures...it had pictures of 
how she looked less than a month ago, which was 30 pounds heavier. She has been 
taking diet pills ,swears by them and is encouraging everyone we know to take 
them. Ill admit she looks awesome. Standing next to her sucks..... I keep telling 
myself that I am doing it the right way and that is cheating but she makes it look so 
effortless.... Please someone tell me that maybe I wont see results as fast as her but 
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Ill get where I need to be with a litlte hard work and dedication... this is the way I 
should be going...right? (Forum F) 
5.4 UWL drug avoidance 
This theme explores some of the issues forum members discussed when thinking about 
using UWL drugs. In particular issues around why women chose not to use these drugs, 
such as the drugs legal status, fear of the dangers of use or side effects and the impact 
taking UWL drugs might have on friends and family. 
5.4.1 Legality: They have been banned for a reason, and a good one at that! 
Particularly in relation to discussion about DNP, women spoke about how they would not 
use UWL drugs due to their legal status, i.e. being unlicensed for use in weight loss. This 
often involved the sharing of incorrect information, however in most cases this 
information was not challenged.  
They are illegal street drugs, not meant for human consumption. That means they 
ARE well regulated and these say do not take them and it is illegal to sell them as 
diet pills. (Forum F) 
Hasn't DNP been illegal for weight loss since 1938? (Forum F) 
Often women talked about how they felt that the drugs were effective but that they were 
dissuaded from using them because they were not legally being sold. In some cases, 
members talked about how they were sports competitors or body building and were 
required or preferred to stay natural.  
I can’t get and don’t want anything illegal- I am an IFPA PRO, a Natural Federation 
so I am drug tested and polygraphed. (Forum F) 
I have heard of clen and I turned down using it for a competition. Never heard of 
DNP, though. I prefer to stay legal, though. No judgement, just the way I roll (Forum 
A) 
For sibutramine, which was a previously licensed drug, women spoke about how its 
changing status meant that they would no longer use it, as it must have been “banned for 
a reason”. There was also some discussion from women who had purchased weight loss 
drugs and later found out they contained sibutramine and were then conflicted about 
whether they should still use them.  
They have been banned for a reason and it’s a good one! Your doctor may have 
been happy to prescribe them then but as research develops we find out new things. 
(Forum H) 
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5.4.2 Fearful of the risks: I'd rather be fat and alive, than a skinny corpse 
The dangers of DNP were discussed frequently with women arguing that whilst it was an 
effective drug, it was too risky for them to consider using.   
In all honesty, there really aren't any legit. supplements. Fat burners etc. are nearly 
all complete bunk. You'll get your best results from a good diet. Edit: Oh, unless of 
course you want to supplement with 2,4Dinitrophenol which isn't advisable (Forum 
A) 
Often fear of use was linked to the legal status of the drugs. Some women suggested that, 
due to these drugs being unlicensed, if they suffered ill effects from using, others would 
blame them for using them when banned. Furthermore, due to its risks and banned status, 
women in some cases tried to quickly shut down discussion of DNP as they did not appear 
to think it an appropriate subject matter.   
I’m worried that if something was to happen id be told it’s my fault for taking them 
when they are banned. (Forum H) 
The only one which allows you to sit on your ass all day and lose weight is DNP but 
it's illegal and highly dangerous. (Forum E) 
DNP is banned. It is for research purposes and not appropriate to talk about on this 
forum, and it CAN KILL YOU. (Forum A) 
There was frequent discussion of DNP and the risks of overheating following its use with 
one woman likening it to “rat poison” and another saying it would turn those who used it 
into a “human torch”. Women also discussed DNPs narrow therapeutic window arguing 
that the effective dose was too close to the lethal dose.  
Probably DNP. You'll turn into the human torch soon enough. (Forum F) 
Don't even think of using it, because its not uncommon to be rushed to the hospital 
with the Dr ordering ice water shot into your colon because they can't cool you 
down (Forum E) 
The reason those are illegal is because their effective dose is so close to their lethal 
dose. (Forum F) 
There was recurring discussion around DNP killing people and many women argued that 
those who used it were stupid to risk their life. Much attention was also given to media 
reports of those who had died following DNP use. 
 DNP can kill you. (Forum A) 
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My god...I didn’t know that such pills were so readily available....what a waste of a 
young mans life..(Forum G) 
Best case scenario is they don't work, worst case scenario does not bare thinking 
about with some of these toxic pills on the internet that jack your body temperature 
right up. A girl in the UK died a few days ago taking some diet pills she got off the 
Internet. Even though she managed to get herself to hospital they could not do 
anything to save her and doctors could only watch her burn up from the inside out. 
(Forum F) 
The side effect of ACTUAL fat burners like DNP is, well, death. DNP literally kills 
people. It's not some weird effect of the drug - the thing that kills people is the 
increased metabolism. They die from the cardiovascular stress or excess body heat. 
So before you pop another pill that you think increases your metabolism, think 
about that. (Forum F) 
For sibutramine and rimonabant, there was less discussion concerning the dangers of 
these drugs. However, some women did cite potential side effects of these drugs as 
reasons not to use them. There was also some discussion from women who been 
prescribed sibutramine pre-ban and expressed fear at continuing to take them post-ban.  
Sounds like Rimonabant. However, reading side effects etc I don't think you want to 
go there!  (Forum C) 
I still have some of the drugs left but I'm scared of taking them.  (Forum F) 
5.4.3 Risk of side effects: It does not sound pleasant says the angel on my left shoulder but 
losing half pound a day would be tempting says the devil on my right shoulder 
 
Many women spoke generally about side effects of taking weight loss drugs and often 
referred to ‘things they had heard’ such as these drugs causing issues with fertility, kidney 
problems or heart attacks. This was a particular feature of fitness forums where there was 
a focus on diet and exercise above weight loss drugs and supplements.  
No diet pills for me, i've read some can negatively affect fertility and and I want 2 
more kids!!!! Plus, just eating right and watching cals and carbs work for me. 
(Forum F) 
To be honest diet pills make things worse such as your health with kidney problems 
and so on. (Forum F) 
Other women spoke about specific side effects about taking UWL drugs. In particular, 
many discussed the risk of cataracts and cancer. Specifically for women there was much 
discussion of the risk of DNP causing problems with fertility.  Furthermore, there was some 
discussion around DNP having perceived added risks following use in women. 
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Besides killing you in less than a day, can also cause cataracts, and cell 
mutations...hmm cell mutations and oestrogen and breast = cancer. (Forum A) 
DNP is effective but there are unknowns when it comes to impact on ovum, which 
to me is a concern for any woman that wants to have kid. (Forum A) 
Sounds like DNP or Dinotrophenol. Its can only be used by males. It can cause 
blindness if used by woman. (Forum F) 
Other women also discussed other side effects from using DNP such as their eyes changing 
colour and bloating. Many women spoke of overheating, sweating and excessive tiredness 
following DNP use.  
I came THIS close to busting out a stash of DNP. . .but it's already 89 ****ing 
degrees here and the last time I tried it, it didn't do anything except make me feel 
like **** and turn my eyes yellow. Oh, and make me bloat during the 
duration. . .which I knew would happen (Forum A) 
DNP significantly speeds up your metabolism. The main side effect? Body heat. 
Taking DNP makes you hot and sweaty and exhausted. (Forum F) 
I just don't want to burn up  (Forum J) 
Many spoke of their temptations to use DNP due to its perceived effectiveness. However, 
this group often did not use it, due to its harsh side effects. 
i just read up on DNP cause I never heard of it, it does not sound pleasant says the 
angel on my left shoulder. but losing half pound a day would be tempting says the 
devil on my right shoulder. (Forum F) 
Don't get me wrong, I understand the appeal. But not at the risk of permanent 
reproductive issues, heart failure, brain damage, and/or death (Forum F) 
Some women however, did consider the potential side effects but felt that they wanted to 
use it anyway, particularly with DNP which they argued would only be for short-term use. 
I’m female too, and read about these side effects, but I wouldn’t be planning long 
term use  (Forum J) 
Women also discussed their concerns around the side effects of using sibutramine and 
rimonabant. An argument was often made that the side effects and risks of using these 
drugs outweighed the potential for weight loss.  
Reductil is Meridia, for those who haven't heard of it.Personally, I'd rather lose 
weight without resorting to psychotropic meds that are controlled substances AND 
increase blood pressure. (Forum E) 
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5.4.4 Other people: I don't want my daughter to learn from me that it is okay to pop pills 
Some women argued that they did not take UWL drugs as they did not want it to impact 
on other people in their life. In particular, women spoke of their role as mothers and their 
responsibilities to their children. Women argued that they did not want to risk their health 
by taking UWL drugs but also that they did not want to set a bad example to their children.  
I was desperate when i posted this thread abit down in the dumps Ive had people 
pm me with names of pill i considered getting some from the USA banned in this 
country but then i looked at my girls and though better of it. They need there 
mummy it just means me putting in abit of hard work. (Forum G) 
Okay, so I'm not going to take it, right now. I'm gonna try another 6 months of doing 
what I've been doing. I did change my calorie intake, and am going to try to lose 
more than I initially planned on. I don't really want to pop a pill to lose weight, I"m 
not a pill popper in the first place, and I don't want my girls to watch and learn that 
it's okay to pop pills. (Forum E) 
Others had seen friends or family suffering ill effects following weight loss drug use and 
this had dissuaded them from using them.  
A friend of mine got quite ill at uni after taking some diet pills she bought off the 
internet that were supposed to increase your body's capacity to burn fat (I think 
that was the idea anyway). I was always very wary of them and unconvinced by 
their effectiveness before that, but now even if they worked as claimed, I wouldn't 
use them because I've seen how unwell she became. (Forum E) 
Some women spoke about how family members did not want them to take weight loss 
drugs and this featured in their decision not to use.  
my husband didn't want me to take those pills anyway, I'll return them, no problem 
at all. (Forum F) 
5.5 Experiences of using UWL drugs 
This theme explores forum members’ experiences of using UWL drugs. Both positive and 
negative experiences are presented as well as side effects that were experienced. Also 
discussed is the level of judgement women experienced from other when using UWL 
drugs.  
5.5.1 Effective: YES IT'S WORKING!!! 
Much discussion on online forums focused on womens experiences of using UWL drugs. 
Often there was a sense that women wanted to share their progress and both positive and 
negative experiences of using these particular drugs with other people.  
118 
 
i used a lot of different things. .. the only things that actually worked though were 
ones that were considered black marketed...."DNP" and "clen" (Forum A) 
Some women discussed how drugs such as DNP were far more effective than other weight 
loss drugs, in some cases including both those currently licensed and those that were 
licensed previously. 
Nobody compares it with DNP. It just beats the pants off every other FDA approved 
weight-loss drug, including orlistat, sibutramine and rimonabant. (Forum A) 
I’ve also used with reductiI , and it works better for me than orlistat. (Forum F) 
I hate when people say magic pills don’t exist. your acai berry or raspberry ketones 
aren’t what you are looking for... (Forum F) 
DNP in particular was considered to be a very effective drug, however women often felt 
that it was too dangerous for them to use. Other women argued that it was effective but 
required prior knowledge before use, e.g. use of complementary supplements to 
counteract side effects and increased water consumption. 
 It’s a shame DNP is dangerous, it's great at burning fat. (Forum F) 
Then there is DNP it's literally like drinking rat poison, but it really burns fat. You 
need supplements when using it just to not die, and if you don't hydrate or overheat 
you WILL die. (Forum F) 
The basics: F/5'7"/155lbs (weighed 09/18/16) BMR ~1500 Calorie consumption 
1200/day Supplementing with a daily multivitamin, vit C, vit E, fish oil, 
antihistamine, and EC stacks. (Forum J) 
Often women appeared to consider the drugs to be effective if they had lost weight 
following their use. 
I first used reductil, i lost 13 kgs in 3 weeks. (Forum E) 
well considering I have lost 14.5 lbs in two weeks and normally it would at the most 
4 lbs I would say, based on that, YES IT'S WORKING!!! (Forum F) 
I took meridia and it worked well, I lost about 30 pounds. (Forum F) 
Effectiveness of the drug was often equated with maximum weight loss and minimum side 
effects. Some women discussed specifically the perceived benefits of the drugs in terms of 
reducing appetite, increasing metabolism and increased energy.   
The best results I had was with Reductil. It seemed to work better the longer I took 
it. I never had any side effects and was not hyped up all the time like when I used 
Phentermine. (Forum B) 
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I'm losing weight with Acomplia It's an appetite suppressant that I was 
recommended by an old friend I managed to buy a supply of these pills online and 
started them right away I take them for about 6 weeks and find them very effective 
at suppressing my appetite, speeding up my metabolism and losing weight fast I've 
already lost 13lbs and I feel so energetic! (Forum G) 
I had a positive experience with Acomplia. I started to take it a while back and it has 
helped me a lot to lose my extra weight. I've lost 18 kilos in weight and not had any 
serious side effects. (Forum I) 
 
Meridia is working pretty good for me. I just started a week ago and I have never 
felt so energetic, also it seems to have curbed my appetite (Forum E) 
Specifically, women discussed how increased energy helped them to increase their 
exercise levels. Women often felt that UWL drugs helped them to have an overall healthier 
lifestyle rather than just relying on the drugs. Women also argued that the drugs helped 
them to adhere to their healthy eating and exercise strategy. 
I am on a low calorie diet and the Reductil helps me to stick to my diet. (Forum H) 
 
Ive been on reductil for about 3 months and ive lost 15 kilos. Is helped me with 
excersise as I have heaps more energy now and actually feel capable doing it, I 
excercise 3-4 times a week mostly cardio but resistance training too, I started off 
just brisk walking for 20 mins and building it up as I lost weight and gained fitness 
Im really happy as i dont feel Im loosing it to fast - about a kilo a week. Its just made 
it easier to change habbits and my lifestyle with less cravings, binging and the usual 
things that would normally have been my pitfall. (Forum E) 
 
Furthermore, women discussed how these drugs made them forget about food and 
change their eating habits. There was much disagreement with forum members who 
argued that UWL drugs were merely a quick fix which, did not deal with underlying reasons 
for overeating. Some women argued that UWL drugs helped them to establish what 
“normal” food portions were and helped them to diet more effectively. In these cases, it 
was argued that UWL drugs were more effective than diet plans.  
I strongly disagree with the statement you made. I have been on Meridia for 6 
months and it has helped me COMPLETELY change how I see food, my approach to 
eating and allowed me to establish new and healthy habits. It only takes 21 days to 
form a habit...and Meridia gives you the time you need to relearn to enjoy healthy 
food. (Forum E) 
 
I'd have to disagree with this. I've been on it for just under 6 weeks. I don't do any 
formal exercise, but am eating a healthy well-balanced 1450 calorie per day diet 
and I've lost 8.7kg (19lbs) (Forum E) 
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What the Meridia did was have me feel full or satisfied with my "normal" sized 
portions. I cannot EVER before remember being satisfied unless absolutely FULL. 
I've tried the eating slowly, low fat/high volume (the WORST types of plans for me), 
boxed food plans (nutrisystem), and have only really had success in the past with 
Atkins. Meridia taught me what normal portions are! It allowed me to STOP eating 
at the right time, so at least I KNOW how much (really, how very little) I can eat to 
lose. (Forum E) 
 
Some women spoke about the ease of using UWL drugs leading them to wonder why they 
hadn’t used them earlier.  
I can recommend Acomplia. These pills control the appetite and you don't have the 
desire to eat so much. I lost almost 13kg in two months with Acomplia. Now I 
wonder why I struggled all those years with the extra kg when it could have been 
so easy just by taking these pills. (Forum I) 
There was also some discussion concerning how the use of these drugs had helped women 
to feel more confident and were consider life changers for those using them.  
I have had some great compliments, and my weight loss really has changed my life 
so much, in every sense, from the jobs I want to do, the confidence i have and the 
courses I’ve taken. (Forum H) 
Some women felt that even despite side effects, the weight loss they had achieved through 
the use of UWL drugs meant that their use was justified.   
I got all the sides: extreme thirst, sleepless nights, lethargy, and the worst- extreme 
sweating!... I'm extremely happy with the results, I was hoping for 7lbs, and I'm a 
month out of my cycle and have easily kept that weight off. (Forum J) 
Whilst not frequent, there were some women who promoted the use of UWL drugs. In 
these cases, women often talked about their own positive experiences of using and 
recommended specific drugs for others to take. Women also suggested specific online 
vendors to purchase these drugs from.  
I can suggest you one drug that help in losing weight which is Acomplia. (Forum C) 
20kg off in just three months, my biggest achievement until now. You can buy them 
as I did, online on [name of website]. The prices are very reasonable here and the 
customer support is also very kind (Forum I) 
5.5.2 Negative experiences: When you go back to "normal" you'll gain it back 
For DNP, women often either used and reported positive experiences or had never used 
and advised against use due to potential side effects. Those who reported experiences of 
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using DNP tended to report other people’s experiences rather than their own and focused 
upon the harms of use.  
DNP is bad news. I don't know loads about but a friend took it as recommended and 
after researching it for 6 months and nearly killed herself. (Forum A) 
 
DNP is BAD I had a friend who nearly died using it. I made her flush it down the 
toilet. DNP shouldn't even be a consideration. (Forum A) 
 
Experience was often considered negative if those using had not lost weight. Some women 
appeared frustrated that they were not seeing results as quickly as they would like to. In 
these cases and for DNP specifically, others on the forum advised users to have a more 
relaxed approach (“It's ten fucking pounds. Chill out”) and that their weight loss would be 
more apparent once they had finished their cycle (“Dnp causes you to hold water, 5 days 
after you stop taking Dnp will show your true weight loss, so don't worry if your not seeing 
results fast”). 
I took reductil for a while and it did nothing. I’m still fat! It was awaste of money 
and misplaced hope! (Forum F) 
 I have tried Reductil three times with no joy (Forum H) 
I'm female, started at 66.7kg and about 19% body fat. I've been taking 500 mg of 
DNP for the last three days and was annoyed that this morning my weight is only 
down .4 kg. (Forum J) 
Some women also discussed that whilst they had lost weight, the weight loss had been 
short term. In some cases, women argued that the weight loss was only due to the drugs 
having a laxative effect.  
Sorry, i say no drugs. May help you lose a bit more to start bu when you go back to 
"normal" you'll gain it back. I did with Meridia many moons ago. (Forum F) 
I was able to maintain from weight loss from Meridia for nearly 17 minutes before 
regaining it plus more. No one had told me that such drugs typically "poop out"29. 
A real medical term which means that at a certain point they stop working, even if 
you increase the dose, and by doing so increase the side effects. (Forum F) 
                                                          
29 Developing a tolerance for a drug so that it is no longer effective 
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Furthermore, some women argued that UWL drug use contributed to them making 
unhealthy food choices. One woman stated that using drugs of this nature perpetuated 
the feelings they had that food was their enemy. 
I took reductil for a while at the beginning of the year, they did help me lose a bit 
but I found the suppressed appetite element didn't help me to eat properly (Forum 
H) 
 
Never again. I'm going to stay with real food and hopefully I will realise that food is 
my friend and not my enemy! (Forum H) 
In contrast to those women who felt that UWL drugs had helped them long-term, some 
argued that the use of this type of drug did not help them to deal with the underlying 
reasons for why they were overeating.   
I honestly feel--as [forum member] also said-that going the tougher route (with the 
help of [forum name]) and just logging your caloric intake, building up the will to 
eat less, and eating better foods, that the weight lost will stay off longer, because 
you will have trained yourself to control your appetite instead of letting a drug do 
the work for you. (Forum E) 
5.5.3 Side effects: I felt freaked out on them 
For sibutramine and rimonabant, the issue of side effects were often discussed in relation 
to the drugs licence withdrawal. Women spoke about their experience of using these drugs 
pre-ban and the side effects they had experienced. Whilst DNP discussion often focused 
more on the fear of using the drug due to side effects, discussion concerning, in particular 
sibutramine mostly focused on experiences of side effects.  
Acomplia has been banned due to side effects which i can confurm (Forum H) 
I know it's [Rimonabant] has been banned. My experience was not good which 
seems to have been the norm? (Forum H) 
Other women spoke about side effects they had experienced such as nausea and increased 
thirst.  
I did get a few sides effects [from rimonabant] at first- i felt a little sick for the 1st 
week. And I itchy itchy on my arms and legs but these both gone now. (Forum G) 
I have no side effects [from rimonabant] except that I'm thirsty and drink a lot of 
water. But this doesn't bother me. (Forum G) 
For sibutramine specifically, women spoke of experiencing irritability, feeling “spaced out” 
and increased heart rate.  
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I had crawling skin, was going hot and cold, was spaced out and generally feeling 
crappy. (Forum E) 
I tried Reductil once. I got them online for around £100.  They didn’t do much for 
me - I felt freaked out on them, hot and cold sweats, drank loads of water, didn't 
eat and didn't lose any weight! (Forum H member) 
 I've tried Meridia - but it made me too irritable! I could not stand myself (Forum E) 
 The only side effects I had was a slightly increased heart rate (Forum E) 
The forum which had a specific sub-forum discussing DNP saw much discussion relating to 
users experience of DNP and side effects associated with them. The most common effects 
experienced, which may be expected given the fat burning properties of DNP were 
overheating and sweating. Additional side effects discussed included diarrhoea, 
constipation, hives and irregular menstrual cycle. 
Dosed this afternoon and had to put a towel on my office chair to prevent me 
sticking to it. Washing spare bed sheets so I can change the sheets on the bed. 
Noticed some shortness of breath in the evening. Slept ok, but sheets were soaked 
still (Forum J) 
 I don’t think solid poo exist whilst taking DNP (Forum J) 
Really bad constipation. I think this might be a dehydration related issue (Forum J) 
Found online similar experiences by other female users on bodybuilding forums, 
from delayed to missed periods (Forum J) 
One woman described a series of side effects from using DNP but appeared frustrated due 
to not losing any weight. 
I'm a 25 year old female. I worked my way up to 600mg per day over two weeks. 
Whilst on the cycle I didn't see any change in my body or on the scales, however I 
got all the sides: extreme thirst, sleepless nights, lethargy, and the worst- extreme 
sweating! (Forum J) 
Others reported suffering no side effects following the use of DNP or stated that the side 
effects they had experienced were manageable. 
I'm feeling pretty good. I haven't experienced any heat or sweating yet. I might be 
a hair warmer today, but I am wearing a thick sweater and uggs, so who knows. 
Sleeping great. No stomach issues. (Forum J) 
Some sweating, but nothing too bad (Forum J) 
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5.5.4 Judgement: So I figure that I will get a lot of flack for this 
Some women reported feeling judged if they admitted to others that they had used weight 
loss drugs or were considering using them. In these instances, it was felt that other people 
did not understand their reasons for taking them and thought they should diet and 
exercise instead.  
When i told my work mates that i was taking slimming pills, they all said same 
thing : just go on a diet . And they are all skinny (uk size 8 i would say) they really 
dont know what dieting to lose weight feels like. (Forum E) 
In some cases, women felt too embarrassed to talk to their family and friends about their 
UWL drugs and instead appeared to feel more comfortable having this discussion with 
other online forum users.  
I haven't told my family or friends (or even my partner) that I am taking reductil as 
I find it embarrassing to talk about my weight but am sure that I won’t feel that 
way talking to fellow slimmers (Forum H) 
Despite this, the forums could be equally judgemental in how forum users viewed UWL 
drug use. This was apparent both in how women discussed their drug use (concerned over 
being judged) and often in how others responded.  
 So I figure that I will get a lot of flack for this (Forum E) 
You're citing banned, illegal substances along side other addictive herbs and such? 
Come on man...it's about health - not what will enhance performance at the 
expense of health. (Forum F) 
This type of negative response was most often evident on forums that promoted fitness 
or healthy eating. In these instances, it was apparent that some women were frustrated 
with the number of threads and posts discussing UWL drugs and instead advocated for 
what they considered to be healthier options. This often led to aggressive dialogue 
between those who used UWL drugs and those who did not. 
Don’t post the millionth thread asking about appetite suppressants and not expect 
to be 'judged' (Forum F) 
I don't expect everyone to be okay with me taking a pill, but at least the numerous 
other people were still helpful with advice and not so cold hearted and downright 
rude! (Forum F) 
Often, women argued that others judgement on the forum was due to their assumptions 
for why people used UWL drugs, such as laziness or a quick fix. 
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People are such haters on here..don't mind them People who JUDGE others have 
something obviously going on in their own life, because in my opinion its never our 
place to Judge. They make ASSUMPTIONS that diet pills are an excuse and a way 
out and cheaitng ETC ETC. (Forum F) 
When discussing DNP in particular, women appeared to be frustrated with those who 
‘hadn’t done their homework’ believing them to be looking for a quick fix, risking their 
health and engaging in dangerous behaviour. 
Are you actually mentally retarded? If you don't know the BASICS of dnp how do 
you expect to run it and not completely shrek yourself? How about before using a 
lethal substance you try putting the fork down and not being a fat land whale. 
(Forum J) 
DNP whilst it isn’t FDA approved is used by Body builders more than you might 
image, also used by female. Moral of the story, whatever you say people can turn 
it around and do stupid ****. (Forum F) 
5.5.5 Polypharmacy: Girl i am the QUEEN of diet pills!! 
Many women discussed the use of multiple UWL drugs. In some cases women stated that 
they had ‘been on every pill imaginable to lose weight’. Others discussed a clear 
progression of weight loss drug use moving on to new drugs or supplements when they 
were not seeing the weight loss results they were after.  
I have been on every pill imaginable to lose weight, xenical, reductil, as well as 
various herbal products, I also tried some dodgy speed type drug (Forum H) 
i have tried hoodia which didnt work for me, i have tried thermobol which worked 
but i didn't like the side effects, I'm now trying hydroxycut on my second tub of 
tablets and haven't lost anything, go to the gym nearly every day always eat healthy 
and nothing seems to work! if any one has any new tablets they could recommend 
that would be great. (Forum I) 
 
In some cases, women felt that their bodies had become tolerant to a particular UWL drug. 
In these cases members often reporting switching to a different drug.  
I notice that my body adjusts to these quite easily and when that happens I usually 
start a completely different set of pills. Comments? Suggestions? (Forum E) 
 
Others discussed how they used UWL drugs concurrently, sometimes cycling them. In one 
case a woman discussed how they used DNP but found this increased their food cravings 
so they also used sibutramine to help in reducing their appetite.  
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I have been taking both sibutramine and rimonabant. Now you can't take these at 
the same time!! I go in shifts. 4 weeks on sibutramine and then three on 
rimonabant. (Forum F) 
 
But there’s sibutramine to help with cravings anyway, so no problem. (Forum J) 
 
Women often discussed using supplements alongside DNP to help them cope with the side 
effects of DNP. Others argued that supplements were not essential but advised the use of 
vitamins alongside DNP use.  
The first day I took my supplements, drank loads of water, followed my diet, and I 
took DNP at night with a melatonin pill to help with the swears. (Forum J) 
You don’t have to use supplements during it, long as you get your usual vitamins. 
(Forum J) 
5.5.6 Purchasing: Do you mind pm'ing me where you got yours from at all? 
There was much discussion on forums about where women should and should not 
purchase UWL drugs from.  Most often women stated that they had purchased their drugs 
online, often after having had them recommended.  
I'm losing weight with Acomplia It's an appetite suppressant that I was 
recommended by an old friend I managed to buy a supply of these pills online and 
started them right away. (Forum G) 
There were many instances of women asking for recommendations of where they should 
purchase their drugs. In some cases, women described how they were struggling to contact 
those who had previously provided them with UWL drugs and often expressed frustration 
at this. Whilst other women did often make suggestions, there were instances where 
members warned of the dangers of buying drugs online. Some women specifically asked 
for websites which did not require a prescription, suggesting that they would not be 
eligible for weight loss drugs available on prescription or that they did not think those 
drugs effective enough. 
Hey, do you mind telling me where you got yours from at all? I cannot seem to get 
replies from [seller name], [seller name], [seller name], or anyone! I'm about ready 
to tear my hair out! (Forum J) 
What else is good for quick weight loss? supplements? names and where I can buy 
them...im desperate. (Forum B) 
Be very careful buying medication online. (Forum B) 
 What online site is best to get diet pills from without a script. (Forum C) 
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Other women were looking for UWL drugs which were inexpensive. In these instances, 
price appeared to be an important contributing factor in purchasing. 
[They] cost about £50 for 40 days,anyone knows any cheaper ones ? (Forum E) 
I've been trying to buy Reductil. I’ve used it before and think it is good and doesn’t 
cause any side effects. The only place I found online sells it for nearly £130 for a 
months supply. I think this is really expensive. Does anyone know where I could find 
it cheaper? Thank you! (Forum H) 
Women often spoke of the convenience of purchasing UWL drugs online and often cited 
the price as being reasonable. Also of importance appeared to be ease of using the 
website, seller discretion and the effectiveness of the drugs.   
I had a good experience with Acomplia diet pill… I purchased my pills from an 
international website: [name of website] - this source offers the best prices Ive 
found (Forum I) 
He's very discrete and it arrived quickly. (Forum J) 
In almost 1 year I achieved the sizes I wanted. I have been buying my acomplia pills 
from [name of website]..overall 100% satisfied with this site and their products! 
(Forum I) 
In some instances, women appeared to have an awareness that purchasing drugs online 
may not be a safe option. However, testimonials and feedback from others appeared to 
help alleviate some of their concerns. Some women also sought feedback from other 
members that the drugs they had purchased were the correct drugs. 
I wanted to get down from 11 stone to 10 stone and I bought some weight-loss pill 
on [name of website] (yes, I know!) but I'd looked at reviews on the internet and at 
the seller's feedback and people were saying they'd lost 4 or 5 pounds in a week, so 
I thought I'd give it ago. (Forum D) 
Stupidly I got some Rimonobant online from India (Forum H) 
They are a small round tangerine orange pill with a imprint of an octagon on one 
side. The reverse side is blank (no numbers, nothing) They claim to be the european 
equivalent to meridia (that's what I've been told) Just double checking to be sure. 
Thanks so much. (Forum B) 
There were some instances where women were very negative towards those asking about 
purchasing UWL drugs likening their behaviour to scoring drugs and arguing that the 
forums were not the right place for discussion of this nature.  
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This is NOT a web site for scoring illegal drugs. Online pharmacy links like you're 
looking for are deleted here as fast as they get posted. You sound like a kid looking 
for some speed. I suggest you seek help for yourself before you end up in trouble. 
(Forum B) 
Some women were also concerned that buying drugs, particularly unlicensed drugs online 
was dangerous due to a lack of knowledge concerning the side effects of these drugs, lack 
of involvement from a health care professional and also potential interactions they may 
have with other medication. There were also concerns around whether the drugs being 
sold online were genuine products and many discussed the high number of ‘dodgy’ or 
‘fake’ drugs which were sold online.  
She bought them online or off the street. At least if you buy legal medication, the 
side effects can be monitored by a doctor. (Forum F) 
Unfortunately there is a lot of dodgy diet pills available on the market so be careful. 
It would be awful to hear something that happened to you over the sake of a couple 
of pounds. (Forum H) 
My advice would be to make sure that you have a medical person check you and be 
careful buying over the internet. (Forum I) 
If you bought them online then there is a good chance that they were fake. They 
could have been anything! (Forum H) 
There was also some discussion around UWL drug sellers ‘preying’ on people who were 
desperate to lose weight in order to make money. Some women did appear to conform to 
this image of an UWL drug user, seeming desperate to try anything and wanting it quickly 
in order to lose weight. Some forum members who were selling UWL drugs appeared to 
specifically aim their products at women. 
There are genuine sellers but because us dieters can be desperate at times we are 
unfortunately preyed upon those who want to make easy money (Forum H) 
I'm very interested in buying 20mg pills. Is there any way to buy them online 
quickly? I'm desperate to start reductil asap. (Forum I) 
i am looking into bringing reductil over to girls that need it. (Forum I) 
hi ladies, i have authentic reductil sending at a price almost half of what to web 
sites are selling. (Forum I) 
Whilst often frowned upon by most of the forums, some women did use the websites to 
promote particular sellers. In some cases, members explicitly stated that they were the 
seller, however on some occasions it was unclear whether the person posting was a UWL 
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drug user or were actually an UWL drug seller. There were also instances of those selling 
UWL drugs dissuading users from other sellers whilst promoting themselves.  
We can supply Rimonabant for the best price and best quality. if interested, e-mail: 
[email address] (Forum B) 
if any one is looking for best diet pills and any type of pain relief or muscle relaxant 
pills then go now [name of website]. (Forum I) 
if you were to go the websites like [name of website] their prices are a total rip off. 
(Forum I) 
5.6 The UWL drug user 
This theme explores the assumptions members had around who uses UWL drugs, in 
particular focus is given to the idea of the informed user as well as differences in how 
female and male UWL drug use is viewed. 
5.6.1 The Informed User: Research and Respect DNP, and it is a powerful tool 
There was much discussion online about who women felt should be using UWL drugs. 
Whilst this discussion was limited for both rimonabant and sibutramine, it was prominent 
for DNP, most likely due to it being perceived as the most dangerous drug. Many forum 
members argued that DNP should only be used by those who were in the bodybuilding 
industry due to the dangers associated with its use. Furthermore, some members argued 
that drugs like DNP would only be effective for bodybuilders or athletes.  
its a really dangerous drug,, its not to be used for people that don't have experience 
in the bodybuilding industry (Forum A) 
a national champion bodybuilder probably using drugs like clenbuterol, T3, DNP, 
etc to help with their weight loss. But for the rest of us, any effect from it will be so 
small it’s not worth worrying about (Forum F) 
Many on the forums appeared to classify DNP use as only associated with bodybuilders or 
elite athletes arguing that both UWL drugs and advice from these groups were not suitable 
for the ‘average person’. 
There are some pills that professional body builders and fitness competitors take 
that don't require diet and exercise to lose weight. Look up DNP for example. 
(Forum F) 
a high-level or pro bodybuilder is the worst possible person for the average person 
to take advice from. Firstly have superior genetics in the first place (or they wouldn't 
be competing at that high a level). Secondly, they’re about 99% likely to be juiced 
to the gills (on steroids/PEDs). (Forum F) 
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Others argued that it should only be used by those who had an understanding of the 
pharmacological properties of the drugs. 
DNP is not safe for kids, or anyone without proper knowledge of chemicals (Forum 
A) 
Most frequently discussed was that DNP should be well researched and respected by those 
who used it and should really only be used by those people who know what they are doing. 
if you do decide to use these compounds PLEASE do thorough research and consult 
with someone who has done these cycles before. (Forum A) 
Do lots of research, and don't rush into it. Make sure you find a reputable place to 
get it from and then make an informed decision. (Forum J) 
If you KNOW what you're doing and are realistic about what to expect then DNP is 
very powerful powerful fat loss drug. (Forum J) 
5.6.2 The uninformed user: If I took a Ferrari and crashed it at 100 mph would you stop buying 
cars? 
Forum members were often very critical of what they classed as novice or newbie DNP 
users. There were many instances across forums where women would ask about using DNP 
and were told it was not suitable for them to use. Others appeared frustrated with new 
users apparent lack of knowledge or respect for the drug. 
You can lose 20 lbs in 11 weeks with just good diet and OTC fatburners. I don't see 
the need to go as far as DNP to lose 8 lbs, esp as a first time competitor. (Forum A) 
Often new forum members posing questions about UWL drug use were met with 
conflicting, and in some cases incorrect, advice for new users 
Do you really want to be suggesting DNP(2,4-Dinitrophenol) and Clenbuterol to the 
OP? She's a first-time competitor trying to lose 7-8 lbs and you suggest Anabolic 
steriods to her? Are you serious?! (Forum A) 
Of most prominence was discussion centred around the idea that uninformed users ruined 
DNP for everybody else. Many argued that those who used UWL drugs incorrectly, took a 
too high dose or had not done their research exacerbated negative attitudes towards this 
drug.  
The reason diet pills get such a bad image is because some people overuse them. 
(Forum E) 
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Media reports of deaths following the use of DNP were also discussed and in some cases 
the argument made that those using had not died from using the drugs but rather from 
using the drug incorrectly. 
Did she die from the pills? Or from taking to many of the pills? (Forum H) 
There was a great deal of disdain for members who had suffered ill effects following UWL 
drug use. 
 Yeah, natural selection at its best (Forum J) 
Lol yeah, unfortunately no matter how many clever people there are, we will always 
be in the minority (Forum J) 
In some cases, women appeared frustrated that they were judged for using UWL drugs or 
had difficulty accessing them due to other people not using them correctly.  
I can’t get "diet pills" anymore because people are too f**king retarded to follow 
directions. (Forum F) 
If I took a Ferrari and crashed it into a one at 100mph would you stop buying cars? 
Of course not, so why apply the same logic to supplements? People used the product 
wrong and they died. Warning labels are put on products for a reason. (Forum F) 
5.6.3 Males only: “You sound like a young inexperienced woman” 
When considering sibutramine and rimonabant, there did not appear to be any discussion 
from forum members around whether these drugs were predominately male or female 
drugs. For DNP however, there were instances where it was argued that these drugs were 
not suitable for women. Whilst this research focused upon female discussion, male 
discussion of the female use of UWL drugs was also evident, particularly on forum J when 
discussing DNP.  In some cases, male forum members discussed how they did not want 
their girlfriend or wife to use DNP due to increased risk of side effects or because they 
thought they were using DNP for the wrong reasons. In some cases, members discussed a 
woman’s role as a mother and how her risking her safety would affect her child. 
Some research suggest that women have a higher chance at cataracts (Forum J) 
You sound like a young inexperienced woman trying to lose weight the easy way. 
this is not for you. (Forum J) 
I did discuss dnp with my girlfriend and she wanted to try it. Initially she just saw it 
as "fast weight loss loose 10lbs in a week? Sign me up! I'll take twice as much as 
loose 20lbs!" It's this reckless attitude that is the exact reason I will not allow her to 
take it. (Forum J) 
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DNP is dangerous. very dangerous.. and with a son if you do something wrong he 
will be without a mother.. or if something bad happens who will watch him while 
your in a hospital or if you have PN and cant walk who will play with him. (Forum J) 
Some male forum members also felt that women did not use DNP or other UWL drugs at 
all and instead were focused only on herbal supplements. 
I don't think a lot of women use dnp, they’re more bothered about bullshit ketone 
supplements…or other ineffective money sinking crap” (Forum J) 
Despite this, many women did discuss the lack of information available for women who 
were using DNP and the lack of female experiences and perspectives. 
Online we need more DNP experiences by women so hello there (Forum J) 
I researched DNP really well, but there are few testimonies for women. (Forum J)  
Whilst women providing information on drug cycling and logs were generally received 
positively, there were instances where women felt that their DNP use was being judged 
negatively simply because they were a woman. 
I'm a female and thank you for publishing this log. It's great to have multiple 
resources. I've been having trouble figuring dosage for women. (Forum J) 
I saw 2 men discussing who were obese and using DNP to lose weight. Nobody had 
a go at them. Nobody called them names or said they were lazy. Nobody questioned 
their diet or eating habits. Yet I get totally blasted because I’m using DNP as an aid 
to help lose some weight. I think you may have a problem with women. (Forum J) 
5.7 Chapter summary 
This chapter has provided an overview of online discussion concerning UWL drug in 
women, in particular identifying motivations for use, attitudes towards UWL drugs and 
side effects from use. The next chapter presents case study interviews with forum 
moderators and UWL drug users.  
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Chapter 6. Interviews with forum moderators and weight loss drug 
users 
6.1 Introduction 
Within this chapter, case studies are presented from interviews with four forum 
moderators (study 2) and three UWL drug users (study 3; figure 6).  
Figure 6. Order of research studies 
 
6.2 Forum moderator interviews 
Forum moderators were recruited from online forums used in the online forum analysis or 
forums which had a similar purpose.   
Despite forums being selected for inclusion because they had a high female presence, all 
moderators recruited were male. Those managing the forums and often viewed as the 
‘experts’ were overwhelmingly male. This mirrors the limited female experiences of UWL 
drugs within the forums, particularly for DNP use. Interviews are presented below as case 
studies.  
Study 1. Online forum 
analysis
Study 2. Interviews 
with forum moderators
Study 3. Interviews 
with UWL drug users
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6.2.1 Josh: “If you’re a guy and you’re known as a bodybuilder they’re going to hit you up 
before they hit up any researcher who looks flabbier”. 
I interviewed Josh30 through a Skype phone call, as he did not want to video chat. Josh also 
did not want to reveal his name so throughout the interview I referred to him by his online 
user name.  The interview lasted approximately an hour and during this time I found Josh 
to be incredibly contradictory and frustrating. At times, I really struggled to know how to 
respond to some of his statements, particularly his comments concerning women and 
people who were overweight. However, despite my unease interviewing Josh, he did offer 
some very useful insights into online communities, which I could not possibly have gleaned 
from just viewing the forum. In particular, Josh told me that on his forum, which he has 
moderated for around two years, he operates under different user names. The user name 
I recruited him through was his moderator name, but he also operates as a seller on the 
forum under multiple different accounts. Whilst there was no way of me knowing this prior 
to the interview, when I realised I was excited and interested to have the opportunity to 
talk to someone who supplies DNP as well as being involved in discussion about it. The 
original reason Josh set up his forum was so that he could sell DNP: “Well I wanted to find 
another audience to sell DNP to”. During the interview, he discussed quite candidly his 
experiences of selling DNP, stating that he gets a few hundred email requests a week with 
5% of these being from women and a large proportion being from men (supposedly) asking 
on behalf of a female partner. Josh discussed “disaster stories” from females using DNP 
such as deaths within the UK, however he argued that incidents like these were not his 
fault saying “it was their fault for using it so (laughs) oh well but people have died and 
people have gone infertile, like women, you know”.  
 
Josh is based within Europe but outside of the UK. However, he frequently sells DNP to the 
UK saying he sells “tons, the Anglosphere is huge for those things, most of my stuff goes to 
the Midlands and places like that”. He talked about how in the past it was quite difficult to 
get drugs through customs but he had become wise to which entry points to send it 
through and where it was least likely to be picked up saying “if you put a note on it saying 
it has to ship through blah blah blah entry points you can send it through the areas they 
put all the affirmative action selection things so they’ll never catch it because they’re 
                                                          
30 Due to Josh’s case study being detailed and due to him illegally selling UWL drugs, I am not revealing 
which forum Josh was recruited from in order to protect his anonymity.  
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incompetent now. Like send it in through London and there will be a Muslim guy going 
through going oh this is normal it says creatine, it must be creatine, it’s yellow and boom 
boom boom never catch it.”  
 
Originally, the main area of Josh’s forum included discussion on the acquisition of DNP 
however, Josh banned this conversation on the main forum and moved it to a private 
section of the site, the digital equivalent of moving his drug sales to a back room.  This was 
because he was concerned about other members of the site reporting DNP sales: “[The 
forum focus was] initially about acquiring it but I started banning that and made it so you 
had to go to the [private section] on [name of forum] which is private to get in because way 
too many narcs exist on [name of forum] like oh is this guy going to shift me I’ll get his 
address and report him to the FBI or something like that”.  
 
Beyond the buying and selling of DNP, the forum also shares health advice. Josh seems 
quite sceptical of much of the advice being shared on his forum arguing that much of it is 
not useful and that “most of it is silly shit on the forums”. In his guise as moderator, Josh 
closed down discussion on any topic of which he disapproved.  This included discussion 
concerning herbal weight loss products as he does not believe they work saying “nothing 
herbal because I tend to ban retarded discussion”. He also bans discussion around holistic 
diets calling those people “hippy dippy retards” as well as suggestions for people to follow 
a vegetarian or vegan diet stating “If I see people recommending shitty diets like go vegan, 
you’re going to get anaemia, you’re going to be fucked up absolutely”. For those members 
who reported negative effects from using DNP or who argue that DNP does not work, Josh 
states that he closes down this conversation as it risks his sales and because he believes 
those suffering ill effects following DNP use do so because they do not take the necessary 
supplements: “A lot of times I do shut down naysayers not because they’re wrong or 
anything like that but I say it because I want to make sales (laughs)…I do leave the ones 
who have legitimate things to say like I’ve got a cataract or something but if it’s because 
they didn’t use the supplements I recommended then they’re retards, it’s all their own 
fault”. Josh does take time to offer DNP users advice on which supplements they should 
take whilst using DNP saying “I tell them, take your Vitamin E, take your zinc, take your 
pyruvate, take selenium, take taurine”.  However, his comments concerning shutting down 
those who had negative experiences of using DNP really concerned me. Prior to this 
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interview, I had assumed that forum moderators were thinking about the best interest of 
their forum members and would only close down threads if they contain information that 
could harm or upset others or went against the rules of the forum. Josh, though, appeared 
to be more concerned about his business selling DNP and other drugs than the safety of 
those on the forum. His hidden role on the forum made me feel that he was abusing a 
position of trust and power and made me question ideas I had around forum moderators 
making ideal peer educators in online harm reduction. 
 
Conversations that Josh does promote and encourage on his forum are what he terms 
“high science” and he is keen to make information on his forum simple and accessible 
explaining “I really hate people who either make what they say too complicated and they 
don’t help anybody…so I go in and put a simple explanation. He is also keen to ensure that 
the advice being shared is what he views as correct advice saying “these people who say 
don’t drink while you’re on DNP like woah woah woah you’re going to die, absolutely going 
to die…they recommend these things and I usually shut them down…they’re completely 
counter to the advice I give”. Josh comes across as intelligent and had vast knowledge of 
bodybuilding and pharmacology having had experience as both as bodybuilder and a 
chemist. However, I felt that he considered himself a guru and that only his advice was 
worth taking. 
 
 Josh argues that a lot of the advice on forums about DNP is not geared towards women 
or as he puts it “we advise based on a male norm model. Basically every bit of advice you’ll 
ever find is about how it works in a man which is different for how it works in a women and 
we might be saying oh take 250 to start whereas for a woman that’s going to make you 
throw up your guts”. This is something I have seen throughout all the forums. Whilst I have 
presented, as much as possible, forum posts I know are from women, these are still in the 
minority and frequently I have seen calls for more female experiences to be shared. When 
asked about how to specifically minimise risk in women, Josh argues that there is not really 
a solution because women take drugs like DNP because they’re unhappy and want to be 
pretty saying “well I mean women have body image issues way more now because they’re 
unhappy. If you want to be realistic and you want to protect women the most you take 
away women’s rights (laughs) that’s not really a viable option though. No I think as society 
becomes more and more shallow you’re going to see more and more girls dying from these 
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drugs”. Josh argues that in Western culture there has been a shift from defined gender 
roles which has resulted in women being unhappy and that this contributes to higher 
numbers of DNP deaths in the UK: “really you’ll never see a DNP death in like Saudi Arabia 
where the women are happier, you’ll never see a DNP death where there are traditional 
social morays for the men and women because the women in those cultures are so much 
happier”. It struck me that Josh was oversimplifying this issue given what I had learned 
about the many pressures on women to look a certain way and the varying motivations for 
why women use UWL drugs. 
 
Josh believes that most people who use his forum and are using or considering using DNP, 
are not based within the fitness or bodybuilding industries, “Umm actual bodybuilders are 
in the minority of people using”. Instead, Josh believes that most DNP users “just want to 
lose some weight, they’re really lazy people who don’t have anything going for them and 
can’t put in the time to cut naturally so they think I’m just going to take a short cut”. It was 
unclear, however, whether Josh still supplied DNP to people he did not think should be 
using it as he also argued that for those who were overweight he would tell them to  look 
at their diet first, for example, “you’re going to go on my forum asking oh how do I use 
DNP, I’m 300 pounds and I want to lose 20 pounds in a week, fuck off buddy, it’s 
ridiculous…No I generally tell people for your diet, if you’re a big fat ass, if you want to lose 
weight quick, do protein sparing modified fast”. Whilst Josh sells a range of enhancement 
products, he says he does not deal in appetite suppressants like sibutramine and 
rimonabant because people misuse them and he believes that their use demonstrates a 
lack of self-control. Josh regularly posts under his selling user name advertising a particular 
product and then validates himself under his moderator username “I always recommend 
oh [Josh selling user name], on the forum I stick in my own [moderator account]”. These 
admissions in particular I found quite surprising and difficult to respond to as Josh 
appeared contradictory in his views. He sold DNP, had previously used DNP and moderates 
a forum of which the primary focus is DNP but appears to have real disdain for those who 
he sells DNP to.   
 
However, Josh later stated that most DNP users were “skinny losers” who think “oh I’m 
going to slim down a little bit more before I bulk and they’re already like way too slim, they 
need to bulk up”. He also discusses the use of drugs such as DNP within those competing 
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in natural bodybuilding competitions stating that “I get plenty of messages from so called 
natural bodybuilders asking about it [DNP], nobody is a natural bodybuilder, there’s no 
such thing. The competitions are always rigged by somebody who cycles”.  
 
Despite Josh having negative views of those using DNP, he believes that other forum 
members view discussion relating to DNP “Hmmm positively, a lot of the people don’t view 
it as like a cop out you know, I view it as a cop out but I don’t care, it’s money”. In particular, 
Josh argues that women should not use DNP as it presents more risks than it does for men: 
“It is much more dangerous for women to take DNP…it can cause women to go infertile, 
it’ll cause a man to lose weight and that’s it but for women it has way more things it can 
do”. Josh argues that those using DNP should do their research first and if they do not then 
they should not blame others when things go wrong. I felt that Josh held quite misogynistic 
views. He commented on women being less likely to know what they were doing and 
therefore more likely to complain to him when things went wrong as well as needing a 
male to help them use DNP correctly stating “That’s another thing I see with women like 
with men a lot of the time they’ll take responsibility and just be like oh shucks well sorry I 
didn’t take your advice but the women they’ll usually complain to me or threaten me for 
money back and things like this but no that’s ridiculous, they hurt themselves way more 
and I think they don’t listen to my instructions as often either unless they have a guy 
administering it.”  One interesting point to come from Josh concerned the varied advice 
on different forums. Josh also moderates another forum and he argues that the advice 
from forum members is very different there, perhaps due to increased anonymity on this 
other community: “On [Other forum Josh moderates], they would usually encourage the 
women to take it because they’d say don’t be a fatass and things like that. On [Josh’s main 
forum], they would tell people more often not to take it or to take extra precautions… cause 
on [other forum] its anonymous nobody really cares and you can’t be tracked down for 
being a jerk or something like that”. Josh’s comments here made me consider the different 
types of information and advice people considering using something like DNP might get 
depending on which online forum they happened to click on.  
 
I was keen to get Josh’s views concerning how harm reduction information could be shared 
across online platforms to those people who are using DNP or other weight loss drugs. 
Josh does think that online forums can be useful places to share good quality information 
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however sometimes this can be lost due to the large volume of poor quality or anecdotal 
information, “A lot of time you’ll get better advice than your doctor not even joking. 
Sometimes you will get really good advice but a lot of time you will not get advice, you’ll 
get trolls, you’ll get people who are going based on their anecdotal experiences”. Josh also 
discussed how an advice page he made about how to use DNP safely meant that others on 
the forum were aware of issues concerning DNP that they may not have been aware of 
otherwise saying “if people did not have my original post from years ago, there would be 
so many people that would a) not use DNP because they didn’t know about it but they also 
would not know how to prevent things from happening or would not know about the side 
effects because they’re not really that public”. I felt it was interesting however, that Josh 
felt that without his forum and his posts that people would not have been aware of DNP 
at all. Josh did not think that researchers or academics could really play a part in harm 
reduction because they would not be taken seriously due to them not having the right 
physical aesthetic. Josh felt DNP users will only respect and take advice from those who 
look the part saying “they’re more likely to listen to other users especially if they have 
pictures of themselves like if you’re a guy and you’re known as a bodybuilder they’re going 
to hit you up before they hit up any researcher who looks flabbier”. He suggests that to 
have your advice taken seriously then first “you’d go to the gym and get really sexy then 
you’d start posting and then you’d be like I have great experience here”. However, despite 
Josh arguing that people using DNP are more likely to take advice from other users who 
have a good physique, he does not think advice through peer educators is the way forward. 
Josh expresses concern about people sharing personal experience and this being used as 
advice for all to follow :“I think it’s very dangerous when people start using their anecdotal 
experiences to give recommendations because they do not take into account that 
everybody is generally different”. However, he does think that someone with a good 
knowledge base and understanding of the drug such as himself should make sure that 
relevant information is being shared saying that “I could probably serve to make more posts 
and promote them and make sure people actually understand the drug. People always read 
that and that’s where the majority of the health advice comes from. Not from studies, not 
from individual experiences, not from anything else it’s from reading that one post when 
the first line is if you use this drug wrong you will kill yourself, you will die, stuff like that 
and it’s really blunt”. Josh had previously mentioned a lack of advice for women so I asked 
him whether he thought a female only weight loss drug forum would be useful. However, 
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Josh felt that this would not work as men would use it in order to find women “everybody 
would regard it as a honeypot, it would not get any traffic”.  
 
I found interviewing Josh an extremely difficult process. Not only did I feel incredibly 
uncomfortable with his deception in order to make money, I also felt that this interview 
should sound alarm bells for anyone considering using online forums as a way of promoting 
harm reduction or sharing information and advice. Whilst Josh came across as 
knowledgeable about DNP and other human enhancement drugs, his dual role as 
moderator and seller means that he has conflicted interests in reducing harm. This is 
particularly evidenced through his comments regarding removing discussion around 
negative DNP experiences, due to the impact this could have on his sales.  What is of most 
interest from this interview is that simply by analysing online forums I would not have been 
able to pick up on Josh’s duplicity. It was only through his own admissions that this became 
evident. Whilst I was surprised at how open Josh was, it made me consider just how much 
I could get to know about the forums by only analysing posts. Whilst online harm reduction 
might still be feasible, it can only take place in a community where there is trust and 
transparency between members and moderators and where the safety of forum members 
is the main consideration of the moderator.  
 
6.2.2 Mark: “We aim to facilitate a substantial long-term harm reduction (by losing weight, 
getting healthy, feeling positive)”. 
Mark is a moderator on a drugs forum, which was not one of the forums analysed in my 
work. The forum did come up during my selection process but was excluded due to a small 
UK audience. I was really keen, however, to speak to Mark as I knew his forum had 
sustained and regular academic input and I was curious as to how this worked on a forum 
with a focus on illicit drugs. I was also keen to speak to Mark because I knew this forum 
had a focus on harm reduction and I was interested in gaining an understanding of how 
this worked and what the successes and challenges of it were. Whilst I had gone through 
threads on this forum, before I spoke to Mark I hadn’t gone into the same depth as I had 
with other forums and I did feel that I came to this interview with less understanding of 
the community Mark moderated than I had in other interviews. Mark requested to 
conduct the interview through Skype chat and one of the first things he asked was how my 
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research was going, stating that I had not chosen an easy area and expressing surprise that 
I had managed to recruit any moderators given the “massive culture of denial”. This was 
something I had repeatedly seen throughout recruitment, with automatic bans from 
forums for simply contacting moderators to ask if they wanted to participate in my 
research as well as denials about UWL drug discussion taking place. Mark however stated 
that he did not have any “no-go areas” and I could ask whatever I wanted. Whilst this 
presented a good opportunity to explore UWL drug discussion on forums and the role of 
the forum within that, I was also aware that this was not the norm within this particular 
community. 
 
Mark has been a moderator on his forum for around two years and the forum was already 
well established by the time he joined the team. Mark is a bodybuilder and weightlifter 
and also has high level knowledge of pharmacology. He believes he was asked to be a 
moderator because of the reasoned and scientific harm reduction content he was posting. 
Mark said that too many people on the forum just “regurgitate copy-paste information 
published elsewhere online” and that he had to fight against entrenched views, which have 
no basis in science. Whilst sometimes Mark feels that when giving advice he is “pissing in 
the wind”, he also spoke about “times others have taken advice and acted upon it directly” 
as well as noticing harm reduction information filtering through the forum. I asked Mark 
what skills he felt were needed to moderate a forum such as his. He felt that his knowledge 
and personal experience offered insight into different approaches and ways of sharing 
information. Whilst having a scientific background could be useful to put across 
arguments, Mark felt that this could alienate people who just wanted “simple yes-no black-
and-white answers to sometimes very complex and contingent questions”. One of the 
issues Mark encountered was people who just wanted to be told what to do and did not 
“want to have to make choices from a selection of reasoned arguments and take personal 
responsibility. Mark felt that sometimes his complex and reasoned arguments were 
sometimes ignored for responses which gave the “simplest, most straightforward answer” 
and Mark said that he spent much of his time trying to think of ways to simplify his 
responses and make them more palatable. Mark also felt that empathy was very 
important, arguing that “if you can't understand what people are trying to do or achieve, 
and how they go about trying to achieve it, you won't know how to connect with them and 
help them make better, healthier choices”.  
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I asked Mark to talk specifically about some of the information shared on his forum 
concerning UWL drugs. He said most of the focus was on clenbuterol and DNP with less 
(but still occurring) discussion around sibutramine and rimonabant and very little of this 
coming from women. It was Mark’s opinion that women may be more likely to rely on 
“social networks - e.g. private Facebook groups, rather than fully public forum as public 
male dominated forums were pretty hostile places”. I was not able to access private 
Facebook groups as part of my research31 and it may be that female UWL drug discussion 
is more prominent in these groups.  
 
When talking about forum discussion content Mark stated that most concerned “how to 
use/what dosage should I take/what should I combine [drug] with”. Most UWL drug 
discussion on this forum is viewed as “perfectly normal” however often forum members 
will “query the diet and exercise regimes of the questioner before answering in any detail”. 
I asked Mark whether there was any discussion that forum members would be less tolerant 
of and he said that this did happen with DNP often being “frowned upon by most forum 
users”. However, again this was only when the person asking did not have an adequate 
diet and exercise regime because it was viewed as a quick fix that would not last without 
“control and a suitable systematic approach to the lifestyle that led them to seek weight 
loss drugs in the first place”. Mark stated that weight loss discussion varied on the forum 
and ranged from caffeine, guarana and yerba mate to growth hormones as well as UWL 
drugs. Mark felt that products such as guarana were seen as  “healthier alternatives to 
prescription or controlled substances” and discussion of these included more women as 
they were considered “easy to use in a more 'casual' way and less requiring any overall 
lifestyle overhaul”.  
 
Mark stated that, from a moderator and harm reduction perspective, he would advise 
against UWL drug use, particularly if he felt that the forum member could meet their 
objectives by lifestyle modification. However, Mark also had an awareness that some 
members will use these drugs regardless and in these instances he would “steer them into 
                                                          
31 The reason for this was an ethical consideration. They are not publicly available spaces with these spaces 
usually set to closed or secret. Closed Facebook groups can be seen by anyone but the content of them 
cannot be seen. Secret Facebook groups are not public at all. Approval/invitation is required in order to 
access content. 
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a least-harmful usage protocol and attempt a kind of 'compromise”. When discussing how 
he impacted on forum members Mark discussed how there would often be “back and 
forth” with members “taking the advice seriously and attempting to understand and 
learn”. However, he also discussed the times when forum members stopped responding 
and in those cases, Mark felt that his advice had been ignored.  
 
I asked Mark about situations when he would close a thread or intervene. Mark told me 
this mostly happened when posters advocated “frankly dangerous and/or harmful 
protocols”. However, in most cases Mark said they would try and bring the discussion to a 
less risky place and only if they could not achieve this would the thread be edited or closed. 
There was also a reluctance from Mark to close threads entirely, quite often he would edit 
a thread and leave it open as an example to others of how not to use these drugs. 
Advertising or selling drugs on the forum is prohibited and the promotion of certain 
websites for purchase was also not allowed so threads doing this would be closed.  For 
threads which were abusive or judgemental, Mark said he would also often close these 
threads.  
 
Mark went on to say he believed that anonymity on forums meant that people were 
harsher in their judgement and argued that this is why he felt women in particular were 
less likely to post. Mark felt that there was often an assumption on the forums that women 
were more likely to be taking a short cut and had not resolved their lifestyle issues first. 
Mark did not personally agree with these assumptions arguing that increased female 
numbers were because “pressures on women to conform to a certain idealised body type 
are much stronger”. These communities being more male orientated repeatedly emerged 
during my research. However, I am also aware from other interviews that women may be 
more reluctant than men to talk about their UWL drug use so it not wholly clear what is 
causing lower numbers of women on online spaces.  
 
Despite this, Mark felt that women specifically asking about UWL drugs would not be 
judged any differently and there was no “preconceived notion that one gender can use 
PEDs but not the other” with “women asking questions about fat loss drugs being actually 
perceived as a normative-type question”. This view differed from other interviews and 
forum discussion where women were judged more harshly for their UWL drug use, 
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however it was clear that gender divides did still exist on Mark’s forum with only some 
drugs being deemed suitable for female use. For example, Mark felt that women discussing 
steroids would be met with resistance on the forum and this would be due to “the 
assumption that the female gender should be feminine and not masculinised through the 
use of androgens”.  
 
We had already touched upon this in the interview, but I wanted to know what type of 
discussion Mark would be really keen to promote or facilitate on the forum. Mark did not 
appear to have an issue with people using drugs to assist in weight loss but it was evident 
that this should not be the only method. Mark was really keen on promoting discussion 
where “someone is trying to turn around their health and become fitter, and is attempting 
to use a weight loss drug merely as a small part of an overall equation and lifestyle change”. 
Mark was keen to promote the creation of a “sustainable platform for long-term change” 
to ensure that “the drug won't simply become a crutch upon which to experience incredibly 
unhealthy yo-yo dieting”. Mark went on to say that losing weight, whether this was with 
the assistance of a drug or not, was helping a person to “facilitate a substantial long-term 
harm reduction (by losing weight, getting healthy, feeling positive etc)”.  
 
I thought this was a good time to ask Mark about harm reduction on his forum. Mark felt 
that there was a “disjuncture between the medical profession and the real-world use of 
PEDs and fat burners” He said most people are becoming aware that GPs know nothing 
about UWL drugs and thus turning to forums to access information. Mark felt that more 
trained healthcare professional presence was needed on the forum, with a focus on 
nutrition and lifestyle as well as how the drugs work. Perhaps surprisingly, Mark did not 
feel that forum moderators should be used as peer educators because they were not 
required to pass any rigorous training for their role. Furthermore, Mark felt that their role 
granted them “(potentially) undue influence over people coming to forums”. Mark also 
discussed the academic influence on the forum, where research is carried out by 
researchers and then the findings of this research are filtered down through the forum. 
Mark stated that at the time of interview there was no researcher employed with a focus 
on enhancement drugs but this would be something he would be interested in seeing 
happen. 
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I found my interview with Mark incredibly positive. He obviously had a lot of knowledge 
but also realised that his suggestions and responses was not the only perspective and had 
an awareness that sometimes his advice would not be suitable for all. I was surprised that 
Mark did not think forum moderators should not be peer educators as I felt someone with 
his experience, understanding and empathy would be the ideal person for such a role. 
However, I was enthused by Mark’s lack of self-importance as I felt he really wanted what 
was best for the forum and its members rather than trying to promote himself as an online 
expert. It was also interesting that Mark did not see his forum as containing much 
discussion from women, and he felt this was due to online forums being hostile towards 
female UWL drug users. Instead, Mark felt that women would be more likely to discuss 
UWL drug use in private Facebook groups. Whilst I had originally felt that online forums 
would allow users to be more open about their drug use and experiences because of the 
anonymity they offer, Marks interview suggested that the reverse was true with people 
being harsher online because they are anonymous. For private Facebook groups, I had 
considered these less likely to contain UWL drug discussion due to user profiles being 
linked to personal identifiable accounts. However, the fact that these groups require an 
invitation to join meaning that everyone allowed to access has to be given permission 
perhaps would offer an environment in which women felt freer to discuss UWL drug use.   
 
6.2.3 Troy: “Giving advice on harm reduction is like banging your head upon a wall” 
Troy is a moderator on a drugs forum, with a focus on all drugs including UWL drugs. Troy 
originally responded to a post I had placed on his forum asking for moderators to take part 
in my study and seemed interested in being involved. Despite this, Troy proved incredibly 
difficult to interview and over a period of four months, many of my emails to him went 
unanswered. Eventually, I decided to email Troy the interview schedule in the hope that I 
might get some level of response. Troy did then respond and answer the questions on the 
interview schedule through email, however his responses were minimal. Unfortunately, 
subsequent emails to Troy to follow up on some of his answers were not responded to. 
Whilst recruiting online is advantageous for research of this nature, it does also come with 
problems; it is very easy for online participants to disengage. I only had an email address 
for Troy and therefore could not follow up on emails to him with phone calls or letters.  
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There was a definite sense from most forum moderators that they were very busy with 
several refusing to take part for this reason and others arguing that they should be paid 
for their time. I also felt in some cases that moderators did not see the value in my 
research, either because they did not believe UWL drug discussion took place on their 
forum or because they did know and were suspicious of my motives. Finally, I felt that 
some online communities were saturated with research and had become annoyed with 
the various requests to take part in different studies. Some forums had even banned 
researchers from posting details of their research studies.  
 
Whilst Troy did respond and fill in the questions, which was more than many I contacted, 
his responses were cursory and I did feel that his treatment of the questions epitomised 
how some forum moderators feel about research on their forums. I felt that this was more 
telling and interesting than his actual responses although his answers did also offer insight 
into moderating an online drugs forum. 
 
Troy has been a moderator of his forum for four years and argues that the purpose of his 
forum is to “provide unbiased discussion/assistance to members with various drug related 
questions”. Troy stated that most of the discussion on his forum focused on “harm 
reduction advice on performance enhancing compounds” as well as information on dosage 
and side effect mitigation. Troy was not aware of any discussion on his forum relating to 
sibutramine and rimonobant, but said that DNP discussion cropped up frequently. 
However, Troy argued that DNP was generally viewed as an ‘experts only’ drug with its use 
only to be advised for “advanced bodybuilders with considerable knowledge and 
experience”. There was a specific question on the interview schedule concerning how 
forum users viewed UWL drug discussion, Troy said the only times members had issue with 
discussion of this nature was when it focused on DNP. If I had been able to I would have 
liked to explore this further to see in which instances this discussion was viewed negatively 
and with which groups of individuals. When asked how forum moderators viewed and 
handled this discussion he stated that the focus was on burning calories and moderating 
food consumption to reduce calorie intake for weight loss with drugs only accounting for 
“minimal fat loss”. I felt, as with Josh, that Troy believed UWL drugs should only be used 
as an addition to a healthy weight loss strategy. In terms of when discussion would be 
banned or closed, Troy stated that discussion was usually allowed so “advice could be given 
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to negate harm potential”. However, where advice was dangerous then the forum 
moderators would intervene and advise. When asked about the promotion of UWL drugs, 
Troy stated that this was not allowed however if the forum was made aware of fake or 
dangerous products they would use to forum to advise on this.  
 
Troy felt that sometimes giving advice on harm reduction was “banging your head upon a 
wall” and, whilst moderators did their best to advise on dose or frequency, often much 
patience was required as “People generally are going to do something anyway” no matter 
what they advised. Despite this, Troy did feel that the best way forward for harm reduction 
was for the forum to continue in the same way; offering “unbiased advice, without 
products for sale”. 
 
Whilst Troy’s interview was useful, I did not feel it added much more than had been 
gleaned from other interviews. It was frustrating that I could not interview Troy by phone 
or chat so that I could follow up on his responses. In particular I was not able from Troy’s 
interview to ascertain any differences within his community between male and female 
UWL drug users or ask about how he and the forum viewed women using this group of 
drugs. Despite this, Troy’s views on DNP specifically were interesting in that he mirrored 
much of the forums’ discussion concerning it being seen as an expert only drug.  
 
6.2.4 Nick: ““If you have a community of people that understand the dangers of such 
products and methods then it makes upholding this view a lot easier” 
Nick has been a moderator of Forum F for approximately two years. Nick was previously a 
member of Forum F and was drawn to this forum so he could chat with people with similar 
interests to himself saying “fitness is my passion and my career, the [Forum F] community 
was my place to go when I logged onto the Internet and discuss things I cared about with 
people that have mutual interests”. Nick is an experienced moderator having moderated a 
number of forums previously. However, when offered the moderator position on Forum 
F, he stepped down from his other moderating roles because he felt that he would not be 
able to keep a “communal feeling” if he was splitting his time across multiple communities. 
I felt during this interview that Nick had a great passion and love for both fitness and the 
forum he moderated and genuinely appeared to care about those who used his forum. 
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Nick stated that the aim of the forum was to help people with health and fitness. There 
was a particular focus on weight: “People use the website for a great number of reasons - 
some to lose weight, some to gain and some to maintain” and the forum also offered 
advice on diet and exercise: “fantastic resource people actively use to assist with their 
fitness and health goals. Sometimes as a stand-alone resource and sometimes alongside 
pre-designed plans”.  
 
When I asked Nick about weight loss drug discussion on his forum, I felt he really did not 
want to spend too long talking about them. He seemed sceptical of their use, was anti-
weight loss drug discussion on his forum and seemed to want to get the conversation back 
onto fitness and diets stating “After all, the only way to loose, maintain or gain body 
composition is to consume over, equal to or above the number of calories each person 
needs in a day. No matter what the product claims to do, there isn't a product that could 
ever change the basic laws of science”. One reason that Nick did not allow UWL drug 
discussion on his forum was the potential risks of someone being harmed after taking 
another forum members advice: “I don't believe that the discussion of unlicensed drugs is 
something that we would ever be willing to permit…The problem that you have to 
understand is with the discussion of any pharmaceutical issue, there is always the question 
of who becomes accountable if somebody takes advice on something such as unlicensed 
products and what happens if things go wrong”. I felt at times that Nick was guarded in his 
answers. He was keen at the start of his interview to state that he was giving his opinion 
and was not speaking on behalf of the forum he moderated. However, I felt that Nick was 
concerned about giving a negative image of his forum and whilst I reassured him that 
neither he or his forum would be named, I still felt as though his responses were somewhat 
closed with frequent references to the forum guidelines. Furthermore, as Nick’s interview 
took place through Skype chat, he had more time to refine and edit his responses. I also 
felt that some of Nick’s comments conflicted with the discussion I saw on Forum F. For 
example, Nick argued that UWL drug discussion was not tolerated on his forum: “I don't 
believe the members of [Name of forum] themselves are fond of such discussions, the 
moderation team and staff are certainly cautious of what we allow to be discussed in open 
forum when it comes to the promotion or use of such drugs” however I did see many 
instances of UWL drug discussion on the forum.  Whilst members did on some occasions 
steer others away from UWL drugs, “the community is geared towards natural weight 
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management methods and discussions of drugs to aid in the process are usually shut down 
by members far quicker than we (moderators) actually get to them” this was not always 
the case. Nick also felt that those using UWL drugs also advocated for unhealthy dietary 
practices and discussion of this nature was banned from the forum saying “there is also 
the fact that a lot of those drugs are geared towards VLCD's (Very Low Calorie Diets), which 
is strictly prohibited from the community”  
 
I asked Nick how he would proceed with forum posts that he felt were not suitable for his 
forum. He stated that due to the volume of posts on the forum he would only take action 
with posts that were reported to him by other members. For conversation which involved 
the advertising or selling of UWL drugs or promoted a particular drug then he would “close 
the thread, issue a warning to the member that started it and post a reason for closing on 
the thread itself”. As well as this, Nick stated that threads discussing UWL drugs would also 
be closed. However, he would allow discussion of, for example herbal remedies or drinking 
coffee to reduce appetite as long as the discussion was deemed safe.  
 
Nick stated that forums were used so members could seek validation about the efficacy 
and validity of their weight loss methods saying “I think that quite often people come to 
communities such as [Name of forum] for reinforcement that the things they have planned 
to take/try is ok. I find that a lot of threads that people are asking advice on such things on 
or more tailored to reinforce and convince themselves that the product is safe and will 
help”. He felt that harm reduction for his forum was in dissuading others against UWL drug 
use: “With regards to what communities and websites can do for damage reduction - 
something that I feel [Name of forum] does already is promote natural methods only”. It 
was difficult to talk to Nick about UWL drug harm reduction as he was so against UWL drug 
discussion. However, he did say that whilst sharing viewpoints and giving information for 
why harmful methods of weight management were discouraged on his forum, this was not 
necessarily the role of the moderator and often fell into the remit of the forum users. Nick 
argued that shared understanding on the forum encouraged positive and safe weight loss 
methods saying “if you have a community of people that understand the dangers of such 
products and methods then it makes upholding this view a lot easier because the power of 
members outweighs any power that staff or moderators could ever have.”. Nick also felt 
that his forum was caring and welcoming to all members including those who were new: 
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“It isn't the moderators or staff that ultimately make [Name of forum] a safe and healthy 
place to be - the general community of caring members do an amazing job of helping new 
and existing members with the continuation and beginning a healthy lifestyles”. Nick also 
felt that generally there needed to be a shift in attitudes towards health and fitness arguing 
that “Unless somebody is prepared to embrace their own health, there is no product in 
existence that will help them”. He placed blame with the media for the bombardment of 
products and felt that there needed to be a move away from a ‘diet quick fix culture’ and 
instead for people to think more about making sustainable lifestyle changes, “as far as 
reaching out to people is concerned, really I'm not sure but I believe that the way forward 
is the discouragement of 'diets' - everybody has a diet, eating 5000kcal of pizza a day would 
be a 'diet' but not one that would be beneficial to health.” 
 
Whilst Nick was obviously invested in his online community and its members and an 
advocate for healthy lifestyles, his distrust and scepticism of UWL drugs made this 
interview very difficult. I was aware that his forum was more geared towards natural 
progression of fitness and that the stance of the forum was likely to be negative towards 
UWL drugs. However, I was equally aware that UWL drug discussion did occur on this 
community. I felt that this forum could do a lot to educate people of the risks of using UWL 
drugs as well as suggesting other ‘safer’ methods, however Nick’s reluctance to engage in 
any UWL drug discussion made this impossible. Despite this, I was enthused by his 
comments concerning how a supportive community can have a positive influence and feel 
that when an online community has a strong identity that peer education is possible.  
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6.3 UWL drug user interviews 
Female forum users were originally recruited via online forums and social media. However, 
recruitment was poor. Many women initially took an interest in taking part. However, due 
to the nature of online forums where people may not log into their accounts on a regular 
basis, they often stopped responding to my messages. Three UWL drug users were 
recruited, one an ex bodybuilder who had used DNP to cut for a bodybuilding competition. 
The second was someone who was overweight and using sibutramine to lose weight. The 
third used DNP for a short period but stopped due to side effects. The interviews are 
presented as case studies.  
6.3.1 Nicola: “I needed to do something a bit radical to speed the process up” 
I recruited Nicola via a contact who knew that Nicola had previously used UWL drugs, in 
particular DNP. Initially Nicola was cautious about taking part in the research due to the 
stigma associated with using DNP.  However, after reassurances about protecting her 
anonymity Nicola agreed to take part. Due to this initial reluctance, I was apprehensive 
going into the interview and concerned about whether any of my questions would cause 
any discomfort or mean that Nicola wanted to withdraw from the research. However, 
during the interview, which was conducted over the telephone, I found Nicola to be 
extremely candid about her experiences. Due to her previous experience moderating 
forums I found her insights as both someone who had used UWL drugs and someone who 
moderated fitness forums extremely valuable. 
Nicola had previously been a bodybuilder who had had used a range of enhancement 
products to assist in achieving her ideal physique. I knew prior to the interview that Nicola 
had used DNP and so asked her where she had first found out about the drug. Nicola could 
not exactly remember where she had first heard about it but thought her awareness came 
from either “talking to other people who competed in bodybuilding” or from “participating 
with people on online forums”. At this point Nicola mentioned that she had previously been 
a forum moderator, which piqued my interest as I had previously recruited forum 
moderators for this research and had only been able to recruit males. The forum Nicola 
moderated was a bodybuilding forum which had a high female presence and a mix of male 
and female moderators. Nicola said that this was quite unusual for bodybuilding forums 
and certainly mirrored my experiences of struggling to recruit a female moderator. Nicola 
described how on other bodybuilding forums, there had never been a female moderator 
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and she felt that this was due to the “chauvinistic attitude” of the moderators and owners 
and an overwhelming sense of the forums being “heavily biased towards men”. Nicola 
cited her own experiences of trying to become a moderator on more male dominant 
forums, saying that despite her being recommended time and time again by other 
members she was never chosen due to the owners not wanting a strong female presence 
and not seeing bodybuilding discussions as particularly female focused.  
Again, I felt this mirrored my research experiences of witnessing online discussion where 
women were told weight loss drugs weren’t for them just because they were women and 
often being dismissed and excluded from the discussion. Nicola also discussed how the 
online forums were very tight knit, and whilst forum members would be very open about 
their personal lives they were particular about who they let into the communities. She felt 
that this was because “99% of the people who come asking for information from outside 
the bodybuilding community are looking to do the community harm in some way”. She said 
that most outside people had a prejudiced and biased view of bodybuilding and 
enhancement drugs and that previous experiences of being involved in research and also 
magazine and newspaper reports had left them very dissatisfied about how they had been 
represented.  
Nicola went on to say that many women were competing in tested bodybuilding 
competitions where weight loss drug use was banned but they were still using them. 
However, due to the stigma associated with use, Nicola said that this group would never 
openly admit that they were using. I asked her whether they would be more likely to 
disclose on online forums due to their potential anonymity. Nicola disagreed with this and 
said both on forums and when participating in research “even if you offer them anonymity 
they will not admit it to anybody”. This really challenged my assumptions of online forum 
use as I felt that due to the perceived anonymity they offered people would be more likely 
to disclose illicit behaviour. However, Nicola was very adamant that this was not the case 
in competing. It may be because bodybuilding is still a relatively small community with few 
members and so fear of being ‘found out’ may be heightened.  
Whilst Nicola did say that forums were “a good source of sharing information” she was 
also very clear that forums were businesses which existed to make money through 
advertising and increased member numbers. Nicola also felt that whilst there were some 
well-educated (both academically and in terms of bodybuilding knowledge) people on the 
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forums who really knew what they were talking about, there was also a lot of anecdotal 
“broscience” giving an example of “my mate in the gym said to do this so I do”. Nicola went 
on to say that whilst some forums did try and pick moderators who were educated and 
knew what they were talking about, in many cases moderator positions were allocated 
“based on popularity”. In these instances Nicola felt that it wasn’t always the best people 
in post as moderators, with people going for those they liked or to keep the peace instead 
of those who could give people the best advice. Nicola also discussed her initial surprise at 
the lack of knowledge on online forums. In her opinion many members did not have “a 
clue what they were doing” with the main question for weight loss being “what drug should 
I take?”. Nicola was very sceptical of people asking about weight loss drugs arguing that 
you should not consider taking any drug unless you are struggling to achieve naturally and 
that it should be an educated decision. 
This then led Nicola to start discussing her own weight loss drug use. Over the years, Nicola 
had used quite a few weight loss products such as clenbuterol which she found “helped 
with weight loss and made doing cardio so much easier”. Nicola had used green tea 
capsules, preparatory blends and ECA stacks.  However she did not use these products all 
the time because she found the side effects quite harsh and because of the pressure they 
put on the circulatory system. Nicola said she knew people who used them “ongoing, day 
to day, just a way to lose weight” and she felt that was a dangerous route to take. I knew 
Nicola had used DNP and asked her if she had used any other UWL drugs (i.e. sibutramine 
and rimonabant). However Nicola felt that appetite suppressants were only for those 
people who lacked willpower and argued that if you struggle with willpower then 
bodybuilding isn’t the right sport for you. We then moved on to discuss DNP. Here, Nicola 
felt she made an “educated decision”, as she had researched the side effects and knew to 
watch out for certain “danger signs” as well as increasing her carbohydrate consumption 
and decreasing her cardio activity in order to not put too much stress on the body. Nicola 
used DNP as she was due to compete in a bodybuilding competition and had not left 
herself enough time to achieve the body she required. Therefore, she decided to do 
“something a bit radical to speed the process up” and took three 250mg tablets a day for 
approximately two to three weeks. Nicola purchased her DNP through a bodybuilding 
contact she knew online. As she purchased from somebody she had known for a long time 
and Nicola felt that this was the safest option for her. Despite using DNP herself, Nicola 
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felt that some people were too quick to use weight loss drugs and argued that, in many 
cases, their use was not required. However, Nicola did stress that if someone was 
struggling to lose weight naturally and their diet and exercise regime was adequate then 
drugs like DNP could be useful. She did not feel however that they should be used as a 
quick fix and argued that for her, whilst she had lost weight using DNP, she did not think it 
was any more than if she had just carried on with a “low carb and high cardio regime”.  
We also discussed why Nicola felt women used weight loss drugs. She felt it was because 
we live in a quick fix society where everyone wants the final product without having to 
work for it and often people weren’t willing to accept that Nicola looked the way she did 
because of hard work, thinking that that there is “a big secret that we’re not telling 
anybody”. Nicola expressed concern that things would only get worse with social media 
putting a lot of pressure on young people in particular and setting their aspirations too 
high. Nicola cited Instagram saying that young people see “photoshopped and filtered 
photos” of others and they think that is reality and then try to achieve the unachievable. 
Nicola expressed concern that if things did not change these pressures would lead to a 
“generation of physically and mentally unwell people” and argued that the pressures from 
social media were “a big contributing factor for why these weight loss pills and drugs are 
more used than ever before”. Nicola also mentioned the change in roles for men in women, 
saying that historically “men were good at stuff and women looked good” but now women 
were expected to look good whilst having careers. Whilst Nicola did feel that this was how 
it should be, she did feel it doubled the pressure for women.  
Other than tiredness, Nicola had not experienced any side effects. Nicola had obviously 
researched DNP and had read a lot of information on forums about dosing and side effects 
as well as speaking to bodybuilding contacts. I asked Nicola if there was any information 
she could have been given which would have made her reconsider using DNP. Nicola did 
not think so, she was aware of the DNP related deaths but felt that was due to people 
taking a “stupidly high dose” and she had been reassured by her supplier that the dosing 
of the tablets she used were accurate. As Nicola felt she was an informed user and only 
took DNP for a short period of time she felt that her use was safe. She then went on to say 
that the only thing which would have dissuaded her from using was if she did not feel she 
was knowledgeable about the drug because all she knew would be the scare stories or 
media reported deaths.  
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We then moved on to talk about how DNP use was viewed and Nicola felt it was really 
divided between “people who think don’t be such an effing arsehole, what a stupid thing 
to do” and those who felt that the use was okay so long as it was “an educated decision 
with knowledge of what you are doing”. She said where most people were in agreement 
was when somebody who had tried no other weight loss strategy asked about DNP use. In 
these cases, Nicola felt “95% of people would tell them don’t be such an idiot”. However 
Nicola also expressed concern about some people on forums who would say “go on, do 
whatever you want” regardless of the person who was asking. Nicola described some 
situations where people would egg others on to increase their dose and that even on 
online forums there was a lot of peer pressure. She said that often these people were 
joking but she had concerns whether others on the forum always realised it was said in 
jest.  
Furthermore, Nicola said that some forums could be very “cliquey” and often new forum 
members got “shot down in flames” and “called stupid” just for asking a question. Nicola 
also commented that often those on the forums who were, in her opinion, truly “experts” 
did not have time to discuss what drugs others should or should not take. Often this meant 
that other, less knowledgeable people shared their advice and this led to “the intelligent 
stuff getting filtered out”. Nicola did feel that forums had a huge influence on members, 
not for somebody like her with a strong sporting background, but for more impressionable 
younger forum members who were seeing others with the body they wanted and were 
seeking information on how to achieve that body. I found this part of the discussion with 
Nicola matched what I had seen on some online forums, where there was an obvious 
hierarchy of members.  
The final part of our discussion centred on how Nicola felt information about DNP and 
other enhancement drugs should be provided. Nicola felt that the places that should 
provide information are the places where people would look for information. Whilst she 
had had positive experiences at needle exchange programmes, where she had gone for 
equipment for enhancement drug use, she did not feel the staff there were qualified to 
offer advice. Whilst Nicola felt that online forums would be a suitable place for delivering 
harm reduction information, she was concerned about the legality of this, namely “Could 
they get prosecuted for telling people how to take it because they’re advising them to do 
something illegal, so that’s a grey area?”. Nicola felt that because of this risk, most forums 
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would not want to offer advice. She acknowledged that some forums did provide protocols 
for drug use, i.e. how to take the drug, however again she felt there were legal risks to 
doing this as well. Finally, Nicola stated that whilst you could have really good advice 
shared on online forums, the risk would always be whether the product was what people 
thought it was, be that the dose or the drug itself. 
Nicola’s interview provided some really good insights into a female bodybuilder’s use of 
DNP and other enhancement drugs. It was clear Nicola did have much knowledge of this 
group of drugs and strongly believed that drugs like DNP should only be used by those 
people who knew what they were doing. Nicola’s experiences as a forum moderator 
highlighted the male dominance on some forums which I also witnessed, particularly on 
bodybuilding forums with men often being seen as the true experts. Whilst I understand 
why those who view themselves as experts want to dissuade those they consider as 
novices from using DNP, the way this information is delivered can vary. For those who were 
called stupid, as Nicola described - where do they go from this point, does this dissuade 
them from using or would they just look for the information somewhere else? Finally, 
Nicola’s views of harm reduction on online forums and the legal implications of this was 
not something I had previously considered. However, it made me consider the lack of 
consistency on online forums and perhaps this in part is due to a lack of true expert 
discussion. At present, online forums have a varied range of information, views, opinions 
and experiences which are confusing to read and make it difficult to separate good advice 
from bad advice.  
6.3.2 Sarah: “I was gutted but not because I was taking a banned substance but because I 
had lost the only thing that has really worked for me”. 
Sarah was recruited from a weight loss forum. She responded to a post I had placed online 
looking for women who had used UWL drugs, telling me that she had previously used 
sibutramine as well as a raft of other weight loss drugs. Sarah requested that we conduct 
the interview through Skype, originally this was supposed to be a Skype call but after failed 
call attempts we switched to the chat function.  I started by asking Sarah where she 
originally got information about UWL drugs from and she said in most cases her 
information came from social media, online forums or through “random dirty google 
searches”. Sarah followed fitness accounts on Twitter and also read forum posts about 
how to lose weight and which weight loss drugs to take. However, Sarah did not often 
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engage in the forums, preferring to lurk, read posts without contributing to discussion 
“looking for the next quick fix”. Sarah said she often searched drug names on Google and 
then from there came across forums discussing the drugs.  
Sarah admitted that her weight loss drug knowledge was sparse. She has a long history of 
using weight loss products, she says she has an issue with “carb consumption” as well as 
finding traditional weight loss methods to be “soul destroying”. She has over the years 
tried multiple weight loss products and strategies looking for that one which will help her 
lose weight without the “pain of maximum effort for minimal output”. These included over 
the counter weight loss drugs, prescription drugs like phentermine, herbal products such 
as raspberry ketones and green tea as well as attending fitness boot camps. She discounted 
fat burners though, believing them to be “too heavy duty” and was concerned about side 
effects such as nausea and not being able to sleep. Sarah seemed to be quite desperate to 
lose weight and willing to try almost anything for that quick fix which would help her to 
achieve her goals. Sarah had purchased herbal products online and received drugs like 
phentermine from friends. The most recent drug she took however, sibutramine, she used 
without being aware of what she was taking. 
Sarah purchased sibutramine as an ‘herbal product’ from an offline shop. She visited a 
“little back street shop” where she paid £10 to receive acupuncture and a week’s supply 
of tablets which she was told to take once a day, as well as green tea which she drank three 
times a day. Sarah used sibutramine for approximately 2 months and found it to be very 
effective saying that it helped with both weight loss and reducing appetite and that the 
drug had no downsides whatsoever. Sarah had no idea that she was taking an unlicensed 
product and only found out that she had been using sibutramine when her supplier was 
arrested for selling unlicensed products. At this point, Sarah said she felt disheartened and 
frustrated stating that “I was gutted but not because I was taking a banned substance but 
because I had lost the only thing that has really worked for me”. I found it interesting that 
Sarah did not seem overly concerned about unwittingly taking a banned substance of 
which she had no knowledge of the potential harms, but rather that her primary concern 
was that she could no longer access the only drug she felt had been effective. 
The other drugs Sarah had tried, had not worked for her. She had previously been 
prescribed orlistat by her GP but said it was “rubbish” and did not work and these feelings 
were mirrored in her experiences of herbal weight loss products. With phentermine, Sarah 
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had not lost much weight but also experienced unpleasant side effects saying that it made 
her feel “bloody awful”, she “didn’t sleep for three weeks” and had fainted whilst using the 
drug.  I felt that finding everything else she had tried to be ineffective or resulting in side 
effects had further exacerbated Sarah’s frustration and disappointment at no longer being 
able to access sibutramine. 
Sarah mentioned that she had considered trying to find a difference source for sibutramine 
but so far had not started using it again. I asked Sarah what her reasons were for this. Sarah 
said the main concerns were her family finding out and her fear of them judging her and 
being worried about her health. She was also worried about potential side effects saying 
that the drug must have been banned for a reason and being scared that its use could kill 
her. I asked Sarah what types of information she thought would be useful for anyone 
considering using an UWL drug. For Sarah, she felt that the information needed to be 
presented in a user friendly way and “not too heavy to read”. However, she also 
acknowledged that awareness of the drugs did not necessarily mean that people would 
stop taking, saying that “like all drugs people know the risks and still take them”.  
Since Sarah had found out that she was using an unlicensed substance she had not 
purchased sibutramine elsewhere. However, she had looked into purchasing it and I felt 
that she was still weighing up the risks. Sarah was very open about her reasons for wanting 
to use weight loss products, saying that “traditional methods are really hard and soul 
destroying”. For me, Sarah represented the stereotypical weight loss drug user that I had 
incorrectly expected to be the typical user. She freely admitted to having a problem with 
her weight and a problem with overeating and had turned to these drugs for a quick fix 
weight loss method due to frustrations at not succeeding through diet and exercise. I found 
it alarming that Sarah had taken a drug without knowing what it was and I found it further 
concerning that she was seeking that magic pill. Whilst it was reassuring that she hadn’t 
since purchased sibutramine, I did get a sense from Sarah that she would try most things 
provided they worked. The fact that she had used sibutramine and found it to be effective 
with no side effects, I felt meant for Sarah that she still considered it a solution to her 
weight concerns.  
6.3.3 Jane “Here is my story if anyone was curious on how it went for a small female” 
Jane was recruited from Forum J. Whilst I did not interview Jane she responded to an 
advert I posted recruiting UWL drug users. Jane had posted on a public forum from which 
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I had already taken user discussion so I felt it was appropriate for me to use the information 
she gave me in her post. However, this meant I was not able to ask Jane specific questions 
or follow up on any posts made. Despite this I still felt that Jane offered an interesting 
account of a woman using DNP and other supplements.  
Jane wanted to post information about her use of DNP because most of the members of 
the forum were men and she thought it was be useful for women to see how “it went for 
a small female”. Jane was introduced to DNP by trainers at the gym she used who 
mentioned it was effective in “getting rid of stubborn fat” and Jane purchased DNP from 
dealers recommended to her by her trainers. However, much of the information Jane had 
about DNP, she had learned from online forums. Jane planned to take DNP for three weeks 
and started with “a very low dosage of 125 mg (powder) the first week and then 150mg 
the second and third”. On her trainers’ recommendations, Jane also took a number of 
supplements including Vitamin C, Vitamin E and V8. Jane also tried to purchase N-
Acetylcysteine (NAC), a drug which is thought to protect against neurological damage 
caused by drugs, but she was unsuccessful. Jane wanted to use NAC due to her fears of 
developing peripheral neuropathy (nerve damage) as this was something she had read 
could be caused by using DNP. Jane described how she had taken her first dose, expecting 
to start to feel the effects (mostly becoming overheated) but had no side effects. However, 
by the third day Jane was experiencing tingling in her hands and due to her fears of 
developing peripheral neuropathy, Jane stopped using the drug.  
Whilst Jane stopped using DNP, she said she would start using it again if she could get NAC. 
Her experience of using DNP left her feeling really frustrated because she had experienced 
no other side effects and thought DNP was going to be effective for her. 
Whilst Jane’s experience only offered a small insight into using DNP, I felt her story was 
interesting. Many of the experiences I had seen online of people using DNP often only 
presented those who had had a positive experience, or those who thought DNP use was a 
ridiculous notion. Jane was somewhere in between, appearing to be a very cautious user 
who was not willing to take huge risks in order to achieve the weight loss she wanted. 
Despite this, Jane had still not ruled out DNP even with the fears of the long term damage 
she thought could be caused by using DNP. Where I also found Jane’s account interesting 
was in her wanting to share her experiences due to the lack of female experiences online. 
Her response to my post came after another comment from a male forum member stating 
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that they did not see DNP as a female drug, arguing that they did not respect the drug and 
were only interested in faddy diets and quick fix “lose 10lbs in a week” weight loss drugs. 
I felt that Jane wanted to share her experiences to show that this wasn’t the case and 
women were using DNP and using it sensibly.  
6.4 Other users 
Both UWL drug user and online communities are rapidly developing. Those UWL drug users 
who were interviewed were guided by the users found within the examined online 
communities. Whilst there was much crossover, the online communities seemed to be split 
between those using UWL drugs for bodybuilding who perceived themselves as informed 
users and those after quick fix weight loss who lacked an awareness of the different types 
of weight loss products. This research can only offer a snapshot of the online communities 
where UWL drug discussion is taking place. However, subsequent online searches for UWL 
drug discussion has found an additional user group not identified in the initial searches.  
Whilst no eating disorder or proana forums were found in original searches, later checks 
have found that discussion relating to UWL drug use is now taking place on these 
communities, seemingly triggered by the death of Eloise Parry, a young women suffering 
with an eating disorder who died in 2015 after taking DNP. Brief searches of these 
communities found women who were proactively endorsing and promoting extreme 
dietary practices. However, whilst there were some women on there who actively stated 
that they were using UWL drugs, as in many of online communities examined they were 
often dissuaded from doing so. Despite this, these forums did contain some worrying 
discussion such as extremely underweight women taking very high doses of DNP, a lack of 
awareness of the need to take additional supplements whilst cycling DNP, experience of 
side effects and a view that DNP in particular was the miracle weight loss product. For 
some on these forums the desire to be thin was the ultimate goal and many were willing 
to try any method possible in order to achieve this. Whilst the current research did not 
include any specific eating disorder or proana forums, these feelings of desperation were 
also seen by members across other online communities and as such are not necessarily 
limited to only those women suffering with an eating disorder. The awareness that UWL 
drugs are being used by those suffering with eating disorders is important in targeting 
service interventions particularly as these users may be the most vulnerable. However, the 
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overall feelings of desperation and willingness to try anything was something that was 
evident across many online forums and by many UWL drug users.  
6.5 Chapter summary 
This chapter has provided an overview of forum moderator and UWL drug user 
perspectives concerning UWL drug in women, in particular identifying motivations for use, 
attitudes towards UWL drugs and side effects from use. The next chapter (Chapter 7) will 
discuss overall findings of the studies, as well as strengths and limitations, suggestions for 
future research and recommendations.  
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Chapter 7. Synthesis of findings and discussion 
7.1 Introduction 
The chapter sets out the overall findings and discussion for all stages of this research. The 
overall aim of this research was to explore the use of UWL drugs in women. Specifically, 
this research aimed to: 
1) Identify attitudes and perceptions of UWL drug use 
2) Identify the self-reported risks of using UWL drugs  
3) Identify the reasons and motivations behind why UWL drug users begin to use 
UWL drugs and the associated trigger points. 
4) To assess the role of online forums in health promotion and sharing of harm 
reduction information 
Whilst these objectives are still used to frame the discussion, the findings considered 
pertinent to this research area have developed. In particular, this chapter concludes that 
that ‘one size does not fit all’, whether that is in identifying user profiles, motivations for 
use, drug use and the role of online forums in online health promotion such as sharing 
health information and harm reduction.   
This study has been broad and exploratory in its approach collecting a large amount of 
data from online forums, supplemented with interviews from forum moderators and UWL 
drug users to provide an overview of UWL drug use in women. Ethical considerations and 
the use of online methods in hard to reach population will be discussed. Additionally, 
particular consideration is devoted to women’s motivations for UWL drug use and those 
who use UWL drugs, the role of online communities in sharing health advice and whether 
online forums are suitable environments for the sharing of health information and harm 
reduction. The original contribution of the thesis and strength of the work is explored 
followed by the limitations and implications for policy, practice and future research within 
this area. 
This chapter will bring together each study conducted. A separate discussion was not 
provided for each study chapter due to the sequential design of this research. Each stage 
was guided by the previous and combined provides a full overview of the topic, therefore 
one discussion presented at the end of all data analysis was considered preferential.  
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A formal triangulation methodology was not adopted, due to each of the stages of research 
focusing on different elements of the research aims and objectives. However, the key 
findings from each stage are outlined in Figure 7 and discussed below. 
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Study 1a. Online forum 
dynamics
•UWL drug discussion happens on varied forum types
•Advice and attitudes concerning UWL drugs are also varied. Mixed users of UWL drugs on forums means there 
is a diffusion of ideas, attitudes, knowledge and perceptionn of UWL drugs. 
•Type of advice offered was heavily dependent on both the attitudes of the forum and the characteristics of 
those asking. 
• There was some evidence of users being influenced by others. This was particularly seen on those forums 
which had a strong identity and were supportive
• On many forums there was a definite hierachy, with bodybuilders at the top of the hierarchy and those using 
UWL drugs for a quick fix, women and those who were overweight further down.
•Lack of a female voice on forums particularly around DNP use.
Study 1b Thematic online 
forum anlysis
•Attitudes towards UWL drug use varied from them being considered ineffective to one component of a 
weight loss strategy to the ultimate solution
•Motivations for use varied considerably. Ultimately, UWL drugs were used to lose weight but motivations 
ranged  from cutting for a competition, losing weight for a planned event to random. Also evident were those 
who are obese or tackling problem areas. Those avoiding UWL drug use did so due to legality of drugs and 
fear of side effects
•Some women appeared willing to try anything to achieve weight loss.
•Variation in peoples experiences of using UWL drugs, both negative and positive as well as experiences of side 
effects (rimonabant - thirsty, nauseous; sibutramine - hot and cold sweats, thirsty,  increased heart rate, 
feeling spaced out, irritable; DNP - overheating and sweating, diarrhoea, constipation, hives and irregular 
menstrual cycle)
• Women often used forums due to not wanting to disclose UWL drug use to those in 'real life'. However many 
of the forums were also judgemental towards women using UWL drugs, particularly DNP. 
• No obvious typology of female UWL drug user. Instead, there was a spectrum of use and motivations as well 
as variations in types of online forums where UWL drug discussion takes place. 
Study 2. Interviews with 
moderators
• Moderators were all male
• They were difficult to engage with responses to research requests resulting in the researcher being banned 
from the forum and a low response rate. 
• Moderators often outwardly mirrored the attitudes within their forum. There were also  indications of 
unscrupulous attitudes and behaviours by moderators which did not align with their forum.
•Moderators were varied in their views and opinions. Different in knowledge base, confidence and 
competance, and attitudes towards UWL drugs
• Moderators may not necessarily be best placed for harm reduction. This needs to be better considered or 
different strategies required
Study 3 Interviews with UWL 
drug users
•Differing users with different motivations, attitudes, knowledge and drug used. For example, one interview 
was with a bodybuilder who  consider themselves knowledgable and who used DNP for competitions versus a 
sibutramine user who used it without realising what she was using.
•These examples epitomise the perceived informed and uninformed users
•Females hiding UWL drug use, especially DNP use. Even when as knowledgeable, female UWL drug users not 
as well respected on forums as their male counterparts.
Figure 7. Overarching findings from each study 
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7.2 Ethics in online research 
The online nature of this research created much consideration around both the value and 
use of this method as well as the potential ethical issues. This section provides an overview 
of many of the ethical issues which occurred during this research and how they were 
handled. Ethical considerations in online research are complicated and nuanced. Issues 
concerning the use of verbatim quotes from online communities, seeking consent, 
protecting from harm and distinctions between private and public spaces in particular have 
generated much debate in recent years (e.g. Barratt 2011, James and Busher 2015, Martin 
and Christin 2016, Barratt and Lenton 2010). As a researcher who had not previously 
undertaken online research, advice was sought from a number of colleagues at the onset 
of this research about whether research of this nature required ethical approval. 
Responses to this question differed with some colleagues suggesting that ethical approval 
would be required and others stating that online forum posts were publically accessible 
and therefore ethical approval was not required. These responses mirror how ethical 
considerations in online research within published works are treated, with some 
researchers outlining in great depth their ethical dilemmas and processes and others giving 
ethics only a cursory mention. However, ethics in online research are complicated and 
whilst they still present the same challenges as in traditional research, they also generate 
fresh ethical challenges (Barratt and Aldridge 2016). For this research, guidance was taken 
from the British Psychological Society (2013) ethics guidelines on conducting internet-
mediated research, recommendations from the Association of Internet Researchers (AoIR) 
ethics working committee (Markham and Buchanan 2012) as well as processes outlined in 
Kozinets (2002) work and therefore ethical approval was sought. Despite this, carrying out 
research of this nature still produced ethical dilemmas and at points caused periods of 
doubt about conducting this type of work. For example, should only public or open forums 
be included? Should the online forums be made aware that they are being researched? 
Should consent be gained? Should direct quotes be used? These concerns and issues were 
exacerbated due to the lack of clarity in ethical guidelines (Trevisan and Reilly 2014) and 
due to this, the inconsistency in how ethics committees view this type of research and how 
researchers interpret and utilise the guidelines. Furthermore, it is often unclear whether 
ethics committees are making use of online research guidelines (Sharkey et al. 2011). 
Guidelines for the conduct of online research have also been criticised for being outdated 
as new medias have evolved (Trevisan and Reilly 2014). This chapter will now go on to 
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discuss some of the main issues associated with online research and how these issues were 
handled within this research, an analysis of online forums (as described in 3.5). Whilst this 
chapter does not provide the definite solution for how each of these issues should be 
resolved, the decisions that were made represented what was felt to be the best fit for 
this particular research.  
7.2.1 Covert netnography 
Kozinets (2002) p.65 recommends four ethical procedures that should be undertaken in 
online research. These are that the: 
1) Researcher should fully disclose their presence, affiliations and intentions to 
online community members 
2) Researcher should ensure confidentiality and anonymity 
3) Researcher should seek and incorporate feedback from online community 
members 
4) Consider the private and public space issue 
Consideration has been given to Kozinets’ recommendations of confidentiality, anonymity 
and private and public space and has been discussed in subsequent sections. This research 
differs from Kozinets (2002) recommendations on disclosure. Kozinets recommends that 
researchers should announce themselves on the online communities they are researching, 
provide credentials and seek permission for using quotations. However, this issue may not 
always be necessary, particularly when public forums are being used. Langer et al. (2005) 
argue that the ethical guidelines set out by Kozinets are sensible when researching 
restricted or private forums but are far too rigorous for all online research. Langer et al. 
(2005) discuss how in their research of cosmetic surgery discussion on Internet message 
boards, they did not announce their presence. This was because they only used public 
message boards that did not require formal registration and because most online users 
had used pseudonyms for their posts. It was also felt that declaring their presence would 
reduce one of netnography’s major advantages, specifically its unobtrusiveness. Langer et 
al. (2005) also argue that declaring researcher presence on an online forum might 
endanger their research and cause forum users to engage in what they termed ‘the spiral 
of silence’. Essentially, researcher presence might stop forum users from posting, meaning 
that only those online users who feel comfortable discussing sensitive topics in the 
presence of researchers would be included. In this research, posts were being analysed 
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retrospectively so there was no concern about forum users not posting. However, 
subsequent stages of the study involved interviews with forum moderators and UWL drug 
users. It was felt that asking permission to use the forum could endanger the involvement 
of both these groups in the later stages. Furthermore, all forums used within this research 
were publically available forums which did not require an account to access threads and 
posts. 
7.2.2 Member feedback and member checks 
Kozinets (2002) discusses two types of engagement with members or online 
users/moderators that are linked. The first of these is member feedback and is concerned 
with seeking and incorporating feedback from members of an online community. The 
second, member checks is concerned with presenting research findings to participants for 
their comments. In traditional research, member checks or feedback is the process of 
presenting research findings to research participants, in order to gain feedback on 
researchers interpretation of the data (Lincoln and Guba 1985). Kozinets (2002) argues 
that member feedback is useful as it allows researchers to gain additional insights into 
meaning. This can be particularly useful in netnography where it is possible for forum posts 
to be misinterpreted. Thomas (2017) argues that many researchers advocate the use of 
member checks such as sending participants interview transcripts or a copy of the research 
report. However, they also state that whilst there is an assumption that carrying out 
member checks will enhance the validity of the research, there is no real evidence or 
justification for this. Furthermore Thomas (2017) argued that whilst member checks may 
be useful for studies involving evaluation, participatory or collaborative research, they 
were unlikely to be relevant for all research.  
Additionally, often member checks results in poor response from participants, additional 
intrusion for participants and ultimately little practical changes to the research. In online 
research specifically, Langer et al. (2005) argue that a pragmatic approach should be used 
and that member checks were not required due to the forums they were using being 
public. However, it appears there are two different issues, 1) the decision whether to 
inform members about the research and 2) the decision whether to seek comments and 
feedback to and from members. Whilst it can be argued for public forums, it is not 
necessary to inform participants, member checks are concerned with attempting to 
improve the quality of the data. Whilst (Thomas 2017) argue that member checks might 
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not always add anything to research, for investigations which are aiming to capture 
participants experiences or perspectives, member checks may be useful. In the current 
research no formal member checks or member feedback were made. However, several 
participants in both the UWL drug user and moderator interviews were recruited via online 
forums. Throughout the interviews, participants in both stages were asked to discuss the 
types of discussion that they had either contributed to or were aware of on online forums. 
Both interview studies were informed by information gleaned from the online forum 
analysis and acted as a way of validating and expanding on information collected during 
this stage.  
7.2.3 Private and public spaces 
Before discussion around private and public spaces can be made, consideration first needs 
to be given to whether information on online forums should be used within research at all. 
Netnography is different from traditional research methods, i.e. focus groups, interviews 
or questionnaires because information is collected and used that has not been given 
specifically to the researcher (Kozinets 2002). Kozinets (2002) p.65 describes online 
researchers as “professional lurkers”, essentially active observers who learn about an 
online community through watching and reading (Kozinets 2010). By its nature, 
netnography is unobtrusive which can be both attractive to researchers but also cause 
issues. As participants are likely to not have consented for their words to be used then 
there is potential for harm to be caused by the publishing of their words. On the other 
hand, it could be considered that if someone has posted something online then they have 
put it there for others to see.  Therefore does the action of posting something online make 
it public information and open to all to access and can we as researchers then use their 
words? This is a ‘grey area’ and means consideration should be given to what the intention 
of the forum post was when it was originally made. Did the forum user realise it would be 
publically available to everyone and did they consider that their comments may be used in 
research one day? Eysenbach (2001) argues that those posting on internet forums are 
unlikely to expect that they may be involved in research and when forum posters were 
aware that researcher involvement had, or was going to occur, that this was often met 
with negative responses.   
 
Eysenbach (2001) also states that it is important to make a distinction between whether 
online forums can be considered private (closed) or public (open) spaces. However, 
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defining and deciding whether forums are public or private is problematic. A forum which 
does not require membership via password protected accounts or an invitation to join 
could be classed as public, whilst forums which do, classified as private. In the case of 
online forum research, this issue should be considered alongside whether the publication 
of information could negatively affect the group. So, in terms of verbatim versus 
paraphrased quotes, is the answer to only use public forums, i.e. those that are publically 
accessible and do not require you to become a member or pay a fee to join? The AoIR 
guidelines discuss how there have been cases where users of private communities had 
reported feeling harmed following researchers using their words in research (Markham 
and Buchanan 2012). In this research, only publically available forums were used but again, 
there are issues with doing this. Barratt (2011) argues that even when a forum does receive 
a public audience it cannot always be presumed that the forum member perceives there 
to be a public audience. This has implications for consent, amid a rising movement to 
protect online communities and their views. Furthermore, the British Psychological Society 
guidelines state that the distinction between what is a private forum and what is a public 
forum can be blurred when forums which were once private and password protected later 
become publically available (British Psychological Society 2013). Others argue that whilst 
there are ‘shades of grey’ in deciphering whether online forums are private or public, 
researchers should take the time to examine online spaces to establish whether its users 
deem it to be a public space or not.  In these cases it can be argued that online communities 
with a large group membership and which are easy to join should be classified as public 
space (Martin and Christin 2016). Those forums with restricted members and which have 
a vetting system in order to be a member should be classed as private spaces (Martin and 
Christin 2016).  
 
In this research, only publically accessible forums were accessed. Whilst there are still 
ethical concerns about using any type of online forum, it was felt that the benefits in terms 
of increased knowledge about the area of UWL drug use outweighed these concerns. 
Furthermore, steps were taken to ensure that participants would be protected from any 
potential harm (Table 12). As recommended by Martin and Christin (2016), forums were 
included and classified as public if they had a large membership and membership was easy 
to gain, i.e. just providing a user name and email address in most cases. Furthermore, 
during the online forum analysis, the researcher did not attempt to gain membership to 
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the forums to ensure that only forums which did not require an account in order to view 
posts were selected. Forums were not named nor were forum user names used. Finally, 
any forum poster who had used what appeared to be their own name or photograph of 
themselves as part of their user profile were excluded.  
Table 12. Public and private forums 
Issue Approach Problems with approach Solutions 
Whether to include 
public or private 
forums 
Public forums 
Large member numbers 
Easy to become a member 
Blurring of public and private 
spaces 
Even when public, users may 
not view the forum in this way 
Publication of information 
could harm forum 
Forums not named 
Forum users and 
moderators not named 
Members who had 
used real name or 
photograph of 
themselves were 
excluded 
 
171 
 
7.2.4 Consent 
The decision concerning whether or not to gain consent from forum users or moderators 
is linked to whether public or private spaces are used. Within this research, the decision 
was made to only include publically available forums, therefore consent was not gained 
from forum users or moderators. Guidelines on seeking consent from both moderators 
and forum users are fairly sparse. However, the British Psychological Society (2013) 
suggest that consent may not be necessary providing the online forum is public and care 
is given to protecting participants from harm. The potential to cause harm is mostly 
concerned with whether participants could be identified through research publications. 
Reflexive pit stop – Online research 
I did not gain consent from forum moderators or forum users due to only public forums being 
used. Additionally, subsequent stages of the study involved interviews with both forum 
moderators and forum users recruited from the forums. However, recruitment for both these 
stages was difficult.  Asking moderators to be involved in the research led to responses ranging 
from disinterested to negative, in some cases resulting in me being banned from the forum. 
Furthermore, asking forum moderators if details of the UWL drug user study could be posted 
on their forum also often led to negative responses and again in some cases led to banning. 
The reluctance of forum moderators to participate in later stages of the PhD caused me to have 
some tension in how those online forums continued to be viewed. If forum moderators did not 
want to be involved in interviews, would they have been willing to allow posts from their forum 
to be included in research? Whilst it is not possible to know this, it did lead to feelings of unease 
about the use of online forums in research despite following all appropriate ethical guidelines. 
Care had been taken to select those forums which met a definition of a public group, however 
those involved in the group were reluctant and in some cases suspicious of being involved in 
the research. During the PhD, I with, three other PhD students who were also carrying out 
online research, established an online methods group (OMG). It was clear that the feelings I 
had  encountered during this research had also been encountered by other members of the 
group. Despite all of us having considered the ethical issues associated with online research in 
great depth there were still feelings of unease about taking peoples words without their 
knowledge or consent. We was also felt that ethical guidelines on this issue were sparse 
although it was also acknowledged that a ‘one size fits all approach’ for this would not be 
suitable. The group published a paper (Germain et al. 2017) that discussed some of the ethical 
issues associated with online research using experiences and reflections from our own 
research. Collaborating on this paper and having the opportunity to share doubts and concerns 
about the use of online methods with colleagues was an extremely useful process. Whilst my 
concerns were not completely allayed, there was a realisation that all possible steps had been 
taken to protect forum users and forums. Furthermore, without using online methods in this 
research it would not have been possible to gain such insight into this group. One of the main 
discussion points that our paper covered was around online methods not being used as an easy 
option or because they are classed as interesting and innovative. Instead online methods 
should be used when they are the most suitable method for the research being undertaken as 
was the case here. We have also recently collaborated on a second paper exploring barriers we 
encountered during online recruitment. This paper is currently under review.  
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The  AoIR guidelines state that consideration should be given to whether consent will be 
gained and again differentiate between whether public or private forums will be used 
(Markham and Buchanan 2012, Convery and Cox 2012). However, as discussed what 
constitutes a public or private forum can become blurred and is often down to researcher 
opinion and interpretation. What is also evident are differences in how researchers 
conduct this type of research. Convery and Cox (2012) discuss how some researchers view 
the internet as public and therefore “fair game” in research whilst others argue how 
researchers should protect participants’ expectations of privacy.  
Consent was not received from forum users due to posts being accessed retrospectively 
and therefore it would have been extremely demanding to contact all forum members 
who had contributed to each thread. Additionally, if consent had been gained, only those 
posts from members who had consented could be used, which would lead to disjointed 
threads with lost richness and meaning. Consent was also not received from forum 
moderators in accessing online forum posts. This was not a deliberate attempt to deceive 
as interviews with moderators of the forum were planned for a subsequent stage. In some 
research where posts are being analysed in real time, consent can be gained from forum 
users to use their forum posts as they are likely to be current and active forum users. In 
addition, the researcher can announce their presence to the forum if they wish to and keep 
doing so as new forum members join or post. However, this will be extremely difficult to 
do in retrospective studies such as this where posts are being analysed from as far back as 
five years ago as, forum users may not still regularly access the forum or may have left the 
forum entirely. 
As only publically available forums were used, consent was not gained from either forum 
users or forum moderators. However, the reluctance of forum moderators and forum 
users to take part in subsequent stages of the study highlighted that just because a forum 
is public does still not necessarily mean that those using the forum expect their words to 
be used in research. Whilst forum moderators did not explicitly state that they were 
unhappy that a researcher had been lurking on their forum, they themselves did not 
appear to want to take part in the research in most cases. This did leave the researcher 
with somewhat of a dilemma in continuing to use forum posts, knowing that those who 
moderated the forums where those posts came from may not wish to be involved in 
research. However, it was felt that ethical guidelines had been adhered to in this case with 
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steps being taken to ensure that forums, forum users and moderators were not identifiable 
(Table 13). For studies where threads are being analysed in real time, there should be an 
expectation that consent is gained from forum moderators. In studies such as this, where 
threads are being analysed retrospectively contact with forum moderators would be made 
at an earlier point in the study to discuss how the research should proceed with regards to 
whether threads could be used in research and whether consent was required.  
Table 13. Consent 
Issue Approach Problems with approach Solutions 
Whether to gain consent from 
forum moderators and forum 
users 
No consent  
Only public 
forums 
Large 
membership 
numbers 
Ownership of words 
Just because forums are public does 
not mean users would consent to their 
words being used 
Not done in this 
study but would 
recommend 
early contact 
with moderator 
 
7.2.5 Verbatim quotations 
In qualitative research, participants’ words are quoted to provide meaning and richness to 
the data. Quotes are usually verbatim, to reduce the risk of misinterpretation by 
paraphrasing (Guest, MacQueen, & Namey, 2012).  In online research however, using 
verbatim quote can cause problems. Due to public forums not requiring a password to 
access them, it is possible to locate the original post by putting the quote into a search 
engine. Therefore, it is necessary to decide the probability of harm to the poster if their 
quote was traced to the original post. This depends on the level of personal information 
and the content of the post. If the forum user has used their own name or a photograph 
then the British Psychological Society (2013) guidelines suggest that in order to maximise 
the level of anonymity given to forum posters, paraphrased quotes could be used. 
However, they also acknowledge that this should be considered alongside the potential 
for causing harm to participants. As an emerging research methodology, the use of 
verbatim quotes taken from online communities appears to be a somewhat ‘grey area’ 
with conflicting interpretation of guidelines resulting in differences in how this type of 
research is conducted. Much research has involved thematic analysis of online 
communities and used verbatim quotes within their research (Hekler 2014, Kjellgren 2011, 
A. Kjellgren, Jonsson, K 2013, A. Kjellgren, Henningson, H., Soussan, C 2013). A specific 
example comes from Arden (2014) whose research examined comments made by women 
around gestational weight management on online parenting forums. Verbatim quotes 
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were used but identifiers such as forum user names, the name of specific forums and any 
other identifying information were removed; this research was granted full ethical 
approval and the authors discussed how the steps taken within their research were in line 
with the British Psychological Society guidelines. The use of online communities within 
research have also been identified as an extremely useful way of gaining information about 
sensitive topics especially when access to participants may be problematic. In work 
conducted by Elliott et al. (2005) online message boards where discussion was focused on 
the use of cosmetic surgery were used. Within this piece of research, verbatim quotes 
were used without consent as the forums were considered a public space. When 
considering the option of taking consent to use quotes or making forum users aware of 
the research, the researchers also felt that by declaring a researcher presence on the 
forum may hinder the research (particularly when prospectively monitoring a forum) as 
this may deter forum users from posting.   
Whilst there is much research that has been carried out using verbatim quotes, there also 
exists research which has either gained consent from forum posters or paraphrased forum 
quotes in order to protect participants’ anonymity. Eysenbach (2001) argues that those 
posting on internet forums are unlikely to expect that they may be involved in research 
and researcher involvement within forums was often met with negative responses. 
Eysenbach (2001) also argues that the use of verbatim quotes may breach participant’s 
confidentiality as Google searches could find the original message. However, Roberts 
(2015) also discusses this issue and describes various ways that this issue could be 
addressed. The first is as suggested by the ethics committee and is the suggestion to 
paraphrase quotes, however other solutions were also given. Researchers could exclude 
the name of the online community and the web address or quotes could be searched via 
search engines by the researcher and slight modifications made to the quotes, without 
changing meaning, to ensure they cannot be found.  
When submitting the ethics application for the online forum analysis study, the University 
Ethics Committee requested that quotes from the forums were paraphrased. However, 
there was a reluctance to do this due to the risk of misinterpreting a quote, changing the 
emphasis of the quote or not reflecting the poster’s intentions. Throughout analysis of the 
online forums, often it was difficult to interpret forum user’s meanings. For examples, one 
post read “take DNP; that’ll burn body fat like crazy”. Whilst on first reading it sounds like 
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the forum posters are advocating the use of DNP, there are other potential explanations, 
e.g. the forum posters might have been warning that DNP can raise the body temperature 
to ‘crazy’ or dangerous levels; the forum poster may have been ‘trolling’ i.e. deliberating 
trying to provoke others by making controversial statements, or they have intended the 
statement to be humorous or sarcastic. Without the other verbal and nonverbal cues that 
you would get in face-to-face methods such as tone of voice, body language, eye contact 
and hand gestures, it is extremely difficult to discern the intended meaning of the 
statement. All qualitative research relies on a level of researcher interpretation, however 
this interpretation is normally presented alongside the original quote, which allows 
readers the opportunity to agree or disagree with the interpretation. By paraphrasing, only 
the researcher’s interpretation of the quotes are presented.  
Within this research, gaining access to and recruiting participants who are using or 
considering using UWL drugs is problematic as for example, there are no defined health 
care services which they may be accessing. It was felt that online forum analysis was the 
optimal method in gaining information about UWL drug users. However as there was a 
reliance on pre-existing forum discussions there was not an opportunity to ask forum users 
to clarify on points made as would be possible in interview or questionnaire settings. Due 
to this, the risk of misinterpretation whilst paraphrasing may be high. The addition of a 
paraphrasing phase alongside usual qualitative thematic analysis may also mean that too 
much emphasis is being given to the researchers own interpretation of the quotes and 
risks potentially losing the personal nature of the quote. The ethical implications of using 
verbatim quotes were considered and it was not felt that using UWL drug user quotes 
would cause harm, as whilst selling UWL drugs is illegal it is not illegal to use them.  In 
addition, through taking certain precautionary measures such as removal of user names, 
forum details, web address and identifiers and the exclusion of forum users who have used 
real names, this minimizes any potential risk to forum users. Checks were also made, 
whereby quotes that were to be reported were Google searched and slight modification 
made to ‘non important’ words (i.e. words that do not influence the meaning of the quote) 
to ensure the quotes are not found within Google searches (Table 14). This argument was 
presented to the ethics committee and they approved the use of verbatim quotes with this 
research.  
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Table 14. Quotations 
Issue Approach Problems with approach Solutions 
Whether to use 
verbatim or 
paraphrased quotes 
Verbatim quotes used Identification of 
forum/forum users 
Potential to cause harm 
Forums not named 
Forum users and moderators 
not named 
Members who had used real 
name or photograph of 
themselves were excluded 
Small changes to non-
important words if ‘Google 
searching’ found the original 
quote 
  
Online research methods can provide a wealth of information and are particularly useful 
for researching vulnerable, hidden or hard to reach groups. However, consideration is 
required around the potential impact of including the words of these communities within 
research. This research has contributed to the discussion around the ethical implications 
of online research. Furthermore, it argues that whilst ethics should not prevent research 
from taking place, researchers must exercise caution in simply seeing these online 
communities as freely available data.  
7.3 Body image pressure and the use of UWL drugs 
The literature discussed in chapter 2 examined the pressures on women to conform to an 
ideal body shape, whether that was linked to societal and cultural pressures and 
expectations (Orbach 2009, Orbach 1986), the role of the media (Halliwell 2013, Harper 
and Tiggemann 2008, Hawkins et al. 2004, Myers and Biocca 1992) or social media (McLean 
et al. 2015, Meier 2013, Royal Society for Public Health 2017, Tiggemann and Slater 2013, 
Tiggemann and Zaccardo 2015). From a feminist perspective, thin ideals and pressures on 
women to conform to those ideals is pervasive (Orbach 1986, Orbach 2009) with body 
monitoring and body dissatisfaction being a major outcome of these pressures (Murnen 
and Seabrook 2012).  Social comparison theory (Tiggemann and Zaccardo 2015, Festinger 
1954) suggests that people evaluate themselves by actively comparing themselves to 
others through upward comparisons (comparing themselves to someone viewed as more 
attractive, better or more elite) or downward comparisons (comparing themselves to 
someone they view as worse off than themselves) which can help a person to feel better 
about themselves. Social comparison theory has been much used in discussing the 
negative impacts of the media and more recently social media, with women comparing 
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themselves to beauty ideals and often failing to meet those standards (Festinger 1954). 
This can encourage negative thoughts about one’s own appearance and is linked with low 
self-esteem and body dissatisfaction. Peer comparisons have also shown to be important 
appearance comparison targets for women (Holland and Tiggemann 2016) and often more 
important than comparisons with models or celebrities. This high level of focus on the body 
is also thought to contribute to appearance modification which includes the use of drugs 
to alter, maintain and improve the body or appearance (O'Dea and Cinelli 2006).  
Within this research, there was a preoccupation with the body. In many cases, the 
discussion was not around women becoming healthier but instead women describing how 
they wanted to improve, hone and perfect their bodies. A recurring theme was the 
preoccupation women had with a ‘body in a bottle’ with UWL drug users often having a 
‘quick fix’ mentality, wanting to achieve their ideal body and physique without having to 
put in any work. This was particularly evident in UWL drug user Sarah’s interview where 
she described wanting maximum outcomes (perfect body) with minimal input (no diet or 
exercise). Peer comparisons were also evident. This was particularly seen in UWL drug 
user, Nicola’s interview where she discussed how within the bodybuilding community 
other women looked up to her, admired her and wanted to know how she achieved the 
body she did, ultimately comparing themselves to Nicola. In turn, Nicola described, how 
when she first got into bodybuilding, it was simply because she wanted to look a certain 
way, because she cared about the way she looked and because she had been influenced 
by the appearance of others.  For Nicola, she felt that with the rise of social media and 
photo-shopped pictures that this issue was only going to get worse for women, viewing 
these unattainable bodies and becoming more and more willing to take more and more 
risks to achieve their ideal body. This was something Nicola discussed within the context 
of bodybuilding but also more generally as a desire to be thin or lean. Looking more broadly 
across the forums, forum members used such phrases as there was “something wrong with 
them” or “they were a joke for overeating” for being over their ideal weight. Similarly, in 
Sarah’s interview there was a sense that she felt she was not good enough at the weight 
she was currently at, referring to herself as fat, and being willing to try most things in order 
to lose weight. This internalised belief by women on the forums and those interviewed 
that they would be better or happier people if they simply lost weight was evident.  
Furthermore, women compared themselves to others. There were frequent mentions of 
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how good a friend looked, or how good somebody else on the forum looked. Where those 
women had used UWL drugs this seemed to incentivise other women to use them also.  
This study has been broad in its approach, looking across forums rather than detailing 
forum member’s journeys and stories. Examining online forum posts can only offer a 
snapshot of what an online user was feeling and willing to share at that point in time. Social 
comparison theory can help to explain why women use UWL drugs since women often 
compared their bodies negatively to others before initiating use or positively as a reason 
to continue using. However, this is part of a bigger societal issue with increasingly 
pressures on women to conform to an idealised body contributing to a desire to enhance, 
hone and improve through risky strategies. Whilst, these pressures are also evident in men 
they are heightened in women due to a focus in today’s society of how women look rather 
than what they achieve.  
7.4 UWL drug user types 
To date, there have been no in-depth studies examining which groups of individuals, 
outside of bodybuilding communities are more likely to use UWL drugs. For DNP, the focus 
up to now has been within bodybuilding communities. This is likely because the online 
markets most often target DNP at bodybuilders and several deaths following DNP use have 
been identified in bodybuilders (Grundlingh et al. 2011). Other research exploring DNP use 
has done so without exploring the sex of the user or other characteristics of users (McVeigh 
et al. 2016). There are also suggestions that DNP is, although to a lesser extent, used by 
extreme dieters and those suffering with eating disorders (Hoxha and Petróczi 2015). The 
media has also reported deaths following DNP use seen across bodybuilding communities 
as well as in those suffering from eating disorders and extreme dieters (BBC News 2015, 
Sawer and Mendick 2013, Brooke 2013, BBC 2012, Matharu 2014). For sibutramine and 
rimonabant the focus of literature and research thus far has been pre withdrawal from the 
market as well as the clinical trials testing its efficacy (Arterburn et al. 2004, Christensen et 
al. 2007, James  et al. 2010, Lean 1997, Sam et al. 2011, Scheen 2011). For all three of these 
drugs however, there is little understanding of the differing users of these three drugs, i.e. 
whether they are all used by the same groups or by distinct and separate groups and what 
decision-making processes are being undertaken in their use.  
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Analysis of the GDS, identified that in a sample of psychoactive drug users, approximately 
5% of women (compared to 3% of men) had ever used a weight loss drug32. For both men 
and women, DNP and rimonabant use was low. For women sibutramine was used far more 
than other UWL drugs and women also used sibutramine more than men. In terms of age 
the majority of female weight loss drug users were aged between 18 and 34 years. 
Interestingly for DNP and rimonabant, although taking into account that numbers were 
small, users came from a range of BMIs, from extremely underweight to obese as well as 
users undertaking different levels of exercise, from no exercise to exercising three to four 
times a week. This suggests that those using these UWL drugs were not necessarily 
restricted to bodybuilders. Sibutramine use was seen more frequently in those who were 
either overweight or obese. Similarly, only a relatively small proportion of weight loss drug 
users said they took part in exercise at least three to four times a week. Also of note is that 
those using weight loss drugs were more likely than the rest of the GDS sample, to have 
tried other drugs that have weight loss properties including caffeine pills and 
amphetamines. Whilst we cannot assume from the GDS that women were using caffeine 
pills and amphetamines for weight loss33 the findings here do suggest women are using a 
range of substances with weight loss properties. Furthermore, this stage set the scene, 
providing a link between the literature and the qualitative stages by setting baseline 
characteristics and identifying the use of UWL drugs in women.  
When beginning to plan the qualitative stages of this research many avenues of 
recruitment where considered such as gyms, beauty salons, modelling agencies, clubbers 
or focusing upon girls and young women. However, as previously discussed, there is little 
evidence concerning who the users of UWL drugs are and focusing on one specific 
population would have been making assumptions about who were the most likely users. 
Data from the GDS suggested that women are using different UWL drugs and for different 
reasons, suggested by variances in both BMI and exercise frequency of these groups. 
Whilst online forums may not attract all potential UWL drug users, they are far-reaching 
and varied, attracting a range of different online users. Within the online forum analysis, 
forums were selected based on whether they had a large female presence or if not, by only 
analysing posts within female specific sub-forums. The systematic manner in which online 
                                                          
32 This includes DNP, sibutramine and rimonabant but also ephedrine, clenbuterol and T3/T4 
33 These drugs can also be used to promote wakefulness 
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forums were selected revealed varied online communities. These included weight loss, 
fitness, bodybuilding, parenting and drugs forums. The sheer variety of forum types 
demonstrates the heterogeneity of online communities where UWL drug discussion is 
taking place.  As would be expected the different forum types elicited different female 
UWL drug users, all very different and who are best thought of as a spectrum of users.  
At one end of this spectrum are those women most often seen within the bodybuilding 
forums or drug-focused forums, typically those users already identified within previous 
DNP related literature (McVeigh et al. 2016). They are often bodybuilders, and although 
women they are using predominately male focused forums. They may also be using a range 
of other drugs and supplements such as steroids or other muscle building drugs in order 
to achieve the physique they require for competition. Whilst this research has focused on 
female discussion of UWL drug use, on these forums discussion from women was far less 
prevalent and often confined to female specific sub-forums within the overall forum. 
Bodybuilders in these forums are using DNP most often for cutting body fat, often in 
preparation for competition and users on these communities range from novice to 
experienced, both in terms of their bodybuilding experience but also their UWL weight loss 
drug experience. Those perceived to be experienced and knowledgeable are viewed within 
the forums as the ultimate ‘top dogs’, often seen as role models with others looking to 
them for advice. However, whilst this group may have experience of muscle building drugs, 
which is often where they initially gained their ‘top dog’ status, this did not mean that they 
had equivalent levels of knowledge regarding UWL drugs. For this group there was no way 
of checking their credentials even if they say they are informed and experienced 
bodybuilders.  Additionally, the purpose of use, aims of use and health, fitness levels and 
diet for bodybuilders will be different to that of other UWL drug users so their knowledge 
and advice may not always be appropriate.  
Towards the other end of the spectrum are those female UWL drug users who are 
overweight and may be using UWL drugs for planned reasons such as to make a target 
weight or for a specific event. These women are more likely, although not always, found 
on forums targeted more generally at weight loss as well as parenting and women only 
communities. Also seen here are those who are using UWL drug seemingly on impulse, 
justifying their use by using terms such as ‘kick-starting’ their weight loss or because they 
have ‘plateaued’ in their weight loss. Finally, at the end of the spectrum are those who are 
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overweight or who are slimmer but using UWL drugs to tackle stubborn areas or to help 
with weight loss following pregnancy. These women appear to be more often using 
sibutramine and rimonabant and the discussion around these drugs tends to take place on 
the more general weight loss forums. 
Across this spectrum, there are a multitude of differing female UWL drug users who are 
using for different reasons, taking different UWL drugs and with a differing levels of 
awareness of the drugs and willingness to take risk. The case studies of UWL drug users 
within Chapter 6 highlights two examples of female UWL drug use with Sarah being the 
non-expert, overweight taking a UWL drug with very little understanding of what she is 
taking compared with Nicola, who views herself as an expert and who has made, what she 
considers an informed decision about the drug and its risks. It would be a mistake to think 
though that these women present the two extremes or typical types of female UWL drug 
users. Due to this research, being so broad in nature, and looking across many different 
forums and female UWL drug users, it has identified that assigning UWL drug users into 
categories is not so simple.  Within public health, there is a tendency to seek typologies of 
those engaging in harmful behaviours and practices and attempt to classify users and 
behaviour within a hierarchy of risk. For example, recent work conducted by Christiansen 
et al. (2017) sought to create a typology of male use of steroids, suggesting four ideal 
types; the expert type, wellbeing, YOLO34 and the athlete. These groups were based on 
steroid users’ approaches to risk as well as how effective the drug was for them. Further 
work exploring these typologies also looked at age and motivations for using steroids 
(Zahnow et al. 2018). In this research, an initial attempt to devise a typology for UWL drug 
users, similar to that for steroid users, came up short. Equivalents of some of the groups 
defined by Christiansen et al. (2017) were seen in this research. The best example was the 
athlete type, who in Christiansen et al. (2017)’s work was epitomised by a willingness to 
take a high level of risk to see a high level of pay off as well as being motivated by muscle 
and strength gains (Zahnow et al. 2018).  In this research, the female bodybuilders taking 
DNP and reporting positive results driven by fat loss and cutting did feature. However, the 
characteristics of the overall population of UWL drug users were more complex and 
nuanced than would be possible to demonstrate by creating typologies of users. Even 
when comparing ‘the athlete typology’, to its closed counterpart in this research, the UWL 
                                                          
34 You only live once 
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drug bodybuilding group, there were differences in terms of motivations, perceptions 
towards the drugs, level of risk taking, and how users viewed the effectiveness of these 
drugs. These users are complex, and it is not as clear-cut to say that bodybuilders are those 
taking the high risks with the higher levels of knowledge. There were many conflicting 
pieces of advice given on bodybuilding forums, including incorrect advice particularly 
around issues of legality or unsubstantiated advice based on anecdotal experiences. 
Furthermore, whilst DNP was more frequently discussed on bodybuilding forums there 
were many who felt the risks were too high and would not consider taking it.  Even for 
those women who were using UWL drugs as a quick fix, perhaps for an upcoming event or 
because they were overweight,  it is not as clear cut as saying these women are more likely 
to take low risks with lower levels of knowledge. These women also varied with some 
wanting those quick results through risky strategies such as DNP, others taking the less 
risky drugs such as sibutramine and rimonabant and others being fearful of the risks of 
using any non-prescribed medicine. For those women who may think they are taking a ‘less 
risky’ approach, this again is not that simple as they are still using drugs not prescribed to 
them with a lack of knowledge concerning potential drug interactions, risk of purchased 
drugs being adulterated or potential risks posed by underlying health conditions.  
Female UWL drug users fall on a spectrum in respect to levels of knowledge about the 
drugs, level of risk taking, reasons for using UWL drugs, perceptions and perceived 
effectiveness of the drugs. Therefore, the notion of a typical UWL drug user does not exist, 
nor in fact does a typical DNP, sibutramine or rimonabant user exist. Whilst this makes 
things difficult to navigate for public health, which deals with populations and groups, it is 
an important and much needed consideration when targeting public health interventions 
or strategies at these groups, or perhaps more accurately individuals.   
7.5 Profiling the forums – Attitudes and perception of UWL drug use 
Online research is a useful tool for researching health related topics (Mitchell et al. 2016, 
Norman et al. 2014, Van Hout 2014a) as well as researching sensitive or illicit behaviour 
(Langer et al. 2005). However, prior to conducting research of this nature, consideration is 
required concerning which online communities are best suited for that particular research. 
For this research, a systematic and wide-ranging approach was taken in identifying online 
communities, taking into account both social media and varied online forums to explore 
where UWL drug discussion was taking place. If assumptions had been made prior to 
183 
 
conducting the research concerning which women were more likely to discuss UWL drugs 
then the focus in this research may have been only on ‘bodybuilding’ or ‘dieting’ forums. 
However, by looking for UWL drug discussion more widely, allowed this research to make 
visible a wider range of female user experiences. This again comes back to the notion of 
typologies and not making an assumption that in research we can decide in advance the 
types of people who are most likely to engage in a particular behaviour. Furthermore, by 
including numerous online forums within this work highlighted just how different they are.  
Online forums and communities are complex and even within those forums that have 
similar topics of discussion, the types of discussion and attitudes of forum members vary 
considerably. What is overwhelmingly clear is that as with UWL drug users there is no 
singular or even several typical online forums.  Instead, online forums where UWL drug 
discussion takes place are mixed and this is in terms of the populations who use them, the 
moderators who run them, the atmosphere of the forum and the types of advice shared 
around UWL drug use. Whilst within the forums, there are overall characteristics which 
have been used to define the forums, such as ‘the in-group bodybuilders’ and the ‘the non-
judgemental novices’, these categories simply offer an overview and do not explain the 
distinctly different ideas explored within the communities by those who use them. 
When looking broadly across the forums, the way in which UWL drug use was perceived 
by women varied from ‘discourage all’ to ‘encourage all’. However, within this again, there 
were variations. For some forums, such as ‘the hardliners’ forum, an exercise and fitness 
driven forum, the advice given was to discourage all UWL drug use regardless of the person 
asking. In this case, it did not matter whether the person asking was a bodybuilder, male, 
female or what their level of knowledge around UWL drugs was. In comparison, ‘the in-
group bodybuilder’ and ‘the self-righteous expert’ forums, dissuaded some forum 
members but not others. In these groups, UWL drugs were seen as very much the ‘expert 
bodybuilder’ domain, not suitable for women or for those looking for a quick fix in order 
to lose weight.  In particular, those women who were viewed on the forums as overweight 
and who had not tried other weight loss strategies where actively dissuaded from using, 
sometimes in a manner which could alienate those forum members.  
At the other end of this spectrum were forums who encouraged all UWL drug use, 
regardless of who was asking. This was seen most frequently in ‘the non-judgemental 
novices’ forum. On this forum there was a clear lack of understanding between the 
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different types of weight loss drugs and supplements, however advice was given in a non-
judgemental manner and seemed to be well intentioned. Furthermore, on this forum 
where women did disagree with each other this often left those seeking advice feeling 
confused and conflicted with which path they should take. Another forum which falls into 
the ‘encourage all’ group was ‘the weight loss drug promoters’ who actively encouraged 
UWL drug use with any anti-UWL drug discussion ignored. Within this forum, however, it 
is important to note that many forum members were using the forum to advertise and 
promote the sale of UWL drugs, suggesting that there may have been ulterior motives for 
their pro UWL drug attitudes. The remaining forums were far more mixed in their 
perceptions of UWL drug use and there was not an obvious forum stance evident in the 
communities already discussed. For women avoiding using UWL drugs, this was due to 
perceived levels of risk in the case of ‘the caregivers’ forum, the forums member’s own 
levels of knowledge about the drugs as in ‘the weight loss journey mums’ or over concerns 
of using non-prescribed medicines in the case of ‘the overweight and frustrated’.  
As in the female UWL drug users, the different forum types can also be considered as a 
spectrum, ranging from the ‘hardcore’ bodybuilders, the fitness fanatics and those 
interested in fitness and diet to forums used by those who are potentially overweight and 
seeking advice on quick fix weight loss. Their attitudes, perceptions and knowledge base 
of UWL drugs vary considerably and similarly what the members want to achieve from 
their weight loss differs. They are mixed population forums, which have a diffusion of 
expectations and ideas. As such research exploring online communities, even when 
focusing on a specific group such as female UWL drug users, cannot consider all online 
communities where relevant discussion takes place to be the same. Furthermore, female 
forum users themselves will be exposed to a range of responses, attitudes and perceptions 
concerning UWL drugs. This is an important consideration when exploring the role of 
online communities in providing health messages. Whilst it is not within the remit of this 
research to explore which online community provides the best or most informed advice, it 
is important to consider these variations and have an awareness that the populations, 
forum stance and attitudes are mixed and complex. As such, what people take away from 
those forums will also vary. 
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7.6 Dynamics of online forums – Sharing advice 
Online forums are often used for sharing advice, knowledge and ways to reduce harm 
(Soussan and Kjellgren 2014, Davey et al. 2012). However, where this works best is in 
communities that are strong, unified with shared goals, ideas and practices. However, the 
forums analysed within this research often did not have this unified and strong identity. 
Social identity theory first devised by Tajfel and Turner (1979), specifies and predicts the 
circumstances under which people feel part of a group (in-group) or not (out-group). Social 
identity theory has been applied previously to online communities, (Pendry and Salvatore 
2015, Nicholls and Rice 2017, Code and Zap 2010) and is concerned with how individuals 
identify themselves and how others view them and identify with them. In order to identify 
with a particular group of people, individuals look for similarities between group members 
and themselves. Those who are ‘in-group members’ are those whose beliefs, attitudes and 
opinions match those of the rest of the group. Those who do not conform to the group’s 
identity are ‘out-group members’. In-group members are more influential than out-group 
members and this applies to how others view the in-groups level of ability and how much 
they are influenced by their decision (Barnum and Markovsky 2007). Specifically within 
online research, in-groups and identification with the online forum led to both increased 
levels of satisfaction with their lives, both online and offline as well as increased levels of 
participation on that forum.  Furthermore, those who identity with a particular group are 
more likely to be influenced by that group, and research has indicated that those with 
shared goals, e.g. of losing weight and a stronger shared social identity within an online  
group are more likely to achieve their goals (Farrow et al. 2016). Whilst this is useful for 
those who have shared goals, what about those online group members who do not have 
that same shared social identity? Furthermore, what are the implications when online 
users are promoting unhealthy or dangerous practices?  
In this research, several of the forums had clear ‘in group members’. This was most obvious 
for the ‘in-group bodybuilders’, ‘the hardliners’, ‘the weight loss drug promoters’ and ‘the 
self-righteous experts’ forums. Whilst this was seen in varying degrees across most of the 
online communities it was those communities where ‘outgroup members’ were most 
obviously evident. Whether women were considered in-group or out-group members was 
sometimes based on the characteristics of the user as seen in Figure 8. For example, for 
the in-group bodybuilders and self-righteous experts forums, those viewed as in-group 
members were the competition bodybuilders with those women looking to use UWL drugs 
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as a quick fix for stubborn weight loss seen as out-group members. Conversely, for the 
‘weight loss drug promoters’ forum, all women asking about UWL drugs were viewed as 
in-group members. Here, those viewed as out-group members was not based on the 
characteristics of the forum users but instead those who frowned upon UWL drug 
discussion. The shared goals of each community differed and how members conformed to 
those shared goals dictated whether they were seen as in-group members or not. This was 
also apparent in how advice was given and received within each of the communities. Figure 
9 shows the  characteristics of advice shared on each forum, with some forums such as the 
‘weight loss drug promoters’ encouraging UWL drug use in all women who sought advice, 
some forums like ‘in-group bodybuilders’ encouraging some and not others and the ‘the 
risk averse’ discouraging UWL drugs for all women.  Within many of the forums, there was 
a perceived hierarchy of users. Male bodybuilders were very much seen as the being at 
the top of this hierarchy both on bodybuilding and non-bodybuilding forums. There were 
frequent references to bodybuilders being the expert group when it comes to UWL drugs, 
many saying that drug use should be confined to these groups and advice from that group 
seen as being optimum. 
As previously discussed forums often took a ‘stance’ around whether to encourage or 
discourage UWL drug, and those who subscribed to that stance where very much viewed 
as the ‘in group members’ with other forum members paying more attention to them, 
responding to their threads and taking their advice on board. Furthermore, for those not 
perceived as being an in group member then the advice offered was often not taken on 
board, or as in the case with UWL drug user, Nicola, meant barriers were put in place, 
preventing those members from becoming a moderator or forum leader.  For ‘outgroup 
members’, how they took this advice was dependent on their views, perceptions and 
attitudes and how much these matched the overall forum stance. For those forum 
members who were discouraged from using UWL drugs, the outcomes from this were 
varied. For newer forum members who were perhaps trying to become in group members, 
the advice was often taken on board. It is however impossible to know outside of the 
forums whether this was the case. Others however, then became alienated from the 
forums, either arguing back, no longer responding to the thread or becoming frustrated 
with the messages they were receiving. For those who do not conform to the group’s 
identity and who disengaged entirely with the online community, it is then impossible to 
187 
 
know what they did next.  Potential outcomes could have been to ignore the advice and 
take UWL drugs regardless, go to another online community (or offline group) and see if 
the response was different there or either on the same forum or a different forum, use a 
different online ID to simply ask the question in a different way. For those who received a 
pro UWL drug response, this was then likely to validate their existing opinions of UWL drug 
use and cement their identity within that group. In these instances, where the forums 
identity was to encourage UWL drug and other drug use, and where there were key leaders 
within the online communities, this creates a cause for concern as forum members’ drug 
use becomes validated. 
This complex interplay between advice sought and the forum dynamics is pivotal in 
offering some level of understanding to how online communities can be used effectively 
in sharing information about UWL drug harm reduction. When forum members took the 
time to explain the risks involved in using the drugs and were not judgemental, as well as 
when the dynamics of the forum was supportive, positive and less dictated by an 
overwhelming group identity, others often reacted in a more positive manner. However, 
for researchers looking to use online forums to deliver public health interventions there 
needs to be consideration given to the online group’s identity. Furthermore, the ways in 
which this information is delivered needs to be considered alongside other factors such as 
the expertise of the person giving the information, how they are viewed on the forum and 
the intentions behind the advice.  
Whilst a strong sense of identity, with shared goals, ideas and practices was seen across 
some forums it was not seen across all.  Additionally, for those communities that had a 
strong identity, for those women who did not conform to the shared goals and who were 
therefore seen as outsiders, this led to an hostile environment and frustrated forum users.  
The diffusion of ideas, experiences and perceptions of UWL drugs seen across the forums 
as well as the variations in those using them ultimately means that the possibility for online 
harm reduction is limited or may require more consideration in supporting  those with 
individual needs and requirements. 
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Figure 8. Types of UWL drug users on online forums 
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Figure 9. UWL drug advice shared on forums 
Discourage all Discourage some Encourage all 
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7.7 Experiences of UWL drug use 
There is very little evidence concerning the experiences of those using UWL drugs. By 
utilising online forums in this research and taking into account the experiences of those 
using different types of UWL drugs and for different types of reasons, this research has 
identified many different user experiences. Many women found the drug they were using 
to be effective citing such changes as ‘increased energy’, ‘weight loss’, ‘suppressed 
appetite’ and ‘increased confidence’ following weight loss. Even some women who 
experienced side effects considered these par for the course and worth it, if it meant they 
lost weight. There were also many women who felt that using an UWL drug, had ‘kick-
started’ them into losing weight and helped them to stick to diet and exercise regimes. 
Conversely, women also reported that the UWL drug did not work for them, or that they 
did but the weight loss was not long term, i.e. as soon as they stopped taking the drugs, 
they put weight back on. A recurring theme was that using UWL drugs did not deal with 
the underlying reasons for why the women had gained weight in the first place. It is 
important to remember that the data presents self-reported effects of UWL drugs that 
cannot be confirmed, nor can we know the role of the nocebo and placebo effects in 
generating these perceived effects 
Far fewer experiences were found for rimonabant when compared to DNP and 
sibutramine, which could suggest that less women are taking rimonabant. It is not clear 
however, whether this was due to perceived side effects of rimonabant, lack of awareness 
of the drug or whether there was just a lack of discussion on the particular forums used 
within this research. In terms of side effects, most commonly reported for both 
sibutramine and rimonabant were nausea and increased thirst. For sibutramine 
specifically, users also reported feeling irritable, spaced out and having an increased heart 
rate. For DNP, most commonly reported side effects were overheating, sweating, 
diarrhoea, constipation, hives and an irregular menstrual cycle. Whilst much of the 
discussion so far has focused upon the female UWL drug user, the ways in which 
information is shared and the dynamics of online communities, a more simple but equally 
important finding are the risks women are willing to take in order to lose weight. Whilst, 
there may be differing levels of risks being taken, dependent on the drug, the dose and 
knowledge base, these three drugs are all unlicensed because they are harmful 
substances. However, what is clear from the online forums is that many women are 
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experiencing side effects from using these drugs but, in many cases, this is not deterring 
them from using the drugs. When female forum users and those interviewed spoke about 
their experiences, positive experiences were synonymous with a high level of weight lost 
and negative experiences synonymous with little or no weight lost. It was rare that the side 
effects were enough to deter use. For this group of women, the effect of the drug 
outweighed any negative health consequences of side effects.  
Purchasing of UWL drugs was not discussed frequently on online forums. This was often 
due to restrictions being placed on forum members prohibiting them from doing so. 
Interviews with forum moderators indicated that this discussion, if it did take place, was in 
closed areas of the forum that were not accessible to the researcher. However, the 
discussion which did take place indicated that most users reported purchasing their drugs 
online. There are many implications of purchasing drugs online mainly that users are 
purchasing an unknown content. The drugs may not be the correct dose, may be 
adulterated or may be something completely different to what the user believes the drug 
to be. Purchasing online also poses a greater risk than purchasing from physical shops as 
there is limited  comeback for the purchaser as well as there having to be trust in those 
who are selling. This group of drugs being unlicensed and people accessing through other 
channels means that health care professionals cannot do relevant screening, e.g. drug 
interactions, or ascertaining whether those using have underlying health problems which 
may exacerbate side effects. This poses a new problem for public health as users who 
might, if seeing a health care professional, not have been prescribed these drugs, may now 
be easily accessing them online.  
7.8 Engaging with online communities - harm reduction online 
As previously outlined, online forums can be effective in influencing other forum members. 
For UWL drug use, however this could mean women are encouraged to engage in risky 
behaviours. This section of the thesis considers the role of online forums in offering harm 
reduction to UWL drug users. Whilst, content on the forums was not checked for quality 
or accuracy of advice, this work can still offer an insight into whether online communities 
are best placed to provide this type of advice. Harm reduction aims to reduce the negative 
consequences, which are associated with a potentially harmful behaviour such as the use 
of drugs. Within drugs research, there are many types of harm reduction strategies ranging 
from specific interventions such as needle and syringe programmes, substitution 
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treatments, drug consumption rooms, drug testing and information, education and 
communication. For UWL drug use, some harm reduction strategies, such as needle and 
syringe programmes are not applicable and for online communities the focus can really 
only be concerned with providing information and education about drug use. Targeted 
information interventions have been proven effective in reducing harm linked with drug 
use (Hunt 2003), however the effectiveness of interventions such as these in UWL drug 
users has not been investigated. Previous research has identified harm reduction and drug 
prevention messages shared within online drug forums (Davey et al. 2012) and made 
suggestions for the consideration of harm reduction strategies delivered through online 
communities as a potential area for future research. Whilst, there is an agreement from 
this research that online forums could be potentially appropriate places for harm 
reduction strategies to take place, key considerations are first required. 
Firstly, who is best placed to deliver the information? Analysis of the online forums 
highlighted that there are those members within online forums who are viewed as the 
‘experts’, who conform to the stance of the forum and are ‘in-group’ forum members. 
These members are often well respected on the forums, however UWL drug interviews 
highlighted that these members often do not have the time to respond to those asking for 
advice. In these instances, other members of the forum who may have less experience and 
knowledge around UWL drugs would offer advice that was not always felt to be the most 
appropriate. Another potential avenue for consideration are the online forum moderators. 
However, what was apparent from the moderator interviews are that whilst some 
moderators do care about their forum members and share what they deem to be the best 
advice, other moderators are duplicitous in their roles. Moderators who are also using the 
forums to sell drugs, or who have other agendas are not suitable for providing online harm 
reduction due to their intentions and motivations not being for the health of the forum 
members. Health care professionals, researchers and academics are another potential 
group. However, the often hidden nature of UWL drug use and suspicions both forum users 
and moderators had towards the researcher in this study means that this would not be an 
easy route. Furthermore, comments seen on both forums and from the forum moderator 
Josh suggested that particularly for bodybuilders or those aspiring to be bodybuilders, the 
aesthetic of those giving advice carried more credence than the level of knowledge. In 
other words, women using these drugs were more likely to listen to somebody who had 
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the body they desired than a health care professional or academic.  Lessons can be learnt 
from forums such as Bluelight35 which has a focus on harm reduction (Chiauzzi et al. 2013) 
and where dialogue between researchers and forum members and moderators is 
encouraged (Barratt and Lenton 2010).  
The second consideration is what information should be shared. There is very little 
evidence concerning how to use UWL drugs in a safer manner. Both sibutramine and 
rimonabant have been withdrawn from the market and for DNP they have been no clinical 
trials testing its efficacy. Furthermore, the information on online forums is often based on 
experiences rather than evidence and is also often, for DNP in particular based on a male 
model. What may be a ‘safe’ dose for a male bodybuilder may be different to what is safe 
for an overweight woman or even a female bodybuilder. Current advice for DNP also 
suggests the use of supplements to minimize harms, however there is no evidence that 
these supplements do reduce harm. Furthermore, those selling UWL drugs are likely also 
to be selling supplements so may have a vested interest in promoting the use additional 
supplements. Advice could be provided concerning the potential risks of using these drugs. 
However, given the narrow therapeutic window, which DNP offers, any advice concerning 
how to take would need a great level of consideration. 
The third consideration, is concerned with where information should be shared. Again, this 
is complicated. Whilst DNP, is potentially the riskiest of the three drugs and most often 
discussed on bodybuilding forums, this does not necessarily mean this is the only place 
education and advice would fit. What information should be shared would need to be 
tailored to which online community it was shared on. The advice a bodybuilder requires 
would differ from the advice required by somebody on a more general lifestyle forum who 
has never used a weight loss product before. Similarly, considerations would also need to 
be given concerning how this information is shared, in terms of how scientific it was, in for 
example giving information concerning the chemical properties of the drugs.   
 
 
                                                          
35 Open drug discussion board 
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7.9 Moving the research forward 
Building upon the literature review, the research presented details a study focusing upon 
the female users of UWL drugs, the underlying motivations for using these drugs, what 
side effects are being experienced as well as exploring ways in which, from a public health 
perspective, UWL drug use can be best addressed. There is little research on UWL drug use 
and none focusing specially on female experiences. Due to a lack of knowledge about who 
uses these drugs and why, there is also nothing in the literature which explores the public 
health implications of UWL drug use in women, or on harm reduction or health strategies. 
This study, using an in-depth online forum analysis (from ten forums) as well as interviews 
with both forum moderators and UWL drug users has identified key female UWL drug users 
and their motivations for using as well as formulating discussion around appropriate harm 
reduction strategies for those online communities. 
This research has demonstrated the sheer volume of online discussion relating to UWL 
drug discussion fuelled by body image concerns and pressures. The perceived need to 
improve, hone and beatify women’s bodies is pervasive and the use of strategies including 
the use of UWL drugs to achieve that look is widespread within online communities. What 
this research has also demonstrated is the use of online forums in discussing UWL drugs. 
This has highlighted the levels in which online users engage with online communities as 
well as the levels of trust they place in those communities epitomised by taking advice on 
which drugs to use, whether they should use them and in some cases, where to purchase 
them.    
This research has also contributed to discussion concerning online research within a health 
setting. This research has set out a systematic way to conduct online research which can 
be utilised by other researchers and a paper has already been published, following this 
work highlighting both the merits of online research as well as ethical considerations. 
7.10 Limitations of the study 
Whilst this study has added to the existing literature on UWL drug use and online research, 
it is acknowledged that there are limitations. 
This research involved the analysis of ten large forums with large amounts of data 
being produced. Whilst this was important for this research, which was exploratory 
in nature, it meant that it was not possible to drill down into the details of 
individuals users on the forum. Quotes have been presented from forums, however 
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as they were analysed by forum rather than individual user, there is no way of 
knowing which quotes came from the same person, only if they came from the 
same forum. This means that it is not possible to know whether the data comes 
from only a small number of vocal people or represents views and experiences 
from many different people. Furthermore, because members were not tracked 
there was no way of identifying long-term effects from UWL drug use, unless the 
forum user explicitly stated that this was the case.  
Linked to the previous limitation was the omission of setting a time period when 
selecting threads and posts. Originally, this was done to explore how forum users 
had handled sibutramine and rimonabant being withdrawn from the market. 
However, it resulted in a lot of irrelevant data being downloaded. This discussion 
was primarily from users who had been prescribed these drugs via a health care 
professional prior to their withdrawal. Whilst the selection process in identifying 
the forums included was systematic, a more systematic process should have been 
used in identifying threads within the forum.  
It is not possible to guarantee that all forum posts used within the online forum 
analysis came from women. However, steps were taken to minimize the risk of men 
being included in the research. The steps included using forums with high 
proportions of female users, taking threads from female specific sub forums, 
looking for threads where forum users specifically stated they were a woman or 
where their gender was specified on their profile and removing discussion where 
the forum user had specified they were a man.  
Whilst approximately 89% of adults within the UK use the internet, 9% do not use 
the internet at all. Furthermore, a smaller proportion of the population use online 
forums to seek health advice. Therefore, this research only explores UWL drug use 
and discussion in women who are using online forums and excluded the views of 
those who do not. 
This research focused on online forums that were based within the UK and had a 
high proportion of UK users. However, it is impossible to know for sure whether all 
quotes used were from women based with the UK, given the far reaching nature of 
the internet. 
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The interview with forum moderator, Josh highlighted that just reading online 
forum post does not mean that a full understanding of online communities was 
gained. Without interviewing Josh, it would not have been apparent that he was 
acting as both moderator and drug seller under different online guises. 
Furthermore, the interview with UWL drug user, Nicola (who was also a moderator) 
who discussed how she was blocked from becoming a moderator for being a 
woman would also have not been apparent just by reading online posts. This is a 
strength of using multi methods research, which advances our understanding. By 
conducting both an online forum analysis and interviews with moderators and UWL 
drug user led to more understanding of how online forums operate. However, for 
those online communities where a moderator or UWL drug user was not recruited, 
it may be that there are other ‘behind the scene’ activities occurring which could 
not have been picked up from this research. 
Online research can only offer a snapshot of discussion at that point in time. 
Subsequent searches of online communities where UWL drug discussion is taking 
place has identified additional communities within eating disorder and proana 
forums. However, these forums were not found during the original searches and 
discussion on these forums relating to UWL drug use appears to have 
predominately taken place post the data collection period. For re-emerging drug 
markets such as these, researchers need to be aware of the rapidly changing nature 
of both the markets and the online communities when conducting research of this 
nature.  
For ethical reasons, only publicly available forums were accessed. No private 
forums were accessed and neither were any other private online groups, e.g. 
private Facebook groups. Given the illicit nature of this drug use, it may be that 
discussion was occurring in more hidden online environments. This was particularly 
highlighted following the interview with Mark (moderator) who discussed the 
culture of denial concerning enhancement drug use.  
Linked to the above limitation is the idea of female disclosure of UWL drug use. The 
interview with Nicola (UWL drug user) highlighted this through her comments 
about how many women will never disclosure their UWL drug use. The hidden 
nature of this particular type of drug use may mean that even on forums, those 
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who are using these drugs may not be engaging with online forums or may not be 
being honest.  
Moderators were only recruited from bodybuilding or drug specific forums 
meaning that an overview of moderating a more general lifestyle forum where 
UWL drug discussion took place was not established. Therefore the opinions of 
moderators presented are only those who arguably may have had a greater 
awareness of UWL drugs, this may have not been the case on other online 
communities, such as dieting, parenting or general lifestyle forums.  
This research did not assess the quality of the information given on forums or that 
given in interviews. Whilst forum users were referred to as being informed or 
uninformed this was linked to how they perceived themselves or were viewed on 
the forums rather than how knowledgeable they were and the accuracy of the 
information they provided.  
Forum moderator consent was not gained to access online forum posts. Whilst this 
had been agreed from an ethical point of view, it was subsequently problematic 
when recruiting forum moderators. Contacting moderators for interview was the 
first time they had heard about the research and as such, it made them suspicious 
and wary, resulting in some cases in the researcher being banned from the forums. 
Likely linked to the previous limitation, were the small interview numbers for both 
the online forum moderators and online UWL drug users. For the moderators, they 
were suspicious of the research and did not want to engage. For both the 
moderator and UWL drug user interviews, the fact they were being recruited online 
meant it was very easy for them to disengage. This happened often, with potential 
participants originally agreeing to take part and then going offline so it was no 
longer possible to engage with them.  
7.11 Implications for policy, practice and future research 
This research identified key issues around UWL drug use in women as well as the role 
online forums play in sharing advice and information. Whilst research already exists which 
explores the discussion of weight loss and other enhancement drugs within online settings 
(Corazza et al. 2014, Davey et al. 2012, Petróczi et al. 2015, McVeigh et al. 2016, Van Hout 
2014b), this research offers a female focus for a group of drugs previously researched 
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within male dominated setting. Furthermore, the inclusion of interviews with both forum 
moderators and women who have used UWL drugs offers further insight into UWL drug 
use and the role and positioning of online communities. The results identified a number of 
implications from this research for policy, practice and future research. 
The widespread nature of idealised thinness and pressures on women to conform to 
unattainable figures needs to be addressed. These pressures are contributing to women 
engaging in increasingly risky behaviours in order to achieve the physique they desire. 
Further, these pressures are having devastating impacts on women’s levels of body 
satisfaction and confidence. Campaigns which aim to celebrate body positivity, such as 
‘fitspiration’, ‘strong is the new skinny’ or those celebrating fuller figures only serve to 
switch body ideals from one to another. The objectification and sexualisation of women, 
as seen in the media only enhances this issue and is part of a bigger societal problem where 
women are still being judged based on how they look rather than what they achieve. 
Whilst in today’s society, this should be an antiquated concept, it is now more pervasive 
than ever.   
This research captured female user experiences of UWL drug use and highlights the diverse 
nature of female UWL drug users arguing against there being a typology of use. The wide 
reaching nature of this research was important in identifying those very different female 
voices and those engaging in public health research should consider the extent to which 
we come to research with assumptions and expectations concerning who our populations 
are. For both policy and practice, when developing specific harm reduction initiatives, 
consideration should be given to the diverse population of UWL drug users with 
recognition that a ‘one size fits all’ model of treatment or intervention may not be 
appropriate. Future research is warranted which explores UWL drug use further. In this 
research, large quantities of data were collected which provided an overview of UWL drug 
use but did not ‘drill down’ into individual’s journeys. In order to further explore UWL drug 
use in women, research should focus on the detailed motivations for UWL drug use and 
explore user’s journeys in order to increase our understanding of the decision processes 
leading to both commencing and continuing drug use as well as long term risks and 
experiences. 
This research demonstrates that women do use UWL drugs. The use of DNP in particular 
in women has not previously been acknowledged. There appeared to be an unwillingness 
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for UWL drug users to discuss their drug use with those in their ‘real life’ such as family 
members, friends and also health care professionals due to fears of judgement, 
embarrassment or stigma. This reluctance appears heightened for women, as engaging in 
risky appearance driven behaviours may be deemed to be at odds with their role as 
mothers or caregivers. Due to the legal and unlicensed status of this group of drugs, they 
are no longer seen as the responsibility of health care providers. However, health care 
providers should be aware that women are using these drugs and in doing so, are putting 
themselves at risk. However, the risks of using these drugs was not always a factor in 
preventing use and there is a particular danger for those users who view themselves as the 
experts as there have been no clinical trials of DNP. Therefore, advice on how to use is only 
based on anecdotal experiences and not evidence and as such there may be an 
overconfidence in use. Health care professionals, such as GPs need to reclaim 
responsibility of UWL drug use and should have an awareness of weight loss supplements 
and drugs, the use of drugs bought online and the risks associated with this. Due to the 
hidden nature of this drug use, health care professionals need to be vigilant and should be 
aware of the presentation of harms, which is associated with UWL drug use.  
The banning of sibutramine and rimonabant, and the fact that DNP has never been 
licensed has not prevented women from using these drugs.  Instead, women are placing 
trust in the internet for both gaining advice and purchasing drugs. These drugs may be 
adulterated, not contain correct information on dosing or may pose a risk of drug 
interactions. Furthermore, women will be using these drugs without health care 
professional supervision 
This research combined UWL drug use, focusing upon sibutramine, rimonabant and DNP. 
However, there are vast differences of experiences and risks of the three drugs. Future 
research should focus on the specifics of each of those drugs, as well as other drugs with 
weight loss properties, in terms of potential risks, experiences and what harm reduction 
message would be of use. Additionally, as all three drugs have an unlicensed status, some 
women may class these drugs as being the same. Considering DNP to be only as dangerous 
as sibutramine and rimonabant is a cause for concern. This issue was exacerbated by 
conflicting advice and information provided online and because online searches for 
‘weight loss drugs’ often groups these drugs together with little differentiation between 
them. A scoping of the online UWL drugs market is required in order to make 
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recommendations of what advice, education and information is required for those 
considering using them.   
Online communities can also play a role in harm reduction however, how this is conducted 
requires planning and thought. This research demonstrates that UWL drug users were 
more likely to listen to those who they respected within online communities and who 
possessed the aesthetic they desired as opposed to health care professionals or 
academics. This seemingly positions online forums as ideal places for the sharing of harm 
reduction information. However, for groups as diverse as female UWL drug users, the 
organisation and structure of online forums delivering such information needs careful 
consideration and should take into account that: 
Much online UWL drug discussion is based on male norm models and may not 
always be applicable to women. Development of specific harm reduction 
information for women who use or are contemplating the use of UWL drugs is 
warranted.  
There are currently few online spaces for women that offer reliable and informative 
harm reduction advice in a non-judgemental way. Online communities were either 
male dominated, offering advice on harm reduction but dismissive of female voices 
or female dominated but with users who had very little experience of UWL drugs. 
Development of online spaces which encourage female input and offers 
information and advice should be considered.  
Not all forum moderators are ideally placed to offer UWL drug harm reduction 
information due to their levels of knowledge and respect within the forums. 
Complexities around what is classed as appropriate harm reduction, the dynamics 
of the online forum, the moderators levels of knowledge and the intentions of 
those moderators all need to be first considered. Furthermore, for those 
moderators who are also supplying the drugs, there is likely to be a conflict of 
interest. 
Women place a great deal of trust in other online forum users. However, there is a 
level of naivety with this. Anonymity online means that online users can share 
advice, make statements and provide information with little comeback. 
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Furthermore, online users can create multiple accounts in order to advocate for a 
particular point or for deceitful reasons such as marketing their products. 
This research has highlighted that online communities where UWL drug discussion takes 
place are diverse. This is terms of the perceived levels of knowledge users have, the  
motivations for use, and level of willingness to take risks. If harm reduction strategies are 
to be put in place within these online communities then they need to be tailored to each 
specific communities requirements.  
Online community members should all receive information on basic awareness and 
education of the different types of UWL drugs and risks of use. Whilst this information will 
be of most use for those forums where users are new to weight loss drugs and do not have 
a great deal of knowledge concerning them, ensuring up to date and evidence based 
information is provided will benefit all of the online communities. For those forums where 
users view themselves as the informed users, previous research has already identified 
reluctance within these users to respond to messages which rely upon scare tactics and 
prevention (Ainsworth et al. 2018). However, these communities are publically accessible 
therefore, not all forum users will have the same knowledge base. Additionally, even 
within those users who perceived themselves as informed there was still much 
unsubstantiated and conflicting information. Involving established forum members in 
discussion about how information should be disseminated will be empowering for those 
users and furthermore will signpost newer members to the most relevant information, 
allowing them to bypass anecdotal experiences and ‘broscience’. Alongside this, 
established forum members should be engaged with by academics and policy makers in 
how to engage newer members on the forum, ensuring that they are receiving appropriate 
harm reduction education, which does not make assumptions about their level of 
knowledge or physique. For these communities, information which focuses upon 
decreasing harm rather than drug use should also be in place. For DNP in particular which 
has such a narrow therapeutic window and where tolerance can differ so much from 
person to person, a shift away from advice based on experience is required. As on many 
of these communities peer experience was valued however, peer to peer provision of 
evidence based information may instead be more appropriate.  
Whilst this research argues that there is no typical weight loss drug user, it has identified 
some users not identified in previous research. These include recent mothers, traditional 
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drug users, fitness fanatics, those generally trying to lose weight and those trying to lose 
weight due to a health condition. For these users, specific and targeted education, advice, 
signposting and engagement is recommended. Engagement is firstly needed with each of 
those health care providers who would be likely to treat or see each of these groups 
including both general health providers such as GPs and practice nurses as well as specific 
services such as those working in the exercise industry, maternity services, drug services 
and weight loss services. Health care professionals should be aware of the risks of using 
these drugs as well as mindful of the presentation of harms associated with use and engage 
with those using these drugs in an empathetic and non-judgemental manner. Signposting 
of relevant information such as the interactions between different drugs for recreational 
drug users and contraindications for those with medical conditions should be provided as 
well as signposting users to those relevant health care providers.  
Future research should explore forums where the integration of academics and health care 
professionals has already been successful, e.g. Bluelight and establish whether the 
structure of those communities can be applied to female UWL drug users. A scoping of the 
feasibility of moderators as gatekeepers for these communities is also warranted.  
Furthermore, the trust that is put into online discussion forums supports the need for early 
education to be offered around who and what to trust online.  
This research contributes to the value of online methods research by outlining a systematic 
process for undertaking this type of research. Further research should utilise these 
methods and expand them into other methods of online communication, e.g. social media, 
blogs and vlogs. Furthermore, this research has also identified a real time discovery of the 
extension of this public health problem with a particularly vulnerable group, those with 
eating disorders.  The fast-paced nature of online communities as well as the diffusion of 
these drugs into different types of users poses another challenge for public health. Those 
working in these field should not assume they already know who these users are, but be 
mindful that this is a constantly changing population. This research has looked 
retrospectively at forum posts, future research should continue to monitor online 
communities prospectively to enable rapid identification of new users of UWL drugs.  The 
internet progresses and develops quickly and researchers should keep abreast of these 
changes in order to adequately research online groups.   
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7.12 Conclusion 
Using large quantities of data from online forums, as well as interviews with forum 
moderators and UWL drug users, this research has presented a structured and systematic 
processes for identifying online samples and categorising both online forum and female 
UWL drug users. This research has provided an overview of female UWL drug use and 
discussion within online communities. In particular, characteristics of UWL drug users and 
forums have been identified as well as an exploration of the influencers, structure, content 
and perceptions of risks on those forums. The motivations for both UWL drug use and 
online engagement have also been explored. This research identified the ways in which 
women engage on online forums as well as exploring the ways in which information is 
shared and how the environment of the forums plays a role in this.  
 This research is the first stage of the process required to fully exploring UWL drug use in 
women. The pervasive nature of body image concerns and the means women will go to in 
order to achieve the body they desire has been identified. Additionally, this research 
highlights that removal of a licence from a drug does not necessarily prevent use and in 
fact causes greater risk through the use of these drugs without supervision. Furthermore, 
fear of side effects or harms is not always a factor in UWL drug use decision making 
processes, with harms often either not being recognised or being downplayed. The trust 
women place in others online is also evident with many using online forums to seek advice 
from online members and potentially naively viewing others as UWL drug experts. 
However, what is also apparent is those providing advice may not always be the best suited 
for providing information on harm reduction. UWL drug user engagement needs to be 
reclaimed as part of a wider health agenda, something that has been lacking due to these 
drugs not being licensed.  Recommendations have been made for engaging with the many 
different users which presented within this research. However, further research and 
consideration is needed concerning what the best approaches for this should be, 
identifying those who have authority and respect within the community, but also have the 
credentials, knowledge, skills and desire to offer advice.  
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Appendix A – Global Drug Survey syntax 
 
IF (perfephedrineever = 2) perfWeightLossEVER = 2 . 
IF (perfdnpever = 2) perfWeightLossEVER = 2 . 
IF (perfsibutramineever = 2) perfWeightLossEVER = 2 . 
IF (perfclenever = 2) perfWeightLossEVER = 2 . 
IF (perfrimonabantever = 2) perfWeightLossEVER = 2 . 
IF (perft3t4ever= 2) perfWeightLossEVER = 2 . 
EXECUTE . 
 
RECODE perfWeightLossEVER (missing=0).  
 
IF (perfephedrine12m = 2) perfWeightLoss12m = 2 . 
IF (perfdnp12m = 2) perfWeightLoss12m = 2 . 
IF (perfsibutramine12m = 2) perfWeightLoss12m = 2 . 
IF (perfclen12m = 2) perfWeightLoss12m = 2 . 
IF (perfrimonabant12m = 2) perfWeightLoss12m = 2 . 
IF (perft3t412m = 2) perfWeightLoss12m = 2 . 
EXECUTE. 
 
RECODE perfWeightLoss12m (missing=0). 
RECODE 
  age 
  (0 thru 17.9999999=1) (18 thru 24.99999=2) (25 thru 34.99999=3) (35 thru 44.99999=4) 
(45 thru 54.99999=5) (55 thru 64.99999=6) (65 thru highest=7)  
 INTO  ageGroupnew. 
EXECUTE . 
 
FORMATS ageGroupnew(F2). 
 
MISSING VALUES ageGroupnew ("0"). 
VALUE LABELS ageGroupnew 
 1 " 0 - 17" 
 2 "18 - 24" 
 3 "25 - 34" 
 4 "35 - 44" 
 5 "45 - 54" 
 6 "55 - 64" 
 7 "65 plus". 
 
RECODE income (Lowest thru 19999=1) (20000 thru 39999=2) (40000 thru 59999=3) 
(60000 thru 99999=4)  
    (100000 thru Highest=5) INTO Incomenew. 
EXECUTE. 
 
RECODE 
ncountry 
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('Afghanistan'=2) ('Albania'=3) ('Algeria'=1) ('Andorra'=3) ('Angola'=1) ('Antigua and 
Barbuda'=4) ('Argentina'=6) ('Aruba'=6) ('Australia'=5) ('Austria'=3) ('Azerbaijan'=2) 
('Bahamas'=4) ('Belarus'=3) ('Belgium'=3) ('Bermuda'=4) ('Bolivia'=6)  
('Bosnia and Herzegovina'=3) ('Brazil'=6) ('Brunei Darussalam'=2) ('Bulgaria'=3) 
('Cambodia'=2) ('Cameroon'=1) ('Canada'=4) ('Cape Verde'=1) ('Cayman Islands'=4) 
('Chile'=6) ('China'=2) ('Colombia'=6) ('Congo, The Democratic Republic of The'=1)  
('Costa Rica'=4) ('Croatia'=3) ('Cyprus'=3) ('Czech Republic'=3) ('Denmark'=3) ('Dominican 
Republic'=4) ('Ecuador'=6) ('Egypt'=1) ('Eritrea'=1) ('Estonia'=3) ('Ethiopia'=1) ('Falkland 
Islands (Malvinas)'=6) ('Faroe Islands'=3) ('Fiji'=5)  
('Finland'=3) ('France'=3) ('French Guiana'=6) ('French Polynesia'=5) ('Gabon'=1) 
('Georgia'=3) ('Germany'=3) ('Ghana'=1) ('Gibraltar'=3) ('Greece'=3) ('Greenland'=4) 
('Guadeloupe'=4) ('Guam'=5) ('Guatemala'=4)  
('Guernsey (Bailiwick of Guernsey)'=3) ('Haiti'=4) ('Holy See (Vatican City State)'=3) 
('Honduras'=4) ('Hong Kong'=2) ('Hungary'=3) ('Iceland'=3) ('India'=2) ('Indonesia'=2) 
('Iran, Islamic Republic of'=2) ('Iraq'=2) ('Ireland'=3) ('Israel'=2) 
('Italy'=3) ('Jamaica'=4) ('Japan'=2) ('Jersey (Bailiwick of Jersey)'=3) ('Jordan'=2) 
('Kenya'=1) ("Korea, Democratic People's Republic of"=2) ('Korea, Republic of'=2) 
('Kuwait'=2) ('Kyrgyzstan'=2) ("Lao People's Democratic Republic"=2)  
('Latvia'=3) ('Lebanon'=2) ('Liberia'=1) ('Liechtenstein'=3) ('Lithuania'=3) ('Luxembourg'=3) 
('Macao'=2) ('Macedonia, The Former Yugoslav Republic of'=3) ('Madagascar'=1) 
('Malawi'=1) ('Malaysia'=2) ('Maldives'=2) ('Mali'=1) ('Malta'=3)  
('Martinique'=4) ('Mauritius'=1) ('Mayotte'=1) ('Mexico'=4) ('Micronesia, Federated 
States of'=5) ('Moldova, Republic of'=3) ('Monaco'=3) ('Mongolia'=2) ('Montserrat'=4) 
('Morocco'=1) ('Mozambique'=1) ('Myanmar'=2) ('Namibia'=1) ('Nepal'=2) 
('Netherlands'=3) ('New Caledonia'=5) ('New Zealand'=5) ('Nicaragua'=4) ('Nigeria'=1) 
('Northern Ireland'=3) ('Norway'=3) ('Pakistan'=2) ('Palestinian Territory, Occupied'=2) 
('Panama'=4) ('Papua New Guinea'=5) ('Paraguay'=6) ('Peru'=6)  
('Philippines'=2) ('Pitcairn'=5) ('Poland'=3) ('Portugal'=3) ('Puerto Rico'=4) ('Qatar'=2) 
('Reunion'=1) ('Romania'=3) ('Russian Federation'=2) ('Rwanda'=1) ('Saint Lucia'=4) ('Sao 
Tome and Principe'=1) ('Saudi Arabia'=2) ('Scotland'=3)  
('Senegal'=1) ('Serbia and Montenegro'=3) ('Seychelles'=1) ('Sierra Leone'=1) 
('Singapore'=2) ('Slovakia'=3) ('Slovenia'=3) ('South Africa'=1) ('Spain'=3) ('Sri Lanka'=2) 
('Sudan'=1) ('Suriname'=6) ('Swaziland'=1) ('Sweden'=3)  
('Switzerland'=3) ('Taiwan, Province of China'=2) ('Taiwan, Republic of China'=2) 
('Tanzania, United Republic of'=1) ('Thailand'=2) ('Timor-leste'=2) ('Togo'=1) ('Tokelau'=5) 
('Trinidad and Tobago'=4) ('Tunisia'=1)  ('Turkey'=2) ('Uganda'=1)  
('Ukraine'=3) ('United Arab Emirates'=2) ('United Kingdom'=3) ('United States'=4) 
('Uruguay'=6) ('Uzbekistan'=2) ('Vanuatu' =5) ('Venezuela'=6) ('Viet Nam'=2) ('Wales'=3) 
('Zambia'=1) ('Zimbabwe'=1)           
INTO Continent. 
EXECUTE.  
 
STRING newContinent (A20).  
RECODE 
Continent 
(1='Africa') (2='Asia') (3='Europe') (4='North America') (5='Oceania') (6='South America')  
INTO newContinent. 
VARIABLE LABELS newContinent 'new cont'. 
EXECUTE. 
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Appendix B – Forum selection 
Forum 1 
Forum 1 was originally found following a search on Google for Dinitrophenol forum. It did 
not appear following searches for other search terms. Forum 1 appeared in searches across 
all three search engines.  
Forum 1 is a body building forum which does not have a female sub-forum or a way of 
identifying female forum posters. It has a lower than average female user population.  
Decision: Excluded 
 
Forum 2 
Forum 2 was originally found following a search on Google for Dinitrophenol forum. It did 
not appear following searches for other search terms. Forum 2 appeared in searches across 
all three search engines. 
Forum 2 is a body building forum which does have a female sub-forum but no way of 
identifying female forum posters.  It has a lower than average female user population. 
Decision: Excluded 
 
Forum 3 
Forum 3 was originally found following a search on Google for Dinitrophenol forum. It did 
not appear following searches for other search terms. Forum 3 only appeared in Google 
searches. 
Forum 3 is a body building forum which does not have a female sub-forum or a way of 
identifying female forum posters. It has a lower than average female user population.  
Decision: Excluded 
 
Forum 4 
Forum 4 was originally found following a search on Google for DNP forum. It did not appear 
following searches for other search terms. Forum 4 only appeared in Google searches. 
Forum 4 is a body building forum which does not have a female sub-forum or a way of 
identifying female forum posters. It has a lower than average female user population.  
Decision: Excluded 
 
Forum 5 
Forum 5 was originally found following a search on Google for Dinitrophenol forum. It did 
not appear following searches for other search terms. Forum 5 appeared in searches across 
all three search engines. 
Forum 5 is a body building forum which does not have a female sub-forum or a way of 
identifying female forum posters. It has a lower than average female user population. 
Decision: Excluded 
 
Forum 6 
Forum 6 was originally found following a search on Google for DNP forum. It also appeared 
in searches for Dinitrophenol forum, Sibutramine forum, Reductil forum, Sibutrex forum, 
Rimonabant forum. Forum 6 appeared in searches across all three search engines 
Forum 6 is a body building forum which does have a female sub-forum and a way of 
identifying female forum posters. It has a higher than average female user population.  
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Forum 6 has a high global ranking (636) and a high UK ranking (306) with 6.4% of its users 
being from the UK.  
Forum 6 has an advanced search function where all open forums can be searched for 
keyword(s). The forum can be searched over any time period and results can be shown as 
either threads or posts.  
Decision: Included 
 
Forum 7 
Forum 7 was originally found following a search on Google for Dinitrophenol forum. It also 
appeared in searches for Sibutramine forum and Rimonabant forum. Forum 7 appeared in 
searches across all three search engines. 
Forum 7 is a drugs forum which does not have a female sub-forum or a way of identifying 
female forum posters. It has a lower than average female user population. 
Decision: Excluded 
 
Forum 8 
Forum 8 was originally found following a search on Google for Dinitrophenol forum. It did 
not appear following searches for other search terms. Forum 8 only appeared in Google 
searches. 
Forum 8 is a body building forum which does not have a female sub-forum or a way of 
identifying female forum posters. It has a lower than average female user population. 
Decision: Excluded 
 
Forum 9 
Forum 9 was originally found following a search on Google for Dinitrophenol forum. It did 
not appear following searches for other search terms. Forum 9 appeared in Bing search 
but not Yahoo. 
Forum 9 is a drugs forum which has a female sub-forum but no way of identifying female 
forum posters. It has a lower than average female user population. 
Decision: Excluded 
 
Forum 10 
Forum 10 was originally found following a search on Google for DNP forum. It also 
appeared in searches for Sibutramine forum, Rimonabant forum and “weight loss drugs” 
forum. Forum 10 appeared in searches across all three search engines. 
Forum 10 is a drugs forum which does not have a female sub-forum but female forum 
posters can be identified. It has a lower than average female user population. 
Decision: Excluded 
 
Forum 11 
Forum 11 was originally found following a search on Google for DNP forum. It also 
appeared in searches for Dinitrophenol forum. Forum 11 appeared in searches across all 
three search engines. 
Forum 11 is a body building forum which has a female sub-forum and a way of identifying 
female forum posters. It has a lower than average female user population 
Decision: Excluded 
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Forum 12 
Forum 12 was originally found following a search on Google for DNP forum. It also 
appeared in searches for Dinitrophenol forum and Sibutramine forum. Forum 12 appeared 
in searches across all three search engines. 
Forum 12 is a body building forum which has a female sub-forum and does not have a way 
of identifying female forum posters. It has a lower than average female user population. 
Decision: Excluded 
 
Forum 13 
Forum 13 was originally found following a search on Google for DNP forum. It also 
appeared in searches for Dinitrophenol forum and Sibutramine forum. Forum 13 appeared 
in searches across all three search engines 
Forum 13 is a drugs forum which does not have a female sub-forum or a way of identifying 
female forum posters. It has a lower than average female user population 
Decision: Excluded 
 
Forum 14 
Forum 14 was originally found following a search on Google for Dinitrophenol forum. It did 
not appear following searches for other search terms. Forum 14 only appeared in Google 
searches. 
Forum 14 is a weight loss forum which does have a female sub-forum but no way of 
identifying female forum posters. There was not enough data to identify gender 
breakdown of website visitors.  
Decision: Excluded 
 
Forum 15 
Forum 15 was originally found following a search on Google for DNP forum. It also 
appeared in searches for Dinitrophenol forum, Sibutramine forum, Slimex forum, 
Rimonabant forum and Acomplia forum. Forum 15 appeared in searches across all three 
search engines. 
Forum 15 is a body building forum which does have a female sub-forum but no way of 
identifying female forum posters. It has a lower than average female user population 
Decision: Excluded 
 
Forum 16 
Forum 16 was originally found following a search on Bing for Dinitrophenol forum. It did 
not appear following searches for other search terms. Forum 16 appeared in Bing and 
Yahoo but not Google search engine. 
Forum 16 is a body building forum which does not have a female sub-forum and no way of 
identifying female forum posters. There was not enough data to identify gender 
breakdown of website visitors. 
Decision: Excluded 
 
Forum 17 
Forum 17 was originally found following a search on Google for Dinitrophenol forum. It 
also appeared in searches for Sibutramine forum, Slimex forum, and “weight loss drugs” 
forum. Forum 17 appeared in all three search engines. 
Forum 17 is a bodybuilding forum which does have a female sub-forum but no way of 
identifying female forum posters. It has a lower than average female user population 
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Decision: Excluded 
 
Forum 18 
Forum 18 was originally found following a search on Google for Rimonabant forum. It did 
not appear following searches for other search terms. Forum 18 only appeared in Google 
searches. 
Forum 18 is a bodybuilding forum which does have a female sub-forum but no way of 
identifying female forum posters. It has a lower than average female user population 
Decision: Excluded 
 
Forum 19 
Forum 19 was originally found following a search on Bing for Rimonabant forum. It did not 
appear following searches for other search terms. Forum 19 only appeared in Bing and 
Yahoo searches.  
Forum 19 is a body building forum which has a female sub-forum but no way of identifying 
female forum posters. It has a lower than average female user population 
Decision: Excluded 
 
Forum 20 
Forum 20 was originally found following a search on a Google for Reductil forum. It did not 
appear following searches for other search terms. Forum 20 appeared in all three search 
engines. Forum 20 is a weight loss forum which does not have a female sub-forum 
(however the forum looks to be aimed at women) and no way of identifying female forum 
posters. It has a higher than average female user population. 
Forum 20 has a low global ranking (57,924) and a low UK ranking (51,527) with only 2.9% 
of its users being from the UK.  
Decision: Excluded 
 
Forum 21 
Forum 21 was originally found following a search on Google for Sibutramine forum. It also 
appeared in searches for Rimonabant forum and “weight loss drugs” forum. Forum 21 
appeared in all three search engines. 
Forum 21 is a drugs forum which does not have a female sub-forum and no way of 
identifying female forum posters. It has a higher than average female user population. 
Forum 21 has a high global ranking (1,209) and a high UK ranking (930) with 4% of users 
being from the UK. 
Forum 21 has an advanced search function where all forums can be searched for 
keyword(s). Searches are shown as threads. 
Decision: Included 
 
Forum 22 
Forum 22 was originally found following a search on Google for Sibutramine forum. It did 
not appear following searches for other search terms. Forum 22 only appeared in Google 
searches. 
Forum 22 is a sex and drugs forum (classified as ‘other’ in earlier text/tables) which does 
not have a female sub-forum but does have a way of identifying female forum posters.  It 
has a lower than average female user population. 
Decision: Excluded 
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Forum 23 
Forum 23 was originally found following a search on Google for Sibutramine forum. It also 
appeared following searches for Rimonabant forum and Acomplia forum. It only appeared 
in Google and Bing searches. 
Forum 23 is a womens forum (classified as ‘other’ in earlier text/tables). It does not have 
a female sub-forum however, the whole forum is aimed at women. It does have a way of 
identifying female forum posters. It has a higher than average female user population. 
It has a medium global ranking (25,971) and a high UK ranking (4,577) and 18.6% of its 
visitors are UK based.  
Forum 23 has only a basic search function where all open forums can be searched for 
keyword(s). The forum can only be searched on the last year of posts. However despite 
this as the forum is aimed at women it will be included.  
Decision: Included 
 
Forum 24 
Forum 24 was originally found following a search on Google for Sibutramine forum. It also 
appeared following searches for Rimonabant forum, Acomplia forum and “weight loss 
pills” forum. It appeared in all three search engines. 
Forum 24 is a Diabetes forum (classified as health specific other in earlier text/tables). It 
does not have a female sub-forum or a way of identifying female forum posters. It has a 
higher than average female user population. 
It has a medium global ranking (33,867) and a high UK ranking (3,878) and 25.4% of its 
visitors are UK based. 
Forum 24 has an advanced search function where all forums can be searched for 
keyword(s). The forum can be searched over any time period and results can be shown as 
either threads or posts.  
Decision: Included 
 
Forum 25 
Forum 25 was originally found following a search on Google for Sibutramine forum. It also 
appeared following searches for Reductil forum and “weight loss pills” forum. It appeared 
in all three search engines. 
Forum 25 is a general health forum. It does have a female section but does not have a way 
of identifying female forum posters. It has a higher than average female user population. 
Forum 25 has a high global rank (4,113) and a high UK rank (361) with 28.8% of its users 
being from the UK. 
Forum 25 has a limited search function and a small number of threads which are focussed 
around UWL drugs  
Decision: Excluded 
 
Forum 26 
Forum 26 was originally found following a search on Google for Reductil forum. It also 
appeared following searches for Sibutrex forum, Rimonabant forum, Acomplia forum and 
“weight loss pills” forum. It appeared in all three search engines. 
Forum 26 is a weight loss forum. It does not have a female section but does have a way of 
identifying female forum posters. It has a higher than average female user population. 
Forum 26 has a mid-global rank (41,607) and a high UK rank (4,325) with 30.9% of its users 
being from the UK. 
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Users can only access the forum by creating an account and paying a subscription fee. As 
users are paying to access this forum there may be the assumption that their posts will be 
private. 
Decision: Excluded 
 
Forum 27 
Forum 27 was originally found following a search on Google for Reductil forum. It also 
appeared following a search for Acomplia forum. It appeared in all three search engines. 
Forum 27 is an entertainment forum (classified as ‘other’ in earlier text/tables). It does not 
have a female section but does have a way of identifying female forum posters. It has a 
higher than average female user population. 
It has a high global ranking (3,198) and a high UK ranking (137) and 58.2% of its visitors are 
UK based.  
Forum 27 has an advanced search function where all open forums can be searched for 
keyword(s). The forum can be searched over any time period and results can be shown as 
either threads or posts.  
Decision: Included 
 
Forum 28 
Forum 28 was originally found following a search on Google for Reductil forum. It also 
appeared following a search for Acomplia forum. It appeared in all three search engines. 
Forum 28 is a weight loss forum. It does not have a female sub-forum and profiles cannot 
be viewed until a user has posted 50 times. It has a higher than average female user 
population. 
It has a low global ranking (182,006) and a high UK ranking (13,448) and 65.9% of its visitors 
are UK based.  
Forum 28 has an advanced search function where all open forums can be searched for 
keyword(s). The forum can be searched over any time period and results can be shown as 
either threads or posts.  
Decision: Included 
 
Forum 29 
Forum 29 was originally found following a search on Google for Reductil forum. It also 
appeared following a search for “weight loss pills” forum. It appeared in all three search 
engines. 
Forum 29 is an area specific forum (classified as ‘other’ in earlier text/tables). This forum 
is aimed at residents of a city within the UK. It does not have a female sub-forum and no 
way of identifying female forum posters. It has a higher than average female user 
population. 
It has a low global ranking (59,419) and a high UK ranking (2,795) with 68.9% of its visitors 
being UK based. 
As forum 29 is only aimed at residents in one city across the UK and not UK residents in 
general it will not be included. 
Decision: Excluded 
 
Forum 30 
Forum 30 was originally found following a search on Bing for Reductil forum. It did not 
appear in any other searches. It only appeared in Bing and Yahoo searches.  
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Forum 30 is a financial forum (classified as ‘other’ in earlier text/tables). It does not have 
a female sub-forum and no way of identifying female forum posters. It has a lower than 
average female user population. 
Decision: Excluded 
 
Forum 31 
Forum 31 was originally found following a search on Bing for “weight loss pills” forum. It 
did not appear in any other searches. It only appeared in Bing and Yahoo searches. 
Forum 31 is a weight loss forum. It does not have a female sub-forum and no way of 
identifying female forum posters. It has a higher than average female user population. 
It has a high global ranking (6,970) and a high UK ranking (5,094) and 4.2% of its visitors 
are UK based.  
Forum 31 has a basis search function where all forums can be searched for keyword(s). 
The forum can be searched over any time period and results can be shown as either 
threads or posts.  
Decision: Included 
 
Forum 32 
Forum 32 was originally found following a search on Bing for “weight loss drugs” forum. It 
did not appear in any other searches. It only appeared in Bing and Yahoo searches. 
Forum 32 is a drugs forum. It does not have a female sub-forum and no way of identifying 
female forum posters. It has a lower than average female user population. 
Decision: Excluded 
 
Forum 33 
Forum 33 was originally found following a search on Google for “weight loss drugs” forum. 
It did not appear in any other searches. It only appeared in Google and Bing searches. 
Forum 33 is a general health forum. It does have a female sub-forum and a way of 
identifying female forum posters. It has a higher than average female user population. 
It has a high global ranking (5,434) and a high UK ranking (2,580) and 4.2% of its visitors 
are UK based.  
Forum 33 has a basic search function where all forums can be searched for keyword(s). 
The forum can be searched over any time period and results can be shown as either 
threads or posts. This forum is monitored by health care professionals who do reply to 
forum posts where needed. As this phase is focusing on discussion of UWL drugs by those 
using or thinking about using this forum will be excluded. 
Decision: Excluded 
 
Forum 34 
Forum 34 was originally found following a search on Google for “weight loss pills” forum. 
It did not appear in any other searches. It only appeared in Google searches. 
Forum 34 is a newspaper forum (classified as ‘other’ in earlier text/tables). It does have a 
female sub-forum but no way of identifying female forum posters. It has a higher than 
average female user population. 
It has a high global ranking (117) and a high UK ranking (14) and 19.7% of its vistors are UK 
based. 
Forum 34 has an advanced search function where all forums can be searched for 
keyword(s). The forum can be searched over any time period and results can be shown as 
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either threads or posts. This forum has limited threads relating to the discussion of UWL 
and will therefore be excluded. 
Decision: Excluded 
 
Forum 35 
Forum 35 was originally found following a search on Yahoo for “weight loss pills” forum. It 
did not appear in any other searches. It only appeared in Yahoo searches. 
Forum 35 is a weight loss forum. It does not have a female sub-forum but does have a way 
of identifying female forum posters. It has a higher than average female user population. 
Forum 35 has a high (696) global ranking and a high UK ranking (360) and 6.2% of its vistors 
are UK based. 
Forum 35 has an advanced search function where all forums can be searched for 
keyword(s). The forum can be searched over any time period. Results are shown as 
threads. 
Decision: Included 
 
Forum 36 
Forum 36 was originally found following a search on Google for “weight loss drugs” forum. 
It did not appear in any other searches. It appeared in all three search engines. 
Forum 36 is a parenting forum (classified as ‘other’ in earlier text/tables). It does not have 
a female sub-forum or a way of identifying female forum posters. The forum is however 
aimed at women. It has a higher than average female user population. 
Forum 36 has a high (8,209) global ranking and a high UK ranking (408) with 54.7% of its 
visitors being from the UK. 
Forum 36 has an advanced search function where all forums can be searched for 
keyword(s). The forum can be searched over any time period. Results are shown as 
threads. 
Decision: Included 
 
Forum 37 
Forum 37 was originally found following a search on Google for “weight loss drugs” forum. 
It did not appear in any other searches. It appeared in all three search engines. 
Forum 37 is a body building forum. It does not have a female sub-forum or a way of 
identifying female forum posters. It has a lower than average female user population. 
Decision: Excluded 
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Appendix C– Forum moderator participant information 
sheet 
 
 
 
 
Title of Project: An exploration of the female use of unlicensed weight loss (UWL) drugs – 
forum moderator interviews 
 
Name of Researcher and School/Faculty: Jennifer Germain, PhD student, Centre for Public 
Health, Faculty of Health, Education and Community 
 
You are being invited to take part in a research study. Before you decide whether to take 
part it is important that you understand why the research is being done and what it 
involves. Please take time to read the following information. Ask us if there is anything that 
is not clear or if you would like more information. Take time to decide if you want to take 
part or not. 
 
1. What is the purpose of the study? 
 
This research will form part of a PhD programme. Interviews will be used to discuss forum 
moderator’s views and perceptions of online discussion related to unlicensed weight loss 
(UWL) drugs. This discussion will include the online forums stance on UWL drug discussion 
and what role forums could play in UWL harm minimisation.  
 
2. Do I have to take part? 
 
No. It is up to you to decide whether or not to take part. If you do, you will be given this 
information sheet and asked to sign a consent form. You are still free to withdraw at any 
time and without giving a reason. A decision to withdraw will not affect your rights.  
Following the interview, there will be a ten day period where you are free to withdraw 
your interview from the study. However, after the interviews have been anonymised and 
written up, it may not be possible to withdraw your information from write up.  
 
3. Why have I been selected to take part? 
You have been selected to take part because you are a moderator on a forum where there 
is discussion around alternative weight loss strategies including UWL drugs.  
 
4. What will happen to me if I take part? 
 
You will be invited to take part in an interview. The interview will last no longer than 60 
minutes. We will agree a mutually convenient time, date and venue for the interview. 
Should a face to face interview not be feasible then we will arrange to conduct the 
interview by telephone or other means if you would be happy with that.  
 
 
LIVERPOOL JOHN MOORES UNIVERSITY 
PARTICIPANT INFORMATION SHEET 
  
230 
 
Prior to the interview you will be asked to read and sign a consent form and the interview 
will be audio recorded.  
 
The interview will follow a guide with a set of questions and you will be given the 
opportunity to discuss the issues at length and also to add any other information which 
you feel is important. You are free to leave the interview at any point should you no longer 
wish to take part.  
 
5. Are there any risks / benefits involved? 
 
There are no risks associated with either taking part or not taking part in the study. 
 
6. Will my taking part in the study be kept confidential? 
 
With your permission we will digitally record the interview, whether it is conducted face 
to face or by telephone. Interview recordings will only be listened to by the researcher and 
supervisor and will be held securely at Liverpool John Moores University. Recordings will 
be deleted after the interview has been written up.    
 
Any hard copies of data will be kept in a locked filing cabinet and electronic versions will 
be held on a password-protected university computer which only the research team can 
access.  
 
We may quote some of your words in publications and reports but to ensure that you 
cannot be recognised, neither your name nor any identifying features (such as the forum 
you moderate or your online user name) will be included. 
 
This study has received ethical approval from LJMU’s Research Ethics Committee 
16/CPH/016 on 17/06/2016 
 
Contact Details of Researcher Jennifer Germain, PhD student, Centre for Public 
Health, Liverpool John Moores University, Henry Cotton Building, 15-21 Webster Street, 
Liverpool, L32ET, 0151 231 4441. 
 
Contact Details of Academic Supervisor Jim McVeigh, Director of  Centre for Public Health, 
Centre for Public Health, Liverpool John Moores University, Henry Cotton Building, 15-21 
Webster Street, Liverpool, L32ET, 0151 231 4511. 
 
If you any concerns regarding your involvement in this research, please discuss these 
with the researcher in the first instance.  If you wish to make a complaint, please 
contact researchethics@ljmu.ac.uk and your communication will be re-directed to an 
independent person as appropriate. 
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Appendix D– Forum moderator consent form 
 
 
 
Title of project: An exploration of the female use of unlicensed weight loss (UWL) drugs – 
forum moderator interviews 
Name of Researcher and School/Faculty: Jennifer Germain, PhD student, Centre for Public 
Health, Faculty of Health, Education and Community 
 
1. I confirm that I have read and understand the information provided for the above 
study. I have had the opportunity to consider the information, ask questions and 
have had these answered satisfactorily 
 
2. I understand that my participation is voluntary and that I am free to withdraw at 
any time, without giving a reason and that this will not affect my legal rights. 
 
3. I understand that any personal information collected during the study will be 
anonymised and remain confidential 
 
4. I agree to take part in the above study. 
 
 
 
5. I understand that the interview will be audio / video recorded and I am happy to 
proceed  
 
6. I understand that parts of our conversation may be used verbatim in future 
publications or presentations but that such quotes will be anonymised. 
 
Name of Participant   Date    Signature 
 
 
 
Name of Researcher   Date   Signature 
 
 
 
Name of Person taking consent  Date   Signature 
(if different from researcher) 
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Appendix E – Forum moderator recruitment messages 
Original message 
Dear **** (forum user name) 
My name is Jenny Germain and I am a PhD student at the Public Health Institute, Liverpool 
John Moores University (http://www.cph.org.uk/). I am contacting you as you are a 
moderator on a xxxxx related forum. I am currently carrying out health related research 
looking at the use of unlicensed weight loss drugs in females and discussion relating to 
weight loss has been identified on your forum.  
I am looking to carry out interviews with forum moderators and this is why I am contacting 
you. I am interested in gaining more knowledge about the forum that you moderate 
including; the types of information given by forum members on your forum about weight 
loss strategies, how this type of discussion is received by other forum users and rules of 
posting and information about unlicensed weight loss drugs. I am interested in your views 
and perceptions of these issues and also the forums stance on what discussion should and 
shouldn’t be allowed. Finally, I am also interested in the role of online forums in harm 
reduction for those people who are using UWL drugs.  
I would like to ask you if you would be interested in taking part in an interview to discuss 
some of these issues. We can conduct the interview in whichever way is most convenient 
to you. Interviews can be via email or through chat platforms such as Instant Messenger. 
We can also do interviews face to face or on the telephone if you’re based in the UK and 
would like to do so. The interview will last no longer than an hour.   
If you think you might be interested in taking part or would like some further information 
then please email me at weightlossdrugs@ljmu.ac.uk . Similarly if you would not like to 
take part and wish to not be contacted again, please email me and I will remove your 
details from my contacts list. 
This study was granted ethical approval by Liverpool John Moores University and no user 
names, forum names or identifiers will be used in any written works resulting from this 
research in order to protect anonymity of both the forum and forum members. 
Kind regards, 
Jenny 
Reminder message 
 
Dear **** (forum user name), 
 
I'm just sending this message as a reminder to check to see if you would be interested 
taking part in my research looking at the use of unlicensed weight loss drugs. Details of 
the study are below: 
 
My name is Jenny Germain and I am a PhD student at The Centre for Public Health, 
Liverpool John Moores University (http://www.cph.org.uk/). I am currently carrying out 
research looking at the use of unlicensed weight loss drugs in females. The first stage of 
my research involved an analysis of online forums, one of which included your forum. 
Your forum was chosen as it contained discussion relating to weight loss strategies 
including weight loss supplements or drugs.  
 
For the second phase of the study, I am carrying out interviews with forum moderators 
and this is why I am contacting you. I am interested in gaining more knowledge about the 
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forum that you moderate including; the types of information given by forum members on 
your forum about weight loss strategies, how this type of discussion is received by other 
forum users and rules of posting and information about unlicensed weight loss drugs. I 
am interested in your views and perceptions of these issues and also the forums stance 
on what discussion should and shouldn’t be allowed. Finally, I am also interested in the 
role of online forums in harm reduction for those people who are using UWL drugs.  
 
I would like to ask you if you would be interested in taking part in an interview to discuss 
some of these issues, the interview can be conducted at a time and place convenient to 
you, can be face-to-face if you are based in the UK, on the telephone or through other 
platforms such as Skype and will last no longer than an hour.  
 
If you think you might be interested in taking part or would like some further information 
then please email me at weightlossdrugs@ljmu.ac.uk . Similarly if you would not like to 
take part and wish to not be contacted again, please email me and I will remove your 
details from my contacts list. 
 
This study was granted ethical approval by Liverpool John Moores University and no user 
names, forum names or identifiers will be used in any written works resulting from this 
research in order to protect anonymity of both the forum and forum members. 
 
Kind regards, 
 
Jenny 
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Appendix F – Forum moderator interview schedule 
 
1) How long have you been a moderator on XXXX forum? 
2) Was the forum already established prior to you becoming a moderator? 
3) Do you moderate any other forums? 
4) How did you come to be a moderator at XXXX forum? 
5) What is the purpose of the forum? 
6) What types of discussion takes place on your forum? 
7) Can you tell me about your awareness of the level of discussion relating to 
unlicensed weight loss (UWL) drugs on the forum you moderate? 
• Prompt: By UWL drugs we are mainly talking about DNP, sibutramine and 
rimonobant but there could also be discussion on other drugs/supplements 
8) How is UWL drug discussion viewed on your forum? 
• Prompt: By other forum users 
• By forum moderators 
• What is the forums stance on UWL drugs discussion, e.g. allowed, close 
thread, discourage 
9) What type of information is given by forum members on your forum around UWL 
drugs? 
10) Is there discussion on your forum concerning the buying and selling of UWL 
drugs? 
• Prompt: What is the forums stance on this discussion 
• What is your level of knowledge on the online drugs market of UWL drugs 
11) How do you manage discussion around different weight loss strategies? 
• Starting with excessive caffeine consumption to herbal weight loss products 
to drugs such as DNP. 
12) In which situations would you facilitate discussion around UWL drugs and how 
would you do this? 
• Prompt: Can you give specific examples? 
13) In which situations would you interject discussion around UWL drugs and how 
would you do this? 
• Prompt: Can you give specific examples? 
14) How early would you interject in different situations? 
• Prompt: Ranging from discussion around excessive caffeine consumption, 
herbal weight loss products to UWL drugs. 
15) Are there any information or skills which are needed to manage those people who 
are drawn towards products like UWL drugs? 
16) Do you think online forums could have a role in online harm reduction? 
• Prompt: What role could the forum take 
•  By forum members  
• By forum moderators (peer educators) 
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Appendix G – UWL drug user recruitment messages 
 
 
 
 
Be involved in a research study looking at the use of weight loss drugs! 
 
If you are female, have ever taken an unlicensed weight loss drug (Dinitrophenol, 
Sibutramine or Rimonabant) and live in the United Kingdom then we would like to hear 
your experiences. For the opportunity to take part in an anonymous interview please 
contact me at weightlossdrugs@ljmu.ac.uk.  
 
Details of study 
 
Research title: An exploration of the female use of unlicensed weight loss drugs 
Name of research and school/faculty: Jennifer Germain, PhD student, Centre for Public Health, 
Faculty of Health, Education and Community 
 
7. What is the purpose of the study? 
This research will form part of a PhD programme. Interviews will be used to discuss your experience 
of using weight loss drugs, your motivations for using weight loss drugs and the role of online 
forums in providing health information.   
 
8. Do I have to take part? 
 
No. It is up to you to decide whether or not to take part. If you do, you will be given this information 
sheet and asked to sign a consent form. You are still free to withdraw at any time and without 
giving a reason. A decision to withdraw will not affect your rights.  Following the interview, there 
will be a ten day period where you are free to withdraw your interview from the study. However, 
after the interviews have been anonymised and written up, it may not be possible to withdraw 
your information from write up.  
 
9. Why have I been selected to take part? 
 
You have been selected to take part because you have used or are currently using an unlicensed 
weight loss drug. The three drugs included in this research are 2,4 Dinitrophenol (also known as 
DNP), Sibutramine (also known as Reductil, Meridia, Sibutrex and Slimex) and Rimonabant (also 
known as Acomplia). Sibutramine and Rimonabant have previously been available on prescription, 
we are only looking to speak to people who have used them since the drugs lost their license 
(Rimonabant in 2008, Sibutramine in 2010).  
 
10. What will happen to me if I take part? 
 
You will be invited to take part in an interview. The interview will last no longer than 60 minutes. 
We will agree a mutually convenient time, date and venue for the interview. Should a face to face 
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interview not be feasible then we will arrange to conduct the interview by telephone or other 
means such as instant messenger if you would be happy with that.  
Prior to the interview you will be asked to read and sign a consent form and the interview will be 
audio recorded. The interview will follow a guide with a set of questions and you will be given the 
opportunity to discuss the issues at length and also to add any other information which you feel is 
important. You are free to leave the interview at any point should you no longer wish to take part.  
 
11. Are there any risks / benefits involved? 
 
It is possible that discussing your motivations and use of weight loss drugs could result in negative 
feelings. If you do become distressed during the interview and would like to stop the interview 
then please make the interviewer aware of this. If you would like to seek support then it is 
recommended that you contact Talk to Frank. To contact Talk to Frank you can visit their website: 
http://www.talktofrank.com/get-help, contact them by telephone: 0300 123 6600 or send a text 
message to 82111.   
 
12. Will my taking part in the study be kept confidential? 
 
With your permission we will digitally record the interview, whether it is conducted face to face or 
by telephone. Interview recordings will only be listened to by the researcher and supervisor and 
will be held securely at Liverpool John Moores University. Recordings will be deleted after the 
interview has been written up.  If the interview is conducted by instant messenger then a copy of 
the interview will be saved. 
Any hard copies of data will be kept in a locked filing cabinet and electronic versions will be held 
on a password-protected university computer which only the research team can access.  
We may quote some of your words in publications and reports but to ensure that you cannot be 
recognised, neither your name nor any identifying features (such as forums or online communities 
that you use, your name or any online user names) will be included. 
 
This study has received ethical approval from LJMU’s Research Ethics Committee Reference 
number 16/CPH/027 
 
Contact Details of Researcher Jennifer Germain, PhD student, Centre for Public Health, Liverpool 
John Moores University, Henry Cotton Building, 15-21 Webster Street, Liverpool, L32ET, 0151 231 
4441. 
 
Contact Details of Academic Supervisor Jim McVeigh, Director of  Centre for Public Health, Centre 
for Public Health, Liverpool John Moores University, Henry Cotton Building, 15-21 Webster Street, 
Liverpool, L32ET, 0151 231 4511. 
 
If you any concerns regarding your involvement in this research, please discuss these with the 
researcher in the first instance.  If you wish to make a complaint, please contact 
researchethics@ljmu.ac.uk and your communication will be re-directed to an independent 
person as appropriate. 
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Appendix H – UWL drug user recruitment messages via 
social media 
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Appendix I– UWL drug user participant information sheet 
 
 
 
 
Title of Project: An exploration of the female use of unlicensed weight loss (UWL) drugs – weight 
loss drug user interviews 
 
Name of Researcher and School/Faculty: Jennifer Germain, PhD student, Centre for Public Health, 
Faculty of Health, Education and Community 
 
You are being invited to take part in a research study. Before you decide whether to take part it is 
important that you understand why the research is being done and what it involves. Please take 
time to read the following information. Ask us if there is anything that is not clear or if you would 
like more information. Take time to decide if you want to take part or not. 
 
13. What is the purpose of the study? 
 
This research will form part of a PhD programme. Interviews will be used to discuss your experience 
of using weight loss drugs, your motivations for using weight loss drugs and the role of online 
forums in providing health information.   
 
14. Do I have to take part? 
 
No. It is up to you to decide whether or not to take part. If you do, you will be given this information 
sheet and asked to sign a consent form. You are still free to withdraw at any time and without 
giving a reason. A decision to withdraw will not affect your rights.  Following the interview, there 
will be a ten day period where you are free to withdraw your interview from the study. However, 
after the interviews have been anonymised and written up, it may not be possible to withdraw 
your information from write up.  
 
15. Why have I been selected to take part? 
You have been selected to take part because you have used or are currently using an unlicensed 
weight loss drug. The three drugs included in this research are 2,4 Dinitrophenol (also known as 
DNP), Sibutramine (also known as Reductil, Meridia, Sibutrex and Slimex) and Rimonabant (also 
known as Acomplia). Sibutramine and Rimonabant have previously been available on prescription, 
we are only looking to speak to people who have used them since the drugs lost their license 
(Rimonabant in 2008, Sibutramine in 2010).  
 
16. What will happen to me if I take part? 
 
You will be invited to take part in an interview. The interview will last no longer than 60 minutes. 
We will agree a mutually convenient time, date and venue for the interview. Should a face to face 
interview not be feasible then we will arrange to conduct the interview by telephone or other 
means such as instant messenger if you would be happy with that.  
 
Prior to the interview you will be asked to read and sign a consent form and the interview will be 
audio recorded.  
 
 
LIVERPOOL JOHN MOORES UNIVERSITY 
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The interview will follow a guide with a set of questions and you will be given the opportunity to 
discuss the issues at length and also to add any other information which you feel is important. You 
are free to leave the interview at any point should you no longer wish to take part.  
 
17. Are there any risks / benefits involved? 
 
It is possible that discussing your motivations and use of weight loss drugs could result in negative 
feelings. If you do become distressed during the interview and would like to stop the interview 
then please make the interviewer aware of this. If you would like to seek support then it is 
recommended that you contact Talk to Frank. To contact Talk to Frank you can visit their website: 
http://www.talktofrank.com/get-help, contact them by telephone: 0300 123 6600 or send a text 
message to 82111.   
 
18. Will my taking part in the study be kept confidential? 
With your permission we will digitally record the interview, whether it is conducted face to face or 
by telephone. Interview recordings will only be listened to by the researcher and supervisor and 
will be held securely at Liverpool John Moores University. Recordings will be deleted after the 
interview has been written up.  If the interview is conducted by instant messenger then a copy of 
the interview will be saved.  
 
Any hard copies of data will be kept in a locked filing cabinet and electronic versions will be held 
on a password-protected university computer which only the research team can access.  
 
We may quote some of your words in publications and reports but to ensure that you cannot be 
recognised, neither your name nor any identifying features (such as forums or online communities 
that you use, your name or any online user names) will be included. 
 
This study has received ethical approval from LJMU’s Research Ethics Committee Reference 
number 16/CPH/027 
 
Contact Details of Researcher Jennifer Germain, PhD student, Centre for Public Health, Liverpool 
John Moores University, Henry Cotton Building, 15-21 Webster Street, Liverpool, L32ET, 0151 231 
4441. 
 
Contact Details of Academic Supervisor Jim McVeigh, Director of  Centre for Public Health, Centre 
for Public Health, Liverpool John Moores University, Henry Cotton Building, 15-21 Webster Street, 
Liverpool, L32ET, 0151 231 4511. 
 
If you any concerns regarding your involvement in this research, please discuss these with the 
researcher in the first instance.  If you wish to make a complaint, please contact 
researchethics@ljmu.ac.uk and your communication will be re-directed to an independent 
person as appropriate. 
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Appendix J– UWL drug user consent form 
 
 
 
 
Title of project: An exploration of the female use of unlicensed weight loss (UWL) drugs – 
weight loss drug users 
 
Name of Researcher and School/Faculty: Jennifer Germain, PhD student, Centre for Public 
Health, Faculty of Health, Education and Community 
 
7. I confirm that I have read and understand the information provided for the above 
study. I have had the opportunity to consider the information, ask questions and 
have had these answered satisfactorily 
 
8. I understand that my participation is voluntary and that I am free to withdraw at 
any time, without giving a reason and that this will not affect my legal rights. 
 
9. I understand that any personal information collected during the study will be 
anonymised and remain confidential 
 
10. I agree to take part in the above study. 
 
 
 
11. I understand that the interview will be audio / video recorded and I am happy to 
proceed  
 
12. I understand that parts of our conversation may be used verbatim in future 
publications or presentations but that such quotes will be anonymised. 
 
 
Name of Participant   Date    Signature 
 
 
 
Name of Researcher   Date   Signature 
 
 
 
Name of Person taking consent  Date   Signature 
(if different from researcher) 
 
 
 
 
LIVERPOOL JOHN MOORES UNIVERSITY 
CONSENT FORM 
241 
 
 
 
Appendix K – UWL drug user interview schedule 
1) How long have you been a member on XXXX forum? 
2) Why did you originally decide to join XXX forum? 
3) What discussion are you involved in on XXXX forum? 
• Prompt: health information, weight loss drugs 
4) What weight loss strategies have you tried? 
• Prompt: Starting with diet and exercise to excessive caffeine consumption 
to herbal weight loss products to drugs. 
5) Are you currently taking UWL drug, if so how long have you been taking?  
6) How often do you use an UWL drug? 
7) What other weight loss strategies are you using in conjunction with UWL drug? 
• If UWL drug stopped when did you stop and why? 
8) Did you consider using any other weight loss strategies in addition to the ones 
already mentioned? 
• If yes, why did you not use them 
9) How and where did you first find out about UWL drugs? 
10) How is UWL discussion viewed on XXXX forum? 
• Prompt by other forum members 
• By the forum moderators 
11) What information have you been given by other forums members about UWL 
drugs? 
• Prompt: what to take, what not to take, dosage, side effects, how to take, 
where to purchase 
12) What information have you shared with other forums members about UWL 
drugs? 
• Prompt: what to take, what not to take, dosage, side effects, how to take, 
where to purchase 
13) Did you use any other online communities to source information about UWL 
drugs? 
14) Can you tell me about the reasons why you started taking 
DNP/Rimonabant/Sibutramine? 
• Prompt: Did the forum you’re a member of influence your decision to take 
DNP/Rimonabant/Sibutramine? 
• Could you tell me the one main reason why you started using the UWL 
drug you did? 
15) What are the best things about using DNP/Rimonabant/Sibutramine? 
16) What are the worst things about using DNP/Rimonabant/Sibutramine? 
• Prompt: Have you experienced any side effects? Can you discuss those 
side effects? 
17) Can you tell me about the places you have purchased UWL drugs from? You 
don’t need to name specific sources. 
• Prompt: Online, shops, friends, family  
18) Is there any information which would have made you reconsider using 
DNP/Rimonabant/Sibutramine? 
• Prompt: What types of information? 
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• Where would you like to have seen this information?  
19) Is there any other information you would have liked made available to you 
around the use of UWL drugs?  
20) Who do you think would be the best groups to deliver information around the 
use of UWL drugs? 
• Prompt: Health care professionals 
• Peer educators/other users 
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Appendix L – Confirmation of ethical approval 
Study 2. Online forum analysis 
 
Dear Jennifer 
 
With reference to your application for Ethical approval 
 
15/EHC/028 -  Jennifer Brizell, PGR - Exploration of the use of unlicensed weight loss 
(UWL) drugs in females using Online Environments (James McVeigh) 
 
Liverpool John Moores University Research Ethics Committee (REC) has reviewed the 
above application and I am pleased to inform you that ethical approval has been granted 
and the study can now commence. 
 
Approval is given on the understanding that: 
 
• any adverse reactions/events which take place during the course of the project are 
reported to the Committee immediately; 
• any unforeseen ethical issues arising during the course of the project will be 
reported to the Committee immediately; 
• the LJMU logo is used for all documentation relating to participant recruitment and 
participation eg poster, information sheets, consent forms, questionnaires. The 
LJMU logo can be accessed at 
http://www.ljmu.ac.uk/corporatecommunications/60486.htm  
                                                 
Where any substantive amendments are proposed to the protocol or study procedures 
further ethical approval must be sought.  
 
Applicants should note that where relevant appropriate gatekeeper / management 
permission must be obtained prior to the study commencing at the study site concerned. 
 
For details on how to report adverse events or request ethical approval of major 
amendments please refer to the information provided at 
http://www.ljmu.ac.uk/RGSO/RGSO_Docs/EC8Adverse.pdf 
 
Please note that ethical approval is given for a period of five years from the date granted 
and therefore the expiry date for this project will be March 2020.  An application for 
extension of approval must be submitted if the project continues after this date. 
 
 
 
Mandy Williams, Research Support Officer 
(Research Ethics and Governance) 
Research and Innovation Services 
Kingsway House, Hatton Garden, Liverpool L3 2AJ 
t: 01519046467 e: a.f.williams@ljmu.ac.uk 
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Study 3. Forum moderator interviews 
 
Dear Jennifer 
 
With reference to your application for Ethical Approval: 
 
16/CPH/016 - Jennifer Germain, PGR - An exploration of the female use of 
unlicensed weight 
loss (UWL) drugs – forum moderator interviews (James McVeigh) 
 
The University Research Ethics Committee (UREC) has considered the above application 
by 
proportionate review and I am pleased to inform you that ethical approval has been 
granted and the 
study can now commence. 
 
Approval is given on the understanding that: 
· any adverse reactions/events which take place during the course of the project 
are reported 
to the Committee immediately; 
· any unforeseen ethical issues arising during the course of the project will be 
reported to the 
Committee immediately; 
· the LJMU logo is used for all documentation relating to participant recruitment 
and 
participation e.g. poster, information sheets, consent forms, questionnaires. The 
LJMU logo 
can be accessed at http://www2.ljmu.ac.uk/corporatecommunications/60486.htm 
Where any substantive amendments are proposed to the protocol or study 
procedures further ethical approval must be sought. 
 
Applicants should note that where relevant appropriate gatekeeper / management 
permission must 
be obtained prior to the study commencing at the study site concerned. 
 
For details on how to report adverse events or request ethical approval of major 
amendments please 
refer to the information provided at http://www2.ljmu.ac.uk/RGSO/93205.htm 
 
Please note that ethical approval is given for a period of five years from the date granted 
and 
therefore the expiry date for this project will be June 2021. An application for extension of 
approval 
must be submitted if the project continues after this date. 
 
Mandy Williams, Research Support Officer 
(Research Ethics and Governance) 
Research and Innovation Services 
Kingsway House, Hatton Garden, Liverpool L3 2AJ 
t: 01519046467 e: a.f.williams@ljmu.ac.uk 
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Study 4. UWL drug user interviews 
 
Dear Jennifer 
 
With reference to your application for Ethical Approval: 
 
16/CPH/027 – Jennifer Germain, PGR - An exploration of the female use of unlicensed 
weight loss (UWL) drugs – weight loss drug user interviews (James McVeigh) 
 
The University Research Ethics Committee (UREC) has considered the above 
application.  I am pleased to inform you that ethical approval has been granted and the 
study can now commence 
 
Approval is given on the understanding that: 
 
•         any adverse reactions/events which take place during the course of the project are 
reported to the Committee immediately; 
•         any unforeseen ethical issues arising during the course of the project will be 
reported to the Committee immediately; 
•         the LJMU logo is used for all documentation relating to participant recruitment and 
participation e.g. poster, information sheets, consent forms, questionnaires. The 
LJMU logo can be accessed at 
http://www.ljmu.ac.uk/corporatecommunications/60486.htm  
                                                 
Where any substantive amendments are proposed to the protocol or study procedures 
further ethical approval must be sought.  
 
Applicants should note that where relevant appropriate gatekeeper / management 
permission must be obtained prior to the study commencing at the study site concerned. 
 
For details on how to report adverse events or request ethical approval of major 
amendments please refer to the information provided at 
http://www.ljmu.ac.uk/RGSO/93205.htm 
 
Please note that ethical approval is given for a period of five years from the date granted 
and therefore the expiry date for this project will be November 2021.  An application for 
extension of approval must be submitted if the project continues after this date. 
 
 
 
